In the present study , we tested whether the highly specific metabotropic glutamate receptor dgb antagonist , DRUGA , reduces dopaminergic and noradrenergic neuronal loss in monkeys rendered parkinsonian by chronic treatment with low doses of DRUGB .
3-[(2-methyl-1,3-thiazol-4-yl) ethynyl] pyridine	drug_n	1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine	drug_n
false

After dgb weeks of DRUGA treatment , all DRUGN / vehicle treated animals displayed parkinsonian symptoms , whereas none of the DRUGN / DRUGB treated monkeys were significantly affected .
1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine	drug_n	3-[(2-methyl-1,3-thiazol-4-yl) ethynyl] pyridine	drug_n
false

After dgb weeks of DRUGN treatment , all DRUGA / vehicle treated animals displayed parkinsonian symptoms , whereas none of the DRUGN / DRUGB treated monkeys were significantly affected .
1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine	drug_n	3-[(2-methyl-1,3-thiazol-4-yl) ethynyl] pyridine	drug_n
false

After dgb weeks of DRUGN treatment , all DRUGN / vehicle treated animals displayed parkinsonian symptoms , whereas none of the DRUGA / DRUGB treated monkeys were significantly affected .
1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine	drug_n	3-[(2-methyl-1,3-thiazol-4-yl) ethynyl] pyridine	drug_n
effect

The DRUGA treatment also had a significant effect on the DRUGB induced loss of norepinephrine neurons in the locus coeruleus and adjoining Adgb and Adgb noradrenaline cell groups .
3-[(2-methyl-1,3-thiazol-4-yl) ethynyl] pyridine	drug_n	1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine	drug_n
effect

Our data demonstrate that chronic treatment with the metabotropic glutamate receptor dgb antagonist , DRUGA , significantly reduces DRUGB toxicity towards dopaminergic and noradrenergic cell groups in non human primates .
3-[(2-methyl-1,3-thiazol-4-yl) ethynyl] pyridine	drug_n	1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine	drug_n
effect

Effect of DRUGA mediated CYPdgbAdgb inhibition on clinical pharmacokinetics of DRUGB ( DRUGN ) , an orally active DRUGN .
ketoconazole	drug	panobinostat	drug
false

Effect of DRUGA mediated CYPdgbAdgb inhibition on clinical pharmacokinetics of DRUGN ( DRUGB ) , an orally active DRUGN .
ketoconazole	drug	LBH589	drug
false

Effect of DRUGA mediated CYPdgbAdgb inhibition on clinical pharmacokinetics of DRUGN ( DRUGN ) , an orally active DRUGB .
ketoconazole	drug	histone deacetylase inhibitor	group
false

Effect of DRUGN mediated CYPdgbAdgb inhibition on clinical pharmacokinetics of DRUGA ( DRUGB ) , an orally active DRUGN .
panobinostat	drug	LBH589	drug
false

Effect of DRUGN mediated CYPdgbAdgb inhibition on clinical pharmacokinetics of DRUGA ( DRUGN ) , an orally active DRUGB .
panobinostat	drug	histone deacetylase inhibitor	group
false

Effect of DRUGN mediated CYPdgbAdgb inhibition on clinical pharmacokinetics of DRUGN ( DRUGA ) , an orally active DRUGB .
LBH589	drug	histone deacetylase inhibitor	group
false

This study evaluated the effect of a potent CYPdgbA inhibitor , DRUGA , on the pharmacokinetics and safety of DRUGB .
ketoconazole	drug	panobinostat	drug
false

On day dgb , a single DRUGA dose was co administered with DRUGB .
panobinostat	drug	ketoconazole	drug
false

In the presence of DRUGA , there was dga and dga fold increase in C ( max ) and AUC of DRUGB , respectively .
ketoconazole	drug	panobinostat	drug
mechanism

Interaction study of DRUGA and DRUGB with co administered drugs .
moxifloxacin	drug	lomefloxacin	drug
false

DRUGA and DRUGB are DRUGN used in treating urinary and respiratory tract infections .
Moxifloxacin	drug	lomefloxacin	drug
false

DRUGA and DRUGN are DRUGB used in treating urinary and respiratory tract infections .
Moxifloxacin	drug	fluoroquinolone antibiotics	group
false

DRUGN and DRUGA are DRUGB used in treating urinary and respiratory tract infections .
lomefloxacin	drug	fluoroquinolone antibiotics	group
false

Being DRUGA and lomefloxacin DRUGB the interaction study of was carried out with DRUGN , DRUGN , DRUGN and DRUGN .
moxifloxacin	drug	fluoroquinolones	group
false

Being DRUGA and lomefloxacin DRUGN the interaction study of was carried out with DRUGB , DRUGN , DRUGN and DRUGN .
moxifloxacin	drug	sucralfate	drug
false

Being DRUGA and lomefloxacin DRUGN the interaction study of was carried out with DRUGN , DRUGB , DRUGN and DRUGN .
moxifloxacin	drug	gelusil	brand
false

Being DRUGA and lomefloxacin DRUGN the interaction study of was carried out with DRUGN , DRUGN , DRUGB and DRUGN .
moxifloxacin	drug	erythromycin	drug
false

Being DRUGA and lomefloxacin DRUGN the interaction study of was carried out with DRUGN , DRUGN , DRUGN and DRUGB .
moxifloxacin	drug	multi minerals	group
false

Being DRUGN and lomefloxacin DRUGA the interaction study of was carried out with DRUGB , DRUGN , DRUGN and DRUGN .
fluoroquinolones	group	sucralfate	drug
false

Being DRUGN and lomefloxacin DRUGA the interaction study of was carried out with DRUGN , DRUGB , DRUGN and DRUGN .
fluoroquinolones	group	gelusil	brand
false

Being DRUGN and lomefloxacin DRUGA the interaction study of was carried out with DRUGN , DRUGN , DRUGB and DRUGN .
fluoroquinolones	group	erythromycin	drug
false

Being DRUGN and lomefloxacin DRUGA the interaction study of was carried out with DRUGN , DRUGN , DRUGN and DRUGB .
fluoroquinolones	group	multi minerals	group
false

Being DRUGN and lomefloxacin DRUGN the interaction study of was carried out with DRUGA , DRUGB , DRUGN and DRUGN .
sucralfate	drug	gelusil	brand
false

Being DRUGN and lomefloxacin DRUGN the interaction study of was carried out with DRUGA , DRUGN , DRUGB and DRUGN .
sucralfate	drug	erythromycin	drug
false

Being DRUGN and lomefloxacin DRUGN the interaction study of was carried out with DRUGA , DRUGN , DRUGN and DRUGB .
sucralfate	drug	multi minerals	group
false

Being DRUGN and lomefloxacin DRUGN the interaction study of was carried out with DRUGN , DRUGA , DRUGB and DRUGN .
gelusil	brand	erythromycin	drug
false

Being DRUGN and lomefloxacin DRUGN the interaction study of was carried out with DRUGN , DRUGA , DRUGN and DRUGB .
gelusil	brand	multi minerals	group
false

Being DRUGN and lomefloxacin DRUGN the interaction study of was carried out with DRUGN , DRUGN , DRUGA and DRUGB .
erythromycin	drug	multi minerals	group
false

The response of DRUGA and DRUGB after interaction with co administered drugs at different conditions and temperature were noted using a Shimadzu HPLC system with PDA detector .
moxifloxacin	drug	lomefloxacin	drug
false

DRUGA and DRUGB reacts faster with DRUGN and DRUGN in acidic media whereas with DRUGN in basic media and DRUGN in neutral media .
Moxifloxacin	drug	Lomefloxacin	drug
false

DRUGA and DRUGN reacts faster with DRUGB and DRUGN in acidic media whereas with DRUGN in basic media and DRUGN in neutral media .
Moxifloxacin	drug	sucralfate	drug
mechanism

DRUGA and DRUGN reacts faster with DRUGN and DRUGB in acidic media whereas with DRUGN in basic media and DRUGN in neutral media .
Moxifloxacin	drug	gelusil	brand
mechanism

DRUGA and DRUGN reacts faster with DRUGN and DRUGN in acidic media whereas with DRUGB in basic media and DRUGN in neutral media .
Moxifloxacin	drug	erythromycin	drug
mechanism

DRUGA and DRUGN reacts faster with DRUGN and DRUGN in acidic media whereas with DRUGN in basic media and DRUGB in neutral media .
Moxifloxacin	drug	multi-minerals	group
mechanism

DRUGN and DRUGA reacts faster with DRUGB and DRUGN in acidic media whereas with DRUGN in basic media and DRUGN in neutral media .
Lomefloxacin	drug	sucralfate	drug
mechanism

DRUGN and DRUGA reacts faster with DRUGN and DRUGB in acidic media whereas with DRUGN in basic media and DRUGN in neutral media .
Lomefloxacin	drug	gelusil	brand
mechanism

DRUGN and DRUGA reacts faster with DRUGN and DRUGN in acidic media whereas with DRUGB in basic media and DRUGN in neutral media .
Lomefloxacin	drug	erythromycin	drug
mechanism

DRUGN and DRUGA reacts faster with DRUGN and DRUGN in acidic media whereas with DRUGN in basic media and DRUGB in neutral media .
Lomefloxacin	drug	multi-minerals	group
mechanism

DRUGN and DRUGN reacts faster with DRUGA and DRUGB in acidic media whereas with DRUGN in basic media and DRUGN in neutral media .
sucralfate	drug	gelusil	brand
false

DRUGN and DRUGN reacts faster with DRUGA and DRUGN in acidic media whereas with DRUGB in basic media and DRUGN in neutral media .
sucralfate	drug	erythromycin	drug
false

DRUGN and DRUGN reacts faster with DRUGA and DRUGN in acidic media whereas with DRUGN in basic media and DRUGB in neutral media .
sucralfate	drug	multi-minerals	group
false

DRUGN and DRUGN reacts faster with DRUGN and DRUGA in acidic media whereas with DRUGB in basic media and DRUGN in neutral media .
gelusil	brand	erythromycin	drug
false

DRUGN and DRUGN reacts faster with DRUGN and DRUGA in acidic media whereas with DRUGN in basic media and DRUGB in neutral media .
gelusil	brand	multi-minerals	group
false

DRUGN and DRUGN reacts faster with DRUGN and DRUGN in acidic media whereas with DRUGA in basic media and DRUGB in neutral media .
erythromycin	drug	multi-minerals	group
false

Exposure to oral DRUGA is unaffected by DRUGB but greatly increased by DRUGN .
S-ketamine	drug	itraconazole	drug
false

Exposure to oral DRUGA is unaffected by DRUGN but greatly increased by DRUGB .
S-ketamine	drug	ticlopidine	drug
effect

Exposure to oral DRUGN is unaffected by DRUGA but greatly increased by DRUGB .
itraconazole	drug	ticlopidine	drug
false

This study examined drug drug interactions of oral DRUGA with the cytochrome Pdgb ( CYP ) dgbBdgb inhibitor DRUGB and the CYPdgbA inhibitor DRUGN .
S-ketamine	drug	ticlopidine	drug
false

This study examined drug drug interactions of oral DRUGA with the cytochrome Pdgb ( CYP ) dgbBdgb inhibitor DRUGN and the CYPdgbA inhibitor DRUGB .
S-ketamine	drug	itraconazole	drug
false

This study examined drug drug interactions of oral DRUGN with the cytochrome Pdgb ( CYP ) dgbBdgb inhibitor DRUGA and the CYPdgbA inhibitor DRUGB .
ticlopidine	drug	itraconazole	drug
false

DRUGA treatment increased the mean area under the plasma concentration time curve extrapolated to infinity ( AUC ( dgb ) ) of oral DRUGB by dga fold , whereas DRUGN treatment did not increase the exposure to DRUGN .
Ticlopidine	drug	ketamine	drug
mechanism

DRUGA treatment increased the mean area under the plasma concentration time curve extrapolated to infinity ( AUC ( dgb ) ) of oral DRUGN by dga fold , whereas DRUGB treatment did not increase the exposure to DRUGN .
Ticlopidine	drug	itraconazole	drug
false

DRUGA treatment increased the mean area under the plasma concentration time curve extrapolated to infinity ( AUC ( dgb ) ) of oral DRUGN by dga fold , whereas DRUGN treatment did not increase the exposure to DRUGB .
Ticlopidine	drug	S-ketamine	drug
false

DRUGN treatment increased the mean area under the plasma concentration time curve extrapolated to infinity ( AUC ( dgb ) ) of oral DRUGA by dga fold , whereas DRUGB treatment did not increase the exposure to DRUGN .
ketamine	drug	itraconazole	drug
false

DRUGN treatment increased the mean area under the plasma concentration time curve extrapolated to infinity ( AUC ( dgb ) ) of oral DRUGA by dga fold , whereas DRUGN treatment did not increase the exposure to DRUGB .
ketamine	drug	S-ketamine	drug
false

DRUGN treatment increased the mean area under the plasma concentration time curve extrapolated to infinity ( AUC ( dgb ) ) of oral DRUGN by dga fold , whereas DRUGA treatment did not increase the exposure to DRUGB .
itraconazole	drug	S-ketamine	drug
false

The ratio of DRUGA AUC ( dgb ) to DRUGB AUC ( dgb ) was significantly decreased in the DRUGN ( P & lt ; dga ) and DRUGN phases ( P = dga ) as compared to placebo .
norketamine	drug_n	ketamine	drug
false

The ratio of DRUGA AUC ( dgb ) to DRUGN AUC ( dgb ) was significantly decreased in the DRUGB ( P & lt ; dga ) and DRUGN phases ( P = dga ) as compared to placebo .
norketamine	drug_n	ticlopidine	drug
false

The ratio of DRUGA AUC ( dgb ) to DRUGN AUC ( dgb ) was significantly decreased in the DRUGN ( P & lt ; dga ) and DRUGB phases ( P = dga ) as compared to placebo .
norketamine	drug_n	itraconazole	drug
false

The ratio of DRUGN AUC ( dgb ) to DRUGA AUC ( dgb ) was significantly decreased in the DRUGB ( P & lt ; dga ) and DRUGN phases ( P = dga ) as compared to placebo .
ketamine	drug	ticlopidine	drug
false

The ratio of DRUGN AUC ( dgb ) to DRUGA AUC ( dgb ) was significantly decreased in the DRUGN ( P & lt ; dga ) and DRUGB phases ( P = dga ) as compared to placebo .
ketamine	drug	itraconazole	drug
false

The ratio of DRUGN AUC ( dgb ) to DRUGN AUC ( dgb ) was significantly decreased in the DRUGA ( P & lt ; dga ) and DRUGB phases ( P = dga ) as compared to placebo .
ticlopidine	drug	itraconazole	drug
false

In the DRUGA and DRUGB phases , the areas under the effect time curves ( self reported drowsiness and performance ) were significantly higher than those in the placebo phase ( P < dga ) .
ticlopidine	drug	itraconazole	drug
false

The findings suggest that the dosage of DRUGA should be reduced in patients receiving DRUGB .
S-ketamine	drug	ticlopidine	drug
advise

The DRUGA ( DRUGB ) , one of S adenosylhomocysteine ( AdoHcy ) hydrolase inhibitors , has shown antitumor activities in a broad range of solid tumors and acute myeloid leukemia .
3-Deazaneplanocin A	drug_n	DZNep	drug_n
false

We also found that Bcl dgb was overexpressed in DRUGA insensitive cells , and cotreatment with DRUGN and DRUGB , a Bcl dgb family inhibitor , synergistically inhibited growth and induced apoptosis of DRUGN insensitive MM cells .
DZNep	drug_n	ABT-737	drug_n
false

We also found that Bcl dgb was overexpressed in DRUGN insensitive cells , and cotreatment with DRUGA and DRUGB , a Bcl dgb family inhibitor , synergistically inhibited growth and induced apoptosis of DRUGN insensitive MM cells .
DZNep	drug_n	ABT-737	drug_n
effect

We also found that Bcl dgb was overexpressed in DRUGN insensitive cells , and cotreatment with DRUGN and DRUGA , a Bcl dgb family inhibitor , synergistically inhibited growth and induced apoptosis of DRUGB insensitive MM cells .
ABT-737	drug_n	DZNep	drug_n
false

In addition , DRUGA insensitivity might be associated with overexpression of Bcl dgb , and the combination of DRUGB and DRUGN could synergistically induced apoptosis .
DZNep	drug_n	ABT-737	drug_n
false

In addition , DRUGN insensitivity might be associated with overexpression of Bcl dgb , and the combination of DRUGA and DRUGB could synergistically induced apoptosis .
ABT-737	drug_n	DZNep	drug_n
effect

DRUGA failure in an HIV positive woman on DRUGB therapy resulting in two ectopic pregnancies .
Implanon	brand	antiretroviral	group
effect

We present an interesting case of an HIV positive woman on DRUGA therapy having tubal pregnancies on two separate occasions with DRUGB in place .
antiretroviral	group	Implanon	brand
effect

DRUGA DRUGB interaction and associated gastrointestinal bleeding risk in a case control study .
Antidepressant	group	warfarin	drug
false

We sought to evaluate whether initiation of an DRUGA increases the risk of hospitalization for gastrointestinal bleeding in DRUGB users .
antidepressant	group	warfarin	drug
false

Also DRUGA , which is not believed to interact with DRUGB , increased the risk of GI bleeding ( OR = dga [ dgb % CI , dga dga ] ) .
mirtazapine	drug	warfarin	drug
effect

DRUGA users who initiated DRUGB , DRUGN , DRUGN , DRUGN , or DRUGN had an increased risk of hospitalization for gastrointestinal bleeding .
Warfarin	drug	citalopram	drug
effect

DRUGA users who initiated DRUGN , DRUGB , DRUGN , DRUGN , or DRUGN had an increased risk of hospitalization for gastrointestinal bleeding .
Warfarin	drug	fluoxetine	drug
effect

DRUGA users who initiated DRUGN , DRUGN , DRUGB , DRUGN , or DRUGN had an increased risk of hospitalization for gastrointestinal bleeding .
Warfarin	drug	paroxetine	drug
effect

DRUGA users who initiated DRUGN , DRUGN , DRUGN , DRUGB , or DRUGN had an increased risk of hospitalization for gastrointestinal bleeding .
Warfarin	drug	amitriptyline	drug
effect

DRUGA users who initiated DRUGN , DRUGN , DRUGN , DRUGN , or DRUGB had an increased risk of hospitalization for gastrointestinal bleeding .
Warfarin	drug	mirtazapine	drug
effect

DRUGN users who initiated DRUGA , DRUGB , DRUGN , DRUGN , or DRUGN had an increased risk of hospitalization for gastrointestinal bleeding .
citalopram	drug	fluoxetine	drug
false

DRUGN users who initiated DRUGA , DRUGN , DRUGB , DRUGN , or DRUGN had an increased risk of hospitalization for gastrointestinal bleeding .
citalopram	drug	paroxetine	drug
false

DRUGN users who initiated DRUGA , DRUGN , DRUGN , DRUGB , or DRUGN had an increased risk of hospitalization for gastrointestinal bleeding .
citalopram	drug	amitriptyline	drug
false

DRUGN users who initiated DRUGA , DRUGN , DRUGN , DRUGN , or DRUGB had an increased risk of hospitalization for gastrointestinal bleeding .
citalopram	drug	mirtazapine	drug
false

DRUGN users who initiated DRUGN , DRUGA , DRUGB , DRUGN , or DRUGN had an increased risk of hospitalization for gastrointestinal bleeding .
fluoxetine	drug	paroxetine	drug
false

DRUGN users who initiated DRUGN , DRUGA , DRUGN , DRUGB , or DRUGN had an increased risk of hospitalization for gastrointestinal bleeding .
fluoxetine	drug	amitriptyline	drug
false

DRUGN users who initiated DRUGN , DRUGA , DRUGN , DRUGN , or DRUGB had an increased risk of hospitalization for gastrointestinal bleeding .
fluoxetine	drug	mirtazapine	drug
false

DRUGN users who initiated DRUGN , DRUGN , DRUGA , DRUGB , or DRUGN had an increased risk of hospitalization for gastrointestinal bleeding .
paroxetine	drug	amitriptyline	drug
false

DRUGN users who initiated DRUGN , DRUGN , DRUGA , DRUGN , or DRUGB had an increased risk of hospitalization for gastrointestinal bleeding .
paroxetine	drug	mirtazapine	drug
false

DRUGN users who initiated DRUGN , DRUGN , DRUGN , DRUGA , or DRUGB had an increased risk of hospitalization for gastrointestinal bleeding .
amitriptyline	drug	mirtazapine	drug
false

The incubations were performed in the absence and presence of the non specific CYP inhibitor , DRUGA ( DRUGB ) and isoform specific inhibitors .
1-aminobenzotriazole	drug_n	ABT	drug_n
false

DRUGA decreased the toxicity of DRUGB , increased exposure to parent compound , and decreased metabolite levels in a dose dependent manner .
ABT	drug_n	precocene I	drug_n
effect

Of the isoform specific CYP inhibitors tested for an effect on the DRUGA metabolite profile , only DRUGB was noticeably effective , indicating a role of CYPs dgbAdgb , dgbCdgb , dgbCldgb , and dgbEdga
precocene I	drug_n	tranylcypromine	drug
false

With respect to toxicity , the order of CYP inhibitor effectiveness was DRUGA > DRUGB ~ DRUGN > DRUGN .
ABT	drug_n	diethyldithiocarbamate	drug_n
false

With respect to toxicity , the order of CYP inhibitor effectiveness was DRUGA > DRUGN ~ DRUGB > DRUGN .
ABT	drug_n	tranylcypromine	drug
false

With respect to toxicity , the order of CYP inhibitor effectiveness was DRUGA > DRUGN ~ DRUGN > DRUGB .
ABT	drug_n	ketoconazole	drug
false

With respect to toxicity , the order of CYP inhibitor effectiveness was DRUGN > DRUGA ~ DRUGB > DRUGN .
diethyldithiocarbamate	drug_n	tranylcypromine	drug
false

With respect to toxicity , the order of CYP inhibitor effectiveness was DRUGN > DRUGA ~ DRUGN > DRUGB .
diethyldithiocarbamate	drug_n	ketoconazole	drug
false

With respect to toxicity , the order of CYP inhibitor effectiveness was DRUGN > DRUGN ~ DRUGA > DRUGB .
tranylcypromine	drug	ketoconazole	drug
false

DRUGA and DRUGB had no effect , while DRUGN appeared to augment DRUGN toxicity .
Furafylline	drug_n	sulfaphenazole	drug_n
false

DRUGA and DRUGN had no effect , while DRUGB appeared to augment DRUGN toxicity .
Furafylline	drug_n	quinidine	drug
false

DRUGA and DRUGN had no effect , while DRUGN appeared to augment DRUGB toxicity .
Furafylline	drug_n	precocene I	drug_n
false

DRUGN and DRUGA had no effect , while DRUGB appeared to augment DRUGN toxicity .
sulfaphenazole	drug_n	quinidine	drug
false

DRUGN and DRUGA had no effect , while DRUGN appeared to augment DRUGB toxicity .
sulfaphenazole	drug_n	precocene I	drug_n
false

DRUGN and DRUGN had no effect , while DRUGA appeared to augment DRUGB toxicity .
quinidine	drug	precocene I	drug_n
effect

To determine whether the co injection of extracellular matrix degrading enzymes improves retinal transduction following intravitreal delivery of DRUGA ( DRUGB ) .
adeno-associated virus-2	drug_n	AAV2	drug_n
false

The addition of DRUGA or DRUGB greatly enhanced transduction of the retinal ganglion cell layer and increased the depth of transduction into the outer retina .
heparinase III	drug_n	chondroitin ABC lyase	drug_n
false

DRUGA had a limited effect and DRUGB was ineffective .
Hyaluronan lyase	drug_n	collagenase	drug_n
false

Electroretinograms survived with higher concentrations of DRUGA and DRUGB than were required for optimal retinal transduction .
heparinase III	drug_n	chondroitin ABC lyase	drug_n
false

DRUGA mediated retinal transduction is improved by co injection of DRUGB or DRUGN .
AAV2	drug_n	heparinase III	drug_n
effect

DRUGA mediated retinal transduction is improved by co injection of DRUGN or DRUGB .
AAV2	drug_n	chondroitin ABC lyase	drug_n
effect

DRUGN mediated retinal transduction is improved by co injection of DRUGA or DRUGB .
heparinase III	drug_n	chondroitin ABC lyase	drug_n
false

Prevention of emergence agitation in seven children receiving low dose DRUGA and DRUGB total intravenous anesthesia .
ketamine	drug	propofol	drug
false

We retrospectively reviewed the records of dgb pediatric oncology patients who received low dose DRUGA in conjunction with DRUGB for total intravenous anesthesia ( TIVA ) repeatedly for radiation therapy .
ketamine	drug	propofol	drug
false

EA signs were observed in all dgb patients in association with DRUGA TIVA but did not recur in any of dgb subsequent anesthetics sessions during which low dose DRUGB was added to DRUGN .
propofol	drug	ketamine	drug
false

EA signs were observed in all dgb patients in association with DRUGN TIVA but did not recur in any of dgb subsequent anesthetics sessions during which low dose DRUGA was added to DRUGB .
ketamine	drug	propofol	drug
false

Based on this experience , we suggest that low dose DRUGA added to DRUGB may be associated with prevention of EA in children with a history of EA with DRUGN TIVA .
ketamine	drug	propofol	drug
effect

Based on this experience , we suggest that low dose DRUGA added to DRUGN may be associated with prevention of EA in children with a history of EA with DRUGB TIVA .
ketamine	drug	propofol	drug
false

DRUGA , an DRUGB , is the standard hormone treatment for breast cancer .
Tamoxifen	drug	estrogen antagonist	group
false

DRUGA and DRUGB reduce the plasma concentration of DRUGN by about dgb % .
Paroxetine	drug	fluoxetine	drug
false

DRUGA and DRUGN reduce the plasma concentration of DRUGB by about dgb % .
Paroxetine	drug	endoxifen	drug_n
mechanism

DRUGN and DRUGA reduce the plasma concentration of DRUGB by about dgb % .
fluoxetine	drug	endoxifen	drug_n
mechanism

It is better to avoid prescribing isoenzyme CYP dgbDdgb inhibitors to women treated with DRUGA for breast cancer , especially DRUGB such as DRUGN and DRUGN .
tamoxifen	drug	SSRI antidepressants	group
advise

It is better to avoid prescribing isoenzyme CYP dgbDdgb inhibitors to women treated with DRUGA for breast cancer , especially DRUGN such as DRUGB and DRUGN .
tamoxifen	drug	paroxetine	drug
advise

It is better to avoid prescribing isoenzyme CYP dgbDdgb inhibitors to women treated with DRUGA for breast cancer , especially DRUGN such as DRUGN and DRUGB .
tamoxifen	drug	fluoxetine	drug
advise

It is better to avoid prescribing isoenzyme CYP dgbDdgb inhibitors to women treated with DRUGN for breast cancer , especially DRUGA such as DRUGB and DRUGN .
SSRI antidepressants	group	paroxetine	drug
false

It is better to avoid prescribing isoenzyme CYP dgbDdgb inhibitors to women treated with DRUGN for breast cancer , especially DRUGA such as DRUGN and DRUGB .
SSRI antidepressants	group	fluoxetine	drug
false

It is better to avoid prescribing isoenzyme CYP dgbDdgb inhibitors to women treated with DRUGN for breast cancer , especially DRUGN such as DRUGA and DRUGB .
paroxetine	drug	fluoxetine	drug
false

Depression does not always require DRUGA therapy , and DRUGB have no proven preventive impact on hot flushes linked to the menopause .
antidepressant drug	group	antidepressants	group
false

If in certain cases , an DRUGA is considered necessary , it may be advisable to replace DRUGB with DRUGN .
antidepressant	group	tamoxifen	drug
advise

If in certain cases , an DRUGA is considered necessary , it may be advisable to replace DRUGN with DRUGB .
antidepressant	group	anastrozole	drug
false

If in certain cases , an DRUGN is considered necessary , it may be advisable to replace DRUGA with DRUGB .
tamoxifen	drug	anastrozole	drug
false

DRUGA locomotor sensitization and conditioned place preference in adolescent male and female rats neonatally treated with DRUGB .
Amphetamine	drug	quinpirole	drug_n
false

The objective was to analyze the effects of neonatal DRUGA treatment on effects of DRUGB in adolescent rats using locomotor sensitization and conditioned place preference procedures .
quinpirole	drug_n	amphetamine	drug
false

In female rats , neonatal DRUGA treatment enhanced DRUGB locomotor sensitization compared with DRUGN free controls sensitized to DRUGN .
quinpirole	drug_n	amphetamine	drug
effect

In female rats , neonatal DRUGA treatment enhanced DRUGN locomotor sensitization compared with DRUGN free controls sensitized to DRUGB .
quinpirole	drug_n	amphetamine	drug
false

In female rats , neonatal DRUGN treatment enhanced DRUGA locomotor sensitization compared with DRUGB free controls sensitized to DRUGN .
amphetamine	drug	quinpirole	drug_n
false

In female rats , neonatal DRUGN treatment enhanced DRUGN locomotor sensitization compared with DRUGA free controls sensitized to DRUGB .
quinpirole	drug_n	amphetamine	drug
false

Male rats demonstrated sensitization to DRUGA , although this was muted compared with female rats , and were unaffected by neonatal DRUGB .
amphetamine	drug	quinpirole	drug_n
false

In vivo CYPdgbA activity is significantly lower in DRUGA treated as compared with DRUGB treated renal allograft recipients .
cyclosporine	drug	tacrolimus	drug
false

In vitro studies have identified DRUGA and DRUGB as CYPdgbA inhibitors .
cyclosporine	drug	tacrolimus	drug
false

The latter displayed DRUGA clearances similar to those in two larger cohorts of nonmatched DRUGB treated patients ( n = dgb and n = dgb ) and to those receiving a DRUGN free regimen ( n = dgb ) .
midazolam	drug	tacrolimus	drug
false

The latter displayed DRUGA clearances similar to those in two larger cohorts of nonmatched DRUGN treated patients ( n = dgb and n = dgb ) and to those receiving a DRUGB free regimen ( n = dgb ) .
midazolam	drug	calcineurin inhibitor	group
false

The latter displayed DRUGN clearances similar to those in two larger cohorts of nonmatched DRUGA treated patients ( n = dgb and n = dgb ) and to those receiving a DRUGB free regimen ( n = dgb ) .
tacrolimus	drug	calcineurin inhibitor	group
false

Improved parathyroid hormone control by DRUGA is associated with reduction in DRUGB requirement in patients with end stage renal disease .
cinacalcet	drug	darbepoetin	drug
false

Uncontrolled hy per parathyroidism causes bone marrow fibrosis , leading to DRUGA ( DRUGB ) resistance .
erythropoietin	drug	EPO	drug
false

Medical treatment with DRUGA is effective in reducing plasma parathyroid hormone ( PTH ) levels , but its effect on DRUGB dosing is unknown .
cinacalcet	drug	darbepoetin	drug
false

The primary objective of the study was to ascertain the difference in DRUGA responsiveness before and after dgb months of DRUGB therapy .
darbepoetin	drug	cinacalcet	drug
false

Reduction of PTH by DRUGA is associated with a decrease in DRUGB requirement .
cinacalcet	drug	darbepoetin	drug
effect

Interaction of DRUGA with different DRUGB is antagonistic in breast but not in other cancer cells .
celecoxib	drug	anti-cancer drugs	group
effect

This study investigates the ability of DRUGA to sensitize cells from different origins to several DRUGB .
cyclooxygenase-2 inhibitors	group	chemotherapeutic agents	group
false

We found antagonism between DRUGA and the four drugs in the breast cancer cells MCFdgb following all incubation schedules and between DRUGN and DRUGB in all cell lines except for two combinations in HCTdgb cells .
celecoxib	drug	doxorubicin	drug
false

We found antagonism between DRUGN and the four drugs in the breast cancer cells MCFdgb following all incubation schedules and between DRUGA and DRUGB in all cell lines except for two combinations in HCTdgb cells .
celecoxib	drug	doxorubicin	drug
effect

These results , if confirmed in vivo , indicate that DRUGA is not a suitable chemosensitizer for breast cancer or with DRUGB for other cancers .
celecoxib	drug	doxorubicin	drug
false

[ Interaction between DRUGA and DRUGB ] .
clopidogrel	drug	proton pump inhibitors	group
false

The drug interaction between DRUGA and DRUGB has been the subject of much study in recent years .
proton pump inhibitors	group	clopidogrel	drug
false

Contradictory results regarding the effect of DRUGA on platelet reactivity and on clinical outcome in DRUGB treated patients have been reported in literature .
proton pump inhibitors	group	clopidogrel	drug
false

DRUGA has a much weaker effect on DRUGB 's pharmacokinetics and on platelet reactivity during concomitant use .
Pantoprazole	drug	clopidogrel	drug
mechanism

The influence of the other DRUGA when used simultaneously with DRUGB has not yet been investigated in adequately randomized studies .
proton pump inhibitors	group	clopidogrel	drug
false

Regulatory agencies state that the combination of DRUGA and the CYPdgbCdgb inhibitors DRUGB and DRUGN should be avoided .
clopidogrel	drug	omeprazole	drug
advise

Regulatory agencies state that the combination of DRUGA and the CYPdgbCdgb inhibitors DRUGN and DRUGB should be avoided .
clopidogrel	drug	esomeprazole	drug
advise

Regulatory agencies state that the combination of DRUGN and the CYPdgbCdgb inhibitors DRUGA and DRUGB should be avoided .
omeprazole	drug	esomeprazole	drug
false

To date , there is no conclusive evidence of a clinically relevant interaction between any of the DRUGA and DRUGB .
proton pump inhibitors	group	clopidogrel	drug
false

In vitro activity of DRUGA combined with DRUGB against clinical isolates of DRUGN resistant Staphylococcus aureus .
minocycline	drug	fosfomycin	drug
false

In vitro activity of DRUGA combined with DRUGN against clinical isolates of DRUGB resistant Staphylococcus aureus .
minocycline	drug	methicillin	drug
false

In vitro activity of DRUGN combined with DRUGA against clinical isolates of DRUGB resistant Staphylococcus aureus .
fosfomycin	drug	methicillin	drug
false

This study aimed to evaluate the in vitro activity of DRUGA combined with DRUGB against isolates of DRUGN resistant Staphylococcus aureus ( MRSA ) .
minocycline	drug	fosfomycin	drug
false

This study aimed to evaluate the in vitro activity of DRUGA combined with DRUGN against isolates of DRUGB resistant Staphylococcus aureus ( MRSA ) .
minocycline	drug	methicillin	drug
false

This study aimed to evaluate the in vitro activity of DRUGN combined with DRUGA against isolates of DRUGB resistant Staphylococcus aureus ( MRSA ) .
fosfomycin	drug	methicillin	drug
false

The susceptibility results for DRUGA and DRUGB were interpreted according to the most relevant criteria .
minocycline	drug	fosfomycin	drug
false

The combination of DRUGA and DRUGB can be synergistic against MRSA .
minocycline	drug	fosfomycin	drug
effect

The authors report the case of an infant with confirmed congenital hypothyroidism on DRUGA who experienced a possible drug interaction with DRUGB .
levothyroxine	drug	simeticone	drug
int

Questioning revealed the child was taking DRUGA drops before feeds while on DRUGB .
Infacol	brand	levothyroxine	drug
false

Drug interaction of DRUGA with DRUGB has not been reported previously and is not listed in the British National Formulary for Children .
thyroxine	drug	simeticone	drug
false

DRUGA does not inhibit the absorption of dgb milligrams of DRUGB or DRUGN at doses less than dgb milligrams in nonpregnant women .
Calcium	drug	nonheme iron	drug
false

DRUGA does not inhibit the absorption of dgb milligrams of DRUGN or DRUGB at doses less than dgb milligrams in nonpregnant women .
Calcium	drug	heme iron	drug
false

DRUGN does not inhibit the absorption of dgb milligrams of DRUGA or DRUGB at doses less than dgb milligrams in nonpregnant women .
nonheme iron	drug	heme iron	drug
false

DRUGA is the only known component in the diet that may affect absorption of both DRUGB and DRUGN .
Calcium	drug	nonheme iron	drug
mechanism

DRUGA is the only known component in the diet that may affect absorption of both DRUGN and DRUGB .
Calcium	drug	heme iron	drug
mechanism

DRUGN is the only known component in the diet that may affect absorption of both DRUGA and DRUGB .
nonheme iron	drug	heme iron	drug
false

However , the evidence for a DRUGA effect on DRUGB absorption mainly comes from studies that did not isolate the effect of DRUGN from that of other dietary components , because it was detected in single meal studies .
calcium	drug	iron	drug
mechanism

However , the evidence for a DRUGN effect on DRUGA absorption mainly comes from studies that did not isolate the effect of DRUGB from that of other dietary components , because it was detected in single meal studies .
iron	drug	calcium	drug
false

Our objective was to establish potential effects of DRUGA on absorption of DRUGB and DRUGN and the dose response for this effect in the absence of a meal .
calcium	drug	nonheme iron	drug
false

Our objective was to establish potential effects of DRUGA on absorption of DRUGN and DRUGB and the dose response for this effect in the absence of a meal .
calcium	drug	heme iron	drug
false

Our objective was to establish potential effects of DRUGN on absorption of DRUGA and DRUGB and the dose response for this effect in the absence of a meal .
nonheme iron	drug	heme iron	drug
false

We evaluated the effects of DRUGA doses between dgb and dgb mg on absorption of dgb mg DRUGB ( as DRUGN ) .
calcium	drug	nonheme iron	drug
false

We evaluated the effects of DRUGA doses between dgb and dgb mg on absorption of dgb mg DRUGN ( as DRUGB ) .
calcium	drug	ferrous sulfate	drug
false

We evaluated the effects of DRUGN doses between dgb and dgb mg on absorption of dgb mg DRUGA ( as DRUGB ) .
nonheme iron	drug	ferrous sulfate	drug
false

We also evaluated the effects of DRUGA doses between dgb and dgb mg on absorption of dgb mg DRUGB [ as concentrated RBC ( CRBC ) ] .
calcium	drug	heme iron	drug
false

DRUGA was administered as DRUGB in all studies and DRUGN were ingested on an empty stomach .
Calcium	drug	calcium chloride	drug
false

DRUGA was administered as DRUGN in all studies and DRUGB were ingested on an empty stomach .
Calcium	drug	minerals	group
false

DRUGN was administered as DRUGA in all studies and DRUGB were ingested on an empty stomach .
calcium chloride	drug	minerals	group
false

DRUGA doses dgb mg diminished DRUGB absorption by an average of dga % .
Calcium	drug	nonheme iron	drug
mechanism

A DRUGA dose of dgb mg diminished absorption of dgb mg DRUGB by dga % .
calcium	drug	heme iron	drug
mechanism

In conclusion , we demonstrated an isolated effect of DRUGA ( as chloride ) on absorption of dgb mg of iron provided as DRUGB ( as sulfate ) and DRUGN ( as CRBC ) iron .
calcium	drug	nonheme iron	drug
mechanism

In conclusion , we demonstrated an isolated effect of DRUGA ( as chloride ) on absorption of dgb mg of iron provided as DRUGN ( as sulfate ) and DRUGB ( as CRBC ) iron .
calcium	drug	heme iron	drug
mechanism

In conclusion , we demonstrated an isolated effect of DRUGN ( as chloride ) on absorption of dgb mg of iron provided as DRUGA ( as sulfate ) and DRUGB ( as CRBC ) iron .
nonheme iron	drug	heme iron	drug
false

Synergistic interaction between DRUGA and DRUGB is sequence dependent in human non small lung cancer with EGFR TKIs resistant mutation .
sunitinib	drug	docetaxel	drug
int

This study was aimed to investigate the efficacy of single use of DRUGA and that of concurrent or sequential administration of DRUGN and DRUGB in NSCLC cell lines that are resistant to EGFR TKIs .
sunitinib	drug	docetaxel	drug
false

This study was aimed to investigate the efficacy of single use of DRUGN and that of concurrent or sequential administration of DRUGA and DRUGB in NSCLC cell lines that are resistant to EGFR TKIs .
sunitinib	drug	docetaxel	drug
false

NSCLC cell lines with EGFR TdgbM mutation and K ras mutation were exposed to either DRUGA or DRUGB or both based on various sequential administrations .
sunitinib	drug	docetaxel	drug
false

DRUGA exhibited dose dependent growth inhibition in NSCLC cell lines and arrested cell cycle at Gdgb phase , whereas DRUGB arrested at S phase .
Sunitinib	drug	docetaxel	drug
false

Although single or concurrent use of DRUGA and DRUGB has some anti proliferative effects , the sequential administrations of both drugs remarkably enhanced anti tumor activity .
sunitinib	drug	docetaxel	drug
effect

When cells were exposed to DRUGA followed by DRUGB , synergism was observed .
docetaxel	drug	sunitinib	drug
effect

The molecular basis of this synergism is that the signaling pathways that were initially activated by DRUGA exposure were efficiently suppressed by the subsequent exposure to DRUGB .
docetaxel	drug	sunitinib	drug
effect

Distinct synergistic action of DRUGA and DRUGB against Pseudomonas aeruginosa .
piperacillin	drug	methylglyoxal	drug_n
false

Results revealed that the strains were resistant to many drugs at high levels , only DRUGA , DRUGB , DRUGN and DRUGN showed resistances at comparatively lower levels .
piperacillin	drug	carbenicillin	drug
false

Results revealed that the strains were resistant to many drugs at high levels , only DRUGA , DRUGN , DRUGB and DRUGN showed resistances at comparatively lower levels .
piperacillin	drug	amikacin	drug
false

Results revealed that the strains were resistant to many drugs at high levels , only DRUGA , DRUGN , DRUGN and DRUGB showed resistances at comparatively lower levels .
piperacillin	drug	ciprofloxacin	drug
false

Results revealed that the strains were resistant to many drugs at high levels , only DRUGN , DRUGA , DRUGB and DRUGN showed resistances at comparatively lower levels .
carbenicillin	drug	amikacin	drug
false

Results revealed that the strains were resistant to many drugs at high levels , only DRUGN , DRUGA , DRUGN and DRUGB showed resistances at comparatively lower levels .
carbenicillin	drug	ciprofloxacin	drug
false

Results revealed that the strains were resistant to many drugs at high levels , only DRUGN , DRUGN , DRUGA and DRUGB showed resistances at comparatively lower levels .
amikacin	drug	ciprofloxacin	drug
false

Distinct and statistically significant synergism was observed between DRUGA and DRUGB by disc diffusion tests when compared with their individual effects .
methylglyoxal	drug_n	piperacillin	drug
effect

Synergism was also noted when DRUGA was combined with DRUGB and DRUGN .
methylglyoxal	drug_n	carbenicillin	drug
effect

Synergism was also noted when DRUGA was combined with DRUGN and DRUGB .
methylglyoxal	drug_n	amikacin	drug
effect

Synergism was also noted when DRUGN was combined with DRUGA and DRUGB .
carbenicillin	drug	amikacin	drug
false

Protective effect of DRUGA and DRUGB against the acute toxicity of diepoxybutane to human lymphocytes .
acetyl-l-carnitine	drug	alpha lipoic acid	drug_n
false

( ii ) DRUGA elicits a significant protective effect on DEB induced toxicity , which was potentiated by DRUGB .
acetyl-l-carnitine	drug	alpha-lipoic acid	drug
effect

[ Influence of DRUGA and DRUGB on MPTP evoked behavior violations in CdgbBL / dgb mice ] .
hemantane	drug_n	doxycycline	drug
false

The effects of DRUGA DRUGB [ DRUGN ] ( dgb mg / kg , p . o . )
anti-parkinsonian drug	group	hemantane	drug_n
false

The effects of DRUGA DRUGN [ DRUGB ] ( dgb mg / kg , p . o . )
anti-parkinsonian drug	group	(2-adamantyl)hexamethylenimine	drug_n
false

The effects of DRUGN DRUGA [ DRUGB ] ( dgb mg / kg , p . o . )
hemantane	drug_n	(2-adamantyl)hexamethylenimine	drug_n
false

and / or DRUGA DRUGB ( dgb mg / kg , p . o . ) , as well as that of neurotoxin DRUGN ( DRUGN ) ( dgb x dgb mg / kg , i. p . )
antibiotic drug	group	doxycycline	drug
false

and / or DRUGA DRUGN ( dgb mg / kg , p . o . ) , as well as that of neurotoxin DRUGB ( DRUGN ) ( dgb x dgb mg / kg , i. p . )
antibiotic drug	group	1-methyl-4-phenyl-1,2,3,4-tetrahydropyridine	drug_n
false

and / or DRUGA DRUGN ( dgb mg / kg , p . o . ) , as well as that of neurotoxin DRUGN ( DRUGB ) ( dgb x dgb mg / kg , i. p . )
antibiotic drug	group	MPTP	drug_n
false

and / or DRUGN DRUGA ( dgb mg / kg , p . o . ) , as well as that of neurotoxin DRUGB ( DRUGN ) ( dgb x dgb mg / kg , i. p . )
doxycycline	drug	1-methyl-4-phenyl-1,2,3,4-tetrahydropyridine	drug_n
false

and / or DRUGN DRUGA ( dgb mg / kg , p . o . ) , as well as that of neurotoxin DRUGN ( DRUGB ) ( dgb x dgb mg / kg , i. p . )
doxycycline	drug	MPTP	drug_n
false

and / or DRUGN DRUGN ( dgb mg / kg , p . o . ) , as well as that of neurotoxin DRUGA ( DRUGB ) ( dgb x dgb mg / kg , i. p . )
1-methyl-4-phenyl-1,2,3,4-tetrahydropyridine	drug_n	MPTP	drug_n
false

Acute administration of DRUGA or DRUGB failed to influence locomotion in mice , while their combination normalized motor activity .
hemantane	drug_n	doxycycline	drug
effect

The role of pdgb ( Kipdgb ) in DRUGA enhanced DRUGB cytotoxicity in human ovarian cancer cells .
dasatinib	drug	paclitaxel	drug
effect

The effect of DRUGA , an inhibitor of Src and Abl kinases , on DRUGB sensitivity was measured in ovarian cancer cells and HEY xenografts .
dasatinib	drug	paclitaxel	drug
false

HEY cells treated with DRUGA plus DRUGB formed fewer colonies than did cells treated with either agent alone .
dasatinib	drug	paclitaxel	drug
effect

DRUGA + DRUGB vs .
dasatinib	drug	paclitaxel	drug
false

Studies with forced expression and siRNA knockdown of Bcl dgb and Cdkdgb suggest that DRUGA mediated induction of pdgb ( Kipdgb ) enhanced DRUGB induced apoptosis by negatively regulating Bcl dgb and Cdkdgb expression .
dasatinib	drug	paclitaxel	drug
effect

Inhibition of Src family and Abl kinases with either siRNAs or DRUGA enhances DRUGB sensitivity of ovarian cancer cells through pdgb ( Kipdgb ) mediated suppression of Bcl dgb and Cdkdgb expression .
dasatinib	drug	paclitaxel	drug
effect

Phase I trial of DRUGA and DRUGB in patients with relapsed multiple myeloma : evidence for DRUGN DRUGN interaction via P glycoprotein .
lenalidomide	drug	CCI-779	drug
false

Phase I trial of DRUGA and DRUGN in patients with relapsed multiple myeloma : evidence for DRUGN DRUGB interaction via P glycoprotein .
lenalidomide	drug	CCI-779	drug
false

Phase I trial of DRUGN and DRUGA in patients with relapsed multiple myeloma : evidence for DRUGB DRUGN interaction via P glycoprotein .
CCI-779	drug	lenalidomide	drug
false

Phase I trial of DRUGN and DRUGN in patients with relapsed multiple myeloma : evidence for DRUGA DRUGB interaction via P glycoprotein .
lenalidomide	drug	CCI-779	drug
false

The preclinical combination of DRUGA with the mTOR inhibitor DRUGB has displayed synergy in vitro and represents a novel combination in MM .
lenalidomide	drug	CCI-779	drug
effect

Enhancement of humoral immune responses to inactivated Newcastle disease and DRUGA by oral administration of DRUGB in chickens .
avian influenza vaccines	group	ginseng stem-and-leaf saponins	drug_n
false

In experiment dgb , oral administration of DRUGA at a dose of dgb mg / kg of BW for dgb d on the immune response in chickens intramuscularly injected with DRUGB was evaluated .
GSLS	drug_n	inactivated ND vaccine	drug
false

In experiment dgb , the same regimen of DRUGA was administered to chickens inoculated with DRUGB , and an enhanced serum antibody response to AI vaccination was also observed .
GSLS	drug_n	inactivated AI vaccines	drug
effect

Interaction of DRUGA and DRUGB , in vitro and in vivo , in human Adgb melanoma cells .
dacarbazine	drug	imexon	drug_n
false

We evaluated mechanisms of interaction between the alkyating agent DRUGA ( DRUGB ) and the pro oxidant , DRUGN , in the human Adgb melanoma cell line .
dacarbazine	drug	DTIC	drug
false

We evaluated mechanisms of interaction between the alkyating agent DRUGA ( DRUGN ) and the pro oxidant , DRUGB , in the human Adgb melanoma cell line .
dacarbazine	drug	imexon	drug
false

We evaluated mechanisms of interaction between the alkyating agent DRUGN ( DRUGA ) and the pro oxidant , DRUGB , in the human Adgb melanoma cell line .
DTIC	drug	imexon	drug
false

There was a > dgb % reduction in cellular glutathione and cysteine with DRUGA but not DRUGB .
imexon	drug	DTIC	drug
false

DRUGA and DRUGB show additive effects in vitro but not in vivo in human Adgb melanoma cells .
Imexon	drug	dacarbazine	drug
effect

DRUGA enhances DRUGB mediated antibody dependent cellular cytotoxicity by up regulation of cell surface HERdgb expression .
Lapatinib	drug	herceptin	brand
effect

We evaluated how DRUGA interacts with DRUGB in HERdgb positive breast cancer , with a particular focus on DRUGN mediated antibody dependent cellular cytotoxicity ( ADCC ) .
lapatinib	drug	Herceptin	brand
false

We evaluated how DRUGA interacts with DRUGN in HERdgb positive breast cancer , with a particular focus on DRUGB mediated antibody dependent cellular cytotoxicity ( ADCC ) .
lapatinib	drug	Herceptin	brand
false

In an in vitro assay , DRUGA induced HERdgb expression at the cell surface of HERdgb positive breast cancer cell lines , leading to the enhancement of DRUGB mediated ADCC .
lapatinib	drug	Herceptin	brand
effect

Furthermore , we present a case report in which a second DRUGA treatment following DRUGB resulted in the marked shrinkage of multiple metastatic tumors in HERdgb positive breast cancer .
Herceptin	brand	lapatinib	drug
effect

DRUGA may have the potential to convert DRUGB refractory to DRUGN sensitive tumors in HERdgb positive breast cancer by up regulation of the cell surface expression of HERdga
Lapatinib	drug	Herceptin	brand
false

DRUGA may have the potential to convert DRUGN refractory to DRUGB sensitive tumors in HERdgb positive breast cancer by up regulation of the cell surface expression of HERdga
Lapatinib	drug	Herceptin	brand
false

The aim of the present study was to investigate whether HB EGF is a therapeutic target for T ALL , and to further elucidate the antitumor effects of a specific inhibitor of HB EGF , DRUGA ( DRUGB ) .
cross-reacting material 197	drug_n	CRM197	drug_n
false

We elucidated the expression of HB EGF in T ALL cell lines , and evaluated the effect of DRUGA on these cells alone or in combination with DRUGB .
CRM197	drug_n	anticancer agent	group
false

DRUGA induced apoptosis , and furthermore , the combination of DRUGN plus DRUGB enhanced cytotoxicity in a T ALL cell line .
CRM197	drug_n	doxorubicin	drug
false

DRUGN induced apoptosis , and furthermore , the combination of DRUGA plus DRUGB enhanced cytotoxicity in a T ALL cell line .
CRM197	drug_n	doxorubicin	drug
effect

DRUGA enhances the antinociceptive effect of DRUGB in mice .
Ephedrine	drug	dexmedetomidine	drug
effect

The purpose of this study was to evaluate whether the psychostimulant drug DRUGA has any effect on DRUGB induced antinociception and locomotor inhibitor activity in mice in acute application .
ephedrine	drug	dexmedetomidine	drug
false

In the hot plate test in mice , co administration of dgb g / kg DRUGA with dgb mg / kg DRUGB intraperitoneally not only enhanced , but also prolonged the duration of antinociception induced by DRUGN .
dexmedetomidine	drug	ephedrine	drug
effect

In the hot plate test in mice , co administration of dgb g / kg DRUGN with dgb mg / kg DRUGA intraperitoneally not only enhanced , but also prolonged the duration of antinociception induced by DRUGB .
ephedrine	drug	dexmedetomidine	drug
false

At the same time , the locomotor inhibitory effect of DRUGA was counteracted by DRUGB .
dexmedetomidine	drug	ephedrine	drug
effect

We concluded that the combined administration of DRUGA with DRUGB may have beneficial effects in the treatment of pain without causing sedation , which limits the use of DRUGN as an DRUGN in humans .
dexmedetomidine	drug	ephedrine	drug
effect

We concluded that the combined administration of DRUGA with DRUGN may have beneficial effects in the treatment of pain without causing sedation , which limits the use of DRUGN as an DRUGB in humans .
dexmedetomidine	drug	analgesic	group
false

We concluded that the combined administration of DRUGN with DRUGA may have beneficial effects in the treatment of pain without causing sedation , which limits the use of DRUGB as an DRUGN in humans .
ephedrine	drug	dexmedetomidine	drug
false

We concluded that the combined administration of DRUGN with DRUGA may have beneficial effects in the treatment of pain without causing sedation , which limits the use of DRUGN as an DRUGB in humans .
ephedrine	drug	analgesic	group
false

We concluded that the combined administration of DRUGN with DRUGN may have beneficial effects in the treatment of pain without causing sedation , which limits the use of DRUGA as an DRUGB in humans .
dexmedetomidine	drug	analgesic	group
false

[ Efficacy of fixed combination DRUGA / DRUGB in hospitalized patients with hypertensive disease ]
amlodipine	drug	valsartan	drug
false

Efficacy and tolerability of fixed DRUGA / DRUGB combination was studied in dgb patients with hypertensive disease hospitalized in departments of general internal medicine or cardiology .
amlodipine	drug	valsartan	drug
false

All patients had indications for antihypertensive therapy and were randomized either to fixed combination DRUGA / DRUGB ( n=dgb ) or to therapy which corresponded to the hospital formulary ( n=dgb ) .
amlodipine	drug	valsartan	drug
false

Rate of achievement of target BP with fixed combination DRUGA / DRUGB ( dgb % ) was comparable with that on traditional therapy ( dgb % ) .
amlodipine	drug	valsartan	drug
false

We have demonstrated appropriateness of inhospital administration of fixed DRUGA / DRUGB combination as an approach allowing to achieve target BP in shorter time , with the use of fewer DRUGN , and diminishing concealed inefficacy of treatment .
amlodipine	drug	valsartan	drug
effect

We have demonstrated appropriateness of inhospital administration of fixed DRUGA / DRUGN combination as an approach allowing to achieve target BP in shorter time , with the use of fewer DRUGB , and diminishing concealed inefficacy of treatment .
amlodipine	drug	antihypertensive drugs	group
false

We have demonstrated appropriateness of inhospital administration of fixed DRUGN / DRUGA combination as an approach allowing to achieve target BP in shorter time , with the use of fewer DRUGB , and diminishing concealed inefficacy of treatment .
valsartan	drug	antihypertensive drugs	group
false

DRUGA ( DRUGB ) better than DRUGN ( DRUGN )
Ticagrelor	drug	Brilinta	brand
false

DRUGA ( DRUGN ) better than DRUGB ( DRUGN )
Ticagrelor	drug	clopidogrel	drug
false

DRUGA ( DRUGN ) better than DRUGN ( DRUGB )
Ticagrelor	drug	Plavix	brand
false

DRUGN ( DRUGA ) better than DRUGB ( DRUGN )
Brilinta	brand	clopidogrel	drug
false

DRUGN ( DRUGA ) better than DRUGN ( DRUGB )
Brilinta	brand	Plavix	brand
false

DRUGN ( DRUGN ) better than DRUGA ( DRUGB )
clopidogrel	drug	Plavix	brand
false

The FDA has approved DRUGA ( DRUGB AstraZeneca ) , an oral DRUGN , for use with low dose DRUGN to reduce the rate of thrombotic cardiovascular events in patients with acute coronary syndrome ( ACS ) .
ticagrelor	drug	Brilinta	brand
false

The FDA has approved DRUGA ( DRUGN AstraZeneca ) , an oral DRUGB , for use with low dose DRUGN to reduce the rate of thrombotic cardiovascular events in patients with acute coronary syndrome ( ACS ) .
ticagrelor	drug	antiplatelet drug	group
false

The FDA has approved DRUGA ( DRUGN AstraZeneca ) , an oral DRUGN , for use with low dose DRUGB to reduce the rate of thrombotic cardiovascular events in patients with acute coronary syndrome ( ACS ) .
ticagrelor	drug	aspirin	brand
effect

The FDA has approved DRUGN ( DRUGA AstraZeneca ) , an oral DRUGB , for use with low dose DRUGN to reduce the rate of thrombotic cardiovascular events in patients with acute coronary syndrome ( ACS ) .
Brilinta	brand	antiplatelet drug	group
false

The FDA has approved DRUGN ( DRUGA AstraZeneca ) , an oral DRUGN , for use with low dose DRUGB to reduce the rate of thrombotic cardiovascular events in patients with acute coronary syndrome ( ACS ) .
Brilinta	brand	aspirin	brand
effect

The FDA has approved DRUGN ( DRUGN AstraZeneca ) , an oral DRUGA , for use with low dose DRUGB to reduce the rate of thrombotic cardiovascular events in patients with acute coronary syndrome ( ACS ) .
antiplatelet drug	group	aspirin	brand
false

It will compete with DRUGA ( DRUGB ) and DRUGN ( DRUGN ) for such use .
clopidogrel	drug	Plavix	brand
false

It will compete with DRUGA ( DRUGN ) and DRUGB ( DRUGN ) for such use .
clopidogrel	drug	prasugrel	drug
false

It will compete with DRUGA ( DRUGN ) and DRUGN ( DRUGB ) for such use .
clopidogrel	drug	Effient	brand
false

It will compete with DRUGN ( DRUGA ) and DRUGB ( DRUGN ) for such use .
Plavix	brand	prasugrel	drug
false

It will compete with DRUGN ( DRUGA ) and DRUGN ( DRUGB ) for such use .
Plavix	brand	Effient	brand
false

It will compete with DRUGN ( DRUGN ) and DRUGA ( DRUGB ) for such use .
prasugrel	drug	Effient	brand
false

Influence of DRUGA on DRUGB induced antinociception and its pharmacokinetics .
piperine	drug_n	ibuprofen	drug
false

In the present study DRUGA ( dgb mg / kg ) significantly increased the dose dependent antinociceptive activity of DRUGB evaluated by both DRUGN writhing and formalin test , when it was administered with DRUGN .
piperine	drug_n	ibuprofen	drug
effect

In the present study DRUGA ( dgb mg / kg ) significantly increased the dose dependent antinociceptive activity of DRUGN evaluated by both DRUGB writhing and formalin test , when it was administered with DRUGN .
piperine	drug_n	acetic acid	drug
false

In the present study DRUGA ( dgb mg / kg ) significantly increased the dose dependent antinociceptive activity of DRUGN evaluated by both DRUGN writhing and formalin test , when it was administered with DRUGB .
piperine	drug_n	ibuprofen	drug
false

In the present study DRUGN ( dgb mg / kg ) significantly increased the dose dependent antinociceptive activity of DRUGA evaluated by both DRUGB writhing and formalin test , when it was administered with DRUGN .
ibuprofen	drug	acetic acid	drug
false

In the present study DRUGN ( dgb mg / kg ) significantly increased the dose dependent antinociceptive activity of DRUGN evaluated by both DRUGA writhing and formalin test , when it was administered with DRUGB .
acetic acid	drug	ibuprofen	drug
false

DRUGA plasma concentration was also increased when it was administered with DRUGB .
Ibuprofen	drug	piperine	drug_n
mechanism

The synergistic antinociception activity of DRUGA when administered with DRUGB can be attributed to increased plasma concentration of DRUGN .
ibuprofen	drug	piperine	drug_n
mechanism

The synergistic antinociception activity of DRUGN when administered with DRUGA can be attributed to increased plasma concentration of DRUGB .
piperine	drug_n	ibuprofen	drug
false

From this study it can be concluded that DRUGA can be used as a bioenhancer along with DRUGB .
piperine	drug_n	ibuprofen	drug
effect

Pharmacokinetic properties of DRUGA were not altered by the addition of either DRUGB or DRUGN or the combination of DRUGN and DRUGN .
abacavir	drug	lamivudine	drug
false

Pharmacokinetic properties of DRUGA were not altered by the addition of either DRUGN or DRUGB or the combination of DRUGN and DRUGN .
abacavir	drug	zidovudine	drug
false

Pharmacokinetic properties of DRUGA were not altered by the addition of either DRUGN or DRUGN or the combination of DRUGB and DRUGN .
abacavir	drug	lamivudine	drug
false

Pharmacokinetic properties of DRUGA were not altered by the addition of either DRUGN or DRUGN or the combination of DRUGN and DRUGB .
abacavir	drug	zidovudine	drug
false

Pharmacokinetic properties of DRUGN were not altered by the addition of either DRUGA or DRUGB or the combination of DRUGN and DRUGN .
lamivudine	drug	zidovudine	drug
false

Pharmacokinetic properties of DRUGN were not altered by the addition of either DRUGA or DRUGN or the combination of DRUGN and DRUGB .
lamivudine	drug	zidovudine	drug
false

Pharmacokinetic properties of DRUGN were not altered by the addition of either DRUGN or DRUGA or the combination of DRUGB and DRUGN .
zidovudine	drug	lamivudine	drug
false

Pharmacokinetic properties of DRUGN were not altered by the addition of either DRUGN or DRUGN or the combination of DRUGA and DRUGB .
lamivudine	drug	zidovudine	drug
false

No clinically significant changes to DRUGA or DRUGB pharmacokinetics were observed following concomitant administration of DRUGN .
lamivudine	drug	zidovudine	drug
false

No clinically significant changes to DRUGA or DRUGN pharmacokinetics were observed following concomitant administration of DRUGB .
lamivudine	drug	abacavir	drug
false

No clinically significant changes to DRUGN or DRUGA pharmacokinetics were observed following concomitant administration of DRUGB .
zidovudine	drug	abacavir	drug
false

DRUGA has no effect on the pharmacokinetic properties of DRUGB .
Abacavir	drug	ethanol	drug
false

DRUGA decreases the elimination of DRUGB causing an increase in overall exposure . The addition of DRUGN has no clinically significant effect on the pharmacokinetic properties of DRUGN .
Ethanol	drug	abacavir	drug
mechanism

DRUGA decreases the elimination of DRUGN causing an increase in overall exposure . The addition of DRUGB has no clinically significant effect on the pharmacokinetic properties of DRUGN .
Ethanol	drug	methadone	drug
false

DRUGA decreases the elimination of DRUGN causing an increase in overall exposure . The addition of DRUGN has no clinically significant effect on the pharmacokinetic properties of DRUGB .
Ethanol	drug	abacavir	drug
false

DRUGN decreases the elimination of DRUGA causing an increase in overall exposure . The addition of DRUGB has no clinically significant effect on the pharmacokinetic properties of DRUGN .
abacavir	drug	methadone	drug
false

DRUGN decreases the elimination of DRUGN causing an increase in overall exposure . The addition of DRUGA has no clinically significant effect on the pharmacokinetic properties of DRUGB .
methadone	drug	abacavir	drug
false

DRUGA : Concomitant DRUGB administration decreased the mean AUC of total DRUGN approximately dgb % .
Cholestyramine	drug	cholestyramine	drug
false

DRUGA : Concomitant DRUGN administration decreased the mean AUC of total DRUGB approximately dgb % .
Cholestyramine	drug	ezetimibe	drug
false

DRUGN : Concomitant DRUGA administration decreased the mean AUC of total DRUGB approximately dgb % .
cholestyramine	drug	ezetimibe	drug
mechanism

The incremental LDL C reduction due to adding DRUGA to DRUGB may be reduced by this interaction .
ezetimibe	drug	cholestyramine	drug
effect

DRUGA : The safety and effectiveness of DRUGB administered with DRUGN have not been established .
Fibrates	group	ezetimibe	drug
false

DRUGA : The safety and effectiveness of DRUGN administered with DRUGB have not been established .
Fibrates	group	fibrates	group
false

DRUGN : The safety and effectiveness of DRUGA administered with DRUGB have not been established .
ezetimibe	drug	fibrates	group
false

Co administration of DRUGA with DRUGB is not recommended until use in patients is studied .
ZETIA	brand	fibrates	group
advise

DRUGA : In a pharmacokinetic study , concomitant DRUGB administration increased total DRUGN concentrations approximately dga fold .
Fenofibrate	drug	fenofibrate	drug
false

DRUGA : In a pharmacokinetic study , concomitant DRUGN administration increased total DRUGB concentrations approximately dga fold .
Fenofibrate	drug	ezetimibe	drug
false

DRUGN : In a pharmacokinetic study , concomitant DRUGA administration increased total DRUGB concentrations approximately dga fold .
fenofibrate	drug	ezetimibe	drug
mechanism

DRUGA : In a pharmacokinetic study , concomitant DRUGB administration increased total DRUGN concentrations approximately dga fold .
Gemfibrozil	drug	gemfibrozil	drug
false

DRUGA : In a pharmacokinetic study , concomitant DRUGN administration increased total DRUGB concentrations approximately dga fold .
Gemfibrozil	drug	ezetimibe	drug
false

DRUGN : In a pharmacokinetic study , concomitant DRUGA administration increased total DRUGB concentrations approximately dga fold .
gemfibrozil	drug	ezetimibe	drug
false

DRUGA : No clinically significant pharmacokinetic interactions were seen when DRUGB was co administered with DRUGN , DRUGN , DRUGN , DRUGN , or DRUGN .
HMG-CoA reductase inhibitors	group	ezetimibe	drug
false

DRUGA : No clinically significant pharmacokinetic interactions were seen when DRUGN was co administered with DRUGB , DRUGN , DRUGN , DRUGN , or DRUGN .
HMG-CoA reductase inhibitors	group	atorvastatin	drug
false

DRUGA : No clinically significant pharmacokinetic interactions were seen when DRUGN was co administered with DRUGN , DRUGB , DRUGN , DRUGN , or DRUGN .
HMG-CoA reductase inhibitors	group	simvastatin	drug
false

DRUGA : No clinically significant pharmacokinetic interactions were seen when DRUGN was co administered with DRUGN , DRUGN , DRUGB , DRUGN , or DRUGN .
HMG-CoA reductase inhibitors	group	pravastatin	drug
false

DRUGA : No clinically significant pharmacokinetic interactions were seen when DRUGN was co administered with DRUGN , DRUGN , DRUGN , DRUGB , or DRUGN .
HMG-CoA reductase inhibitors	group	lovastatin	drug
false

DRUGA : No clinically significant pharmacokinetic interactions were seen when DRUGN was co administered with DRUGN , DRUGN , DRUGN , DRUGN , or DRUGB .
HMG-CoA reductase inhibitors	group	fluvastatin	drug
false

DRUGN : No clinically significant pharmacokinetic interactions were seen when DRUGA was co administered with DRUGB , DRUGN , DRUGN , DRUGN , or DRUGN .
ezetimibe	drug	atorvastatin	drug
false

DRUGN : No clinically significant pharmacokinetic interactions were seen when DRUGA was co administered with DRUGN , DRUGB , DRUGN , DRUGN , or DRUGN .
ezetimibe	drug	simvastatin	drug
false

DRUGN : No clinically significant pharmacokinetic interactions were seen when DRUGA was co administered with DRUGN , DRUGN , DRUGB , DRUGN , or DRUGN .
ezetimibe	drug	pravastatin	drug
false

DRUGN : No clinically significant pharmacokinetic interactions were seen when DRUGA was co administered with DRUGN , DRUGN , DRUGN , DRUGB , or DRUGN .
ezetimibe	drug	lovastatin	drug
false

DRUGN : No clinically significant pharmacokinetic interactions were seen when DRUGA was co administered with DRUGN , DRUGN , DRUGN , DRUGN , or DRUGB .
ezetimibe	drug	fluvastatin	drug
false

DRUGN : No clinically significant pharmacokinetic interactions were seen when DRUGN was co administered with DRUGA , DRUGB , DRUGN , DRUGN , or DRUGN .
atorvastatin	drug	simvastatin	drug
false

DRUGN : No clinically significant pharmacokinetic interactions were seen when DRUGN was co administered with DRUGA , DRUGN , DRUGB , DRUGN , or DRUGN .
atorvastatin	drug	pravastatin	drug
false

DRUGN : No clinically significant pharmacokinetic interactions were seen when DRUGN was co administered with DRUGA , DRUGN , DRUGN , DRUGB , or DRUGN .
atorvastatin	drug	lovastatin	drug
false

DRUGN : No clinically significant pharmacokinetic interactions were seen when DRUGN was co administered with DRUGA , DRUGN , DRUGN , DRUGN , or DRUGB .
atorvastatin	drug	fluvastatin	drug
false

DRUGN : No clinically significant pharmacokinetic interactions were seen when DRUGN was co administered with DRUGN , DRUGA , DRUGB , DRUGN , or DRUGN .
simvastatin	drug	pravastatin	drug
false

DRUGN : No clinically significant pharmacokinetic interactions were seen when DRUGN was co administered with DRUGN , DRUGA , DRUGN , DRUGB , or DRUGN .
simvastatin	drug	lovastatin	drug
false

DRUGN : No clinically significant pharmacokinetic interactions were seen when DRUGN was co administered with DRUGN , DRUGA , DRUGN , DRUGN , or DRUGB .
simvastatin	drug	fluvastatin	drug
false

DRUGN : No clinically significant pharmacokinetic interactions were seen when DRUGN was co administered with DRUGN , DRUGN , DRUGA , DRUGB , or DRUGN .
pravastatin	drug	lovastatin	drug
false

DRUGN : No clinically significant pharmacokinetic interactions were seen when DRUGN was co administered with DRUGN , DRUGN , DRUGA , DRUGN , or DRUGB .
pravastatin	drug	fluvastatin	drug
false

DRUGN : No clinically significant pharmacokinetic interactions were seen when DRUGN was co administered with DRUGN , DRUGN , DRUGN , DRUGA , or DRUGB .
lovastatin	drug	fluvastatin	drug
false

DRUGA : The total DRUGB level increased dgb fold in one renal transplant patient receiving multiple medications , including DRUGN .
Cyclosporine	drug	ezetimibe	drug
false

DRUGA : The total DRUGN level increased dgb fold in one renal transplant patient receiving multiple medications , including DRUGB .
Cyclosporine	drug	cyclosporine	drug
false

DRUGN : The total DRUGA level increased dgb fold in one renal transplant patient receiving multiple medications , including DRUGB .
ezetimibe	drug	cyclosporine	drug
mechanism

Patients who take both DRUGA and DRUGB should be carefully monitored .
ezetimibe	drug	cyclosporine	drug
advise

Multiple dose studies of DRUGA given in combination with DRUGB ( DRUGN ) in rats and rabbits during organogenesis result in higher DRUGN and statin exposures .
ezetimibe	drug	HMG-CoA reductase inhibitors	group
false

Multiple dose studies of DRUGA given in combination with DRUGN ( DRUGB ) in rats and rabbits during organogenesis result in higher DRUGN and statin exposures .
ezetimibe	drug	statins	group
false

Multiple dose studies of DRUGN given in combination with DRUGA ( DRUGB ) in rats and rabbits during organogenesis result in higher DRUGN and statin exposures .
HMG-CoA reductase inhibitors	group	statins	group
false

Multiple dose studies of DRUGN given in combination with DRUGA ( DRUGN ) in rats and rabbits during organogenesis result in higher DRUGB and statin exposures .
HMG-CoA reductase inhibitors	group	ezetimibe	drug
false

Multiple dose studies of DRUGN given in combination with DRUGN ( DRUGA ) in rats and rabbits during organogenesis result in higher DRUGB and statin exposures .
statins	group	ezetimibe	drug
false

When DRUGA is administered with an DRUGB in a woman of childbearing potential , refer to the pregnancy category and package labeling for the DRUGN .
ZETIA	brand	HMG-CoA reductase inhibitor	group
false

When DRUGA is administered with an DRUGN in a woman of childbearing potential , refer to the pregnancy category and package labeling for the DRUGB .
ZETIA	brand	HMG-CoA reductase inhibitor	drug
false

one fatality has been reported from hypoglycemia in association with combined DRUGA and DRUGB use .
DIFLUCAN	brand	glyburide	drug
effect

DRUGA reduces the metabolism of DRUGB , DRUGN , and DRUGN and increases the plasma concentration of these agents .
DIFLUCAN	brand	tolbutamide	drug
mechanism

DRUGA reduces the metabolism of DRUGN , DRUGB , and DRUGN and increases the plasma concentration of these agents .
DIFLUCAN	brand	glyburide	drug
mechanism

DRUGA reduces the metabolism of DRUGN , DRUGN , and DRUGB and increases the plasma concentration of these agents .
DIFLUCAN	brand	glipizide	drug
mechanism

DRUGN reduces the metabolism of DRUGA , DRUGB , and DRUGN and increases the plasma concentration of these agents .
tolbutamide	drug	glyburide	drug
false

DRUGN reduces the metabolism of DRUGA , DRUGN , and DRUGB and increases the plasma concentration of these agents .
tolbutamide	drug	glipizide	drug
false

DRUGN reduces the metabolism of DRUGN , DRUGA , and DRUGB and increases the plasma concentration of these agents .
glyburide	drug	glipizide	drug
false

When DRUGA is used concomitantly with these or other DRUGB , blood glucose concentrations should be carefully monitored and the dose of the DRUGN should be adjusted as necessary .
DIFLUCAN	brand	sulfonylurea oral hypoglycemic agents	group
advise

When DRUGA is used concomitantly with these or other DRUGN , blood glucose concentrations should be carefully monitored and the dose of the DRUGB should be adjusted as necessary .
DIFLUCAN	brand	sulfonylurea	group
false

When DRUGN is used concomitantly with these or other DRUGA , blood glucose concentrations should be carefully monitored and the dose of the DRUGB should be adjusted as necessary .
sulfonylurea oral hypoglycemic agents	group	sulfonylurea	group
false

DRUGA : Prothrombin time may be increased in patients receiving concomitant DRUGB and DRUGN .
Coumarin-type anticoagulants	group	DIFLUCAN	brand
false

DRUGA : Prothrombin time may be increased in patients receiving concomitant DRUGN and DRUGB .
Coumarin-type anticoagulants	group	coumarin-type anticoagulants	group
false

DRUGN : Prothrombin time may be increased in patients receiving concomitant DRUGA and DRUGB .
DIFLUCAN	brand	coumarin-type anticoagulants	group
effect

Careful monitoring of prothrombin time in patients receiving DRUGA and DRUGB is recommended .
DIFLUCAN	brand	coumarin-type anticoagulants	group
advise

DRUGA : DRUGB increases the plasma concentrations of DRUGN .
Phenytoin	drug	DIFLUCAN	brand
false

DRUGA : DRUGN increases the plasma concentrations of DRUGB .
Phenytoin	drug	phenytoin	drug
false

DRUGN : DRUGA increases the plasma concentrations of DRUGB .
DIFLUCAN	brand	phenytoin	drug
mechanism

Careful monitoring of DRUGA concentrations in patients receiving DRUGB and DRUGN is recommended .
phenytoin	drug	DIFLUCAN	brand
false

Careful monitoring of DRUGN concentrations in patients receiving DRUGA and DRUGB is recommended .
DIFLUCAN	brand	phenytoin	drug
advise

DRUGA : DRUGB may significantly increase DRUGN levels in renal transplant patients with or without renal impairment .
Cyclosporine	drug	DIFLUCAN	brand
false

DRUGA : DRUGN may significantly increase DRUGB levels in renal transplant patients with or without renal impairment .
Cyclosporine	drug	cyclosporine	drug
false

DRUGN : DRUGA may significantly increase DRUGB levels in renal transplant patients with or without renal impairment .
DIFLUCAN	brand	cyclosporine	drug
mechanism

Careful monitoring of DRUGA concentrations and serum creatinine is recommended in patients receiving DRUGB and DRUGN .
cyclosporine	drug	DIFLUCAN	brand
false

Careful monitoring of DRUGN concentrations and serum creatinine is recommended in patients receiving DRUGA and DRUGB .
DIFLUCAN	brand	cyclosporine	drug
advise

DRUGA : DRUGN enhances the metabolism of concurrently administered DRUGB .
Rifampin	drug	DIFLUCAN	brand
false

DRUGN : DRUGA enhances the metabolism of concurrently administered DRUGB .
Rifampin	drug	DIFLUCAN	brand
mechanism

Depending on clinical circumstances , consideration should be given to increasing the dose of DRUGA when it is administered with DRUGB .
DIFLUCAN	brand	rifampin	drug
advise

DRUGA : DRUGB increases the serum concentrations of DRUGN .
Theophylline	drug	DIFLUCAN	brand
false

DRUGA : DRUGN increases the serum concentrations of DRUGB .
Theophylline	drug	theophylline	drug
false

DRUGN : DRUGA increases the serum concentrations of DRUGB .
DIFLUCAN	brand	theophylline	drug
mechanism

Careful monitoring of serum DRUGA concentrations in patients receiving DRUGB and DRUGN is recommended .
theophylline	drug	DIFLUCAN	brand
false

Careful monitoring of serum DRUGN concentrations in patients receiving DRUGA and DRUGB is recommended .
DIFLUCAN	brand	theophylline	drug
advise

DRUGA : Because of the occurrence of serious cardiac dysrhythmias secondary to prolongation of the QTc interval in patients receiving DRUGB in conjunction with DRUGN , interaction studies have been performed .
Terfenadine	drug	azole antifungals	group
false

DRUGA : Because of the occurrence of serious cardiac dysrhythmias secondary to prolongation of the QTc interval in patients receiving DRUGN in conjunction with DRUGB , interaction studies have been performed .
Terfenadine	drug	terfenadine	drug
false

DRUGN : Because of the occurrence of serious cardiac dysrhythmias secondary to prolongation of the QTc interval in patients receiving DRUGA in conjunction with DRUGB , interaction studies have been performed .
azole antifungals	group	terfenadine	drug
effect

Another study at a dgb mg and dgb mg daily dose of DRUGA demonstrated that DRUGB taken in doses of dgb mg per day or greater significantly increases plasma levels of DRUGN when taken concomitantly .
fluconazole	drug	DIFLUCAN	brand
false

Another study at a dgb mg and dgb mg daily dose of DRUGA demonstrated that DRUGN taken in doses of dgb mg per day or greater significantly increases plasma levels of DRUGB when taken concomitantly .
fluconazole	drug	terfenadine	drug
false

Another study at a dgb mg and dgb mg daily dose of DRUGN demonstrated that DRUGA taken in doses of dgb mg per day or greater significantly increases plasma levels of DRUGB when taken concomitantly .
DIFLUCAN	brand	terfenadine	drug
mechanism

The combined use of DRUGA at doses of dgb mg or greater with DRUGB is contraindicated .
fluconazole	drug	terfenadine	drug
advise

The coadministration of DRUGA at doses lower than dgb mg / day with DRUGB should be carefully monitored .
fluconazole	drug	terfenadine	drug
advise

DRUGA : There have been reports of cardiac events , including torsade de pointes in patients to whom DRUGB and DRUGN were coadministered .
Cisapride	drug	fluconazole	drug
false

DRUGA : There have been reports of cardiac events , including torsade de pointes in patients to whom DRUGN and DRUGB were coadministered .
Cisapride	drug	cisapride	drug
false

DRUGN : There have been reports of cardiac events , including torsade de pointes in patients to whom DRUGA and DRUGB were coadministered .
fluconazole	drug	cisapride	drug
effect

A controlled study found that concomitant DRUGA dgb mg once daily and DRUGB dgb mg four times a day yielded a significant increase in DRUGN plasma levels and prolongation of QTc interval .
fluconazole	drug	cisapride	drug
mechanism

A controlled study found that concomitant DRUGA dgb mg once daily and DRUGN dgb mg four times a day yielded a significant increase in DRUGB plasma levels and prolongation of QTc interval .
fluconazole	drug	cisapride	drug
false

The combined use of DRUGA with DRUGB is contraindicated .
fluconazole	drug	cisapride	drug
advise

DRUGA : The use of DRUGB in patients concurrently taking DRUGN or other drugs metabolized by the cytochrome Pdgb system may be associated with elevations in serum levels of these drugs .
Astemizole	drug	fluconazole	drug
false

DRUGA : The use of DRUGN in patients concurrently taking DRUGB or other drugs metabolized by the cytochrome Pdgb system may be associated with elevations in serum levels of these drugs .
Astemizole	drug	astemizole	drug
false

DRUGN : The use of DRUGA in patients concurrently taking DRUGB or other drugs metabolized by the cytochrome Pdgb system may be associated with elevations in serum levels of these drugs .
fluconazole	drug	astemizole	drug
mechanism

DRUGA : There have been reports of uveitis in patients to whom DRUGB and DRUGN were coadministered .
Rifabutin	drug	fluconazole	drug
false

DRUGA : There have been reports of uveitis in patients to whom DRUGN and DRUGB were coadministered .
Rifabutin	drug	rifabutin	drug
false

DRUGN : There have been reports of uveitis in patients to whom DRUGA and DRUGB were coadministered .
fluconazole	drug	rifabutin	drug
effect

Patients receiving DRUGA and DRUGB concomitantly should be carefully monitored .
rifabutin	drug	fluconazole	drug
advise

DRUGA : There have been reports of nephrotoxicity in patients to whom DRUGB and DRUGN were coadministered .
Tacrolimus	drug	fluconazole	drug
false

DRUGA : There have been reports of nephrotoxicity in patients to whom DRUGN and DRUGB were coadministered .
Tacrolimus	drug	tacrolimus	drug
false

DRUGN : There have been reports of nephrotoxicity in patients to whom DRUGA and DRUGB were coadministered .
fluconazole	drug	tacrolimus	drug
effect

Patients receiving DRUGA and DRUGB concomitantly should be carefully monitored .
tacrolimus	drug	fluconazole	drug
advise

DRUGA : Following oral administration of DRUGB , DRUGN resulted in substantial increases in DRUGN concentrations and psychomotor effects .
Short-acting Benzodiazepines	group	midazolam	drug
false

DRUGA : Following oral administration of DRUGN , DRUGB resulted in substantial increases in DRUGN concentrations and psychomotor effects .
Short-acting Benzodiazepines	group	fluconazole	drug
false

DRUGA : Following oral administration of DRUGN , DRUGN resulted in substantial increases in DRUGB concentrations and psychomotor effects .
Short-acting Benzodiazepines	group	midazolam	drug
false

DRUGN : Following oral administration of DRUGA , DRUGB resulted in substantial increases in DRUGN concentrations and psychomotor effects .
midazolam	drug	fluconazole	drug
mechanism

DRUGN : Following oral administration of DRUGN , DRUGA resulted in substantial increases in DRUGB concentrations and psychomotor effects .
fluconazole	drug	midazolam	drug
false

This effect on DRUGA appears to be more pronounced following oral administration of DRUGB than with DRUGN administered intravenously .
midazolam	drug	fluconazole	drug
effect

This effect on DRUGA appears to be more pronounced following oral administration of DRUGN than with DRUGB administered intravenously .
midazolam	drug	fluconazole	drug
false

If DRUGA , which are metabolized by the cytochrome Pdgb system , are concomitantly administered with DRUGB , consideration should be given to decreasing the DRUGN dosage , and the patients should be appropriately monitored .
short-acting benzodiazepines	group	fluconazole	drug
advise

If DRUGA , which are metabolized by the cytochrome Pdgb system , are concomitantly administered with DRUGN , consideration should be given to decreasing the DRUGB dosage , and the patients should be appropriately monitored .
short-acting benzodiazepines	group	benzodiazepine	group
false

If DRUGN , which are metabolized by the cytochrome Pdgb system , are concomitantly administered with DRUGA , consideration should be given to decreasing the DRUGB dosage , and the patients should be appropriately monitored .
fluconazole	drug	benzodiazepine	group
false

DRUGA tablets coadministered with DRUGB and DRUGN containing oral DRUGN produced an overall mean increase in DRUGN and DRUGN levels ;
Fluconazole	drug	ethinyl estradiol	drug
mechanism

DRUGA tablets coadministered with DRUGN and DRUGB containing oral DRUGN produced an overall mean increase in DRUGN and DRUGN levels ;
Fluconazole	drug	levonorgestrel	drug
mechanism

DRUGA tablets coadministered with DRUGN and DRUGN containing oral DRUGB produced an overall mean increase in DRUGN and DRUGN levels ;
Fluconazole	drug	contraceptives	group
false

DRUGA tablets coadministered with DRUGN and DRUGN containing oral DRUGN produced an overall mean increase in DRUGB and DRUGN levels ;
Fluconazole	drug	ethinyl estradiol	drug
false

DRUGA tablets coadministered with DRUGN and DRUGN containing oral DRUGN produced an overall mean increase in DRUGN and DRUGB levels ;
Fluconazole	drug	levonorgestrel	drug
false

DRUGN tablets coadministered with DRUGA and DRUGB containing oral DRUGN produced an overall mean increase in DRUGN and DRUGN levels ;
ethinyl estradiol	drug	levonorgestrel	drug
false

DRUGN tablets coadministered with DRUGA and DRUGN containing oral DRUGB produced an overall mean increase in DRUGN and DRUGN levels ;
ethinyl estradiol	drug	contraceptives	group
false

DRUGN tablets coadministered with DRUGA and DRUGN containing oral DRUGN produced an overall mean increase in DRUGN and DRUGB levels ;
ethinyl estradiol	drug	levonorgestrel	drug
false

DRUGN tablets coadministered with DRUGN and DRUGA containing oral DRUGB produced an overall mean increase in DRUGN and DRUGN levels ;
levonorgestrel	drug	contraceptives	group
false

DRUGN tablets coadministered with DRUGN and DRUGA containing oral DRUGN produced an overall mean increase in DRUGB and DRUGN levels ;
levonorgestrel	drug	ethinyl estradiol	drug
false

DRUGN tablets coadministered with DRUGN and DRUGN containing oral DRUGA produced an overall mean increase in DRUGB and DRUGN levels ;
contraceptives	group	ethinyl estradiol	drug
false

DRUGN tablets coadministered with DRUGN and DRUGN containing oral DRUGA produced an overall mean increase in DRUGN and DRUGB levels ;
contraceptives	group	levonorgestrel	drug
false

DRUGN tablets coadministered with DRUGN and DRUGN containing oral DRUGN produced an overall mean increase in DRUGA and DRUGB levels ;
ethinyl estradiol	drug	levonorgestrel	drug
false

however , in some patients there were decreases up to dgb % and dgb % of DRUGA and DRUGB levels .
ethinyl estradiol	drug	levonorgestrel	drug
false

The data presently available indicate that the decreases in some individual DRUGA and DRUGB AUC values with DRUGN treatment are likely the result of random variation .
ethinyl estradiol	drug	levonorgestrel	drug
false

The data presently available indicate that the decreases in some individual DRUGA and DRUGN AUC values with DRUGB treatment are likely the result of random variation .
ethinyl estradiol	drug	fluconazole	drug
false

The data presently available indicate that the decreases in some individual DRUGN and DRUGA AUC values with DRUGB treatment are likely the result of random variation .
levonorgestrel	drug	fluconazole	drug
false

While there is evidence that DRUGA can inhibit the metabolism of DRUGB and DRUGN , there is no evidence that DRUGN is a net inducer of DRUGN or DRUGN metabolism .
fluconazole	drug	ethinyl estradiol	drug
mechanism

While there is evidence that DRUGA can inhibit the metabolism of DRUGN and DRUGB , there is no evidence that DRUGN is a net inducer of DRUGN or DRUGN metabolism .
fluconazole	drug	levonorgestrel	drug
mechanism

While there is evidence that DRUGA can inhibit the metabolism of DRUGN and DRUGN , there is no evidence that DRUGN is a net inducer of DRUGB or DRUGN metabolism .
fluconazole	drug	ethinyl estradiol	drug
false

While there is evidence that DRUGA can inhibit the metabolism of DRUGN and DRUGN , there is no evidence that DRUGN is a net inducer of DRUGN or DRUGB metabolism .
fluconazole	drug	levonorgestrel	drug
false

While there is evidence that DRUGN can inhibit the metabolism of DRUGA and DRUGB , there is no evidence that DRUGN is a net inducer of DRUGN or DRUGN metabolism .
ethinyl estradiol	drug	levonorgestrel	drug
false

While there is evidence that DRUGN can inhibit the metabolism of DRUGA and DRUGN , there is no evidence that DRUGB is a net inducer of DRUGN or DRUGN metabolism .
ethinyl estradiol	drug	fluconazole	drug
false

While there is evidence that DRUGN can inhibit the metabolism of DRUGA and DRUGN , there is no evidence that DRUGN is a net inducer of DRUGN or DRUGB metabolism .
ethinyl estradiol	drug	levonorgestrel	drug
false

While there is evidence that DRUGN can inhibit the metabolism of DRUGN and DRUGA , there is no evidence that DRUGB is a net inducer of DRUGN or DRUGN metabolism .
levonorgestrel	drug	fluconazole	drug
false

While there is evidence that DRUGN can inhibit the metabolism of DRUGN and DRUGA , there is no evidence that DRUGN is a net inducer of DRUGB or DRUGN metabolism .
levonorgestrel	drug	ethinyl estradiol	drug
false

While there is evidence that DRUGN can inhibit the metabolism of DRUGN and DRUGN , there is no evidence that DRUGA is a net inducer of DRUGB or DRUGN metabolism .
fluconazole	drug	ethinyl estradiol	drug
false

While there is evidence that DRUGN can inhibit the metabolism of DRUGN and DRUGN , there is no evidence that DRUGA is a net inducer of DRUGN or DRUGB metabolism .
fluconazole	drug	levonorgestrel	drug
false

While there is evidence that DRUGN can inhibit the metabolism of DRUGN and DRUGN , there is no evidence that DRUGN is a net inducer of DRUGA or DRUGB metabolism .
ethinyl estradiol	drug	levonorgestrel	drug
false

You can not take DRUGA if you have taken a DRUGB ( DRUGN ) such as DRUGN ( DRUGN ) , DRUGN ( DRUGN ) , or DRUGN ( DRUGN ) in the last dgb days .
mazindol	drug	monoamine oxidase inhibitor	group
advise

You can not take DRUGA if you have taken a DRUGN ( DRUGB ) such as DRUGN ( DRUGN ) , DRUGN ( DRUGN ) , or DRUGN ( DRUGN ) in the last dgb days .
mazindol	drug	MAOI	group
advise

You can not take DRUGA if you have taken a DRUGN ( DRUGN ) such as DRUGB ( DRUGN ) , DRUGN ( DRUGN ) , or DRUGN ( DRUGN ) in the last dgb days .
mazindol	drug	isocarboxazid	drug
advise

You can not take DRUGA if you have taken a DRUGN ( DRUGN ) such as DRUGN ( DRUGB ) , DRUGN ( DRUGN ) , or DRUGN ( DRUGN ) in the last dgb days .
mazindol	drug	Marplan	brand
advise

You can not take DRUGA if you have taken a DRUGN ( DRUGN ) such as DRUGN ( DRUGN ) , DRUGB ( DRUGN ) , or DRUGN ( DRUGN ) in the last dgb days .
mazindol	drug	tranylcypromine	drug
advise

You can not take DRUGA if you have taken a DRUGN ( DRUGN ) such as DRUGN ( DRUGN ) , DRUGN ( DRUGB ) , or DRUGN ( DRUGN ) in the last dgb days .
mazindol	drug	Parnate	brand
advise

You can not take DRUGA if you have taken a DRUGN ( DRUGN ) such as DRUGN ( DRUGN ) , DRUGN ( DRUGN ) , or DRUGB ( DRUGN ) in the last dgb days .
mazindol	drug	phenelzine	drug
advise

You can not take DRUGA if you have taken a DRUGN ( DRUGN ) such as DRUGN ( DRUGN ) , DRUGN ( DRUGN ) , or DRUGN ( DRUGB ) in the last dgb days .
mazindol	drug	Nardil	brand
advise

You can not take DRUGN if you have taken a DRUGA ( DRUGB ) such as DRUGN ( DRUGN ) , DRUGN ( DRUGN ) , or DRUGN ( DRUGN ) in the last dgb days .
monoamine oxidase inhibitor	group	MAOI	group
false

You can not take DRUGN if you have taken a DRUGA ( DRUGN ) such as DRUGB ( DRUGN ) , DRUGN ( DRUGN ) , or DRUGN ( DRUGN ) in the last dgb days .
monoamine oxidase inhibitor	group	isocarboxazid	drug
false

You can not take DRUGN if you have taken a DRUGA ( DRUGN ) such as DRUGN ( DRUGB ) , DRUGN ( DRUGN ) , or DRUGN ( DRUGN ) in the last dgb days .
monoamine oxidase inhibitor	group	Marplan	brand
false

You can not take DRUGN if you have taken a DRUGA ( DRUGN ) such as DRUGN ( DRUGN ) , DRUGB ( DRUGN ) , or DRUGN ( DRUGN ) in the last dgb days .
monoamine oxidase inhibitor	group	tranylcypromine	drug
false

You can not take DRUGN if you have taken a DRUGA ( DRUGN ) such as DRUGN ( DRUGN ) , DRUGN ( DRUGB ) , or DRUGN ( DRUGN ) in the last dgb days .
monoamine oxidase inhibitor	group	Parnate	brand
false

You can not take DRUGN if you have taken a DRUGA ( DRUGN ) such as DRUGN ( DRUGN ) , DRUGN ( DRUGN ) , or DRUGB ( DRUGN ) in the last dgb days .
monoamine oxidase inhibitor	group	phenelzine	drug
false

You can not take DRUGN if you have taken a DRUGA ( DRUGN ) such as DRUGN ( DRUGN ) , DRUGN ( DRUGN ) , or DRUGN ( DRUGB ) in the last dgb days .
monoamine oxidase inhibitor	group	Nardil	brand
false

You can not take DRUGN if you have taken a DRUGN ( DRUGA ) such as DRUGB ( DRUGN ) , DRUGN ( DRUGN ) , or DRUGN ( DRUGN ) in the last dgb days .
MAOI	group	isocarboxazid	drug
false

You can not take DRUGN if you have taken a DRUGN ( DRUGA ) such as DRUGN ( DRUGB ) , DRUGN ( DRUGN ) , or DRUGN ( DRUGN ) in the last dgb days .
MAOI	group	Marplan	brand
false

You can not take DRUGN if you have taken a DRUGN ( DRUGA ) such as DRUGN ( DRUGN ) , DRUGB ( DRUGN ) , or DRUGN ( DRUGN ) in the last dgb days .
MAOI	group	tranylcypromine	drug
false

You can not take DRUGN if you have taken a DRUGN ( DRUGA ) such as DRUGN ( DRUGN ) , DRUGN ( DRUGB ) , or DRUGN ( DRUGN ) in the last dgb days .
MAOI	group	Parnate	brand
false

You can not take DRUGN if you have taken a DRUGN ( DRUGA ) such as DRUGN ( DRUGN ) , DRUGN ( DRUGN ) , or DRUGB ( DRUGN ) in the last dgb days .
MAOI	group	phenelzine	drug
false

You can not take DRUGN if you have taken a DRUGN ( DRUGA ) such as DRUGN ( DRUGN ) , DRUGN ( DRUGN ) , or DRUGN ( DRUGB ) in the last dgb days .
MAOI	group	Nardil	brand
false

You can not take DRUGN if you have taken a DRUGN ( DRUGN ) such as DRUGA ( DRUGB ) , DRUGN ( DRUGN ) , or DRUGN ( DRUGN ) in the last dgb days .
isocarboxazid	drug	Marplan	brand
false

You can not take DRUGN if you have taken a DRUGN ( DRUGN ) such as DRUGA ( DRUGN ) , DRUGB ( DRUGN ) , or DRUGN ( DRUGN ) in the last dgb days .
isocarboxazid	drug	tranylcypromine	drug
false

You can not take DRUGN if you have taken a DRUGN ( DRUGN ) such as DRUGA ( DRUGN ) , DRUGN ( DRUGB ) , or DRUGN ( DRUGN ) in the last dgb days .
isocarboxazid	drug	Parnate	brand
false

You can not take DRUGN if you have taken a DRUGN ( DRUGN ) such as DRUGA ( DRUGN ) , DRUGN ( DRUGN ) , or DRUGB ( DRUGN ) in the last dgb days .
isocarboxazid	drug	phenelzine	drug
false

You can not take DRUGN if you have taken a DRUGN ( DRUGN ) such as DRUGA ( DRUGN ) , DRUGN ( DRUGN ) , or DRUGN ( DRUGB ) in the last dgb days .
isocarboxazid	drug	Nardil	brand
false

You can not take DRUGN if you have taken a DRUGN ( DRUGN ) such as DRUGN ( DRUGA ) , DRUGB ( DRUGN ) , or DRUGN ( DRUGN ) in the last dgb days .
Marplan	brand	tranylcypromine	drug
false

You can not take DRUGN if you have taken a DRUGN ( DRUGN ) such as DRUGN ( DRUGA ) , DRUGN ( DRUGB ) , or DRUGN ( DRUGN ) in the last dgb days .
Marplan	brand	Parnate	brand
false

You can not take DRUGN if you have taken a DRUGN ( DRUGN ) such as DRUGN ( DRUGA ) , DRUGN ( DRUGN ) , or DRUGB ( DRUGN ) in the last dgb days .
Marplan	brand	phenelzine	drug
false

You can not take DRUGN if you have taken a DRUGN ( DRUGN ) such as DRUGN ( DRUGA ) , DRUGN ( DRUGN ) , or DRUGN ( DRUGB ) in the last dgb days .
Marplan	brand	Nardil	brand
false

You can not take DRUGN if you have taken a DRUGN ( DRUGN ) such as DRUGN ( DRUGN ) , DRUGA ( DRUGB ) , or DRUGN ( DRUGN ) in the last dgb days .
tranylcypromine	drug	Parnate	brand
false

You can not take DRUGN if you have taken a DRUGN ( DRUGN ) such as DRUGN ( DRUGN ) , DRUGA ( DRUGN ) , or DRUGB ( DRUGN ) in the last dgb days .
tranylcypromine	drug	phenelzine	drug
false

You can not take DRUGN if you have taken a DRUGN ( DRUGN ) such as DRUGN ( DRUGN ) , DRUGA ( DRUGN ) , or DRUGN ( DRUGB ) in the last dgb days .
tranylcypromine	drug	Nardil	brand
false

You can not take DRUGN if you have taken a DRUGN ( DRUGN ) such as DRUGN ( DRUGN ) , DRUGN ( DRUGA ) , or DRUGB ( DRUGN ) in the last dgb days .
Parnate	brand	phenelzine	drug
false

You can not take DRUGN if you have taken a DRUGN ( DRUGN ) such as DRUGN ( DRUGN ) , DRUGN ( DRUGA ) , or DRUGN ( DRUGB ) in the last dgb days .
Parnate	brand	Nardil	brand
false

You can not take DRUGN if you have taken a DRUGN ( DRUGN ) such as DRUGN ( DRUGN ) , DRUGN ( DRUGN ) , or DRUGA ( DRUGB ) in the last dgb days .
phenelzine	drug	Nardil	brand
false

Changes in DRUGA and other diabetes drug therapies may be necessary during treatment with DRUGB .
insulin	drug	mazindol	drug
advise

DRUGA may reduce the effects of DRUGB ( DRUGN ) .
Mazindol	drug	guanethidine	drug
effect

DRUGA may reduce the effects of DRUGN ( DRUGB ) .
Mazindol	drug	Ismelin	brand
effect

DRUGN may reduce the effects of DRUGA ( DRUGB ) .
guanethidine	drug	Ismelin	brand
false

Preliminary evidence suggests that DRUGA inhibits DRUGB metabolism and may result in an increase in plasma concentrations of DRUGN .
cimetidine	drug	mebendazole	drug
mechanism

Preliminary evidence suggests that DRUGA inhibits DRUGN metabolism and may result in an increase in plasma concentrations of DRUGB .
cimetidine	drug	mebendazole	drug
false

Patients receiving DRUGA and DRUGB generally should not be treated with DRUGN .
antibiotics	group	sulfonamides	group
false

Patients receiving DRUGA and DRUGN generally should not be treated with DRUGB .
antibiotics	group	ganglion blockers	group
advise

Patients receiving DRUGN and DRUGA generally should not be treated with DRUGB .
sulfonamides	group	ganglion blockers	group
advise

The action of DRUGA may be potentiated by anesthesia , other DRUGB and DRUGN .
Mecamylamine	drug	antihypertensive drugs	group
effect

The action of DRUGA may be potentiated by anesthesia , other DRUGN and DRUGB .
Mecamylamine	drug	alcohol	drug
effect

The action of DRUGN may be potentiated by anesthesia , other DRUGA and DRUGB .
antihypertensive drugs	group	alcohol	drug
false

DRUGA administered concomitantly with DRUGB may significantly decrease the serum concentrations of DRUGN .
Aminoglutethimide	drug	depo-subQ provera 104	brand
mechanism

DRUGA administered concomitantly with DRUGN may significantly decrease the serum concentrations of DRUGB .
Aminoglutethimide	drug	MPA	drug
false

DRUGN administered concomitantly with DRUGA may significantly decrease the serum concentrations of DRUGB .
depo-subQ provera 104	brand	MPA	drug
false

Pharmacokinetic studies show that there are no significant alterations in pharmacokinetic parameters of DRUGA or DRUGB to warrant dosage adjustment when DRUGN is administered with these drugs .
zidovudine	drug	rifabutin	drug
false

Pharmacokinetic studies show that there are no significant alterations in pharmacokinetic parameters of DRUGA or DRUGN to warrant dosage adjustment when DRUGB is administered with these drugs .
zidovudine	drug	megestrol acetate	drug
false

Pharmacokinetic studies show that there are no significant alterations in pharmacokinetic parameters of DRUGN or DRUGA to warrant dosage adjustment when DRUGB is administered with these drugs .
rifabutin	drug	megestrol acetate	drug
false

A pharmacokinetic study demonstrated that coadministration of DRUGA and DRUGB results in a significant decrease in the pharmacokinetic parameters ( ~dgb % for Cmax and ~dgb % for AUC ) of DRUGN .
megestrol acetate	drug	indinavir	drug
mechanism

A pharmacokinetic study demonstrated that coadministration of DRUGA and DRUGN results in a significant decrease in the pharmacokinetic parameters ( ~dgb % for Cmax and ~dgb % for AUC ) of DRUGB .
megestrol acetate	drug	indinavir	drug
false

Administration of a higher dose of DRUGA should be considered when coadministering with DRUGB .
indinavir	drug	megestrol acetate	drug
advise

The effects of DRUGA , DRUGB or DRUGN on the pharmacokinetics of DRUGN were not studied .
indinavir	drug	zidovudine	drug
false

The effects of DRUGA , DRUGN or DRUGB on the pharmacokinetics of DRUGN were not studied .
indinavir	drug	rifabutin	drug
false

The effects of DRUGA , DRUGN or DRUGN on the pharmacokinetics of DRUGB were not studied .
indinavir	drug	megestrol acetate	drug
false

The effects of DRUGN , DRUGA or DRUGB on the pharmacokinetics of DRUGN were not studied .
zidovudine	drug	rifabutin	drug
false

The effects of DRUGN , DRUGA or DRUGN on the pharmacokinetics of DRUGB were not studied .
zidovudine	drug	megestrol acetate	drug
false

The effects of DRUGN , DRUGN or DRUGA on the pharmacokinetics of DRUGB were not studied .
rifabutin	drug	megestrol acetate	drug
false

DRUGA Reports suggest that DRUGB may diminish the antihypertensive effect of DRUGN .
ACE inhibitors	group	NSAIDs	group
false

DRUGA Reports suggest that DRUGN may diminish the antihypertensive effect of DRUGB .
ACE inhibitors	group	angiotensin-converting enzyme (ACE) inhibitors	group
false

DRUGN Reports suggest that DRUGA may diminish the antihypertensive effect of DRUGB .
NSAIDs	group	angiotensin-converting enzyme (ACE) inhibitors	group
effect

This interaction should be given consideration in patients taking DRUGA concomitantly with DRUGB .
NSAIDs	group	ACE inhibitors	group
advise

DRUGA : Concomitant administration of DRUGB ( dgb mg TID ) to healthy volunteers tended to increase the AUC ( dgb % ) and Cmax ( dgb % ) of DRUGN .
Aspirin	brand	aspirin	brand
false

DRUGA : Concomitant administration of DRUGN ( dgb mg TID ) to healthy volunteers tended to increase the AUC ( dgb % ) and Cmax ( dgb % ) of DRUGB .
Aspirin	brand	meloxicam	drug
false

DRUGN : Concomitant administration of DRUGA ( dgb mg TID ) to healthy volunteers tended to increase the AUC ( dgb % ) and Cmax ( dgb % ) of DRUGB .
aspirin	brand	meloxicam	drug
mechanism

however , as with other DRUGA , concomitant administration of DRUGB and DRUGN is not generally recommended because of the potential for increased adverse effects .
NSAIDs	group	meloxicam	drug
false

however , as with other DRUGA , concomitant administration of DRUGN and DRUGB is not generally recommended because of the potential for increased adverse effects .
NSAIDs	group	aspirin	brand
advise

however , as with other DRUGN , concomitant administration of DRUGA and DRUGB is not generally recommended because of the potential for increased adverse effects .
meloxicam	drug	aspirin	brand
advise

Concomitant administration of low dose DRUGA with DRUGB may result in an increased rate of GI ulceration or other complications , compared to use of DRUGN alone .
aspirin	brand	MOBIC	brand
effect

Concomitant administration of low dose DRUGA with DRUGN may result in an increased rate of GI ulceration or other complications , compared to use of DRUGB alone .
aspirin	brand	MOBIC	brand
false

DRUGA is not a substitute for DRUGB for cardiovascular prophylaxis .
MOBIC	brand	aspirin	brand
false

DRUGA : Pretreatment for four days with DRUGB significantly increased the clearance of DRUGN by dgb % .
Cholestyramine	drug	cholestyramine	drug
false

DRUGA : Pretreatment for four days with DRUGN significantly increased the clearance of DRUGB by dgb % .
Cholestyramine	drug	meloxicam	drug
false

DRUGN : Pretreatment for four days with DRUGA significantly increased the clearance of DRUGB by dgb % .
cholestyramine	drug	meloxicam	drug
mechanism

DRUGA : Concomitant administration of dgb mg DRUGB QID did not alter the single dose pharmacokinetics of dgb mg DRUGN .
Cimetidine	drug	cimetidine	drug
false

DRUGA : Concomitant administration of dgb mg DRUGN QID did not alter the single dose pharmacokinetics of dgb mg DRUGB .
Cimetidine	drug	meloxicam	drug
false

DRUGN : Concomitant administration of dgb mg DRUGA QID did not alter the single dose pharmacokinetics of dgb mg DRUGB .
cimetidine	drug	meloxicam	drug
false

DRUGA : DRUGB dgb mg once daily for dgb days did not alter the plasma concentration profile of DRUGN after b acetyldigoxin administration for dgb days at clinical doses .
Digoxin	drug	Meloxicam	drug
false

DRUGA : DRUGN dgb mg once daily for dgb days did not alter the plasma concentration profile of DRUGB after b acetyldigoxin administration for dgb days at clinical doses .
Digoxin	drug	digoxin	drug
false

DRUGN : DRUGA dgb mg once daily for dgb days did not alter the plasma concentration profile of DRUGB after b acetyldigoxin administration for dgb days at clinical doses .
Meloxicam	drug	digoxin	drug
false

In vitro testing found no protein binding drug interaction between DRUGA and DRUGB .
digoxin	drug	meloxicam	drug
false

DRUGA : Clinical studies , as well as post marketing observations , have shown that DRUGB can reduce the natriuretic effect of DRUGN and DRUGN in some patients .
Furosemide	drug	NSAIDs	group
false

DRUGA : Clinical studies , as well as post marketing observations , have shown that DRUGN can reduce the natriuretic effect of DRUGB and DRUGN in some patients .
Furosemide	drug	furosemide	drug
false

DRUGA : Clinical studies , as well as post marketing observations , have shown that DRUGN can reduce the natriuretic effect of DRUGN and DRUGB in some patients .
Furosemide	drug	thiazide diuretics	group
false

DRUGN : Clinical studies , as well as post marketing observations , have shown that DRUGA can reduce the natriuretic effect of DRUGB and DRUGN in some patients .
NSAIDs	group	furosemide	drug
effect

DRUGN : Clinical studies , as well as post marketing observations , have shown that DRUGA can reduce the natriuretic effect of DRUGN and DRUGB in some patients .
NSAIDs	group	thiazide diuretics	group
effect

DRUGN : Clinical studies , as well as post marketing observations , have shown that DRUGN can reduce the natriuretic effect of DRUGA and DRUGB in some patients .
furosemide	drug	thiazide diuretics	group
false

Studies with DRUGA agents and DRUGB have not demonstrated a reduction in natriuretic effect .
furosemide	drug	meloxicam	drug
false

DRUGA : single and multiple dose pharmacodynamics and pharmacokinetics are not affected by multiple doses of DRUGB .
Furosemide	drug	meloxicam	drug
false

Nevertheless , during concomitant therapy with DRUGA and DRUGB , patients should be observed closely for signs of declining renal function , as well as to assure diuretic efficacy .
furosemide	drug	MOBIC	brand
advise

DRUGA : In clinical trials , DRUGB have produced an elevation of plasma DRUGN levels and a reduction in renal DRUGN clearance .
Lithium	drug	NSAIDs	group
false

DRUGA : In clinical trials , DRUGN have produced an elevation of plasma DRUGB levels and a reduction in renal DRUGN clearance .
Lithium	drug	lithium	drug
false

DRUGA : In clinical trials , DRUGN have produced an elevation of plasma DRUGN levels and a reduction in renal DRUGB clearance .
Lithium	drug	lithium	drug
false

DRUGN : In clinical trials , DRUGA have produced an elevation of plasma DRUGB levels and a reduction in renal DRUGN clearance .
NSAIDs	group	lithium	drug
mechanism

DRUGN : In clinical trials , DRUGA have produced an elevation of plasma DRUGN levels and a reduction in renal DRUGB clearance .
NSAIDs	group	lithium	drug
false

Patients on DRUGA treatment should be closely monitored when DRUGB is introduced or withdrawn .
lithium	drug	MOBIC	brand
advise

DRUGA : A study in dgb rheumatoid arthritis ( RA ) patients evaluated the effects of multiple doses of DRUGB on the pharmacokinetics of DRUGN taken once weekly .
Methotrexate	drug	meloxicam	drug
false

DRUGA : A study in dgb rheumatoid arthritis ( RA ) patients evaluated the effects of multiple doses of DRUGN on the pharmacokinetics of DRUGB taken once weekly .
Methotrexate	drug	methotrexate	drug
false

DRUGN : A study in dgb rheumatoid arthritis ( RA ) patients evaluated the effects of multiple doses of DRUGA on the pharmacokinetics of DRUGB taken once weekly .
meloxicam	drug	methotrexate	drug
false

DRUGA did not have a significant effect on the pharmacokinetics of single doses of DRUGB .
Meloxicam	drug	methotrexate	drug
false

In vitro , DRUGA did not displace DRUGB from its human serum binding sites .
methotrexate	drug	meloxicam	drug
false

DRUGA : Anticoagulant activity should be monitored , particularly in the first few days after initiating or changing DRUGB therapy in patients receiving DRUGN or similar agents , since these patients are at an increased risk of bleeding .
Warfarin	drug	MOBIC	brand
false

DRUGA : Anticoagulant activity should be monitored , particularly in the first few days after initiating or changing DRUGN therapy in patients receiving DRUGB or similar agents , since these patients are at an increased risk of bleeding .
Warfarin	drug	warfarin	drug
false

DRUGN : Anticoagulant activity should be monitored , particularly in the first few days after initiating or changing DRUGA therapy in patients receiving DRUGB or similar agents , since these patients are at an increased risk of bleeding .
MOBIC	brand	warfarin	drug
advise

The effect of DRUGA on the anticoagulant effect of DRUGB was studied in a group of healthy subjects receiving daily doses of DRUGN that produced an INR ( International Normalized Ratio ) between dga and dga .
meloxicam	drug	warfarin	drug
false

The effect of DRUGA on the anticoagulant effect of DRUGN was studied in a group of healthy subjects receiving daily doses of DRUGB that produced an INR ( International Normalized Ratio ) between dga and dga .
meloxicam	drug	warfarin	drug
false

In these subjects , DRUGA did not alter DRUGB pharmacokinetics and the average anticoagulant effect of DRUGN as determined by prothrombin time .
meloxicam	drug	warfarin	drug
false

In these subjects , DRUGA did not alter DRUGN pharmacokinetics and the average anticoagulant effect of DRUGB as determined by prothrombin time .
meloxicam	drug	warfarin	drug
false

Caution should be used when administering DRUGA with DRUGB since patients on DRUGN may experience changes in INR and an increased risk of bleeding complications when a new medication is introduced .
MOBIC	brand	warfarin	drug
advise

Caution should be used when administering DRUGA with DRUGN since patients on DRUGB may experience changes in INR and an increased risk of bleeding complications when a new medication is introduced .
MOBIC	brand	warfarin	drug
false

DRUG INTERACTIONS There are no known drug / drug interactions with oral DRUGA Vaccinations with DRUGB are not recommended in immunocompromised individuals DRUGN together with high dose intravenous DRUGN has caused deaths in children due to haemorrhagic enterocolitis .
ALKERAN	brand	live organism vaccines	group
false

DRUG INTERACTIONS There are no known drug / drug interactions with oral DRUGA Vaccinations with DRUGN are not recommended in immunocompromised individuals DRUGB together with high dose intravenous DRUGN has caused deaths in children due to haemorrhagic enterocolitis .
ALKERAN	brand	Nalidixic acid	drug
false

DRUG INTERACTIONS There are no known drug / drug interactions with oral DRUGA Vaccinations with DRUGN are not recommended in immunocompromised individuals DRUGN together with high dose intravenous DRUGB has caused deaths in children due to haemorrhagic enterocolitis .
ALKERAN	brand	melphalan	drug
false

DRUG INTERACTIONS There are no known drug / drug interactions with oral DRUGN Vaccinations with DRUGA are not recommended in immunocompromised individuals DRUGB together with high dose intravenous DRUGN has caused deaths in children due to haemorrhagic enterocolitis .
live organism vaccines	group	Nalidixic acid	drug
false

DRUG INTERACTIONS There are no known drug / drug interactions with oral DRUGN Vaccinations with DRUGA are not recommended in immunocompromised individuals DRUGN together with high dose intravenous DRUGB has caused deaths in children due to haemorrhagic enterocolitis .
live organism vaccines	group	melphalan	drug
false

DRUG INTERACTIONS There are no known drug / drug interactions with oral DRUGN Vaccinations with DRUGN are not recommended in immunocompromised individuals DRUGA together with high dose intravenous DRUGB has caused deaths in children due to haemorrhagic enterocolitis .
Nalidixic acid	drug	melphalan	drug
effect

Impaired renal function has been described in bone marrow transplant patients who were conditioned with high dose intravenous DRUGA and who subsequently received DRUGB to prevent graft versus host disease
melphalan	drug	cyclosporin	drug
effect

DRUGA antagonize the effects of DRUGB .
Anticholinergics	group	antiglaucoma agents	group
effect

DRUGA in the presence of increased intraocular pressure may be hazardous when taken concurrently with agents such as DRUGB .
Anticholinergic drugs	group	corticosteroids	group
effect

DRUGA may affect gastrointestinal absorption of various drugs , such as slowly dissolving dosage forms of DRUGB ;
Anticholinergic agents	group	digoxin	drug
mechanism

DRUGA may antagonize the effects of drugs that alter gastrointestinal motility , such as DRUGB .
Anticholinergic drugs	group	metoclopramide	drug
effect

Because DRUGA may interfere with the absorption of DRUGB , simultaneous use of these drugs should be avoided .
antacids	group	anticholinergic agents	group
mechanism

Some DRUGA may interact with DRUGB .
anticonvulsants	group	Mephenytoin	drug
int

Those DRUGA include DRUGB , DRUGN , and DRUGN .
anticonvulsants	group	divalproex sodium	drug
false

Those DRUGA include DRUGN , DRUGB , and DRUGN .
anticonvulsants	group	valproic acid	drug
false

Those DRUGA include DRUGN , DRUGN , and DRUGB .
anticonvulsants	group	phenobarbital	drug
false

Those DRUGN include DRUGA , DRUGB , and DRUGN .
divalproex sodium	drug	valproic acid	drug
false

Those DRUGN include DRUGA , DRUGN , and DRUGB .
divalproex sodium	drug	phenobarbital	drug
false

Those DRUGN include DRUGN , DRUGA , and DRUGB .
valproic acid	drug	phenobarbital	drug
false

DRUGA can interact with DRUGB , DRUGN , DRUGN , DRUGN , and DRUGN .
Mequitazine	drug	CNS depressant	group
int

DRUGA can interact with DRUGN , DRUGB , DRUGN , DRUGN , and DRUGN .
Mequitazine	drug	antichlolinergic	group
int

DRUGA can interact with DRUGN , DRUGN , DRUGB , DRUGN , and DRUGN .
Mequitazine	drug	TCA	group
int

DRUGA can interact with DRUGN , DRUGN , DRUGN , DRUGB , and DRUGN .
Mequitazine	drug	MAOIs	group
int

DRUGA can interact with DRUGN , DRUGN , DRUGN , DRUGN , and DRUGB .
Mequitazine	drug	alcohol	drug
int

DRUGN can interact with DRUGA , DRUGB , DRUGN , DRUGN , and DRUGN .
CNS depressant	group	antichlolinergic	group
false

DRUGN can interact with DRUGA , DRUGN , DRUGB , DRUGN , and DRUGN .
CNS depressant	group	TCA	group
false

DRUGN can interact with DRUGA , DRUGN , DRUGN , DRUGB , and DRUGN .
CNS depressant	group	MAOIs	group
false

DRUGN can interact with DRUGA , DRUGN , DRUGN , DRUGN , and DRUGB .
CNS depressant	group	alcohol	drug
false

DRUGN can interact with DRUGN , DRUGA , DRUGB , DRUGN , and DRUGN .
antichlolinergic	group	TCA	group
false

DRUGN can interact with DRUGN , DRUGA , DRUGN , DRUGB , and DRUGN .
antichlolinergic	group	MAOIs	group
false

DRUGN can interact with DRUGN , DRUGA , DRUGN , DRUGN , and DRUGB .
antichlolinergic	group	alcohol	drug
false

DRUGN can interact with DRUGN , DRUGN , DRUGA , DRUGB , and DRUGN .
TCA	group	MAOIs	group
false

DRUGN can interact with DRUGN , DRUGN , DRUGA , DRUGN , and DRUGB .
TCA	group	alcohol	drug
false

DRUGN can interact with DRUGN , DRUGN , DRUGN , DRUGA , and DRUGB .
MAOIs	group	alcohol	drug
false

DRUGA competes with DRUGB for active tubular secretion and thus inhibits the renal excretion of DRUGN .
Probenecid	drug	meropenem	drug
mechanism

DRUGA competes with DRUGN for active tubular secretion and thus inhibits the renal excretion of DRUGB .
Probenecid	drug	meropenem	drug
false

Therefore , the coadministration of DRUGA with DRUGB is not recommended .
probenecid	drug	meropenem	drug
advise

There is evidence that DRUGA may reduce serum levels of DRUGB to subtherapeutic levels ( therapeutic range considered to be dgb to dgb g / mL total DRUGN ) .
meropenem	drug	valproic acid	drug
mechanism

There is evidence that DRUGA may reduce serum levels of DRUGN to subtherapeutic levels ( therapeutic range considered to be dgb to dgb g / mL total DRUGB ) .
meropenem	drug	valproate	drug
false

There is evidence that DRUGN may reduce serum levels of DRUGA to subtherapeutic levels ( therapeutic range considered to be dgb to dgb g / mL total DRUGB ) .
valproic acid	drug	valproate	drug
false

DRUGA should be used with caution in digitalized patients , since the combination of DRUGB and DRUGN may cause ectopic arrhythmias .
ARAMINE	brand	digitalis	group
false

DRUGA should be used with caution in digitalized patients , since the combination of DRUGN and DRUGB may cause ectopic arrhythmias .
ARAMINE	brand	sympathomimetic amines	group
false

DRUGN should be used with caution in digitalized patients , since the combination of DRUGA and DRUGB may cause ectopic arrhythmias .
digitalis	group	sympathomimetic amines	group
effect

DRUGA or DRUGB may potentiate the action of DRUGN .
Monoamine oxidase inhibitors	group	tricyclic antidepressants	group
false

DRUGA or DRUGN may potentiate the action of DRUGB .
Monoamine oxidase inhibitors	group	sympathomimetic amines	group
effect

DRUGN or DRUGA may potentiate the action of DRUGB .
tricyclic antidepressants	group	sympathomimetic amines	group
effect

DRUGA may enhance the effects of DRUGB , DRUGN and other DRUGN .
SKELAXIN	brand	alcohol	drug
effect

DRUGA may enhance the effects of DRUGN , DRUGB and other DRUGN .
SKELAXIN	brand	barbiturates	group
effect

DRUGA may enhance the effects of DRUGN , DRUGN and other DRUGB .
SKELAXIN	brand	CNS depressants	group
effect

DRUGN may enhance the effects of DRUGA , DRUGB and other DRUGN .
alcohol	drug	barbiturates	group
false

DRUGN may enhance the effects of DRUGA , DRUGN and other DRUGB .
alcohol	drug	CNS depressants	group
false

DRUGN may enhance the effects of DRUGN , DRUGA and other DRUGB .
barbiturates	group	CNS depressants	group
false

Caution is advised for patients receiving high dose DRUGA and DRUGB concomitantly , as anorexia , tachypnea , lethargy , coma and death have been reported with concomitant use of high dose DRUGN and DRUGN .
aspirin	brand	methazolamide	drug
advise

Caution is advised for patients receiving high dose DRUGA and DRUGN concomitantly , as anorexia , tachypnea , lethargy , coma and death have been reported with concomitant use of high dose DRUGN and DRUGB .
aspirin	brand	carbonic anhydrase inhibitors	group
false

Caution is advised for patients receiving high dose DRUGN and DRUGA concomitantly , as anorexia , tachypnea , lethargy , coma and death have been reported with concomitant use of high dose DRUGB and DRUGN .
methazolamide	drug	aspirin	brand
false

Caution is advised for patients receiving high dose DRUGN and DRUGA concomitantly , as anorexia , tachypnea , lethargy , coma and death have been reported with concomitant use of high dose DRUGN and DRUGB .
methazolamide	drug	carbonic anhydrase inhibitors	group
false

Caution is advised for patients receiving high dose DRUGN and DRUGN concomitantly , as anorexia , tachypnea , lethargy , coma and death have been reported with concomitant use of high dose DRUGA and DRUGB .
aspirin	brand	carbonic anhydrase inhibitors	group
effect

DRUGA ( oral ) : The activity of oral DRUGB may be potentiated by anti vitamin K activity attributed to DRUGN .
Anticoagulants	group	anticoagulants	group
false

DRUGA ( oral ) : The activity of oral DRUGN may be potentiated by anti vitamin K activity attributed to DRUGB .
Anticoagulants	group	methimazole	drug
false

DRUGN ( oral ) : The activity of oral DRUGA may be potentiated by anti vitamin K activity attributed to DRUGB .
anticoagulants	group	methimazole	drug
effect

DRUGA : Serum digitalis levels may be increased when hyperthyroid patients on a stable DRUGB regimen become euthyroid ;
Digitalis glycosides	group	digitalis glycoside	group
false

DRUGA : DRUGN clearance may decrease when hyperthyroid patients on a stable DRUGB regimen become euthyroid ;
Theophylline	drug	theophylline	drug
false

DRUGN : DRUGA clearance may decrease when hyperthyroid patients on a stable DRUGB regimen become euthyroid ;
Theophylline	drug	theophylline	drug
false

Dosages of concomitantly administered DRUGA should be reduced by approximately half , because DRUGB amplifies the therapeutic actions and side effects of DRUGN .
opioids	group	levomepromazine	drug
effect

Dosages of concomitantly administered DRUGN should be reduced by approximately half , because DRUGA amplifies the therapeutic actions and side effects of DRUGB .
levomepromazine	drug	opioids	group
effect

Combination with DRUGA ( DRUGB ) is associated with increased risk of seizures .
tramadol	drug	Ultram	brand
false

Additive sedative effects and confusional states may emerge if DRUGA is given with DRUGB or DRUGN .
levomepromazine	drug	benzodiazepines	group
effect

Additive sedative effects and confusional states may emerge if DRUGA is given with DRUGN or DRUGB .
levomepromazine	drug	barbiturates	group
effect

Additive sedative effects and confusional states may emerge if DRUGN is given with DRUGA or DRUGB .
benzodiazepines	group	barbiturates	group
false

Exert particular caution in combining DRUGA with other DRUGB ( DRUGN and DRUGN ) : Particularly the elderly may develop delirium , high fever , severe obstipation , even ileus and glaucoma .
levomepromazine	drug	anticholinergic drugs	group
advise

Exert particular caution in combining DRUGA with other DRUGN ( DRUGB and DRUGN ) : Particularly the elderly may develop delirium , high fever , severe obstipation , even ileus and glaucoma .
levomepromazine	drug	tricyclic antidepressants	group
advise

Exert particular caution in combining DRUGA with other DRUGN ( DRUGN and DRUGB ) : Particularly the elderly may develop delirium , high fever , severe obstipation , even ileus and glaucoma .
levomepromazine	drug	antiparkinsonian-agents	group
advise

Exert particular caution in combining DRUGN with other DRUGA ( DRUGB and DRUGN ) : Particularly the elderly may develop delirium , high fever , severe obstipation , even ileus and glaucoma .
anticholinergic drugs	group	tricyclic antidepressants	group
false

Exert particular caution in combining DRUGN with other DRUGA ( DRUGN and DRUGB ) : Particularly the elderly may develop delirium , high fever , severe obstipation , even ileus and glaucoma .
anticholinergic drugs	group	antiparkinsonian-agents	group
false

Exert particular caution in combining DRUGN with other DRUGN ( DRUGA and DRUGB ) : Particularly the elderly may develop delirium , high fever , severe obstipation , even ileus and glaucoma .
tricyclic antidepressants	group	antiparkinsonian-agents	group
false

DRUGA and / or stimulantes of the DRUGB / DRUGN type may counteract the specific actions of DRUGN .
Caffeine	drug	ephedrine	drug
false

DRUGA and / or stimulantes of the DRUGN / DRUGB type may counteract the specific actions of DRUGN .
Caffeine	drug	amphetamine	drug
false

DRUGA and / or stimulantes of the DRUGN / DRUGN type may counteract the specific actions of DRUGB .
Caffeine	drug	levomepromazine	drug
effect

DRUGN and / or stimulantes of the DRUGA / DRUGB type may counteract the specific actions of DRUGN .
ephedrine	drug	amphetamine	drug
false

DRUGN and / or stimulantes of the DRUGA / DRUGN type may counteract the specific actions of DRUGB .
ephedrine	drug	levomepromazine	drug
effect

DRUGN and / or stimulantes of the DRUGN / DRUGA type may counteract the specific actions of DRUGB .
amphetamine	drug	levomepromazine	drug
effect

Since DRUGA ( DRUGB ) may interact with concurrently administered DRUGN , periodic serum level determinations of these drugs may be necessary ( eg DRUGN may increase the plasma concentrations of DRUGN and DRUGN ) .
Celontin	brand	methsuximide	drug
false

Since DRUGA ( DRUGN ) may interact with concurrently administered DRUGB , periodic serum level determinations of these drugs may be necessary ( eg DRUGN may increase the plasma concentrations of DRUGN and DRUGN ) .
Celontin	brand	antiepileptic drugs	group
advise

Since DRUGA ( DRUGN ) may interact with concurrently administered DRUGN , periodic serum level determinations of these drugs may be necessary ( eg DRUGB may increase the plasma concentrations of DRUGN and DRUGN ) .
Celontin	brand	methsuximide	drug
false

Since DRUGA ( DRUGN ) may interact with concurrently administered DRUGN , periodic serum level determinations of these drugs may be necessary ( eg DRUGN may increase the plasma concentrations of DRUGB and DRUGN ) .
Celontin	brand	phenytoin	drug
false

Since DRUGA ( DRUGN ) may interact with concurrently administered DRUGN , periodic serum level determinations of these drugs may be necessary ( eg DRUGN may increase the plasma concentrations of DRUGN and DRUGB ) .
Celontin	brand	phenobarbital	drug
false

Since DRUGN ( DRUGA ) may interact with concurrently administered DRUGB , periodic serum level determinations of these drugs may be necessary ( eg DRUGN may increase the plasma concentrations of DRUGN and DRUGN ) .
methsuximide	drug	antiepileptic drugs	group
advise

Since DRUGN ( DRUGA ) may interact with concurrently administered DRUGN , periodic serum level determinations of these drugs may be necessary ( eg DRUGN may increase the plasma concentrations of DRUGB and DRUGN ) .
methsuximide	drug	phenytoin	drug
false

Since DRUGN ( DRUGA ) may interact with concurrently administered DRUGN , periodic serum level determinations of these drugs may be necessary ( eg DRUGN may increase the plasma concentrations of DRUGN and DRUGB ) .
methsuximide	drug	phenobarbital	drug
false

Since DRUGN ( DRUGN ) may interact with concurrently administered DRUGA , periodic serum level determinations of these drugs may be necessary ( eg DRUGB may increase the plasma concentrations of DRUGN and DRUGN ) .
antiepileptic drugs	group	methsuximide	drug
false

Since DRUGN ( DRUGN ) may interact with concurrently administered DRUGA , periodic serum level determinations of these drugs may be necessary ( eg DRUGN may increase the plasma concentrations of DRUGB and DRUGN ) .
antiepileptic drugs	group	phenytoin	drug
false

Since DRUGN ( DRUGN ) may interact with concurrently administered DRUGA , periodic serum level determinations of these drugs may be necessary ( eg DRUGN may increase the plasma concentrations of DRUGN and DRUGB ) .
antiepileptic drugs	group	phenobarbital	drug
false

Since DRUGN ( DRUGN ) may interact with concurrently administered DRUGN , periodic serum level determinations of these drugs may be necessary ( eg DRUGA may increase the plasma concentrations of DRUGB and DRUGN ) .
methsuximide	drug	phenytoin	drug
mechanism

Since DRUGN ( DRUGN ) may interact with concurrently administered DRUGN , periodic serum level determinations of these drugs may be necessary ( eg DRUGA may increase the plasma concentrations of DRUGN and DRUGB ) .
methsuximide	drug	phenobarbital	drug
mechanism

Since DRUGN ( DRUGN ) may interact with concurrently administered DRUGN , periodic serum level determinations of these drugs may be necessary ( eg DRUGN may increase the plasma concentrations of DRUGA and DRUGB ) .
phenytoin	drug	phenobarbital	drug
false

Hypokalemia may develop during concomitant use of DRUGA or DRUGB .
steroids	group	ACTH	drug
false

DRUGA may decrease arterial responsiveness to DRUGB .
Thiazides	group	norepinephrine	drug
effect

DRUGA may increase the responsiveness of DRUGB .
Thiazide drugs	group	tubocurarine	drug
effect

DRUGA renal clearance is reduced by DRUGB , increasing the risk of DRUGN toxicity .
Lithium	drug	thiazides	group
mechanism

DRUGA renal clearance is reduced by DRUGN , increasing the risk of DRUGB toxicity .
Lithium	drug	lithium	drug
false

DRUGN renal clearance is reduced by DRUGA , increasing the risk of DRUGB toxicity .
thiazides	group	lithium	drug
false

DRUGA may add to or potentiate the action of other DRUGB .
Thiazides	group	antihypertensive drugs	group
effect

Potentiation occurs with DRUGA or DRUGB .
ganglionic adrenergic blocking drugs	group	peripheral adrenergic blocking drugs	group
false

When DRUGA is used with other DRUGB , potentiation of antihypertensive effect may occur .
methyldopa	drug	antihypertensive drugs	group
effect

Patients may require reduced doses of DRUGA when on DRUGB .
anesthetics	group	methyldopa	drug
advise

When DRUGA and DRUGB are given concomitantly the patient should be carefully monitored for symptoms of DRUGN toxicity .
methyldopa	drug	lithium	drug
advise

When DRUGA and DRUGN are given concomitantly the patient should be carefully monitored for symptoms of DRUGB toxicity .
methyldopa	drug	lithium	drug
false

Several studies demonstrate a decrease in the bioavailability of DRUGA when it is ingested with DRUGB or DRUGN .
methyldopa	drug	ferrous sulfate	drug
mechanism

Several studies demonstrate a decrease in the bioavailability of DRUGA when it is ingested with DRUGN or DRUGB .
methyldopa	drug	ferrous gluconate	drug
mechanism

Several studies demonstrate a decrease in the bioavailability of DRUGN when it is ingested with DRUGA or DRUGB .
ferrous sulfate	drug	ferrous gluconate	drug
false

Coadministration of DRUGA with DRUGB or DRUGN is not recommended .
methyldopa	drug	ferrous sulfate	drug
advise

Coadministration of DRUGA with DRUGN or DRUGB is not recommended .
methyldopa	drug	ferrous gluconate	drug
advise

Coadministration of DRUGN with DRUGA or DRUGB is not recommended .
ferrous sulfate	drug	ferrous gluconate	drug
false

DRUGA does not interfere with measurement of DRUGB ( DRUGN ) , a test for pheochromocytoma , by those methods which convert DRUGN to DRUGN .
Methyldopa	drug	VMA	drug_n
false

DRUGA does not interfere with measurement of DRUGN ( DRUGB ) , a test for pheochromocytoma , by those methods which convert DRUGN to DRUGN .
Methyldopa	drug	vanillylmandelic acid	drug_n
false

DRUGA does not interfere with measurement of DRUGN ( DRUGN ) , a test for pheochromocytoma , by those methods which convert DRUGB to DRUGN .
Methyldopa	drug	VMA	drug_n
false

DRUGA does not interfere with measurement of DRUGN ( DRUGN ) , a test for pheochromocytoma , by those methods which convert DRUGN to DRUGB .
Methyldopa	drug	vanillin	drug_n
false

DRUGN does not interfere with measurement of DRUGA ( DRUGB ) , a test for pheochromocytoma , by those methods which convert DRUGN to DRUGN .
VMA	drug_n	vanillylmandelic acid	drug_n
false

DRUGN does not interfere with measurement of DRUGA ( DRUGN ) , a test for pheochromocytoma , by those methods which convert DRUGN to DRUGB .
VMA	drug_n	vanillin	drug_n
false

DRUGN does not interfere with measurement of DRUGN ( DRUGA ) , a test for pheochromocytoma , by those methods which convert DRUGB to DRUGN .
vanillylmandelic acid	drug_n	VMA	drug_n
false

DRUGN does not interfere with measurement of DRUGN ( DRUGA ) , a test for pheochromocytoma , by those methods which convert DRUGN to DRUGB .
vanillylmandelic acid	drug_n	vanillin	drug_n
false

DRUGN does not interfere with measurement of DRUGN ( DRUGN ) , a test for pheochromocytoma , by those methods which convert DRUGA to DRUGB .
VMA	drug_n	vanillin	drug_n
false

Less potent inhibitors include DRUGA , DRUGB , DRUGN , grapefruit juice , DRUGN , DRUGN , DRUGN , and DRUGN .
saquinavir	drug	nefazodone	drug
false

Less potent inhibitors include DRUGA , DRUGN , DRUGB , grapefruit juice , DRUGN , DRUGN , DRUGN , and DRUGN .
saquinavir	drug	fluconazole	drug
false

Less potent inhibitors include DRUGA , DRUGN , DRUGN , grapefruit juice , DRUGB , DRUGN , DRUGN , and DRUGN .
saquinavir	drug	fluoxetine	drug
false

Less potent inhibitors include DRUGA , DRUGN , DRUGN , grapefruit juice , DRUGN , DRUGB , DRUGN , and DRUGN .
saquinavir	drug	fluvoxamine	drug
false

Less potent inhibitors include DRUGA , DRUGN , DRUGN , grapefruit juice , DRUGN , DRUGN , DRUGB , and DRUGN .
saquinavir	drug	zileuton	drug
false

Less potent inhibitors include DRUGA , DRUGN , DRUGN , grapefruit juice , DRUGN , DRUGN , DRUGN , and DRUGB .
saquinavir	drug	clotrimazole	drug
false

Less potent inhibitors include DRUGN , DRUGA , DRUGB , grapefruit juice , DRUGN , DRUGN , DRUGN , and DRUGN .
nefazodone	drug	fluconazole	drug
false

Less potent inhibitors include DRUGN , DRUGA , DRUGN , grapefruit juice , DRUGB , DRUGN , DRUGN , and DRUGN .
nefazodone	drug	fluoxetine	drug
false

Less potent inhibitors include DRUGN , DRUGA , DRUGN , grapefruit juice , DRUGN , DRUGB , DRUGN , and DRUGN .
nefazodone	drug	fluvoxamine	drug
false

Less potent inhibitors include DRUGN , DRUGA , DRUGN , grapefruit juice , DRUGN , DRUGN , DRUGB , and DRUGN .
nefazodone	drug	zileuton	drug
false

Less potent inhibitors include DRUGN , DRUGA , DRUGN , grapefruit juice , DRUGN , DRUGN , DRUGN , and DRUGB .
nefazodone	drug	clotrimazole	drug
false

Less potent inhibitors include DRUGN , DRUGN , DRUGA , grapefruit juice , DRUGB , DRUGN , DRUGN , and DRUGN .
fluconazole	drug	fluoxetine	drug
false

Less potent inhibitors include DRUGN , DRUGN , DRUGA , grapefruit juice , DRUGN , DRUGB , DRUGN , and DRUGN .
fluconazole	drug	fluvoxamine	drug
false

Less potent inhibitors include DRUGN , DRUGN , DRUGA , grapefruit juice , DRUGN , DRUGN , DRUGB , and DRUGN .
fluconazole	drug	zileuton	drug
false

Less potent inhibitors include DRUGN , DRUGN , DRUGA , grapefruit juice , DRUGN , DRUGN , DRUGN , and DRUGB .
fluconazole	drug	clotrimazole	drug
false

Less potent inhibitors include DRUGN , DRUGN , DRUGN , grapefruit juice , DRUGA , DRUGB , DRUGN , and DRUGN .
fluoxetine	drug	fluvoxamine	drug
false

Less potent inhibitors include DRUGN , DRUGN , DRUGN , grapefruit juice , DRUGA , DRUGN , DRUGB , and DRUGN .
fluoxetine	drug	zileuton	drug
false

Less potent inhibitors include DRUGN , DRUGN , DRUGN , grapefruit juice , DRUGA , DRUGN , DRUGN , and DRUGB .
fluoxetine	drug	clotrimazole	drug
false

Less potent inhibitors include DRUGN , DRUGN , DRUGN , grapefruit juice , DRUGN , DRUGA , DRUGB , and DRUGN .
fluvoxamine	drug	zileuton	drug
false

Less potent inhibitors include DRUGN , DRUGN , DRUGN , grapefruit juice , DRUGN , DRUGA , DRUGN , and DRUGB .
fluvoxamine	drug	clotrimazole	drug
false

Less potent inhibitors include DRUGN , DRUGN , DRUGN , grapefruit juice , DRUGN , DRUGN , DRUGA , and DRUGB .
zileuton	drug	clotrimazole	drug
false

Caution should be exercised when DRUGA ( DRUGB ) is used concurrently with other DRUGN or DRUGN .
Methergine	brand	methylergonovine maleate	drug
false

Caution should be exercised when DRUGA ( DRUGN ) is used concurrently with other DRUGB or DRUGN .
Methergine	brand	vasoconstrictors	group
advise

Caution should be exercised when DRUGA ( DRUGN ) is used concurrently with other DRUGN or DRUGB .
Methergine	brand	ergot alkaloids	group
advise

Caution should be exercised when DRUGN ( DRUGA ) is used concurrently with other DRUGB or DRUGN .
methylergonovine maleate	drug	vasoconstrictors	group
advise

Caution should be exercised when DRUGN ( DRUGA ) is used concurrently with other DRUGN or DRUGB .
methylergonovine maleate	drug	ergot alkaloids	group
false

Caution should be exercised when DRUGN ( DRUGN ) is used concurrently with other DRUGA or DRUGB .
vasoconstrictors	group	ergot alkaloids	group
false

DRUGA may decrease the hypotensive effect of DRUGB .
Ritalin	brand	guanethidine	drug
effect

Human pharmacologic studies have shown that DRUGA may inhibit the metabolism of DRUGB , DRUGN ( DRUGN , DRUGN , DRUGN ) , DRUGN , and DRUGN ( DRUGN , DRUGN , DRUGN ) .
Ritalin	brand	coumarin anticoagulants	group
mechanism

Human pharmacologic studies have shown that DRUGA may inhibit the metabolism of DRUGN , DRUGB ( DRUGN , DRUGN , DRUGN ) , DRUGN , and DRUGN ( DRUGN , DRUGN , DRUGN ) .
Ritalin	brand	anticonvulsants	group
mechanism

Human pharmacologic studies have shown that DRUGA may inhibit the metabolism of DRUGN , DRUGN ( DRUGB , DRUGN , DRUGN ) , DRUGN , and DRUGN ( DRUGN , DRUGN , DRUGN ) .
Ritalin	brand	phenobarbital	drug
mechanism

Human pharmacologic studies have shown that DRUGA may inhibit the metabolism of DRUGN , DRUGN ( DRUGN , DRUGB , DRUGN ) , DRUGN , and DRUGN ( DRUGN , DRUGN , DRUGN ) .
Ritalin	brand	diphenylhydantoin	drug
mechanism

Human pharmacologic studies have shown that DRUGA may inhibit the metabolism of DRUGN , DRUGN ( DRUGN , DRUGN , DRUGB ) , DRUGN , and DRUGN ( DRUGN , DRUGN , DRUGN ) .
Ritalin	brand	primidone	drug
mechanism

Human pharmacologic studies have shown that DRUGA may inhibit the metabolism of DRUGN , DRUGN ( DRUGN , DRUGN , DRUGN ) , DRUGB , and DRUGN ( DRUGN , DRUGN , DRUGN ) .
Ritalin	brand	phenylbutazone	drug
mechanism

Human pharmacologic studies have shown that DRUGA may inhibit the metabolism of DRUGN , DRUGN ( DRUGN , DRUGN , DRUGN ) , DRUGN , and DRUGB ( DRUGN , DRUGN , DRUGN ) .
Ritalin	brand	tricyclic drugs	group
mechanism

Human pharmacologic studies have shown that DRUGA may inhibit the metabolism of DRUGN , DRUGN ( DRUGN , DRUGN , DRUGN ) , DRUGN , and DRUGN ( DRUGB , DRUGN , DRUGN ) .
Ritalin	brand	imipramine	drug
mechanism

Human pharmacologic studies have shown that DRUGA may inhibit the metabolism of DRUGN , DRUGN ( DRUGN , DRUGN , DRUGN ) , DRUGN , and DRUGN ( DRUGN , DRUGB , DRUGN ) .
Ritalin	brand	clomipramine	drug
mechanism

Human pharmacologic studies have shown that DRUGA may inhibit the metabolism of DRUGN , DRUGN ( DRUGN , DRUGN , DRUGN ) , DRUGN , and DRUGN ( DRUGN , DRUGN , DRUGB ) .
Ritalin	brand	desipramine	drug
mechanism

Human pharmacologic studies have shown that DRUGN may inhibit the metabolism of DRUGA , DRUGB ( DRUGN , DRUGN , DRUGN ) , DRUGN , and DRUGN ( DRUGN , DRUGN , DRUGN ) .
coumarin anticoagulants	group	anticonvulsants	group
false

Human pharmacologic studies have shown that DRUGN may inhibit the metabolism of DRUGA , DRUGN ( DRUGB , DRUGN , DRUGN ) , DRUGN , and DRUGN ( DRUGN , DRUGN , DRUGN ) .
coumarin anticoagulants	group	phenobarbital	drug
false

Human pharmacologic studies have shown that DRUGN may inhibit the metabolism of DRUGA , DRUGN ( DRUGN , DRUGB , DRUGN ) , DRUGN , and DRUGN ( DRUGN , DRUGN , DRUGN ) .
coumarin anticoagulants	group	diphenylhydantoin	drug
false

Human pharmacologic studies have shown that DRUGN may inhibit the metabolism of DRUGA , DRUGN ( DRUGN , DRUGN , DRUGB ) , DRUGN , and DRUGN ( DRUGN , DRUGN , DRUGN ) .
coumarin anticoagulants	group	primidone	drug
false

Human pharmacologic studies have shown that DRUGN may inhibit the metabolism of DRUGA , DRUGN ( DRUGN , DRUGN , DRUGN ) , DRUGB , and DRUGN ( DRUGN , DRUGN , DRUGN ) .
coumarin anticoagulants	group	phenylbutazone	drug
false

Human pharmacologic studies have shown that DRUGN may inhibit the metabolism of DRUGA , DRUGN ( DRUGN , DRUGN , DRUGN ) , DRUGN , and DRUGB ( DRUGN , DRUGN , DRUGN ) .
coumarin anticoagulants	group	tricyclic drugs	group
false

Human pharmacologic studies have shown that DRUGN may inhibit the metabolism of DRUGA , DRUGN ( DRUGN , DRUGN , DRUGN ) , DRUGN , and DRUGN ( DRUGB , DRUGN , DRUGN ) .
coumarin anticoagulants	group	imipramine	drug
false

Human pharmacologic studies have shown that DRUGN may inhibit the metabolism of DRUGA , DRUGN ( DRUGN , DRUGN , DRUGN ) , DRUGN , and DRUGN ( DRUGN , DRUGB , DRUGN ) .
coumarin anticoagulants	group	clomipramine	drug
false

Human pharmacologic studies have shown that DRUGN may inhibit the metabolism of DRUGA , DRUGN ( DRUGN , DRUGN , DRUGN ) , DRUGN , and DRUGN ( DRUGN , DRUGN , DRUGB ) .
coumarin anticoagulants	group	desipramine	drug
false

Human pharmacologic studies have shown that DRUGN may inhibit the metabolism of DRUGN , DRUGA ( DRUGB , DRUGN , DRUGN ) , DRUGN , and DRUGN ( DRUGN , DRUGN , DRUGN ) .
anticonvulsants	group	phenobarbital	drug
false

Human pharmacologic studies have shown that DRUGN may inhibit the metabolism of DRUGN , DRUGA ( DRUGN , DRUGB , DRUGN ) , DRUGN , and DRUGN ( DRUGN , DRUGN , DRUGN ) .
anticonvulsants	group	diphenylhydantoin	drug
false

Human pharmacologic studies have shown that DRUGN may inhibit the metabolism of DRUGN , DRUGA ( DRUGN , DRUGN , DRUGB ) , DRUGN , and DRUGN ( DRUGN , DRUGN , DRUGN ) .
anticonvulsants	group	primidone	drug
false

Human pharmacologic studies have shown that DRUGN may inhibit the metabolism of DRUGN , DRUGA ( DRUGN , DRUGN , DRUGN ) , DRUGB , and DRUGN ( DRUGN , DRUGN , DRUGN ) .
anticonvulsants	group	phenylbutazone	drug
false

Human pharmacologic studies have shown that DRUGN may inhibit the metabolism of DRUGN , DRUGA ( DRUGN , DRUGN , DRUGN ) , DRUGN , and DRUGB ( DRUGN , DRUGN , DRUGN ) .
anticonvulsants	group	tricyclic drugs	group
false

Human pharmacologic studies have shown that DRUGN may inhibit the metabolism of DRUGN , DRUGA ( DRUGN , DRUGN , DRUGN ) , DRUGN , and DRUGN ( DRUGB , DRUGN , DRUGN ) .
anticonvulsants	group	imipramine	drug
false

Human pharmacologic studies have shown that DRUGN may inhibit the metabolism of DRUGN , DRUGA ( DRUGN , DRUGN , DRUGN ) , DRUGN , and DRUGN ( DRUGN , DRUGB , DRUGN ) .
anticonvulsants	group	clomipramine	drug
false

Human pharmacologic studies have shown that DRUGN may inhibit the metabolism of DRUGN , DRUGA ( DRUGN , DRUGN , DRUGN ) , DRUGN , and DRUGN ( DRUGN , DRUGN , DRUGB ) .
anticonvulsants	group	desipramine	drug
false

Human pharmacologic studies have shown that DRUGN may inhibit the metabolism of DRUGN , DRUGN ( DRUGA , DRUGB , DRUGN ) , DRUGN , and DRUGN ( DRUGN , DRUGN , DRUGN ) .
phenobarbital	drug	diphenylhydantoin	drug
false

Human pharmacologic studies have shown that DRUGN may inhibit the metabolism of DRUGN , DRUGN ( DRUGA , DRUGN , DRUGB ) , DRUGN , and DRUGN ( DRUGN , DRUGN , DRUGN ) .
phenobarbital	drug	primidone	drug
false

Human pharmacologic studies have shown that DRUGN may inhibit the metabolism of DRUGN , DRUGN ( DRUGA , DRUGN , DRUGN ) , DRUGB , and DRUGN ( DRUGN , DRUGN , DRUGN ) .
phenobarbital	drug	phenylbutazone	drug
false

Human pharmacologic studies have shown that DRUGN may inhibit the metabolism of DRUGN , DRUGN ( DRUGA , DRUGN , DRUGN ) , DRUGN , and DRUGB ( DRUGN , DRUGN , DRUGN ) .
phenobarbital	drug	tricyclic drugs	group
false

Human pharmacologic studies have shown that DRUGN may inhibit the metabolism of DRUGN , DRUGN ( DRUGA , DRUGN , DRUGN ) , DRUGN , and DRUGN ( DRUGB , DRUGN , DRUGN ) .
phenobarbital	drug	imipramine	drug
false

Human pharmacologic studies have shown that DRUGN may inhibit the metabolism of DRUGN , DRUGN ( DRUGA , DRUGN , DRUGN ) , DRUGN , and DRUGN ( DRUGN , DRUGB , DRUGN ) .
phenobarbital	drug	clomipramine	drug
false

Human pharmacologic studies have shown that DRUGN may inhibit the metabolism of DRUGN , DRUGN ( DRUGA , DRUGN , DRUGN ) , DRUGN , and DRUGN ( DRUGN , DRUGN , DRUGB ) .
phenobarbital	drug	desipramine	drug
false

Human pharmacologic studies have shown that DRUGN may inhibit the metabolism of DRUGN , DRUGN ( DRUGN , DRUGA , DRUGB ) , DRUGN , and DRUGN ( DRUGN , DRUGN , DRUGN ) .
diphenylhydantoin	drug	primidone	drug
false

Human pharmacologic studies have shown that DRUGN may inhibit the metabolism of DRUGN , DRUGN ( DRUGN , DRUGA , DRUGN ) , DRUGB , and DRUGN ( DRUGN , DRUGN , DRUGN ) .
diphenylhydantoin	drug	phenylbutazone	drug
false

Human pharmacologic studies have shown that DRUGN may inhibit the metabolism of DRUGN , DRUGN ( DRUGN , DRUGA , DRUGN ) , DRUGN , and DRUGB ( DRUGN , DRUGN , DRUGN ) .
diphenylhydantoin	drug	tricyclic drugs	group
false

Human pharmacologic studies have shown that DRUGN may inhibit the metabolism of DRUGN , DRUGN ( DRUGN , DRUGA , DRUGN ) , DRUGN , and DRUGN ( DRUGB , DRUGN , DRUGN ) .
diphenylhydantoin	drug	imipramine	drug
false

Human pharmacologic studies have shown that DRUGN may inhibit the metabolism of DRUGN , DRUGN ( DRUGN , DRUGA , DRUGN ) , DRUGN , and DRUGN ( DRUGN , DRUGB , DRUGN ) .
diphenylhydantoin	drug	clomipramine	drug
false

Human pharmacologic studies have shown that DRUGN may inhibit the metabolism of DRUGN , DRUGN ( DRUGN , DRUGA , DRUGN ) , DRUGN , and DRUGN ( DRUGN , DRUGN , DRUGB ) .
diphenylhydantoin	drug	desipramine	drug
false

Human pharmacologic studies have shown that DRUGN may inhibit the metabolism of DRUGN , DRUGN ( DRUGN , DRUGN , DRUGA ) , DRUGB , and DRUGN ( DRUGN , DRUGN , DRUGN ) .
primidone	drug	phenylbutazone	drug
false

Human pharmacologic studies have shown that DRUGN may inhibit the metabolism of DRUGN , DRUGN ( DRUGN , DRUGN , DRUGA ) , DRUGN , and DRUGB ( DRUGN , DRUGN , DRUGN ) .
primidone	drug	tricyclic drugs	group
false

Human pharmacologic studies have shown that DRUGN may inhibit the metabolism of DRUGN , DRUGN ( DRUGN , DRUGN , DRUGA ) , DRUGN , and DRUGN ( DRUGB , DRUGN , DRUGN ) .
primidone	drug	imipramine	drug
false

Human pharmacologic studies have shown that DRUGN may inhibit the metabolism of DRUGN , DRUGN ( DRUGN , DRUGN , DRUGA ) , DRUGN , and DRUGN ( DRUGN , DRUGB , DRUGN ) .
primidone	drug	clomipramine	drug
false

Human pharmacologic studies have shown that DRUGN may inhibit the metabolism of DRUGN , DRUGN ( DRUGN , DRUGN , DRUGA ) , DRUGN , and DRUGN ( DRUGN , DRUGN , DRUGB ) .
primidone	drug	desipramine	drug
false

Human pharmacologic studies have shown that DRUGN may inhibit the metabolism of DRUGN , DRUGN ( DRUGN , DRUGN , DRUGN ) , DRUGA , and DRUGB ( DRUGN , DRUGN , DRUGN ) .
phenylbutazone	drug	tricyclic drugs	group
false

Human pharmacologic studies have shown that DRUGN may inhibit the metabolism of DRUGN , DRUGN ( DRUGN , DRUGN , DRUGN ) , DRUGA , and DRUGN ( DRUGB , DRUGN , DRUGN ) .
phenylbutazone	drug	imipramine	drug
false

Human pharmacologic studies have shown that DRUGN may inhibit the metabolism of DRUGN , DRUGN ( DRUGN , DRUGN , DRUGN ) , DRUGA , and DRUGN ( DRUGN , DRUGB , DRUGN ) .
phenylbutazone	drug	clomipramine	drug
false

Human pharmacologic studies have shown that DRUGN may inhibit the metabolism of DRUGN , DRUGN ( DRUGN , DRUGN , DRUGN ) , DRUGA , and DRUGN ( DRUGN , DRUGN , DRUGB ) .
phenylbutazone	drug	desipramine	drug
false

Human pharmacologic studies have shown that DRUGN may inhibit the metabolism of DRUGN , DRUGN ( DRUGN , DRUGN , DRUGN ) , DRUGN , and DRUGA ( DRUGB , DRUGN , DRUGN ) .
tricyclic drugs	group	imipramine	drug
false

Human pharmacologic studies have shown that DRUGN may inhibit the metabolism of DRUGN , DRUGN ( DRUGN , DRUGN , DRUGN ) , DRUGN , and DRUGA ( DRUGN , DRUGB , DRUGN ) .
tricyclic drugs	group	clomipramine	drug
false

Human pharmacologic studies have shown that DRUGN may inhibit the metabolism of DRUGN , DRUGN ( DRUGN , DRUGN , DRUGN ) , DRUGN , and DRUGA ( DRUGN , DRUGN , DRUGB ) .
tricyclic drugs	group	desipramine	drug
false

Human pharmacologic studies have shown that DRUGN may inhibit the metabolism of DRUGN , DRUGN ( DRUGN , DRUGN , DRUGN ) , DRUGN , and DRUGN ( DRUGA , DRUGB , DRUGN ) .
imipramine	drug	clomipramine	drug
false

Human pharmacologic studies have shown that DRUGN may inhibit the metabolism of DRUGN , DRUGN ( DRUGN , DRUGN , DRUGN ) , DRUGN , and DRUGN ( DRUGA , DRUGN , DRUGB ) .
imipramine	drug	desipramine	drug
false

Human pharmacologic studies have shown that DRUGN may inhibit the metabolism of DRUGN , DRUGN ( DRUGN , DRUGN , DRUGN ) , DRUGN , and DRUGN ( DRUGN , DRUGA , DRUGB ) .
clomipramine	drug	desipramine	drug
false

The safety of using DRUGA in combination with DRUGB or other centrally acting DRUGN has not been systemically evaluated .
methylphenidate	drug	clonidine	drug
false

The safety of using DRUGA in combination with DRUGN or other centrally acting DRUGB has not been systemically evaluated .
methylphenidate	drug	alpha-2 agonists	group
false

The safety of using DRUGN in combination with DRUGA or other centrally acting DRUGB has not been systemically evaluated .
clonidine	drug	alpha-2 agonists	group
false

Mutual inhibition of metabolism occurs with concurrent use of DRUGA and DRUGB ;
cyclosporin	drug	methylprednisolone	drug
mechanism

convulsions have been reported with concurrent use of DRUGA and DRUGB .
methylprednisolone	drug	cyclosporin	drug
effect

Drugs that induce hepatic enzymes such as DRUGA , DRUGB , and DRUGN may increase the clearance of DRUGN and may require increased in DRUGN dose to achieve the desired response .
phenobarbital	drug	phenytoin	drug
false

Drugs that induce hepatic enzymes such as DRUGA , DRUGN , and DRUGB may increase the clearance of DRUGN and may require increased in DRUGN dose to achieve the desired response .
phenobarbital	drug	rifampin	drug
false

Drugs that induce hepatic enzymes such as DRUGA , DRUGN , and DRUGN may increase the clearance of DRUGB and may require increased in DRUGN dose to achieve the desired response .
phenobarbital	drug	methylprednisolone	drug
mechanism

Drugs that induce hepatic enzymes such as DRUGA , DRUGN , and DRUGN may increase the clearance of DRUGN and may require increased in DRUGB dose to achieve the desired response .
phenobarbital	drug	methylprednisolone	drug
advise

Drugs that induce hepatic enzymes such as DRUGN , DRUGA , and DRUGB may increase the clearance of DRUGN and may require increased in DRUGN dose to achieve the desired response .
phenytoin	drug	rifampin	drug
false

Drugs that induce hepatic enzymes such as DRUGN , DRUGA , and DRUGN may increase the clearance of DRUGB and may require increased in DRUGN dose to achieve the desired response .
phenytoin	drug	methylprednisolone	drug
mechanism

Drugs that induce hepatic enzymes such as DRUGN , DRUGA , and DRUGN may increase the clearance of DRUGN and may require increased in DRUGB dose to achieve the desired response .
phenytoin	drug	methylprednisolone	drug
advise

Drugs that induce hepatic enzymes such as DRUGN , DRUGN , and DRUGA may increase the clearance of DRUGB and may require increased in DRUGN dose to achieve the desired response .
rifampin	drug	methylprednisolone	drug
mechanism

Drugs that induce hepatic enzymes such as DRUGN , DRUGN , and DRUGA may increase the clearance of DRUGN and may require increased in DRUGB dose to achieve the desired response .
rifampin	drug	methylprednisolone	drug
advise

Drugs such as DRUGA and DRUGB may inhibit the metabolism of DRUGN and thus decrease its clearance .
troleandomycin	drug	ketoconazole	drug
false

Drugs such as DRUGA and DRUGN may inhibit the metabolism of DRUGB and thus decrease its clearance .
troleandomycin	drug	methylprednisolone	drug
mechanism

Drugs such as DRUGN and DRUGA may inhibit the metabolism of DRUGB and thus decrease its clearance .
ketoconazole	drug	methylprednisolone	drug
mechanism

DRUGA may increase the clearance of chronic high dose DRUGB .
Methylprednisolone	drug	aspirin	brand
mechanism

This could lead to decreased DRUGA serum levels or increase the risk of DRUGN toxicity when DRUGB is withdrawn .
salicylate	group	methylprednisolone	drug
false

This could lead to decreased DRUGN serum levels or increase the risk of DRUGA toxicity when DRUGB is withdrawn .
salicylate	group	methylprednisolone	drug
effect

DRUGA should be used cautiously in conjunction with DRUGB in patients suffering from hypoprothrombinemia .
Aspirin	brand	corticosteroids	group
advise

The effect of DRUGA on oral DRUGB is variable .
methylprednisolone	drug	anticoagulants	group
false

There are reports of enhanced as well as diminished effects of DRUGA when given concurrently with DRUGB .
anticoagulant	group	corticosteroids	group
effect

Concurrent use of DRUGA and other DRUGB may increase the CNS depressant effects of DRUGN or these other medications .
alcohol	drug	CNS depression-producing drugs	group
false

Concurrent use of DRUGA and other DRUGN may increase the CNS depressant effects of DRUGB or these other medications .
alcohol	drug	methyprylon	drug
effect

Concurrent use of DRUGN and other DRUGA may increase the CNS depressant effects of DRUGB or these other medications .
CNS depression-producing drugs	group	methyprylon	drug
effect

DRUGA may reverse the analgesic activity of DRUGB .
Methysergide	drug	narcotic analgesics	group
effect

Concurrent use with DRUGA including DRUGB , DRUGN , and DRUGN ( e.g . smoking ) may result in enhanced vasoconstriction .
vasoconstrictor agents	group	ergot alkaloids	group
false

Concurrent use with DRUGA including DRUGN , DRUGB , and DRUGN ( e.g . smoking ) may result in enhanced vasoconstriction .
vasoconstrictor agents	group	sumatriptan	drug
false

Concurrent use with DRUGA including DRUGN , DRUGN , and DRUGB ( e.g . smoking ) may result in enhanced vasoconstriction .
vasoconstrictor agents	group	nicotine	drug
false

Concurrent use with DRUGN including DRUGA , DRUGB , and DRUGN ( e.g . smoking ) may result in enhanced vasoconstriction .
ergot alkaloids	group	sumatriptan	drug
false

Concurrent use with DRUGN including DRUGA , DRUGN , and DRUGB ( e.g . smoking ) may result in enhanced vasoconstriction .
ergot alkaloids	group	nicotine	drug
false

Concurrent use with DRUGN including DRUGN , DRUGA , and DRUGB ( e.g . smoking ) may result in enhanced vasoconstriction .
sumatriptan	drug	nicotine	drug
false

The effects of DRUGA on gastrointestinal motility are antagonized by DRUGB and DRUGN .
metoclopramide	drug	anticholinergic drugs	group
effect

The effects of DRUGA on gastrointestinal motility are antagonized by DRUGN and DRUGB .
metoclopramide	drug	narcotic analgesics	group
effect

The effects of DRUGN on gastrointestinal motility are antagonized by DRUGA and DRUGB .
anticholinergic drugs	group	narcotic analgesics	group
false

Additive sedative effects can occur when DRUGA is given with DRUGB , DRUGN , DRUGN , DRUGN , or DRUGN .
metoclopramide	drug	alcohol	drug
effect

Additive sedative effects can occur when DRUGA is given with DRUGN , DRUGB , DRUGN , DRUGN , or DRUGN .
metoclopramide	drug	sedatives	group
effect

Additive sedative effects can occur when DRUGA is given with DRUGN , DRUGN , DRUGB , DRUGN , or DRUGN .
metoclopramide	drug	hypnotics	group
effect

Additive sedative effects can occur when DRUGA is given with DRUGN , DRUGN , DRUGN , DRUGB , or DRUGN .
metoclopramide	drug	narcotics	group
effect

Additive sedative effects can occur when DRUGA is given with DRUGN , DRUGN , DRUGN , DRUGN , or DRUGB .
metoclopramide	drug	tranquilizers	group
effect

Additive sedative effects can occur when DRUGN is given with DRUGA , DRUGB , DRUGN , DRUGN , or DRUGN .
alcohol	drug	sedatives	group
false

Additive sedative effects can occur when DRUGN is given with DRUGA , DRUGN , DRUGB , DRUGN , or DRUGN .
alcohol	drug	hypnotics	group
false

Additive sedative effects can occur when DRUGN is given with DRUGA , DRUGN , DRUGN , DRUGB , or DRUGN .
alcohol	drug	narcotics	group
false

Additive sedative effects can occur when DRUGN is given with DRUGA , DRUGN , DRUGN , DRUGN , or DRUGB .
alcohol	drug	tranquilizers	group
false

Additive sedative effects can occur when DRUGN is given with DRUGN , DRUGA , DRUGB , DRUGN , or DRUGN .
sedatives	group	hypnotics	group
false

Additive sedative effects can occur when DRUGN is given with DRUGN , DRUGA , DRUGN , DRUGB , or DRUGN .
sedatives	group	narcotics	group
false

Additive sedative effects can occur when DRUGN is given with DRUGN , DRUGA , DRUGN , DRUGN , or DRUGB .
sedatives	group	tranquilizers	group
false

Additive sedative effects can occur when DRUGN is given with DRUGN , DRUGN , DRUGA , DRUGB , or DRUGN .
hypnotics	group	narcotics	group
false

Additive sedative effects can occur when DRUGN is given with DRUGN , DRUGN , DRUGA , DRUGN , or DRUGB .
hypnotics	group	tranquilizers	group
false

Additive sedative effects can occur when DRUGN is given with DRUGN , DRUGN , DRUGN , DRUGA , or DRUGB .
narcotics	group	tranquilizers	group
false

The finding that DRUGA releases catecholamines in patients with essential hypertension suggests that it should be used cautiously , if at all , in patients receiving DRUGB .
metoclopramide	drug	monoamine oxi-dase inhibitors	group
advise

Because the action of DRUGA will influence the delivery of food to the intestines and thus the rate of absorption , DRUGB dosage or timing of dosage may require adjustment .
metoclopramide	drug	insulin	drug
advise

DRUGA : DRUGB and probably other DRUGN given concomitantly with DRUGN can cause unusually large or prolonged losses of fluid and electrolytes .
Diuretics	group	Furosemide	drug
false

DRUGA : DRUGN and probably other DRUGB given concomitantly with DRUGN can cause unusually large or prolonged losses of fluid and electrolytes .
Diuretics	group	loop diuretics	group
false

DRUGA : DRUGN and probably other DRUGN given concomitantly with DRUGB can cause unusually large or prolonged losses of fluid and electrolytes .
Diuretics	group	metolazone	drug
false

DRUGN : DRUGA and probably other DRUGB given concomitantly with DRUGN can cause unusually large or prolonged losses of fluid and electrolytes .
Furosemide	drug	loop diuretics	group
false

DRUGN : DRUGA and probably other DRUGN given concomitantly with DRUGB can cause unusually large or prolonged losses of fluid and electrolytes .
Furosemide	drug	metolazone	drug
effect

DRUGN : DRUGN and probably other DRUGA given concomitantly with DRUGB can cause unusually large or prolonged losses of fluid and electrolytes .
loop diuretics	group	metolazone	drug
effect

Other DRUGA : When DRUGB Tablets are used with other DRUGN , care must be taken , especially during initial therapy .
Antihypertensives	group	MYKROX	brand
false

Other DRUGA : When DRUGN Tablets are used with other DRUGB , care must be taken , especially during initial therapy .
Antihypertensives	group	antihypertensive drugs	group
false

Other DRUGN : When DRUGA Tablets are used with other DRUGB , care must be taken , especially during initial therapy .
MYKROX	brand	antihypertensive drugs	group
advise

DRUGA , DRUGB , and DRUGN : The hypotensive effects of these drugs may be potentiated by the volume contraction that may be associated with DRUGN therapy .
Alcohol	drug	Barbiturates	group
false

DRUGA , DRUGN , and DRUGB : The hypotensive effects of these drugs may be potentiated by the volume contraction that may be associated with DRUGN therapy .
Alcohol	drug	Narcotics	group
false

DRUGA , DRUGN , and DRUGN : The hypotensive effects of these drugs may be potentiated by the volume contraction that may be associated with DRUGB therapy .
Alcohol	drug	metolazone	drug
false

DRUGN , DRUGA , and DRUGB : The hypotensive effects of these drugs may be potentiated by the volume contraction that may be associated with DRUGN therapy .
Barbiturates	group	Narcotics	group
false

DRUGN , DRUGA , and DRUGN : The hypotensive effects of these drugs may be potentiated by the volume contraction that may be associated with DRUGB therapy .
Barbiturates	group	metolazone	drug
false

DRUGN , DRUGN , and DRUGA : The hypotensive effects of these drugs may be potentiated by the volume contraction that may be associated with DRUGB therapy .
Narcotics	group	metolazone	drug
false

DRUGA : DRUGB induced hypokalemia can increase the sensitivity of the myocardium to DRUGN .
Digitalis Glycosides	group	Diuretic	group
false

DRUGA : DRUGN induced hypokalemia can increase the sensitivity of the myocardium to DRUGB .
Digitalis Glycosides	group	digitalis	group
false

DRUGN : DRUGA induced hypokalemia can increase the sensitivity of the myocardium to DRUGB .
Diuretic	group	digitalis	group
effect

DRUGA or DRUGB : May increase the risk of hypokalemia and increase salt and water retention .
Corticosteroids	group	ACTH	drug
false

DRUGA : Serum DRUGB levels may increase .
Lithium	drug	lithium	drug
false

DRUGA : DRUGB induced hypokalemia may enhance neuromuscular blocking effects of DRUGN ( such as DRUGN ) the most serious effect would be respiratory depression which could proceed to apnea .
Curariform Drugs	group	Diuretic	group
false

DRUGA : DRUGN induced hypokalemia may enhance neuromuscular blocking effects of DRUGB ( such as DRUGN ) the most serious effect would be respiratory depression which could proceed to apnea .
Curariform Drugs	group	curariform drugs	group
false

DRUGA : DRUGN induced hypokalemia may enhance neuromuscular blocking effects of DRUGN ( such as DRUGB ) the most serious effect would be respiratory depression which could proceed to apnea .
Curariform Drugs	group	tubocurarine	drug
false

DRUGN : DRUGA induced hypokalemia may enhance neuromuscular blocking effects of DRUGB ( such as DRUGN ) the most serious effect would be respiratory depression which could proceed to apnea .
Diuretic	group	curariform drugs	group
effect

DRUGN : DRUGA induced hypokalemia may enhance neuromuscular blocking effects of DRUGN ( such as DRUGB ) the most serious effect would be respiratory depression which could proceed to apnea .
Diuretic	group	tubocurarine	drug
effect

DRUGN : DRUGN induced hypokalemia may enhance neuromuscular blocking effects of DRUGA ( such as DRUGB ) the most serious effect would be respiratory depression which could proceed to apnea .
curariform drugs	group	tubocurarine	drug
false

DRUGA and Other DRUGB : May decrease the antihypertensive effects of DRUGN Tablets .
Salicylates	group	Non-Steroidal Anti-Inflammatory Drugs	group
false

DRUGA and Other DRUGN : May decrease the antihypertensive effects of DRUGB Tablets .
Salicylates	group	MYKROX	brand
effect

DRUGN and Other DRUGA : May decrease the antihypertensive effects of DRUGB Tablets .
Non-Steroidal Anti-Inflammatory Drugs	group	MYKROX	brand
effect

DRUGA : DRUGB may decrease arterial responsiveness to DRUGN , but this diminution is not sufficient to preclude effectiveness of the pressor agent for therapeutic use .
Sympathomimetics	group	Metolazone	drug
false

DRUGA : DRUGN may decrease arterial responsiveness to DRUGB , but this diminution is not sufficient to preclude effectiveness of the pressor agent for therapeutic use .
Sympathomimetics	group	norepinephrine	drug
false

DRUGN : DRUGA may decrease arterial responsiveness to DRUGB , but this diminution is not sufficient to preclude effectiveness of the pressor agent for therapeutic use .
Metolazone	drug	norepinephrine	drug
effect

DRUGA : Efficacy may be decreased due to urinary alkalizing effect of DRUGB .
Methenamine	drug	metolazone	drug
effect

DRUGA : DRUGB , as well as other DRUGN , may affect the hypoprothrombinemic response to DRUGN ;
Anticoagulants	group	Metolazone	drug
false

DRUGA : DRUGN , as well as other DRUGB , may affect the hypoprothrombinemic response to DRUGN ;
Anticoagulants	group	thiazide-like diuretics	group
false

DRUGA : DRUGN , as well as other DRUGN , may affect the hypoprothrombinemic response to DRUGB ;
Anticoagulants	group	anticoagulants	group
false

DRUGN : DRUGA , as well as other DRUGB , may affect the hypoprothrombinemic response to DRUGN ;
Metolazone	drug	thiazide-like diuretics	group
false

DRUGN : DRUGA , as well as other DRUGN , may affect the hypoprothrombinemic response to DRUGB ;
Metolazone	drug	anticoagulants	group
effect

DRUGN : DRUGN , as well as other DRUGA , may affect the hypoprothrombinemic response to DRUGB ;
thiazide-like diuretics	group	anticoagulants	group
false

Catecholamine depleting drugs ( e.g . , DRUGA ) may have an additive effect when given with DRUGB .
reserpine	drug	beta-blocking agents	group
effect

Oral DRUGA has been reported to potentiate the anticoagulant effect of DRUGB and DRUGN , resulting in a prolongation of prothrombin time .
metronidazole	drug	coumarin	group
effect

Oral DRUGA has been reported to potentiate the anticoagulant effect of DRUGN and DRUGB , resulting in a prolongation of prothrombin time .
metronidazole	drug	warfarin	drug
effect

Oral DRUGN has been reported to potentiate the anticoagulant effect of DRUGA and DRUGB , resulting in a prolongation of prothrombin time .
coumarin	group	warfarin	drug
false

The metabolism of DRUGA is accelerated by DRUGB ;
Metopirone	brand	phenytoin	drug
mechanism

DRUGA inhibits the glucuronidation of DRUGB and could possibly potentiate DRUGN toxicity .
Metopirone	brand	acetaminophen	drug
mechanism

DRUGA inhibits the glucuronidation of DRUGN and could possibly potentiate DRUGB toxicity .
Metopirone	brand	acetaminophen	drug
effect

Caution should be observed in administering DRUGA to patients receiving DRUGB or DRUGN because the extrapyramidal effects of these drugs can be expected to be potentiated by inhibition of catecholamine synthesis .
DEMSER	brand	phenothiazines	group
advise

Caution should be observed in administering DRUGA to patients receiving DRUGN or DRUGB because the extrapyramidal effects of these drugs can be expected to be potentiated by inhibition of catecholamine synthesis .
DEMSER	brand	haloperidol	drug
advise

Caution should be observed in administering DRUGN to patients receiving DRUGA or DRUGB because the extrapyramidal effects of these drugs can be expected to be potentiated by inhibition of catecholamine synthesis .
phenothiazines	group	haloperidol	drug
false

Concurrent use of DRUGA with DRUGB or other DRUGN can increase their sedative effects .
DEMSER	brand	alcohol	drug
effect

Concurrent use of DRUGA with DRUGN or other DRUGB can increase their sedative effects .
DEMSER	brand	CNS depressants	drug
effect

Concurrent use of DRUGN with DRUGA or other DRUGB can increase their sedative effects .
alcohol	drug	CNS depressants	drug
false

Since DRUGA is a substrate for the metabolic pathways involving CYPdgbDdgb and CYPdgbAdgb enzymes , inhibition or induction of either of these enzymes would be expected to alter DRUGB plasma concentrations .
MEXITIL	brand	mexiletine	drug
false

In a formal , single dose interaction study ( n = dgb males ) the clearance of DRUGA was decreased by dgb % following the coadministration of DRUGB , an inhibitor of CYPdgbAdga
mexiletine	drug	fluvoxamine	drug
mechanism

In another formal study ( n = dgb extensive and n = dgb poor metabolizers of CYPdgbDdgb ) , coadministration of DRUGA did not alter the kinetics of DRUGB in the poor CYPdgbDdgb metabolizer group .
propafenone	drug	mexiletine	drug
false

In this crossover steady state study , the pharmacokinetics of DRUGA were unaffected in either phenotype by the coadministration of DRUGB .
propafenone	drug	mexiletine	drug
false

Addition of DRUGA to DRUGB did not lead to further electrocardiographic parameters changes of QRS , QTc , RR , and PR intervals than DRUGN alone .
mexiletine	drug	propafenone	drug
false

Addition of DRUGA to DRUGN did not lead to further electrocardiographic parameters changes of QRS , QTc , RR , and PR intervals than DRUGB alone .
mexiletine	drug	propafenone	drug
false

In a large compassionate use program DRUGA has been used concurrently with commonly employed antianginal , DRUGB , and DRUGN without observed interactions .
Mexitil	brand	antihypertensive	group
false

In a large compassionate use program DRUGA has been used concurrently with commonly employed antianginal , DRUGN , and DRUGB without observed interactions .
Mexitil	brand	anticoagulant drugs	group
false

In a large compassionate use program DRUGN has been used concurrently with commonly employed antianginal , DRUGA , and DRUGB without observed interactions .
antihypertensive	group	anticoagulant drugs	group
false

A variety of DRUGA such as DRUGB or DRUGN were also added , sometimes with improved control of ventricular ectopy .
antiarrhythmics	group	quinidine	drug
false

A variety of DRUGA such as DRUGN or DRUGB were also added , sometimes with improved control of ventricular ectopy .
antiarrhythmics	group	propranolol	drug
false

A variety of DRUGN such as DRUGA or DRUGB were also added , sometimes with improved control of ventricular ectopy .
quinidine	drug	propranolol	drug
false

When DRUGA or other hepatic enzyme inducers such as DRUGB and DRUGN have been taken concurrently with DRUGN , lowered DRUGN plasma levels have been reported .
phenytoin	drug	rifampin	drug
false

When DRUGA or other hepatic enzyme inducers such as DRUGN and DRUGB have been taken concurrently with DRUGN , lowered DRUGN plasma levels have been reported .
phenytoin	drug	phenobarbital	drug
false

When DRUGA or other hepatic enzyme inducers such as DRUGN and DRUGN have been taken concurrently with DRUGB , lowered DRUGN plasma levels have been reported .
phenytoin	drug	Mexitil	brand
mechanism

When DRUGA or other hepatic enzyme inducers such as DRUGN and DRUGN have been taken concurrently with DRUGN , lowered DRUGB plasma levels have been reported .
phenytoin	drug	Mexitil	brand
false

When DRUGN or other hepatic enzyme inducers such as DRUGA and DRUGB have been taken concurrently with DRUGN , lowered DRUGN plasma levels have been reported .
rifampin	drug	phenobarbital	drug
false

When DRUGN or other hepatic enzyme inducers such as DRUGA and DRUGN have been taken concurrently with DRUGB , lowered DRUGN plasma levels have been reported .
rifampin	drug	Mexitil	brand
mechanism

When DRUGN or other hepatic enzyme inducers such as DRUGA and DRUGN have been taken concurrently with DRUGN , lowered DRUGB plasma levels have been reported .
rifampin	drug	Mexitil	brand
false

When DRUGN or other hepatic enzyme inducers such as DRUGN and DRUGA have been taken concurrently with DRUGB , lowered DRUGN plasma levels have been reported .
phenobarbital	drug	Mexitil	brand
mechanism

When DRUGN or other hepatic enzyme inducers such as DRUGN and DRUGA have been taken concurrently with DRUGN , lowered DRUGB plasma levels have been reported .
phenobarbital	drug	Mexitil	brand
false

In a formal study , DRUGA were shown not to affect DRUGB plasma concentrations .
benzodiazepines	group	Mexitil	brand
false

ECG intervals ( PR , QRS , and QT ) were not affected by concurrent DRUGA and DRUGB , DRUGN , or DRUGN .
Mexitil	brand	digoxin	drug
false

ECG intervals ( PR , QRS , and QT ) were not affected by concurrent DRUGA and DRUGN , DRUGB , or DRUGN .
Mexitil	brand	diuretics	group
false

ECG intervals ( PR , QRS , and QT ) were not affected by concurrent DRUGA and DRUGN , DRUGN , or DRUGB .
Mexitil	brand	propranolol	drug
false

ECG intervals ( PR , QRS , and QT ) were not affected by concurrent DRUGN and DRUGA , DRUGB , or DRUGN .
digoxin	drug	diuretics	group
false

ECG intervals ( PR , QRS , and QT ) were not affected by concurrent DRUGN and DRUGA , DRUGN , or DRUGB .
digoxin	drug	propranolol	drug
false

ECG intervals ( PR , QRS , and QT ) were not affected by concurrent DRUGN and DRUGN , DRUGA , or DRUGB .
diuretics	group	propranolol	drug
false

Concurrent administration of DRUGA and DRUGB has been reported to increase , decrease , or leave unchanged DRUGN plasma levels ;
cimetidine	drug	Mexitil	brand
mechanism

Concurrent administration of DRUGA and DRUGN has been reported to increase , decrease , or leave unchanged DRUGB plasma levels ;
cimetidine	drug	Mexitil	brand
false

DRUGA does not alter serum DRUGB levels but DRUGN , when used to treat gastrointestinal symptoms due to DRUGN , has been reported to lower serum DRUGN levels .
Mexitil	brand	digoxin	drug
false

DRUGA does not alter serum DRUGN levels but DRUGB , when used to treat gastrointestinal symptoms due to DRUGN , has been reported to lower serum DRUGN levels .
Mexitil	brand	magnesium-aluminum hydroxide	drug
false

DRUGA does not alter serum DRUGN levels but DRUGN , when used to treat gastrointestinal symptoms due to DRUGN , has been reported to lower serum DRUGB levels .
Mexitil	brand	digoxin	drug
false

DRUGN does not alter serum DRUGA levels but DRUGB , when used to treat gastrointestinal symptoms due to DRUGN , has been reported to lower serum DRUGN levels .
digoxin	drug	magnesium-aluminum hydroxide	drug
false

DRUGN does not alter serum DRUGA levels but DRUGN , when used to treat gastrointestinal symptoms due to DRUGB , has been reported to lower serum DRUGN levels .
digoxin	drug	Mexitil	brand
false

DRUGN does not alter serum DRUGN levels but DRUGA , when used to treat gastrointestinal symptoms due to DRUGB , has been reported to lower serum DRUGN levels .
magnesium-aluminum hydroxide	drug	Mexitil	brand
false

DRUGN does not alter serum DRUGN levels but DRUGA , when used to treat gastrointestinal symptoms due to DRUGN , has been reported to lower serum DRUGB levels .
magnesium-aluminum hydroxide	drug	digoxin	drug
mechanism

DRUGN does not alter serum DRUGN levels but DRUGN , when used to treat gastrointestinal symptoms due to DRUGA , has been reported to lower serum DRUGB levels .
Mexitil	brand	digoxin	drug
false

Concurrent use of DRUGA and DRUGB may lead to increased plasma DRUGN levels .
Mexitil	brand	theophylline	drug
mechanism

Concurrent use of DRUGA and DRUGN may lead to increased plasma DRUGB levels .
Mexitil	brand	theophylline	drug
false

Additionally , in one controlled study in five normal subjects and seven patients , the clearance of DRUGA was decreased dgb % following the administration of DRUGB .
caffeine	drug	Mexitil	brand
mechanism

DRUGA inhibits some of the liver 's ability to metabolize some other drugs DRUGB , DRUGN , DRUGN , DRUGN , and DRUGN .
Posicor	brand	terfenadine	drug
mechanism

DRUGA inhibits some of the liver 's ability to metabolize some other drugs DRUGN , DRUGB , DRUGN , DRUGN , and DRUGN .
Posicor	brand	astemizole	drug
mechanism

DRUGA inhibits some of the liver 's ability to metabolize some other drugs DRUGN , DRUGN , DRUGB , DRUGN , and DRUGN .
Posicor	brand	cisapride	drug
mechanism

DRUGA inhibits some of the liver 's ability to metabolize some other drugs DRUGN , DRUGN , DRUGN , DRUGB , and DRUGN .
Posicor	brand	cyclosporine	drug
mechanism

DRUGA inhibits some of the liver 's ability to metabolize some other drugs DRUGN , DRUGN , DRUGN , DRUGN , and DRUGB .
Posicor	brand	tricyclic antidepressants	group
mechanism

DRUGN inhibits some of the liver 's ability to metabolize some other drugs DRUGA , DRUGB , DRUGN , DRUGN , and DRUGN .
terfenadine	drug	astemizole	drug
false

DRUGN inhibits some of the liver 's ability to metabolize some other drugs DRUGA , DRUGN , DRUGB , DRUGN , and DRUGN .
terfenadine	drug	cisapride	drug
false

DRUGN inhibits some of the liver 's ability to metabolize some other drugs DRUGA , DRUGN , DRUGN , DRUGB , and DRUGN .
terfenadine	drug	cyclosporine	drug
false

DRUGN inhibits some of the liver 's ability to metabolize some other drugs DRUGA , DRUGN , DRUGN , DRUGN , and DRUGB .
terfenadine	drug	tricyclic antidepressants	group
false

DRUGN inhibits some of the liver 's ability to metabolize some other drugs DRUGN , DRUGA , DRUGB , DRUGN , and DRUGN .
astemizole	drug	cisapride	drug
false

DRUGN inhibits some of the liver 's ability to metabolize some other drugs DRUGN , DRUGA , DRUGN , DRUGB , and DRUGN .
astemizole	drug	cyclosporine	drug
false

DRUGN inhibits some of the liver 's ability to metabolize some other drugs DRUGN , DRUGA , DRUGN , DRUGN , and DRUGB .
astemizole	drug	tricyclic antidepressants	group
false

DRUGN inhibits some of the liver 's ability to metabolize some other drugs DRUGN , DRUGN , DRUGA , DRUGB , and DRUGN .
cisapride	drug	cyclosporine	drug
false

DRUGN inhibits some of the liver 's ability to metabolize some other drugs DRUGN , DRUGN , DRUGA , DRUGN , and DRUGB .
cisapride	drug	tricyclic antidepressants	group
false

DRUGN inhibits some of the liver 's ability to metabolize some other drugs DRUGN , DRUGN , DRUGN , DRUGA , and DRUGB .
cyclosporine	drug	tricyclic antidepressants	group
false

There was no effect of a single dose or multiple doses of DRUGA on DRUGB , DRUGN , DRUGN , DRUGN , and DRUGN pharmacokinetics .
MYCAMINE	brand	mycophenolate mofetil	drug
false

There was no effect of a single dose or multiple doses of DRUGA on DRUGN , DRUGB , DRUGN , DRUGN , and DRUGN pharmacokinetics .
MYCAMINE	brand	cyclosporine	drug
false

There was no effect of a single dose or multiple doses of DRUGA on DRUGN , DRUGN , DRUGB , DRUGN , and DRUGN pharmacokinetics .
MYCAMINE	brand	tacrolimus	drug
false

There was no effect of a single dose or multiple doses of DRUGA on DRUGN , DRUGN , DRUGN , DRUGB , and DRUGN pharmacokinetics .
MYCAMINE	brand	prednisolone	drug
false

There was no effect of a single dose or multiple doses of DRUGA on DRUGN , DRUGN , DRUGN , DRUGN , and DRUGB pharmacokinetics .
MYCAMINE	brand	fluconazole	drug
false

There was no effect of a single dose or multiple doses of DRUGN on DRUGA , DRUGB , DRUGN , DRUGN , and DRUGN pharmacokinetics .
mycophenolate mofetil	drug	cyclosporine	drug
false

There was no effect of a single dose or multiple doses of DRUGN on DRUGA , DRUGN , DRUGB , DRUGN , and DRUGN pharmacokinetics .
mycophenolate mofetil	drug	tacrolimus	drug
false

There was no effect of a single dose or multiple doses of DRUGN on DRUGA , DRUGN , DRUGN , DRUGB , and DRUGN pharmacokinetics .
mycophenolate mofetil	drug	prednisolone	drug
false

There was no effect of a single dose or multiple doses of DRUGN on DRUGA , DRUGN , DRUGN , DRUGN , and DRUGB pharmacokinetics .
mycophenolate mofetil	drug	fluconazole	drug
false

There was no effect of a single dose or multiple doses of DRUGN on DRUGN , DRUGA , DRUGB , DRUGN , and DRUGN pharmacokinetics .
cyclosporine	drug	tacrolimus	drug
false

There was no effect of a single dose or multiple doses of DRUGN on DRUGN , DRUGA , DRUGN , DRUGB , and DRUGN pharmacokinetics .
cyclosporine	drug	prednisolone	drug
false

There was no effect of a single dose or multiple doses of DRUGN on DRUGN , DRUGA , DRUGN , DRUGN , and DRUGB pharmacokinetics .
cyclosporine	drug	fluconazole	drug
false

There was no effect of a single dose or multiple doses of DRUGN on DRUGN , DRUGN , DRUGA , DRUGB , and DRUGN pharmacokinetics .
tacrolimus	drug	prednisolone	drug
false

There was no effect of a single dose or multiple doses of DRUGN on DRUGN , DRUGN , DRUGA , DRUGN , and DRUGB pharmacokinetics .
tacrolimus	drug	fluconazole	drug
false

There was no effect of a single dose or multiple doses of DRUGN on DRUGN , DRUGN , DRUGN , DRUGA , and DRUGB pharmacokinetics .
prednisolone	drug	fluconazole	drug
false

DRUGA AUC was increased by dgb % with no effect on Cmax in the presence of steady state DRUGB compared with DRUGN alone .
Sirolimus	drug	MYCAMINE	brand
mechanism

DRUGA AUC was increased by dgb % with no effect on Cmax in the presence of steady state DRUGN compared with DRUGB alone .
Sirolimus	drug	sirolimus	drug
false

DRUGN AUC was increased by dgb % with no effect on Cmax in the presence of steady state DRUGA compared with DRUGB alone .
MYCAMINE	brand	sirolimus	drug
false

DRUGA AUC and Cmax were increased by dgb % and dgb % , respectively , in the presence of steady state DRUGB compared with DRUGN alone .
Nifedipine	drug	MYCAMINE	brand
mechanism

DRUGA AUC and Cmax were increased by dgb % and dgb % , respectively , in the presence of steady state DRUGN compared with DRUGB alone .
Nifedipine	drug	nifedipine	drug
false

DRUGN AUC and Cmax were increased by dgb % and dgb % , respectively , in the presence of steady state DRUGA compared with DRUGB alone .
MYCAMINE	brand	nifedipine	drug
false

Patients receiving DRUGA or DRUGB in combination with DRUGN should be monitored for DRUGN or DRUGN toxicity and DRUGN or DRUGN dosage should be reduced if necessary .
sirolimus	drug	nifedipine	drug
false

Patients receiving DRUGA or DRUGN in combination with DRUGB should be monitored for DRUGN or DRUGN toxicity and DRUGN or DRUGN dosage should be reduced if necessary .
sirolimus	drug	MYCAMINE	brand
advise

Patients receiving DRUGA or DRUGN in combination with DRUGN should be monitored for DRUGN or DRUGB toxicity and DRUGN or DRUGN dosage should be reduced if necessary .
sirolimus	drug	nifedipine	drug
false

Patients receiving DRUGA or DRUGN in combination with DRUGN should be monitored for DRUGN or DRUGN toxicity and DRUGN or DRUGB dosage should be reduced if necessary .
sirolimus	drug	nifedipine	drug
false

Patients receiving DRUGN or DRUGA in combination with DRUGB should be monitored for DRUGN or DRUGN toxicity and DRUGN or DRUGN dosage should be reduced if necessary .
nifedipine	drug	MYCAMINE	brand
advise

Patients receiving DRUGN or DRUGA in combination with DRUGN should be monitored for DRUGB or DRUGN toxicity and DRUGN or DRUGN dosage should be reduced if necessary .
nifedipine	drug	sirolimus	drug
false

Patients receiving DRUGN or DRUGA in combination with DRUGN should be monitored for DRUGN or DRUGN toxicity and DRUGB or DRUGN dosage should be reduced if necessary .
nifedipine	drug	sirolimus	drug
false

Patients receiving DRUGN or DRUGN in combination with DRUGA should be monitored for DRUGB or DRUGN toxicity and DRUGN or DRUGN dosage should be reduced if necessary .
MYCAMINE	brand	sirolimus	drug
false

Patients receiving DRUGN or DRUGN in combination with DRUGA should be monitored for DRUGN or DRUGB toxicity and DRUGN or DRUGN dosage should be reduced if necessary .
MYCAMINE	brand	nifedipine	drug
false

Patients receiving DRUGN or DRUGN in combination with DRUGA should be monitored for DRUGN or DRUGN toxicity and DRUGB or DRUGN dosage should be reduced if necessary .
MYCAMINE	brand	sirolimus	drug
false

Patients receiving DRUGN or DRUGN in combination with DRUGA should be monitored for DRUGN or DRUGN toxicity and DRUGN or DRUGB dosage should be reduced if necessary .
MYCAMINE	brand	nifedipine	drug
false

Patients receiving DRUGN or DRUGN in combination with DRUGN should be monitored for DRUGA or DRUGB toxicity and DRUGN or DRUGN dosage should be reduced if necessary .
sirolimus	drug	nifedipine	drug
false

Patients receiving DRUGN or DRUGN in combination with DRUGN should be monitored for DRUGA or DRUGN toxicity and DRUGN or DRUGB dosage should be reduced if necessary .
sirolimus	drug	nifedipine	drug
false

Patients receiving DRUGN or DRUGN in combination with DRUGN should be monitored for DRUGN or DRUGA toxicity and DRUGB or DRUGN dosage should be reduced if necessary .
nifedipine	drug	sirolimus	drug
false

Patients receiving DRUGN or DRUGN in combination with DRUGN should be monitored for DRUGN or DRUGN toxicity and DRUGA or DRUGB dosage should be reduced if necessary .
sirolimus	drug	nifedipine	drug
false

Drugs such as DRUGA , DRUGB , DRUGN , DRUGN , DRUGN and DRUGN were shown to significantly increase the C max and AUC of orally administered DRUGN .
erythromycin	drug	diltiazem	drug
false

Drugs such as DRUGA , DRUGN , DRUGB , DRUGN , DRUGN and DRUGN were shown to significantly increase the C max and AUC of orally administered DRUGN .
erythromycin	drug	verapamil	drug
false

Drugs such as DRUGA , DRUGN , DRUGN , DRUGB , DRUGN and DRUGN were shown to significantly increase the C max and AUC of orally administered DRUGN .
erythromycin	drug	ketoconazole	drug
false

Drugs such as DRUGA , DRUGN , DRUGN , DRUGN , DRUGB and DRUGN were shown to significantly increase the C max and AUC of orally administered DRUGN .
erythromycin	drug	fluconazole	drug
false

Drugs such as DRUGA , DRUGN , DRUGN , DRUGN , DRUGN and DRUGB were shown to significantly increase the C max and AUC of orally administered DRUGN .
erythromycin	drug	itraconazole	drug
false

Drugs such as DRUGA , DRUGN , DRUGN , DRUGN , DRUGN and DRUGN were shown to significantly increase the C max and AUC of orally administered DRUGB .
erythromycin	drug	midazolam	drug
mechanism

Drugs such as DRUGN , DRUGA , DRUGB , DRUGN , DRUGN and DRUGN were shown to significantly increase the C max and AUC of orally administered DRUGN .
diltiazem	drug	verapamil	drug
false

Drugs such as DRUGN , DRUGA , DRUGN , DRUGB , DRUGN and DRUGN were shown to significantly increase the C max and AUC of orally administered DRUGN .
diltiazem	drug	ketoconazole	drug
false

Drugs such as DRUGN , DRUGA , DRUGN , DRUGN , DRUGB and DRUGN were shown to significantly increase the C max and AUC of orally administered DRUGN .
diltiazem	drug	fluconazole	drug
false

Drugs such as DRUGN , DRUGA , DRUGN , DRUGN , DRUGN and DRUGB were shown to significantly increase the C max and AUC of orally administered DRUGN .
diltiazem	drug	itraconazole	drug
false

Drugs such as DRUGN , DRUGA , DRUGN , DRUGN , DRUGN and DRUGN were shown to significantly increase the C max and AUC of orally administered DRUGB .
diltiazem	drug	midazolam	drug
mechanism

Drugs such as DRUGN , DRUGN , DRUGA , DRUGB , DRUGN and DRUGN were shown to significantly increase the C max and AUC of orally administered DRUGN .
verapamil	drug	ketoconazole	drug
false

Drugs such as DRUGN , DRUGN , DRUGA , DRUGN , DRUGB and DRUGN were shown to significantly increase the C max and AUC of orally administered DRUGN .
verapamil	drug	fluconazole	drug
false

Drugs such as DRUGN , DRUGN , DRUGA , DRUGN , DRUGN and DRUGB were shown to significantly increase the C max and AUC of orally administered DRUGN .
verapamil	drug	itraconazole	drug
false

Drugs such as DRUGN , DRUGN , DRUGA , DRUGN , DRUGN and DRUGN were shown to significantly increase the C max and AUC of orally administered DRUGB .
verapamil	drug	midazolam	drug
mechanism

Drugs such as DRUGN , DRUGN , DRUGN , DRUGA , DRUGB and DRUGN were shown to significantly increase the C max and AUC of orally administered DRUGN .
ketoconazole	drug	fluconazole	drug
false

Drugs such as DRUGN , DRUGN , DRUGN , DRUGA , DRUGN and DRUGB were shown to significantly increase the C max and AUC of orally administered DRUGN .
ketoconazole	drug	itraconazole	drug
false

Drugs such as DRUGN , DRUGN , DRUGN , DRUGA , DRUGN and DRUGN were shown to significantly increase the C max and AUC of orally administered DRUGB .
ketoconazole	drug	midazolam	drug
mechanism

Drugs such as DRUGN , DRUGN , DRUGN , DRUGN , DRUGA and DRUGB were shown to significantly increase the C max and AUC of orally administered DRUGN .
fluconazole	drug	itraconazole	drug
false

Drugs such as DRUGN , DRUGN , DRUGN , DRUGN , DRUGA and DRUGN were shown to significantly increase the C max and AUC of orally administered DRUGB .
fluconazole	drug	midazolam	drug
mechanism

Drugs such as DRUGN , DRUGN , DRUGN , DRUGN , DRUGN and DRUGA were shown to significantly increase the C max and AUC of orally administered DRUGB .
itraconazole	drug	midazolam	drug
mechanism

Although not studied , the potent cytochrome Pdgb dgbAdgb inhibitors DRUGA and DRUGB may cause intense and prolonged sedation and respiratory depression due to a decrease in plasma clearance of DRUGN .
ritonavir	drug	nelfinavir	drug
false

Although not studied , the potent cytochrome Pdgb dgbAdgb inhibitors DRUGA and DRUGN may cause intense and prolonged sedation and respiratory depression due to a decrease in plasma clearance of DRUGB .
ritonavir	drug	midazolam	drug
mechanism

Although not studied , the potent cytochrome Pdgb dgbAdgb inhibitors DRUGN and DRUGA may cause intense and prolonged sedation and respiratory depression due to a decrease in plasma clearance of DRUGB .
nelfinavir	drug	midazolam	drug
mechanism

Inducers of CYPdgbAdgb Isozymes : Cytochrome Pdgb inducers , such as DRUGA , DRUGB , and DRUGN , induce metabolism and caused a markedly decreased C max and AUC of oral DRUGN in adult studies .
rifampin	drug	carbamazepine	drug
false

Inducers of CYPdgbAdgb Isozymes : Cytochrome Pdgb inducers , such as DRUGA , DRUGN , and DRUGB , induce metabolism and caused a markedly decreased C max and AUC of oral DRUGN in adult studies .
rifampin	drug	phenytoin	drug
false

Inducers of CYPdgbAdgb Isozymes : Cytochrome Pdgb inducers , such as DRUGA , DRUGN , and DRUGN , induce metabolism and caused a markedly decreased C max and AUC of oral DRUGB in adult studies .
rifampin	drug	midazolam	drug
mechanism

Inducers of CYPdgbAdgb Isozymes : Cytochrome Pdgb inducers , such as DRUGN , DRUGA , and DRUGB , induce metabolism and caused a markedly decreased C max and AUC of oral DRUGN in adult studies .
carbamazepine	drug	phenytoin	drug
false

Inducers of CYPdgbAdgb Isozymes : Cytochrome Pdgb inducers , such as DRUGN , DRUGA , and DRUGN , induce metabolism and caused a markedly decreased C max and AUC of oral DRUGB in adult studies .
carbamazepine	drug	midazolam	drug
mechanism

Inducers of CYPdgbAdgb Isozymes : Cytochrome Pdgb inducers , such as DRUGN , DRUGN , and DRUGA , induce metabolism and caused a markedly decreased C max and AUC of oral DRUGB in adult studies .
phenytoin	drug	midazolam	drug
mechanism

The difficulty in achieving adequate sedation may have been the result of decreased absorption of the DRUGA due to both the gastrointestinal effects and stimulant effects of DRUGB .
sedatives	group	methylphenidate	drug
false

No significant adverse interactions with common premedications ( such as DRUGA , DRUGB , DRUGN , DRUGN , DRUGN , and other DRUGN ) or local DRUGN have been observed .
atropine	drug	scopolamine	drug
false

No significant adverse interactions with common premedications ( such as DRUGA , DRUGN , DRUGB , DRUGN , DRUGN , and other DRUGN ) or local DRUGN have been observed .
atropine	drug	glycopyrrolate	drug
false

No significant adverse interactions with common premedications ( such as DRUGA , DRUGN , DRUGN , DRUGB , DRUGN , and other DRUGN ) or local DRUGN have been observed .
atropine	drug	diazepam	drug
false

No significant adverse interactions with common premedications ( such as DRUGA , DRUGN , DRUGN , DRUGN , DRUGB , and other DRUGN ) or local DRUGN have been observed .
atropine	drug	hydroxyzine	drug
false

No significant adverse interactions with common premedications ( such as DRUGA , DRUGN , DRUGN , DRUGN , DRUGN , and other DRUGB ) or local DRUGN have been observed .
atropine	drug	muscle relaxants	group
false

No significant adverse interactions with common premedications ( such as DRUGA , DRUGN , DRUGN , DRUGN , DRUGN , and other DRUGN ) or local DRUGB have been observed .
atropine	drug	anesthetics	group
false

No significant adverse interactions with common premedications ( such as DRUGN , DRUGA , DRUGB , DRUGN , DRUGN , and other DRUGN ) or local DRUGN have been observed .
scopolamine	drug	glycopyrrolate	drug
false

No significant adverse interactions with common premedications ( such as DRUGN , DRUGA , DRUGN , DRUGB , DRUGN , and other DRUGN ) or local DRUGN have been observed .
scopolamine	drug	diazepam	drug
false

No significant adverse interactions with common premedications ( such as DRUGN , DRUGA , DRUGN , DRUGN , DRUGB , and other DRUGN ) or local DRUGN have been observed .
scopolamine	drug	hydroxyzine	drug
false

No significant adverse interactions with common premedications ( such as DRUGN , DRUGA , DRUGN , DRUGN , DRUGN , and other DRUGB ) or local DRUGN have been observed .
scopolamine	drug	muscle relaxants	group
false

No significant adverse interactions with common premedications ( such as DRUGN , DRUGA , DRUGN , DRUGN , DRUGN , and other DRUGN ) or local DRUGB have been observed .
scopolamine	drug	anesthetics	group
false

No significant adverse interactions with common premedications ( such as DRUGN , DRUGN , DRUGA , DRUGB , DRUGN , and other DRUGN ) or local DRUGN have been observed .
glycopyrrolate	drug	diazepam	drug
false

No significant adverse interactions with common premedications ( such as DRUGN , DRUGN , DRUGA , DRUGN , DRUGB , and other DRUGN ) or local DRUGN have been observed .
glycopyrrolate	drug	hydroxyzine	drug
false

No significant adverse interactions with common premedications ( such as DRUGN , DRUGN , DRUGA , DRUGN , DRUGN , and other DRUGB ) or local DRUGN have been observed .
glycopyrrolate	drug	muscle relaxants	group
false

No significant adverse interactions with common premedications ( such as DRUGN , DRUGN , DRUGA , DRUGN , DRUGN , and other DRUGN ) or local DRUGB have been observed .
glycopyrrolate	drug	anesthetics	group
false

No significant adverse interactions with common premedications ( such as DRUGN , DRUGN , DRUGN , DRUGA , DRUGB , and other DRUGN ) or local DRUGN have been observed .
diazepam	drug	hydroxyzine	drug
false

No significant adverse interactions with common premedications ( such as DRUGN , DRUGN , DRUGN , DRUGA , DRUGN , and other DRUGB ) or local DRUGN have been observed .
diazepam	drug	muscle relaxants	group
false

No significant adverse interactions with common premedications ( such as DRUGN , DRUGN , DRUGN , DRUGA , DRUGN , and other DRUGN ) or local DRUGB have been observed .
diazepam	drug	anesthetics	group
false

No significant adverse interactions with common premedications ( such as DRUGN , DRUGN , DRUGN , DRUGN , DRUGA , and other DRUGB ) or local DRUGN have been observed .
hydroxyzine	drug	muscle relaxants	group
false

No significant adverse interactions with common premedications ( such as DRUGN , DRUGN , DRUGN , DRUGN , DRUGA , and other DRUGN ) or local DRUGB have been observed .
hydroxyzine	drug	anesthetics	group
false

No significant adverse interactions with common premedications ( such as DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , and other DRUGA ) or local DRUGB have been observed .
muscle relaxants	group	anesthetics	group
false

When administered concomitantly with DRUGA , DRUGB may enhance or precipitate bradycardia , A.V .
ProAmatine	brand	cardiac glycosides	group
effect

DRUGA has been used in patients concomitantly treated with salt retaining steroid therapy ( i.e . , DRUGB ) , with or without salt supplementation .
ProAmatine	brand	fludrocortisone acetate	drug
false

Furthermore , DRUGA , DRUGB , St .
rifampin	drug	dexamethasone	drug
false

John s Wort , and certain DRUGA ( DRUGB , DRUGN , DRUGN ) may induce DRUGN metabolism ( lowering serum levels of DRUGN ) .
anticonvulsants	group	phenytoin	drug
false

John s Wort , and certain DRUGA ( DRUGN , DRUGB , DRUGN ) may induce DRUGN metabolism ( lowering serum levels of DRUGN ) .
anticonvulsants	group	phenobarbital	drug
false

John s Wort , and certain DRUGA ( DRUGN , DRUGN , DRUGB ) may induce DRUGN metabolism ( lowering serum levels of DRUGN ) .
anticonvulsants	group	carbamazepine	drug
false

John s Wort , and certain DRUGA ( DRUGN , DRUGN , DRUGN ) may induce DRUGB metabolism ( lowering serum levels of DRUGN ) .
anticonvulsants	group	mifepristone	drug
mechanism

John s Wort , and certain DRUGA ( DRUGN , DRUGN , DRUGN ) may induce DRUGN metabolism ( lowering serum levels of DRUGB ) .
anticonvulsants	group	mifepristone	drug
false

John s Wort , and certain DRUGN ( DRUGA , DRUGB , DRUGN ) may induce DRUGN metabolism ( lowering serum levels of DRUGN ) .
phenytoin	drug	phenobarbital	drug
false

John s Wort , and certain DRUGN ( DRUGA , DRUGN , DRUGB ) may induce DRUGN metabolism ( lowering serum levels of DRUGN ) .
phenytoin	drug	carbamazepine	drug
false

John s Wort , and certain DRUGN ( DRUGA , DRUGN , DRUGN ) may induce DRUGB metabolism ( lowering serum levels of DRUGN ) .
phenytoin	drug	mifepristone	drug
mechanism

John s Wort , and certain DRUGN ( DRUGA , DRUGN , DRUGN ) may induce DRUGN metabolism ( lowering serum levels of DRUGB ) .
phenytoin	drug	mifepristone	drug
false

John s Wort , and certain DRUGN ( DRUGN , DRUGA , DRUGB ) may induce DRUGN metabolism ( lowering serum levels of DRUGN ) .
phenobarbital	drug	carbamazepine	drug
false

John s Wort , and certain DRUGN ( DRUGN , DRUGA , DRUGN ) may induce DRUGB metabolism ( lowering serum levels of DRUGN ) .
phenobarbital	drug	mifepristone	drug
mechanism

John s Wort , and certain DRUGN ( DRUGN , DRUGA , DRUGN ) may induce DRUGN metabolism ( lowering serum levels of DRUGB ) .
phenobarbital	drug	mifepristone	drug
false

John s Wort , and certain DRUGN ( DRUGN , DRUGN , DRUGA ) may induce DRUGB metabolism ( lowering serum levels of DRUGN ) .
carbamazepine	drug	mifepristone	drug
mechanism

John s Wort , and certain DRUGN ( DRUGN , DRUGN , DRUGA ) may induce DRUGN metabolism ( lowering serum levels of DRUGB ) .
carbamazepine	drug	mifepristone	drug
false

While co administration of DRUGA appeared to increase the clearance of DRUGB by dgb % , these results are not conclusive because of the small number of subjects studied and because patients took variable doses of DRUGN .
ZAVESCA	brand	Cerezyme	brand
mechanism

While co administration of DRUGA appeared to increase the clearance of DRUGN by dgb % , these results are not conclusive because of the small number of subjects studied and because patients took variable doses of DRUGB .
ZAVESCA	brand	Cerezyme	brand
false

Combination therapy with DRUGA ( DRUGB ) and DRUGN is not indicated .
Cerezyme	brand	imiglucerase	drug
false

Combination therapy with DRUGA ( DRUGN ) and DRUGB is not indicated .
Cerezyme	brand	ZAVESCA	brand
advise

Combination therapy with DRUGN ( DRUGA ) and DRUGB is not indicated .
imiglucerase	drug	ZAVESCA	brand
advise

Because DRUGA have been shown to depress plasma prothrombin activity , patients who are on DRUGB therapy may require downward adjustment of their DRUGN dosage .
tetracyclines	group	anticoagulant	group
advise

Because DRUGA have been shown to depress plasma prothrombin activity , patients who are on DRUGN therapy may require downward adjustment of their DRUGB dosage .
tetracyclines	group	anticoagulant	group
false

Since bacteriostatic drugs may interfere with the bactericidal action of DRUGA , it is advisable to avoid giving DRUGB in conjunction with DRUGN .
penicillin	drug	tetracycline class drugs	group
false

Since bacteriostatic drugs may interfere with the bactericidal action of DRUGN , it is advisable to avoid giving DRUGA in conjunction with DRUGB .
tetracycline class drugs	group	penicillin	drug
advise

Absorption of DRUGA is impaired by DRUGB containing DRUGN , DRUGN or DRUGN , and DRUGN containing preparations .
tetracyclines	group	antacids	group
false

Absorption of DRUGA is impaired by DRUGN containing DRUGB , DRUGN or DRUGN , and DRUGN containing preparations .
tetracyclines	group	aluminum	drug
mechanism

Absorption of DRUGA is impaired by DRUGN containing DRUGN , DRUGB or DRUGN , and DRUGN containing preparations .
tetracyclines	group	calcium	drug
mechanism

Absorption of DRUGA is impaired by DRUGN containing DRUGN , DRUGN or DRUGB , and DRUGN containing preparations .
tetracyclines	group	magnesium	drug
mechanism

Absorption of DRUGA is impaired by DRUGN containing DRUGN , DRUGN or DRUGN , and DRUGB containing preparations .
tetracyclines	group	iron	drug
mechanism

Absorption of DRUGN is impaired by DRUGA containing DRUGB , DRUGN or DRUGN , and DRUGN containing preparations .
antacids	group	aluminum	drug
false

Absorption of DRUGN is impaired by DRUGA containing DRUGN , DRUGB or DRUGN , and DRUGN containing preparations .
antacids	group	calcium	drug
false

Absorption of DRUGN is impaired by DRUGA containing DRUGN , DRUGN or DRUGB , and DRUGN containing preparations .
antacids	group	magnesium	drug
false

Absorption of DRUGN is impaired by DRUGA containing DRUGN , DRUGN or DRUGN , and DRUGB containing preparations .
antacids	group	iron	drug
false

Absorption of DRUGN is impaired by DRUGN containing DRUGA , DRUGB or DRUGN , and DRUGN containing preparations .
aluminum	drug	calcium	drug
false

Absorption of DRUGN is impaired by DRUGN containing DRUGA , DRUGN or DRUGB , and DRUGN containing preparations .
aluminum	drug	magnesium	drug
false

Absorption of DRUGN is impaired by DRUGN containing DRUGA , DRUGN or DRUGN , and DRUGB containing preparations .
aluminum	drug	iron	drug
false

Absorption of DRUGN is impaired by DRUGN containing DRUGN , DRUGA or DRUGB , and DRUGN containing preparations .
calcium	drug	magnesium	drug
false

Absorption of DRUGN is impaired by DRUGN containing DRUGN , DRUGA or DRUGN , and DRUGB containing preparations .
calcium	drug	iron	drug
false

Absorption of DRUGN is impaired by DRUGN containing DRUGN , DRUGN or DRUGA , and DRUGB containing preparations .
magnesium	drug	iron	drug
false

The concurrent use of DRUGA and DRUGB has been reported to result in fatal renal toxicity .
tetracycline	group	methoxyflurane	drug
effect

Concurrent use of DRUGA with oral DRUGB may render oral DRUGN less effective .
tetracyclines	group	contraceptives	group
effect

Concurrent use of DRUGA with oral DRUGN may render oral DRUGB less effective .
tetracyclines	group	contraceptives	group
false

Interaction with DRUGA : Although DRUGB does not itself cause orthostatic hypotension , its administration to patients already receiving DRUGN can result in profound orthostatic effects .
Guanethidine	drug	minoxidil	drug
false

Interaction with DRUGA : Although DRUGN does not itself cause orthostatic hypotension , its administration to patients already receiving DRUGB can result in profound orthostatic effects .
Guanethidine	drug	guanethidine	drug
false

Interaction with DRUGN : Although DRUGA does not itself cause orthostatic hypotension , its administration to patients already receiving DRUGB can result in profound orthostatic effects .
minoxidil	drug	guanethidine	drug
effect

If at all possible DRUGA should be discontinued well before DRUGB is begun .
guanethidine	drug	minoxidil	drug
advise

Drugs Affecting Hepatic Metabolism The metabolism and pharmacokinetics of DRUGA ( DRUGB ) Orally Disintegrating Tablets may be affected by the induction or inhibition of drug metab olizing enzymes .
REMERON SolTab	brand	mirtazapine	drug
false

DRUGA : Concomitant administration of DRUGB ( equivalent to dgb g ) had a minimal effect on plasma levels of DRUGN ( dgb mg ) in dgb healthy male subjects .
Alcohol	drug	alcohol	drug
false

DRUGA : Concomitant administration of DRUGN ( equivalent to dgb g ) had a minimal effect on plasma levels of DRUGB ( dgb mg ) in dgb healthy male subjects .
Alcohol	drug	mirtazapine	drug
false

DRUGN : Concomitant administration of DRUGA ( equivalent to dgb g ) had a minimal effect on plasma levels of DRUGB ( dgb mg ) in dgb healthy male subjects .
alcohol	drug	mirtazapine	drug
mechanism

However , the impairment of cognitive and motor skills produced by DRUGA were shown to be additive with those produced by DRUGB .
REMERON	brand	alcohol	drug
effect

However , the impairment of motor skills produced by DRUGA has been shown to be additive with those caused by DRUGB .
REMERON	brand	diazepam	drug
effect

Accordingly , patients should be advised to avoid DRUGA and other similar drugs while taking DRUGB .
diazepam	drug	REMERON SolTab	brand
advise

DRUGA has been reported to accelerate the metabolism of DRUGB by the mechanism of hepatic microsomal enzyme induction , leading to an increase in dosage requirements for DRUGN .
Mitotane	drug	warfarin	drug
mechanism

DRUGA has been reported to accelerate the metabolism of DRUGN by the mechanism of hepatic microsomal enzyme induction , leading to an increase in dosage requirements for DRUGB .
Mitotane	drug	warfarin	drug
false

Therefore , physicians should closely monitor patients for a change in DRUGA dosage requirements when administering DRUGB to patients on DRUGN .
anticoagulant	group	Mitotane	drug
false

Therefore , physicians should closely monitor patients for a change in DRUGA dosage requirements when administering DRUGN to patients on DRUGB .
anticoagulant	group	coumarin-type anticoagulants	group
false

Therefore , physicians should closely monitor patients for a change in DRUGN dosage requirements when administering DRUGA to patients on DRUGB .
Mitotane	drug	coumarin-type anticoagulants	group
advise

Although DRUGA ( a mixture of three stereoisomers ) has been administered safely following succinylcholine facilitated tracheal intubation , the interaction between DRUGN and DRUGB has not been systematically studied .
MIVACRON	brand	succinylcholine	drug
false

Although DRUGN ( a mixture of three stereoisomers ) has been administered safely following succinylcholine facilitated tracheal intubation , the interaction between DRUGA and DRUGB has not been systematically studied .
MIVACRON	brand	succinylcholine	drug
false

Prior administration of DRUGA can potentiate the neuromuscular blocking effects of DRUGB .
succinylcholine	drug	nondepolarizing agents	group
effect

Evidence of spontaneous recovery from DRUGA should be observed before the administration of DRUGB .
succinylcholine	drug	MIVACRON	brand
advise

The use of DRUGA before DRUGB to attenuate some of the side effects of DRUGN has not been studied .
MIVACRON	brand	succinylcholine	drug
false

The use of DRUGA before DRUGN to attenuate some of the side effects of DRUGB has not been studied .
MIVACRON	brand	succinylcholine	drug
false

There are no clinical data on the use of DRUGA with other DRUGB .
MIVACRON	brand	nondepolarizing neuromuscular blocking agents	group
false

DRUGA and DRUGB ( administered with DRUGN / DRUGN to achieve dga M.C .
Isoflurane	drug	enflurane	drug
false

DRUGA and DRUGN ( administered with DRUGB / DRUGN to achieve dga M.C .
Isoflurane	drug	nitrous oxide	drug
false

DRUGA and DRUGN ( administered with DRUGN / DRUGB to achieve dga M.C .
Isoflurane	drug	oxygen	drug
false

DRUGN and DRUGA ( administered with DRUGB / DRUGN to achieve dga M.C .
enflurane	drug	nitrous oxide	drug
false

DRUGN and DRUGA ( administered with DRUGN / DRUGB to achieve dga M.C .
enflurane	drug	oxygen	drug
false

DRUGN and DRUGN ( administered with DRUGA / DRUGB to achieve dga M.C .
nitrous oxide	drug	oxygen	drug
false

A greater potentiation of the neuromuscular blocking effects of DRUGA may be expected with higher concentrations of DRUGB or DRUGN .
MIVACRON	brand	enflurane	drug
false

A greater potentiation of the neuromuscular blocking effects of DRUGA may be expected with higher concentrations of DRUGN or DRUGB .
MIVACRON	brand	isoflurane	drug
false

A greater potentiation of the neuromuscular blocking effects of DRUGN may be expected with higher concentrations of DRUGA or DRUGB .
enflurane	drug	isoflurane	drug
false

While the effects of chronic DRUGA or DRUGB therapy on the action of DRUGN are unknown , slightly shorter durations of neuromuscular block may be anticipated and infusion rate requirements may be higher .
phenytoin	drug	carbamazepine	drug
false

While the effects of chronic DRUGA or DRUGN therapy on the action of DRUGB are unknown , slightly shorter durations of neuromuscular block may be anticipated and infusion rate requirements may be higher .
phenytoin	drug	MIVACRON	brand
effect

While the effects of chronic DRUGN or DRUGA therapy on the action of DRUGB are unknown , slightly shorter durations of neuromuscular block may be anticipated and infusion rate requirements may be higher .
carbamazepine	drug	MIVACRON	brand
effect

DRUGA : Excessive reductions in blood pressure may occur in patients on diuretic therapy when DRUGB are started .
Diuretics	group	ACE inhibitors	group
false

DRUGA Supplements and DRUGB : DRUGN can increase serum potassium because it decreases aldosterone secretion .
Potassium	drug	Potassium-Sparing Diuretics	group
false

DRUGA Supplements and DRUGN : DRUGB can increase serum potassium because it decreases aldosterone secretion .
Potassium	drug	UNIVASC	brand
false

DRUGN Supplements and DRUGA : DRUGB can increase serum potassium because it decreases aldosterone secretion .
Potassium-Sparing Diuretics	group	UNIVASC	brand
false

Use of DRUGA ( DRUGB , DRUGN , DRUGN ) or DRUGN supplements concomitantly with DRUGN can increase the risk of hyperkalemia .
potassium-sparing diuretics	group	spironolactone	drug
false

Use of DRUGA ( DRUGN , DRUGB , DRUGN ) or DRUGN supplements concomitantly with DRUGN can increase the risk of hyperkalemia .
potassium-sparing diuretics	group	triamterene	drug
false

Use of DRUGA ( DRUGN , DRUGN , DRUGB ) or DRUGN supplements concomitantly with DRUGN can increase the risk of hyperkalemia .
potassium-sparing diuretics	group	amiloride	drug
false

Use of DRUGA ( DRUGN , DRUGN , DRUGN ) or DRUGB supplements concomitantly with DRUGN can increase the risk of hyperkalemia .
potassium-sparing diuretics	group	potassium	drug
false

Use of DRUGA ( DRUGN , DRUGN , DRUGN ) or DRUGN supplements concomitantly with DRUGB can increase the risk of hyperkalemia .
potassium-sparing diuretics	group	ACE inhibitors	group
effect

Use of DRUGN ( DRUGA , DRUGB , DRUGN ) or DRUGN supplements concomitantly with DRUGN can increase the risk of hyperkalemia .
spironolactone	drug	triamterene	drug
false

Use of DRUGN ( DRUGA , DRUGN , DRUGB ) or DRUGN supplements concomitantly with DRUGN can increase the risk of hyperkalemia .
spironolactone	drug	amiloride	drug
false

Use of DRUGN ( DRUGA , DRUGN , DRUGN ) or DRUGB supplements concomitantly with DRUGN can increase the risk of hyperkalemia .
spironolactone	drug	potassium	drug
false

Use of DRUGN ( DRUGA , DRUGN , DRUGN ) or DRUGN supplements concomitantly with DRUGB can increase the risk of hyperkalemia .
spironolactone	drug	ACE inhibitors	group
effect

Use of DRUGN ( DRUGN , DRUGA , DRUGB ) or DRUGN supplements concomitantly with DRUGN can increase the risk of hyperkalemia .
triamterene	drug	amiloride	drug
false

Use of DRUGN ( DRUGN , DRUGA , DRUGN ) or DRUGB supplements concomitantly with DRUGN can increase the risk of hyperkalemia .
triamterene	drug	potassium	drug
false

Use of DRUGN ( DRUGN , DRUGA , DRUGN ) or DRUGN supplements concomitantly with DRUGB can increase the risk of hyperkalemia .
triamterene	drug	ACE inhibitors	group
effect

Use of DRUGN ( DRUGN , DRUGN , DRUGA ) or DRUGB supplements concomitantly with DRUGN can increase the risk of hyperkalemia .
amiloride	drug	potassium	drug
false

Use of DRUGN ( DRUGN , DRUGN , DRUGA ) or DRUGN supplements concomitantly with DRUGB can increase the risk of hyperkalemia .
amiloride	drug	ACE inhibitors	group
effect

Use of DRUGN ( DRUGN , DRUGN , DRUGN ) or DRUGA supplements concomitantly with DRUGB can increase the risk of hyperkalemia .
potassium	drug	ACE inhibitors	group
effect

Oral DRUGA : Interaction studies with DRUGB failed to identify any clinically important effect on the serum concentrations of the DRUGN or on its anticoagulant effect .
Anticoagulants	group	warfarin	drug
false

Oral DRUGA : Interaction studies with DRUGN failed to identify any clinically important effect on the serum concentrations of the DRUGB or on its anticoagulant effect .
Anticoagulants	group	anticoagulant	group
false

Oral DRUGN : Interaction studies with DRUGA failed to identify any clinically important effect on the serum concentrations of the DRUGB or on its anticoagulant effect .
warfarin	drug	anticoagulant	group
false

DRUGA : Increased serum DRUGB levels and symptoms of DRUGN toxicity have been reported in patients receiving DRUGN during therapy with DRUGN .
Lithium	drug	lithium	drug
false

DRUGA : Increased serum DRUGN levels and symptoms of DRUGB toxicity have been reported in patients receiving DRUGN during therapy with DRUGN .
Lithium	drug	lithium	drug
false

DRUGA : Increased serum DRUGN levels and symptoms of DRUGN toxicity have been reported in patients receiving DRUGB during therapy with DRUGN .
Lithium	drug	ACE inhibitors	group
false

DRUGA : Increased serum DRUGN levels and symptoms of DRUGN toxicity have been reported in patients receiving DRUGN during therapy with DRUGB .
Lithium	drug	lithium	drug
false

DRUGN : Increased serum DRUGA levels and symptoms of DRUGN toxicity have been reported in patients receiving DRUGB during therapy with DRUGN .
lithium	drug	ACE inhibitors	group
false

DRUGN : Increased serum DRUGN levels and symptoms of DRUGA toxicity have been reported in patients receiving DRUGB during therapy with DRUGN .
lithium	drug	ACE inhibitors	group
false

DRUGN : Increased serum DRUGN levels and symptoms of DRUGN toxicity have been reported in patients receiving DRUGA during therapy with DRUGB .
ACE inhibitors	group	lithium	drug
effect

If a DRUGA is also used , the risk of DRUGB toxicity may be increased .
diuretic	group	lithium	drug
effect

Other Agents : No clinically important pharmacokinetic interactions occurred when DRUGA was administered concomitantly with DRUGB , DRUGN , or DRUGN .
UNIVASC	brand	hydrochlorothiazide	drug
false

Other Agents : No clinically important pharmacokinetic interactions occurred when DRUGA was administered concomitantly with DRUGN , DRUGB , or DRUGN .
UNIVASC	brand	digoxin	drug
false

Other Agents : No clinically important pharmacokinetic interactions occurred when DRUGA was administered concomitantly with DRUGN , DRUGN , or DRUGB .
UNIVASC	brand	cimetidine	drug
false

Other Agents : No clinically important pharmacokinetic interactions occurred when DRUGN was administered concomitantly with DRUGA , DRUGB , or DRUGN .
hydrochlorothiazide	drug	digoxin	drug
false

Other Agents : No clinically important pharmacokinetic interactions occurred when DRUGN was administered concomitantly with DRUGA , DRUGN , or DRUGB .
hydrochlorothiazide	drug	cimetidine	drug
false

Other Agents : No clinically important pharmacokinetic interactions occurred when DRUGN was administered concomitantly with DRUGN , DRUGA , or DRUGB .
digoxin	drug	cimetidine	drug
false

DRUGA has been used in clinical trials concomitantly with DRUGB , DRUGN , DRUGN , DRUGN , oral DRUGN , and cholesterol lowering agents .
UNIVASC	brand	calcium-channel-blocking agents	group
false

DRUGA has been used in clinical trials concomitantly with DRUGN , DRUGB , DRUGN , DRUGN , oral DRUGN , and cholesterol lowering agents .
UNIVASC	brand	diuretics	group
false

DRUGA has been used in clinical trials concomitantly with DRUGN , DRUGN , DRUGB , DRUGN , oral DRUGN , and cholesterol lowering agents .
UNIVASC	brand	H2 blockers	group
false

DRUGA has been used in clinical trials concomitantly with DRUGN , DRUGN , DRUGN , DRUGB , oral DRUGN , and cholesterol lowering agents .
UNIVASC	brand	digoxin	drug
false

DRUGA has been used in clinical trials concomitantly with DRUGN , DRUGN , DRUGN , DRUGN , oral DRUGB , and cholesterol lowering agents .
UNIVASC	brand	hypoglycemic agents	group
false

DRUGN has been used in clinical trials concomitantly with DRUGA , DRUGB , DRUGN , DRUGN , oral DRUGN , and cholesterol lowering agents .
calcium-channel-blocking agents	group	diuretics	group
false

DRUGN has been used in clinical trials concomitantly with DRUGA , DRUGN , DRUGB , DRUGN , oral DRUGN , and cholesterol lowering agents .
calcium-channel-blocking agents	group	H2 blockers	group
false

DRUGN has been used in clinical trials concomitantly with DRUGA , DRUGN , DRUGN , DRUGB , oral DRUGN , and cholesterol lowering agents .
calcium-channel-blocking agents	group	digoxin	drug
false

DRUGN has been used in clinical trials concomitantly with DRUGA , DRUGN , DRUGN , DRUGN , oral DRUGB , and cholesterol lowering agents .
calcium-channel-blocking agents	group	hypoglycemic agents	group
false

DRUGN has been used in clinical trials concomitantly with DRUGN , DRUGA , DRUGB , DRUGN , oral DRUGN , and cholesterol lowering agents .
diuretics	group	H2 blockers	group
false

DRUGN has been used in clinical trials concomitantly with DRUGN , DRUGA , DRUGN , DRUGB , oral DRUGN , and cholesterol lowering agents .
diuretics	group	digoxin	drug
false

DRUGN has been used in clinical trials concomitantly with DRUGN , DRUGA , DRUGN , DRUGN , oral DRUGB , and cholesterol lowering agents .
diuretics	group	hypoglycemic agents	group
false

DRUGN has been used in clinical trials concomitantly with DRUGN , DRUGN , DRUGA , DRUGB , oral DRUGN , and cholesterol lowering agents .
H2 blockers	group	digoxin	drug
false

DRUGN has been used in clinical trials concomitantly with DRUGN , DRUGN , DRUGA , DRUGN , oral DRUGB , and cholesterol lowering agents .
H2 blockers	group	hypoglycemic agents	group
false

DRUGN has been used in clinical trials concomitantly with DRUGN , DRUGN , DRUGN , DRUGA , oral DRUGB , and cholesterol lowering agents .
digoxin	drug	hypoglycemic agents	group
false

However , DRUGA , a potent inhibitor of cytochrome Pdgb dgbAdgb , may increase plasma levels of DRUGB during concomitant dosing .
ketoconazole	drug	mometasone furoate	drug
mechanism

DRUGA at a Dose of dgb mg Once Daily Dosed to Pharmacokinetic Steady State did not cause clinically significant changes in the kinetics of a single intravenous dose of DRUGB ( predominantly a cytochrome Pdgb dgbAdgb substrate ) .
Montelukast	drug	theophylline	drug
false

DRUGA at Doses of dgb mg Daily Dosed to Pharmacokinetic Steady State : did not significantly alter the plasma concentrations of either component of an oral DRUGB containing DRUGN dgb mg / ethinyl DRUGN dgb mcg .
Montelukast	drug	contraceptive	group
false

DRUGA at Doses of dgb mg Daily Dosed to Pharmacokinetic Steady State : did not significantly alter the plasma concentrations of either component of an oral DRUGN containing DRUGB dgb mg / ethinyl DRUGN dgb mcg .
Montelukast	drug	norethindrone	drug
false

DRUGA at Doses of dgb mg Daily Dosed to Pharmacokinetic Steady State : did not significantly alter the plasma concentrations of either component of an oral DRUGN containing DRUGN dgb mg / ethinyl DRUGB dgb mcg .
Montelukast	drug	estradiol	drug
false

DRUGN at Doses of dgb mg Daily Dosed to Pharmacokinetic Steady State : did not significantly alter the plasma concentrations of either component of an oral DRUGA containing DRUGB dgb mg / ethinyl DRUGN dgb mcg .
contraceptive	group	norethindrone	drug
false

DRUGN at Doses of dgb mg Daily Dosed to Pharmacokinetic Steady State : did not significantly alter the plasma concentrations of either component of an oral DRUGA containing DRUGN dgb mg / ethinyl DRUGB dgb mcg .
contraceptive	group	estradiol	drug
false

DRUGN at Doses of dgb mg Daily Dosed to Pharmacokinetic Steady State : did not significantly alter the plasma concentrations of either component of an oral DRUGN containing DRUGA dgb mg / ethinyl DRUGB dgb mcg .
norethindrone	drug	estradiol	drug
false

did not cause any clinically significant change in plasma profiles of DRUGA or DRUGB following administration of either oral DRUGN or intravenous DRUGN .
prednisone	drug	prednisolone	drug
false

did not cause any clinically significant change in plasma profiles of DRUGA or DRUGN following administration of either oral DRUGN or intravenous DRUGB .
prednisone	drug	prednisolone	drug
false

did not cause any clinically significant change in plasma profiles of DRUGN or DRUGA following administration of either oral DRUGB or intravenous DRUGN .
prednisolone	drug	prednisone	drug
false

did not cause any clinically significant change in plasma profiles of DRUGN or DRUGN following administration of either oral DRUGA or intravenous DRUGB .
prednisone	drug	prednisolone	drug
false

DRUGA , which induces hepatic metabolism , decreased the AUC of DRUGB approximately dgb % following a single dgb mg dose of DRUGN .
Phenobarbital	drug	montelukast	drug
false

DRUGA , which induces hepatic metabolism , decreased the AUC of DRUGN approximately dgb % following a single dgb mg dose of DRUGB .
Phenobarbital	drug	montelukast	drug
false

It is reasonable to employ appropriate clinical monitoring when potent cytochrome Pdgb enzyme inducers , such as DRUGA or DRUGB , are co administered with DRUGN .
phenobarbital	drug	rifampin	drug
false

It is reasonable to employ appropriate clinical monitoring when potent cytochrome Pdgb enzyme inducers , such as DRUGA or DRUGN , are co administered with DRUGB .
phenobarbital	drug	montelukast	drug
advise

It is reasonable to employ appropriate clinical monitoring when potent cytochrome Pdgb enzyme inducers , such as DRUGN or DRUGA , are co administered with DRUGB .
rifampin	drug	montelukast	drug
advise

These medications included DRUGA , DRUGB , DRUGN , DRUGN , and DRUGN .
thyroid hormones	group	sedative hypnotics	group
false

These medications included DRUGA , DRUGN , DRUGB , DRUGN , and DRUGN .
thyroid hormones	group	non-steroidal anti-inflammatory agents	group
false

These medications included DRUGA , DRUGN , DRUGN , DRUGB , and DRUGN .
thyroid hormones	group	benzodiazepines	group
false

These medications included DRUGA , DRUGN , DRUGN , DRUGN , and DRUGB .
thyroid hormones	group	decongestants	group
false

These medications included DRUGN , DRUGA , DRUGB , DRUGN , and DRUGN .
sedative hypnotics	group	non-steroidal anti-inflammatory agents	group
false

These medications included DRUGN , DRUGA , DRUGN , DRUGB , and DRUGN .
sedative hypnotics	group	benzodiazepines	group
false

These medications included DRUGN , DRUGA , DRUGN , DRUGN , and DRUGB .
sedative hypnotics	group	decongestants	group
false

These medications included DRUGN , DRUGN , DRUGA , DRUGB , and DRUGN .
non-steroidal anti-inflammatory agents	group	benzodiazepines	group
false

These medications included DRUGN , DRUGN , DRUGA , DRUGN , and DRUGB .
non-steroidal anti-inflammatory agents	group	decongestants	group
false

These medications included DRUGN , DRUGN , DRUGN , DRUGA , and DRUGB .
benzodiazepines	group	decongestants	group
false

DRUGA , which induces hepatic metabolism , decreased the AUC of DRUGB approximately dgb % following a single dgb mg dose of DRUGN .
Phenobarbital	drug	montelukast	drug
false

DRUGA , which induces hepatic metabolism , decreased the AUC of DRUGN approximately dgb % following a single dgb mg dose of DRUGB .
Phenobarbital	drug	montelukast	drug
false

It is reasonable to employ appropriate clinical monitoring when potent cytochrome Pdgb enzyme inducers , such as DRUGA or DRUGB , are co administered with DRUGN .
phenobarbital	drug	rifampin	drug
false

It is reasonable to employ appropriate clinical monitoring when potent cytochrome Pdgb enzyme inducers , such as DRUGA or DRUGN , are co administered with DRUGB .
phenobarbital	drug	montelukast	drug
advise

It is reasonable to employ appropriate clinical monitoring when potent cytochrome Pdgb enzyme inducers , such as DRUGN or DRUGA , are co administered with DRUGB .
rifampin	drug	montelukast	drug
advise

Use with Other DRUGA : The depressant effects of DRUGB are potentiated by the presence of other DRUGN such as DRUGN , DRUGN , DRUGN , or DRUGN .
Central Nervous System Depressants	group	morphine	drug
false

Use with Other DRUGA : The depressant effects of DRUGN are potentiated by the presence of other DRUGB such as DRUGN , DRUGN , DRUGN , or DRUGN .
Central Nervous System Depressants	group	CNS depressants	group
false

Use with Other DRUGA : The depressant effects of DRUGN are potentiated by the presence of other DRUGN such as DRUGB , DRUGN , DRUGN , or DRUGN .
Central Nervous System Depressants	group	alcohol	drug
false

Use with Other DRUGA : The depressant effects of DRUGN are potentiated by the presence of other DRUGN such as DRUGN , DRUGB , DRUGN , or DRUGN .
Central Nervous System Depressants	group	sedatives	group
false

Use with Other DRUGA : The depressant effects of DRUGN are potentiated by the presence of other DRUGN such as DRUGN , DRUGN , DRUGB , or DRUGN .
Central Nervous System Depressants	group	antihistaminics	group
false

Use with Other DRUGA : The depressant effects of DRUGN are potentiated by the presence of other DRUGN such as DRUGN , DRUGN , DRUGN , or DRUGB .
Central Nervous System Depressants	group	psychotropic drugs	group
false

Use with Other DRUGN : The depressant effects of DRUGA are potentiated by the presence of other DRUGB such as DRUGN , DRUGN , DRUGN , or DRUGN .
morphine	drug	CNS depressants	group
effect

Use with Other DRUGN : The depressant effects of DRUGA are potentiated by the presence of other DRUGN such as DRUGB , DRUGN , DRUGN , or DRUGN .
morphine	drug	alcohol	drug
effect

Use with Other DRUGN : The depressant effects of DRUGA are potentiated by the presence of other DRUGN such as DRUGN , DRUGB , DRUGN , or DRUGN .
morphine	drug	sedatives	group
effect

Use with Other DRUGN : The depressant effects of DRUGA are potentiated by the presence of other DRUGN such as DRUGN , DRUGN , DRUGB , or DRUGN .
morphine	drug	antihistaminics	group
effect

Use with Other DRUGN : The depressant effects of DRUGA are potentiated by the presence of other DRUGN such as DRUGN , DRUGN , DRUGN , or DRUGB .
morphine	drug	psychotropic drugs	group
effect

Use with Other DRUGN : The depressant effects of DRUGN are potentiated by the presence of other DRUGA such as DRUGB , DRUGN , DRUGN , or DRUGN .
CNS depressants	group	alcohol	drug
false

Use with Other DRUGN : The depressant effects of DRUGN are potentiated by the presence of other DRUGA such as DRUGN , DRUGB , DRUGN , or DRUGN .
CNS depressants	group	sedatives	group
false

Use with Other DRUGN : The depressant effects of DRUGN are potentiated by the presence of other DRUGA such as DRUGN , DRUGN , DRUGB , or DRUGN .
CNS depressants	group	antihistaminics	group
false

Use with Other DRUGN : The depressant effects of DRUGN are potentiated by the presence of other DRUGA such as DRUGN , DRUGN , DRUGN , or DRUGB .
CNS depressants	group	psychotropic drugs	group
false

Use with Other DRUGN : The depressant effects of DRUGN are potentiated by the presence of other DRUGN such as DRUGA , DRUGB , DRUGN , or DRUGN .
alcohol	drug	sedatives	group
false

Use with Other DRUGN : The depressant effects of DRUGN are potentiated by the presence of other DRUGN such as DRUGA , DRUGN , DRUGB , or DRUGN .
alcohol	drug	antihistaminics	group
false

Use with Other DRUGN : The depressant effects of DRUGN are potentiated by the presence of other DRUGN such as DRUGA , DRUGN , DRUGN , or DRUGB .
alcohol	drug	psychotropic drugs	group
false

Use with Other DRUGN : The depressant effects of DRUGN are potentiated by the presence of other DRUGN such as DRUGN , DRUGA , DRUGB , or DRUGN .
sedatives	group	antihistaminics	group
false

Use with Other DRUGN : The depressant effects of DRUGN are potentiated by the presence of other DRUGN such as DRUGN , DRUGA , DRUGN , or DRUGB .
sedatives	group	psychotropic drugs	group
false

Use with Other DRUGN : The depressant effects of DRUGN are potentiated by the presence of other DRUGN such as DRUGN , DRUGN , DRUGA , or DRUGB .
antihistaminics	group	psychotropic drugs	group
false

Use of DRUGA in conjunction with oral DRUGB may increase the risk of respiratory depression , hypotension and profound sedation or coma .
neuroleptics	group	morphine	drug
effect

Interaction with DRUGA : DRUGB ( i.e . , DRUGN , DRUGN , DRUGN , or DRUGN ) should NOT be administered to patients who have received or are receiving a course of therapy with a proof DRUGN .
Mixed Agonist/Antagonist Opioid Analgesics	group	Agonist/antagonist analgesics	group
false

Interaction with DRUGA : DRUGN ( i.e . , DRUGB , DRUGN , DRUGN , or DRUGN ) should NOT be administered to patients who have received or are receiving a course of therapy with a proof DRUGN .
Mixed Agonist/Antagonist Opioid Analgesics	group	pentazocine	drug
false

Interaction with DRUGA : DRUGN ( i.e . , DRUGN , DRUGB , DRUGN , or DRUGN ) should NOT be administered to patients who have received or are receiving a course of therapy with a proof DRUGN .
Mixed Agonist/Antagonist Opioid Analgesics	group	nalbuphine	drug
false

Interaction with DRUGA : DRUGN ( i.e . , DRUGN , DRUGN , DRUGB , or DRUGN ) should NOT be administered to patients who have received or are receiving a course of therapy with a proof DRUGN .
Mixed Agonist/Antagonist Opioid Analgesics	group	butorphanol	drug
false

Interaction with DRUGA : DRUGN ( i.e . , DRUGN , DRUGN , DRUGN , or DRUGB ) should NOT be administered to patients who have received or are receiving a course of therapy with a proof DRUGN .
Mixed Agonist/Antagonist Opioid Analgesics	group	buprenorphine	drug
false

Interaction with DRUGA : DRUGN ( i.e . , DRUGN , DRUGN , DRUGN , or DRUGN ) should NOT be administered to patients who have received or are receiving a course of therapy with a proof DRUGB .
Mixed Agonist/Antagonist Opioid Analgesics	group	opioid agonist analgesic	group
false

Interaction with DRUGN : DRUGA ( i.e . , DRUGB , DRUGN , DRUGN , or DRUGN ) should NOT be administered to patients who have received or are receiving a course of therapy with a proof DRUGN .
Agonist/antagonist analgesics	group	pentazocine	drug
false

Interaction with DRUGN : DRUGA ( i.e . , DRUGN , DRUGB , DRUGN , or DRUGN ) should NOT be administered to patients who have received or are receiving a course of therapy with a proof DRUGN .
Agonist/antagonist analgesics	group	nalbuphine	drug
false

Interaction with DRUGN : DRUGA ( i.e . , DRUGN , DRUGN , DRUGB , or DRUGN ) should NOT be administered to patients who have received or are receiving a course of therapy with a proof DRUGN .
Agonist/antagonist analgesics	group	butorphanol	drug
false

Interaction with DRUGN : DRUGA ( i.e . , DRUGN , DRUGN , DRUGN , or DRUGB ) should NOT be administered to patients who have received or are receiving a course of therapy with a proof DRUGN .
Agonist/antagonist analgesics	group	buprenorphine	drug
false

Interaction with DRUGN : DRUGA ( i.e . , DRUGN , DRUGN , DRUGN , or DRUGN ) should NOT be administered to patients who have received or are receiving a course of therapy with a proof DRUGB .
Agonist/antagonist analgesics	group	opioid agonist analgesic	group
advise

Interaction with DRUGN : DRUGN ( i.e . , DRUGA , DRUGB , DRUGN , or DRUGN ) should NOT be administered to patients who have received or are receiving a course of therapy with a proof DRUGN .
pentazocine	drug	nalbuphine	drug
false

Interaction with DRUGN : DRUGN ( i.e . , DRUGA , DRUGN , DRUGB , or DRUGN ) should NOT be administered to patients who have received or are receiving a course of therapy with a proof DRUGN .
pentazocine	drug	butorphanol	drug
false

Interaction with DRUGN : DRUGN ( i.e . , DRUGA , DRUGN , DRUGN , or DRUGB ) should NOT be administered to patients who have received or are receiving a course of therapy with a proof DRUGN .
pentazocine	drug	buprenorphine	drug
false

Interaction with DRUGN : DRUGN ( i.e . , DRUGA , DRUGN , DRUGN , or DRUGN ) should NOT be administered to patients who have received or are receiving a course of therapy with a proof DRUGB .
pentazocine	drug	opioid agonist analgesic	group
advise

Interaction with DRUGN : DRUGN ( i.e . , DRUGN , DRUGA , DRUGB , or DRUGN ) should NOT be administered to patients who have received or are receiving a course of therapy with a proof DRUGN .
nalbuphine	drug	butorphanol	drug
false

Interaction with DRUGN : DRUGN ( i.e . , DRUGN , DRUGA , DRUGN , or DRUGB ) should NOT be administered to patients who have received or are receiving a course of therapy with a proof DRUGN .
nalbuphine	drug	buprenorphine	drug
false

Interaction with DRUGN : DRUGN ( i.e . , DRUGN , DRUGA , DRUGN , or DRUGN ) should NOT be administered to patients who have received or are receiving a course of therapy with a proof DRUGB .
nalbuphine	drug	opioid agonist analgesic	group
advise

Interaction with DRUGN : DRUGN ( i.e . , DRUGN , DRUGN , DRUGA , or DRUGB ) should NOT be administered to patients who have received or are receiving a course of therapy with a proof DRUGN .
butorphanol	drug	buprenorphine	drug
false

Interaction with DRUGN : DRUGN ( i.e . , DRUGN , DRUGN , DRUGA , or DRUGN ) should NOT be administered to patients who have received or are receiving a course of therapy with a proof DRUGB .
butorphanol	drug	opioid agonist analgesic	group
advise

Interaction with DRUGN : DRUGN ( i.e . , DRUGN , DRUGN , DRUGN , or DRUGA ) should NOT be administered to patients who have received or are receiving a course of therapy with a proof DRUGB .
buprenorphine	drug	opioid agonist analgesic	group
advise

It is recommended that DRUGA and DRUGB not be administered simultaneously .
Myfortic	drug	antacids	group
advise

DRUGA : When studied in stable renal transplant patients , DRUGB , USP ( MODIFIED ) pharmacokinetics were unaffected by steady state dosing of DRUGN .
Cyclosporine	drug	cyclosporine	drug
false

DRUGA : When studied in stable renal transplant patients , DRUGN , USP ( MODIFIED ) pharmacokinetics were unaffected by steady state dosing of DRUGB .
Cyclosporine	drug	Myfortic	brand
false

DRUGN : When studied in stable renal transplant patients , DRUGA , USP ( MODIFIED ) pharmacokinetics were unaffected by steady state dosing of DRUGB .
cyclosporine	drug	Myfortic	brand
false

DRUGA / DRUGB : may be taken with DRUGN ;
Acyclovir	drug	Ganciclovir	drug
false

DRUGA / DRUGN : may be taken with DRUGB ;
Acyclovir	drug	Myfortic	brand
false

DRUGN / DRUGA : may be taken with DRUGB ;
Ganciclovir	drug	Myfortic	brand
false

Both DRUGA / DRUGB and DRUGN concentrations are increased in the presence of renal impairment , their coexistence may compete for tubular secretion and further increase in the concentrations of the two .
acyclovir	drug	ganciclovir	drug
false

Both DRUGA / DRUGN and DRUGB concentrations are increased in the presence of renal impairment , their coexistence may compete for tubular secretion and further increase in the concentrations of the two .
acyclovir	drug	MPAG	drug_n
false

Both DRUGN / DRUGA and DRUGB concentrations are increased in the presence of renal impairment , their coexistence may compete for tubular secretion and further increase in the concentrations of the two .
ganciclovir	drug	MPAG	drug_n
false

DRUGA / DRUGB : Given that DRUGN and DRUGN inhibit purine metabolism , it is recommended that DRUGN not be administered concomitantly with DRUGN or DRUGN .
Azathioprine	drug	Mycophenolate Mofetil	drug
false

DRUGA / DRUGN : Given that DRUGB and DRUGN inhibit purine metabolism , it is recommended that DRUGN not be administered concomitantly with DRUGN or DRUGN .
Azathioprine	drug	azathioprine	drug
false

DRUGA / DRUGN : Given that DRUGN and DRUGB inhibit purine metabolism , it is recommended that DRUGN not be administered concomitantly with DRUGN or DRUGN .
Azathioprine	drug	mycophenolate mofetil	drug
false

DRUGA / DRUGN : Given that DRUGN and DRUGN inhibit purine metabolism , it is recommended that DRUGB not be administered concomitantly with DRUGN or DRUGN .
Azathioprine	drug	Myfortic	brand
false

DRUGA / DRUGN : Given that DRUGN and DRUGN inhibit purine metabolism , it is recommended that DRUGN not be administered concomitantly with DRUGB or DRUGN .
Azathioprine	drug	azathioprine	drug
false

DRUGA / DRUGN : Given that DRUGN and DRUGN inhibit purine metabolism , it is recommended that DRUGN not be administered concomitantly with DRUGN or DRUGB .
Azathioprine	drug	mycophenolate mofetil	drug
false

DRUGN / DRUGA : Given that DRUGB and DRUGN inhibit purine metabolism , it is recommended that DRUGN not be administered concomitantly with DRUGN or DRUGN .
Mycophenolate Mofetil	drug	azathioprine	drug
false

DRUGN / DRUGA : Given that DRUGN and DRUGB inhibit purine metabolism , it is recommended that DRUGN not be administered concomitantly with DRUGN or DRUGN .
Mycophenolate Mofetil	drug	mycophenolate mofetil	drug
false

DRUGN / DRUGA : Given that DRUGN and DRUGN inhibit purine metabolism , it is recommended that DRUGB not be administered concomitantly with DRUGN or DRUGN .
Mycophenolate Mofetil	drug	Myfortic	brand
false

DRUGN / DRUGA : Given that DRUGN and DRUGN inhibit purine metabolism , it is recommended that DRUGN not be administered concomitantly with DRUGB or DRUGN .
Mycophenolate Mofetil	drug	azathioprine	drug
false

DRUGN / DRUGA : Given that DRUGN and DRUGN inhibit purine metabolism , it is recommended that DRUGN not be administered concomitantly with DRUGN or DRUGB .
Mycophenolate Mofetil	drug	mycophenolate mofetil	drug
false

DRUGN / DRUGN : Given that DRUGA and DRUGB inhibit purine metabolism , it is recommended that DRUGN not be administered concomitantly with DRUGN or DRUGN .
azathioprine	drug	mycophenolate mofetil	drug
false

DRUGN / DRUGN : Given that DRUGA and DRUGN inhibit purine metabolism , it is recommended that DRUGB not be administered concomitantly with DRUGN or DRUGN .
azathioprine	drug	Myfortic	brand
false

DRUGN / DRUGN : Given that DRUGA and DRUGN inhibit purine metabolism , it is recommended that DRUGN not be administered concomitantly with DRUGN or DRUGB .
azathioprine	drug	mycophenolate mofetil	drug
false

DRUGN / DRUGN : Given that DRUGN and DRUGA inhibit purine metabolism , it is recommended that DRUGB not be administered concomitantly with DRUGN or DRUGN .
mycophenolate mofetil	drug	Myfortic	brand
false

DRUGN / DRUGN : Given that DRUGN and DRUGA inhibit purine metabolism , it is recommended that DRUGN not be administered concomitantly with DRUGB or DRUGN .
mycophenolate mofetil	drug	azathioprine	drug
false

DRUGN / DRUGN : Given that DRUGN and DRUGN inhibit purine metabolism , it is recommended that DRUGA not be administered concomitantly with DRUGB or DRUGN .
Myfortic	brand	azathioprine	drug
advise

DRUGN / DRUGN : Given that DRUGN and DRUGN inhibit purine metabolism , it is recommended that DRUGA not be administered concomitantly with DRUGN or DRUGB .
Myfortic	brand	mycophenolate mofetil	drug
advise

DRUGN / DRUGN : Given that DRUGN and DRUGN inhibit purine metabolism , it is recommended that DRUGN not be administered concomitantly with DRUGA or DRUGB .
azathioprine	drug	mycophenolate mofetil	drug
false

DRUGA and Drugs that Bind Bile Acids : These drugs interrupt enterohepatic recirculation and reduce DRUGB exposure when coadministered with DRUGN .
Cholestyramine	drug	MPA	drug_n
false

DRUGA and Drugs that Bind Bile Acids : These drugs interrupt enterohepatic recirculation and reduce DRUGN exposure when coadministered with DRUGB .
Cholestyramine	drug	mycophenolate mofetil	drug
false

DRUGN and Drugs that Bind Bile Acids : These drugs interrupt enterohepatic recirculation and reduce DRUGA exposure when coadministered with DRUGB .
MPA	drug_n	mycophenolate mofetil	drug
false

Oral DRUGA : Given the different metabolism of DRUGB and oral DRUGN , no drug interaction between these two classes of drug is expected .
Contraceptives	group	Myfortic	brand
false

Oral DRUGA : Given the different metabolism of DRUGN and oral DRUGB , no drug interaction between these two classes of drug is expected .
Contraceptives	group	contraceptives	group
false

Oral DRUGN : Given the different metabolism of DRUGA and oral DRUGB , no drug interaction between these two classes of drug is expected .
Myfortic	brand	contraceptives	group
false

However , in a drug drug interaction study , mean DRUGA AUC was decreased by dgb % when coadministered with DRUGB .
levonorgesterol	drug	mycophenolate mofetil	drug
mechanism

Therefore , it is recommended that oral DRUGA are co administered with DRUGB with caution and additional birth control methods be considered .
contraceptives	group	Myfortic	brand
advise

DRUGA : During treatment with DRUGB , the use of DRUGN should be avoided and patients should be advised that vaccinations may be less effective .
Live Vaccines	group	Myfortic	drug
false

DRUGA : During treatment with DRUGN , the use of DRUGB should be avoided and patients should be advised that vaccinations may be less effective .
Live Vaccines	group	live attenuated vaccines	group
false

DRUGN : During treatment with DRUGA , the use of DRUGB should be avoided and patients should be advised that vaccinations may be less effective .
Myfortic	drug	live attenuated vaccines	group
advise

Interference of DRUGA hydrolysis may lead to less DRUGB available for absorption .
MPAG	drug_n	MPA	drug_n
false

In humans , DRUGA , DRUGB , and DRUGN do not affect the pharmacokinetics of DRUGN .
carmustine	drug	etoposide	drug
false

In humans , DRUGA , DRUGN , and DRUGB do not affect the pharmacokinetics of DRUGN .
carmustine	drug	cisplatin	drug
false

In humans , DRUGA , DRUGN , and DRUGN do not affect the pharmacokinetics of DRUGB .
carmustine	drug	ondansetron	drug
false

In humans , DRUGN , DRUGA , and DRUGB do not affect the pharmacokinetics of DRUGN .
etoposide	drug	cisplatin	drug
false

In humans , DRUGN , DRUGA , and DRUGN do not affect the pharmacokinetics of DRUGB .
etoposide	drug	ondansetron	drug
false

In humans , DRUGN , DRUGN , and DRUGA do not affect the pharmacokinetics of DRUGB .
cisplatin	drug	ondansetron	drug
false

DRUGA did not increase blood levels of high dose DRUGB .
ondansetron	drug	methotrexate	drug
false

Other DRUGA should not be used concomitantly with DRUGB ( DRUGN USP ) because they may have additive effects .
beta adrenergic aerosol bronchodilators	group	Alupent	brand
advise

Other DRUGA should not be used concomitantly with DRUGN ( DRUGB USP ) because they may have additive effects .
beta adrenergic aerosol bronchodilators	group	metaproterenol sulfate	drug
advise

Other DRUGN should not be used concomitantly with DRUGA ( DRUGB USP ) because they may have additive effects .
Alupent	brand	metaproterenol sulfate	drug
false

DRUGA should be administered with caution to patients being treated with DRUGB or DRUGN , since the action of DRUGN on the vascular system may be potentiated .
Beta adrenergic agonists	group	monoamine oxidase inhibitors	group
advise

DRUGA should be administered with caution to patients being treated with DRUGN or DRUGB , since the action of DRUGN on the vascular system may be potentiated .
Beta adrenergic agonists	group	tricyclic antidepressants	group
advise

DRUGA should be administered with caution to patients being treated with DRUGN or DRUGN , since the action of DRUGB on the vascular system may be potentiated .
Beta adrenergic agonists	group	beta adrenergic agonists	group
false

DRUGN should be administered with caution to patients being treated with DRUGA or DRUGB , since the action of DRUGN on the vascular system may be potentiated .
monoamine oxidase inhibitors	group	tricyclic antidepressants	group
false

DRUGN should be administered with caution to patients being treated with DRUGA or DRUGN , since the action of DRUGB on the vascular system may be potentiated .
monoamine oxidase inhibitors	group	beta adrenergic agonists	group
false

DRUGN should be administered with caution to patients being treated with DRUGN or DRUGA , since the action of DRUGB on the vascular system may be potentiated .
tricyclic antidepressants	group	beta adrenergic agonists	group
false

DRUGA : Preliminary data from a DRUGB and DRUGN drug interaction study indicate a reduction in DRUGN plasma levels when DRUGN was coadministered with DRUGN .
Cyclosporine	drug	XENICAL	brand
false

DRUGA : Preliminary data from a DRUGN and DRUGB drug interaction study indicate a reduction in DRUGN plasma levels when DRUGN was coadministered with DRUGN .
Cyclosporine	drug	cyclosporine	drug
false

DRUGA : Preliminary data from a DRUGN and DRUGN drug interaction study indicate a reduction in DRUGB plasma levels when DRUGN was coadministered with DRUGN .
Cyclosporine	drug	cyclosporine	drug
false

DRUGA : Preliminary data from a DRUGN and DRUGN drug interaction study indicate a reduction in DRUGN plasma levels when DRUGB was coadministered with DRUGN .
Cyclosporine	drug	XENICAL	brand
false

DRUGA : Preliminary data from a DRUGN and DRUGN drug interaction study indicate a reduction in DRUGN plasma levels when DRUGN was coadministered with DRUGB .
Cyclosporine	drug	cyclosporine	drug
false

DRUGN : Preliminary data from a DRUGA and DRUGB drug interaction study indicate a reduction in DRUGN plasma levels when DRUGN was coadministered with DRUGN .
XENICAL	brand	cyclosporine	drug
false

DRUGN : Preliminary data from a DRUGA and DRUGN drug interaction study indicate a reduction in DRUGB plasma levels when DRUGN was coadministered with DRUGN .
XENICAL	brand	cyclosporine	drug
false

DRUGN : Preliminary data from a DRUGA and DRUGN drug interaction study indicate a reduction in DRUGN plasma levels when DRUGN was coadministered with DRUGB .
XENICAL	brand	cyclosporine	drug
false

DRUGN : Preliminary data from a DRUGN and DRUGA drug interaction study indicate a reduction in DRUGN plasma levels when DRUGB was coadministered with DRUGN .
cyclosporine	drug	XENICAL	brand
false

DRUGN : Preliminary data from a DRUGN and DRUGN drug interaction study indicate a reduction in DRUGA plasma levels when DRUGB was coadministered with DRUGN .
cyclosporine	drug	XENICAL	brand
false

DRUGN : Preliminary data from a DRUGN and DRUGN drug interaction study indicate a reduction in DRUGN plasma levels when DRUGA was coadministered with DRUGB .
XENICAL	brand	cyclosporine	drug
mechanism

DRUGA : In dgb normal weight subjects receiving DRUGB dgb mg three times a day for dgb days , DRUGN did not alter the pharmacokinetics of a single dose of DRUGN .
Digoxin	drug	XENICAL	brand
false

DRUGA : In dgb normal weight subjects receiving DRUGN dgb mg three times a day for dgb days , DRUGB did not alter the pharmacokinetics of a single dose of DRUGN .
Digoxin	drug	XENICAL	brand
false

DRUGA : In dgb normal weight subjects receiving DRUGN dgb mg three times a day for dgb days , DRUGN did not alter the pharmacokinetics of a single dose of DRUGB .
Digoxin	drug	digoxin	drug
false

DRUGN : In dgb normal weight subjects receiving DRUGA dgb mg three times a day for dgb days , DRUGN did not alter the pharmacokinetics of a single dose of DRUGB .
XENICAL	brand	digoxin	drug
false

DRUGN : In dgb normal weight subjects receiving DRUGN dgb mg three times a day for dgb days , DRUGA did not alter the pharmacokinetics of a single dose of DRUGB .
XENICAL	brand	digoxin	drug
false

DRUGA and Analogues : A pharmacokinetic interaction study showed a dgb % reduction in DRUGB supplement absorption when concomitantly administered with DRUGN .
Fat-soluble Vitamin Supplements	group	beta-carotene	drug
false

DRUGA and Analogues : A pharmacokinetic interaction study showed a dgb % reduction in DRUGN supplement absorption when concomitantly administered with DRUGB .
Fat-soluble Vitamin Supplements	group	XENICAL	brand
false

DRUGN and Analogues : A pharmacokinetic interaction study showed a dgb % reduction in DRUGA supplement absorption when concomitantly administered with DRUGB .
beta-carotene	drug	XENICAL	brand
mechanism

DRUGA inhibited absorption of a DRUGB supplement by approximately dgb % .
XENICAL	brand	vitamin E acetate	drug
mechanism

The effect of DRUGA on the absorption of supplemental DRUGB , DRUGN , and nutritionally derived DRUGN is not known at this time .
orlistat	drug	vitamin D	group
false

The effect of DRUGA on the absorption of supplemental DRUGN , DRUGB , and nutritionally derived DRUGN is not known at this time .
orlistat	drug	vitamin A	group
false

The effect of DRUGA on the absorption of supplemental DRUGN , DRUGN , and nutritionally derived DRUGB is not known at this time .
orlistat	drug	vitamin K	group
false

The effect of DRUGN on the absorption of supplemental DRUGA , DRUGB , and nutritionally derived DRUGN is not known at this time .
vitamin D	group	vitamin A	group
false

The effect of DRUGN on the absorption of supplemental DRUGA , DRUGN , and nutritionally derived DRUGB is not known at this time .
vitamin D	group	vitamin K	group
false

The effect of DRUGN on the absorption of supplemental DRUGN , DRUGA , and nutritionally derived DRUGB is not known at this time .
vitamin A	group	vitamin K	group
false

DRUGA : In dgb normal weight subjects receiving DRUGB dgb mg three times a day for dgb days , DRUGN did not alter the pharmacokinetics or pharmacodynamics ( blood glucose lowering ) of DRUGN .
Glyburide	drug	orlistat	drug
false

DRUGA : In dgb normal weight subjects receiving DRUGN dgb mg three times a day for dgb days , DRUGB did not alter the pharmacokinetics or pharmacodynamics ( blood glucose lowering ) of DRUGN .
Glyburide	drug	orlistat	drug
false

DRUGA : In dgb normal weight subjects receiving DRUGN dgb mg three times a day for dgb days , DRUGN did not alter the pharmacokinetics or pharmacodynamics ( blood glucose lowering ) of DRUGB .
Glyburide	drug	glyburide	drug
false

DRUGN : In dgb normal weight subjects receiving DRUGA dgb mg three times a day for dgb days , DRUGN did not alter the pharmacokinetics or pharmacodynamics ( blood glucose lowering ) of DRUGB .
orlistat	drug	glyburide	drug
false

DRUGN : In dgb normal weight subjects receiving DRUGN dgb mg three times a day for dgb days , DRUGA did not alter the pharmacokinetics or pharmacodynamics ( blood glucose lowering ) of DRUGB .
orlistat	drug	glyburide	drug
false

DRUGA ( extended release tablets ) : In dgb normal weight subjects receiving DRUGB dgb mg three times a day for dgb days , DRUGN did not alter the bioavailability of DRUGN ( extended release tablets ) .
Nifedipine	drug	XENICAL	brand
false

DRUGA ( extended release tablets ) : In dgb normal weight subjects receiving DRUGN dgb mg three times a day for dgb days , DRUGB did not alter the bioavailability of DRUGN ( extended release tablets ) .
Nifedipine	drug	XENICAL	brand
false

DRUGA ( extended release tablets ) : In dgb normal weight subjects receiving DRUGN dgb mg three times a day for dgb days , DRUGN did not alter the bioavailability of DRUGB ( extended release tablets ) .
Nifedipine	drug	nifedipine	drug
false

DRUGN ( extended release tablets ) : In dgb normal weight subjects receiving DRUGA dgb mg three times a day for dgb days , DRUGN did not alter the bioavailability of DRUGB ( extended release tablets ) .
XENICAL	brand	nifedipine	drug
false

DRUGN ( extended release tablets ) : In dgb normal weight subjects receiving DRUGN dgb mg three times a day for dgb days , DRUGA did not alter the bioavailability of DRUGB ( extended release tablets ) .
XENICAL	brand	nifedipine	drug
false

Oral DRUGA : In dgb normal weight female subjects , the treatment of DRUGB dgb mg three times a day for dgb days resulted in no changes in the ovulation suppressing action of oral DRUGN .
Contraceptives	group	XENICAL	brand
false

Oral DRUGA : In dgb normal weight female subjects , the treatment of DRUGN dgb mg three times a day for dgb days resulted in no changes in the ovulation suppressing action of oral DRUGB .
Contraceptives	group	contraceptives	group
false

Oral DRUGN : In dgb normal weight female subjects , the treatment of DRUGA dgb mg three times a day for dgb days resulted in no changes in the ovulation suppressing action of oral DRUGB .
XENICAL	brand	contraceptives	group
false

DRUGA : In dgb normal weight subjects receiving DRUGB dgb mg three times a day for dgb days , DRUGN did not alter the pharmacokinetics of a single dgb mg dose of DRUGN .
Phenytoin	drug	XENICAL	brand
false

DRUGA : In dgb normal weight subjects receiving DRUGN dgb mg three times a day for dgb days , DRUGB did not alter the pharmacokinetics of a single dgb mg dose of DRUGN .
Phenytoin	drug	XENICAL	brand
false

DRUGA : In dgb normal weight subjects receiving DRUGN dgb mg three times a day for dgb days , DRUGN did not alter the pharmacokinetics of a single dgb mg dose of DRUGB .
Phenytoin	drug	phenytoin	drug
false

DRUGN : In dgb normal weight subjects receiving DRUGA dgb mg three times a day for dgb days , DRUGN did not alter the pharmacokinetics of a single dgb mg dose of DRUGB .
XENICAL	brand	phenytoin	drug
false

DRUGN : In dgb normal weight subjects receiving DRUGN dgb mg three times a day for dgb days , DRUGA did not alter the pharmacokinetics of a single dgb mg dose of DRUGB .
XENICAL	brand	phenytoin	drug
false

DRUGA : In a dgb way crossover study of dgb normal weight , mildly hypercholesterolemic patients receiving DRUGB dgb mg three times a day for dgb days , DRUGN did not affect the pharmacokinetics of DRUGN .
Pravastatin	drug	XENICAL	brand
false

DRUGA : In a dgb way crossover study of dgb normal weight , mildly hypercholesterolemic patients receiving DRUGN dgb mg three times a day for dgb days , DRUGB did not affect the pharmacokinetics of DRUGN .
Pravastatin	drug	XENICAL	brand
false

DRUGA : In a dgb way crossover study of dgb normal weight , mildly hypercholesterolemic patients receiving DRUGN dgb mg three times a day for dgb days , DRUGN did not affect the pharmacokinetics of DRUGB .
Pravastatin	drug	pravastatin	drug
false

DRUGN : In a dgb way crossover study of dgb normal weight , mildly hypercholesterolemic patients receiving DRUGA dgb mg three times a day for dgb days , DRUGN did not affect the pharmacokinetics of DRUGB .
XENICAL	brand	pravastatin	drug
false

DRUGN : In a dgb way crossover study of dgb normal weight , mildly hypercholesterolemic patients receiving DRUGN dgb mg three times a day for dgb days , DRUGA did not affect the pharmacokinetics of DRUGB .
XENICAL	brand	pravastatin	drug
false

Therefore , as DRUGA absorption may be decreased with DRUGB , patients on chronic stable doses of DRUGN who are prescribed DRUGN should be monitored closely for changes in coagulation parameters .
vitamin K	group	XENICAL	brand
mechanism

Therefore , as DRUGA absorption may be decreased with DRUGN , patients on chronic stable doses of DRUGB who are prescribed DRUGN should be monitored closely for changes in coagulation parameters .
vitamin K	group	warfarin	drug
false

Therefore , as DRUGA absorption may be decreased with DRUGN , patients on chronic stable doses of DRUGN who are prescribed DRUGB should be monitored closely for changes in coagulation parameters .
vitamin K	group	XENICAL	brand
false

Therefore , as DRUGN absorption may be decreased with DRUGA , patients on chronic stable doses of DRUGB who are prescribed DRUGN should be monitored closely for changes in coagulation parameters .
XENICAL	brand	warfarin	drug
false

Therefore , as DRUGN absorption may be decreased with DRUGN , patients on chronic stable doses of DRUGA who are prescribed DRUGB should be monitored closely for changes in coagulation parameters .
warfarin	drug	XENICAL	brand
advise

DRUGA , a bacteriostatic DRUGB , may antagonize the bactericidal effect of DRUGN and concurrent use of these drugs should be avoided .
Tetracycline	group	antibiotic	group
false

DRUGA , a bacteriostatic DRUGN , may antagonize the bactericidal effect of DRUGB and concurrent use of these drugs should be avoided .
Tetracycline	group	penicillin	drug
effect

DRUGN , a bacteriostatic DRUGA , may antagonize the bactericidal effect of DRUGB and concurrent use of these drugs should be avoided .
antibiotic	group	penicillin	drug
false

No pharmacokinetic interaction between dgb mg / mdgb DRUGA and infusional DRUGB has been observed in patients treated every dgb weeks .
ELOXATIN	brand	5-FU	drug
false

Increases of DRUGA plasma concentrations by approximately dgb % have been observed with doses of dgb mg / mdgb DRUGB dosed every dgb weeks .
5-FU	drug	ELOXATIN	brand
mechanism

DRUGA DRUGB may increase sensitivity to oral DRUGN .
Anticoagulants	group	Anabolic steroids	group
false

DRUGA DRUGN may increase sensitivity to oral DRUGB .
Anticoagulants	group	anticoagulants	group
false

DRUGN DRUGA may increase sensitivity to oral DRUGB .
Anabolic steroids	group	anticoagulants	group
effect

Furthermore , in patients receiving both drugs , careful monitoring of the INR or PT , and adjustment of the DRUGA dosage if indicated are recommended when the DRUGB dose is changed or discontinued .
warfarin	drug	oxandrolone	drug
advise

Oral DRUGA DRUGB may inhibit the metabolism of oral DRUGN .
hypoglycemic agents	group	Oxandrolone	drug
false

Oral DRUGN DRUGA may inhibit the metabolism of oral DRUGB .
Oxandrolone	drug	hypoglycemic agents	group
mechanism

DRUGA or DRUGB In patients with edema , concomitant administration with DRUGN or DRUGN may increase the edema .
Adrenal steroids	group	ACTH	drug
false

DRUGA or DRUGN In patients with edema , concomitant administration with DRUGB or DRUGN may increase the edema .
Adrenal steroids	group	adrenal cortical steroids	group
false

DRUGA or DRUGN In patients with edema , concomitant administration with DRUGN or DRUGB may increase the edema .
Adrenal steroids	group	ACTH	drug
false

DRUGN or DRUGA In patients with edema , concomitant administration with DRUGB or DRUGN may increase the edema .
ACTH	drug	adrenal cortical steroids	group
false

DRUGN or DRUGN In patients with edema , concomitant administration with DRUGA or DRUGB may increase the edema .
adrenal cortical steroids	group	ACTH	drug
false

Mean DRUGA plasma concentrations were approximately dgb fold higher when DRUGB was administered with DRUGN , a potent CYPdgbAdgb inhibitor .
oxybutynin chloride	drug	DITROPAN XL	brand
false

Mean DRUGA plasma concentrations were approximately dgb fold higher when DRUGN was administered with DRUGB , a potent CYPdgbAdgb inhibitor .
oxybutynin chloride	drug	ketoconazole	drug
false

Mean DRUGN plasma concentrations were approximately dgb fold higher when DRUGA was administered with DRUGB , a potent CYPdgbAdgb inhibitor .
DITROPAN XL	brand	ketoconazole	drug
mechanism

Concurrent ingestion of DRUGA ( dgb mL of DRUGN containing DRUGB , DRUGN , and DRUGN ) did not significantly affect the exposure of DRUGN or DRUGN .
antacid	group	aluminum hydroxide	drug
false

Concurrent ingestion of DRUGA ( dgb mL of DRUGN containing DRUGN , DRUGB , and DRUGN ) did not significantly affect the exposure of DRUGN or DRUGN .
antacid	group	magnesium hydroxide	drug
false

Concurrent ingestion of DRUGA ( dgb mL of DRUGN containing DRUGN , DRUGN , and DRUGB ) did not significantly affect the exposure of DRUGN or DRUGN .
antacid	group	simethicone	drug
false

Concurrent ingestion of DRUGA ( dgb mL of DRUGN containing DRUGN , DRUGN , and DRUGN ) did not significantly affect the exposure of DRUGB or DRUGN .
antacid	group	oxybutynin	drug
false

Concurrent ingestion of DRUGA ( dgb mL of DRUGN containing DRUGN , DRUGN , and DRUGN ) did not significantly affect the exposure of DRUGN or DRUGB .
antacid	group	desethyloxybutynin	drug_n
false

Concurrent ingestion of DRUGN ( dgb mL of DRUGA containing DRUGB , DRUGN , and DRUGN ) did not significantly affect the exposure of DRUGN or DRUGN .
antacid	group	aluminum hydroxide	drug
false

Concurrent ingestion of DRUGN ( dgb mL of DRUGA containing DRUGN , DRUGB , and DRUGN ) did not significantly affect the exposure of DRUGN or DRUGN .
antacid	group	magnesium hydroxide	drug
false

Concurrent ingestion of DRUGN ( dgb mL of DRUGA containing DRUGN , DRUGN , and DRUGB ) did not significantly affect the exposure of DRUGN or DRUGN .
antacid	group	simethicone	drug
false

Concurrent ingestion of DRUGN ( dgb mL of DRUGA containing DRUGN , DRUGN , and DRUGN ) did not significantly affect the exposure of DRUGB or DRUGN .
antacid	group	oxybutynin	drug
false

Concurrent ingestion of DRUGN ( dgb mL of DRUGA containing DRUGN , DRUGN , and DRUGN ) did not significantly affect the exposure of DRUGN or DRUGB .
antacid	group	desethyloxybutynin	drug_n
false

Concurrent ingestion of DRUGN ( dgb mL of DRUGN containing DRUGA , DRUGB , and DRUGN ) did not significantly affect the exposure of DRUGN or DRUGN .
aluminum hydroxide	drug	magnesium hydroxide	drug
false

Concurrent ingestion of DRUGN ( dgb mL of DRUGN containing DRUGA , DRUGN , and DRUGB ) did not significantly affect the exposure of DRUGN or DRUGN .
aluminum hydroxide	drug	simethicone	drug
false

Concurrent ingestion of DRUGN ( dgb mL of DRUGN containing DRUGA , DRUGN , and DRUGN ) did not significantly affect the exposure of DRUGB or DRUGN .
aluminum hydroxide	drug	oxybutynin	drug
false

Concurrent ingestion of DRUGN ( dgb mL of DRUGN containing DRUGA , DRUGN , and DRUGN ) did not significantly affect the exposure of DRUGN or DRUGB .
aluminum hydroxide	drug	desethyloxybutynin	drug_n
false

Concurrent ingestion of DRUGN ( dgb mL of DRUGN containing DRUGN , DRUGA , and DRUGB ) did not significantly affect the exposure of DRUGN or DRUGN .
magnesium hydroxide	drug	simethicone	drug
false

Concurrent ingestion of DRUGN ( dgb mL of DRUGN containing DRUGN , DRUGA , and DRUGN ) did not significantly affect the exposure of DRUGB or DRUGN .
magnesium hydroxide	drug	oxybutynin	drug
false

Concurrent ingestion of DRUGN ( dgb mL of DRUGN containing DRUGN , DRUGA , and DRUGN ) did not significantly affect the exposure of DRUGN or DRUGB .
magnesium hydroxide	drug	desethyloxybutynin	drug_n
false

Concurrent ingestion of DRUGN ( dgb mL of DRUGN containing DRUGN , DRUGN , and DRUGA ) did not significantly affect the exposure of DRUGB or DRUGN .
simethicone	drug	oxybutynin	drug
false

Concurrent ingestion of DRUGN ( dgb mL of DRUGN containing DRUGN , DRUGN , and DRUGA ) did not significantly affect the exposure of DRUGN or DRUGB .
simethicone	drug	desethyloxybutynin	drug_n
false

Concurrent ingestion of DRUGN ( dgb mL of DRUGN containing DRUGN , DRUGN , and DRUGN ) did not significantly affect the exposure of DRUGA or DRUGB .
oxybutynin	drug	desethyloxybutynin	drug_n
false

The CNS depressant effects of DRUGA may be additive with that of other DRUGB ..
oxycodone hydrochloride	drug	CNS depressants	group
effect

The concomitant use of other DRUGA including DRUGB , DRUGN , DRUGN , general DRUGN , DRUGN , other DRUGN , DRUGN , DRUGN , and DRUGN may produce additive CNS depressant effects .
CNS depressants	group	sedatives	group
false

The concomitant use of other DRUGA including DRUGN , DRUGB , DRUGN , general DRUGN , DRUGN , other DRUGN , DRUGN , DRUGN , and DRUGN may produce additive CNS depressant effects .
CNS depressants	group	hypnotics	group
false

The concomitant use of other DRUGA including DRUGN , DRUGN , DRUGB , general DRUGN , DRUGN , other DRUGN , DRUGN , DRUGN , and DRUGN may produce additive CNS depressant effects .
CNS depressants	group	tranquilizers	group
false

The concomitant use of other DRUGA including DRUGN , DRUGN , DRUGN , general DRUGB , DRUGN , other DRUGN , DRUGN , DRUGN , and DRUGN may produce additive CNS depressant effects .
CNS depressants	group	anesthetics	group
false

The concomitant use of other DRUGA including DRUGN , DRUGN , DRUGN , general DRUGN , DRUGB , other DRUGN , DRUGN , DRUGN , and DRUGN may produce additive CNS depressant effects .
CNS depressants	group	phenothiazines	group
false

The concomitant use of other DRUGA including DRUGN , DRUGN , DRUGN , general DRUGN , DRUGN , other DRUGB , DRUGN , DRUGN , and DRUGN may produce additive CNS depressant effects .
CNS depressants	group	opioids	group
false

The concomitant use of other DRUGA including DRUGN , DRUGN , DRUGN , general DRUGN , DRUGN , other DRUGN , DRUGB , DRUGN , and DRUGN may produce additive CNS depressant effects .
CNS depressants	group	tricyclic antidepressants	group
false

The concomitant use of other DRUGA including DRUGN , DRUGN , DRUGN , general DRUGN , DRUGN , other DRUGN , DRUGN , DRUGB , and DRUGN may produce additive CNS depressant effects .
CNS depressants	group	monoamine oxidase (MAO) inhibitors	group
false

The concomitant use of other DRUGA including DRUGN , DRUGN , DRUGN , general DRUGN , DRUGN , other DRUGN , DRUGN , DRUGN , and DRUGB may produce additive CNS depressant effects .
CNS depressants	group	alcohol	drug
false

The concomitant use of other DRUGN including DRUGA , DRUGB , DRUGN , general DRUGN , DRUGN , other DRUGN , DRUGN , DRUGN , and DRUGN may produce additive CNS depressant effects .
sedatives	group	hypnotics	group
false

The concomitant use of other DRUGN including DRUGA , DRUGN , DRUGB , general DRUGN , DRUGN , other DRUGN , DRUGN , DRUGN , and DRUGN may produce additive CNS depressant effects .
sedatives	group	tranquilizers	group
false

The concomitant use of other DRUGN including DRUGA , DRUGN , DRUGN , general DRUGB , DRUGN , other DRUGN , DRUGN , DRUGN , and DRUGN may produce additive CNS depressant effects .
sedatives	group	anesthetics	group
false

The concomitant use of other DRUGN including DRUGA , DRUGN , DRUGN , general DRUGN , DRUGB , other DRUGN , DRUGN , DRUGN , and DRUGN may produce additive CNS depressant effects .
sedatives	group	phenothiazines	group
false

The concomitant use of other DRUGN including DRUGA , DRUGN , DRUGN , general DRUGN , DRUGN , other DRUGB , DRUGN , DRUGN , and DRUGN may produce additive CNS depressant effects .
sedatives	group	opioids	group
false

The concomitant use of other DRUGN including DRUGA , DRUGN , DRUGN , general DRUGN , DRUGN , other DRUGN , DRUGB , DRUGN , and DRUGN may produce additive CNS depressant effects .
sedatives	group	tricyclic antidepressants	group
false

The concomitant use of other DRUGN including DRUGA , DRUGN , DRUGN , general DRUGN , DRUGN , other DRUGN , DRUGN , DRUGB , and DRUGN may produce additive CNS depressant effects .
sedatives	group	monoamine oxidase (MAO) inhibitors	group
false

The concomitant use of other DRUGN including DRUGA , DRUGN , DRUGN , general DRUGN , DRUGN , other DRUGN , DRUGN , DRUGN , and DRUGB may produce additive CNS depressant effects .
sedatives	group	alcohol	drug
false

The concomitant use of other DRUGN including DRUGN , DRUGA , DRUGB , general DRUGN , DRUGN , other DRUGN , DRUGN , DRUGN , and DRUGN may produce additive CNS depressant effects .
hypnotics	group	tranquilizers	group
false

The concomitant use of other DRUGN including DRUGN , DRUGA , DRUGN , general DRUGB , DRUGN , other DRUGN , DRUGN , DRUGN , and DRUGN may produce additive CNS depressant effects .
hypnotics	group	anesthetics	group
false

The concomitant use of other DRUGN including DRUGN , DRUGA , DRUGN , general DRUGN , DRUGB , other DRUGN , DRUGN , DRUGN , and DRUGN may produce additive CNS depressant effects .
hypnotics	group	phenothiazines	group
false

The concomitant use of other DRUGN including DRUGN , DRUGA , DRUGN , general DRUGN , DRUGN , other DRUGB , DRUGN , DRUGN , and DRUGN may produce additive CNS depressant effects .
hypnotics	group	opioids	group
false

The concomitant use of other DRUGN including DRUGN , DRUGA , DRUGN , general DRUGN , DRUGN , other DRUGN , DRUGB , DRUGN , and DRUGN may produce additive CNS depressant effects .
hypnotics	group	tricyclic antidepressants	group
false

The concomitant use of other DRUGN including DRUGN , DRUGA , DRUGN , general DRUGN , DRUGN , other DRUGN , DRUGN , DRUGB , and DRUGN may produce additive CNS depressant effects .
hypnotics	group	monoamine oxidase (MAO) inhibitors	group
false

The concomitant use of other DRUGN including DRUGN , DRUGA , DRUGN , general DRUGN , DRUGN , other DRUGN , DRUGN , DRUGN , and DRUGB may produce additive CNS depressant effects .
hypnotics	group	alcohol	drug
false

The concomitant use of other DRUGN including DRUGN , DRUGN , DRUGA , general DRUGB , DRUGN , other DRUGN , DRUGN , DRUGN , and DRUGN may produce additive CNS depressant effects .
tranquilizers	group	anesthetics	group
false

The concomitant use of other DRUGN including DRUGN , DRUGN , DRUGA , general DRUGN , DRUGB , other DRUGN , DRUGN , DRUGN , and DRUGN may produce additive CNS depressant effects .
tranquilizers	group	phenothiazines	group
false

The concomitant use of other DRUGN including DRUGN , DRUGN , DRUGA , general DRUGN , DRUGN , other DRUGB , DRUGN , DRUGN , and DRUGN may produce additive CNS depressant effects .
tranquilizers	group	opioids	group
false

The concomitant use of other DRUGN including DRUGN , DRUGN , DRUGA , general DRUGN , DRUGN , other DRUGN , DRUGB , DRUGN , and DRUGN may produce additive CNS depressant effects .
tranquilizers	group	tricyclic antidepressants	group
false

The concomitant use of other DRUGN including DRUGN , DRUGN , DRUGA , general DRUGN , DRUGN , other DRUGN , DRUGN , DRUGB , and DRUGN may produce additive CNS depressant effects .
tranquilizers	group	monoamine oxidase (MAO) inhibitors	group
false

The concomitant use of other DRUGN including DRUGN , DRUGN , DRUGA , general DRUGN , DRUGN , other DRUGN , DRUGN , DRUGN , and DRUGB may produce additive CNS depressant effects .
tranquilizers	group	alcohol	drug
false

The concomitant use of other DRUGN including DRUGN , DRUGN , DRUGN , general DRUGA , DRUGB , other DRUGN , DRUGN , DRUGN , and DRUGN may produce additive CNS depressant effects .
anesthetics	group	phenothiazines	group
false

The concomitant use of other DRUGN including DRUGN , DRUGN , DRUGN , general DRUGA , DRUGN , other DRUGB , DRUGN , DRUGN , and DRUGN may produce additive CNS depressant effects .
anesthetics	group	opioids	group
false

The concomitant use of other DRUGN including DRUGN , DRUGN , DRUGN , general DRUGA , DRUGN , other DRUGN , DRUGB , DRUGN , and DRUGN may produce additive CNS depressant effects .
anesthetics	group	tricyclic antidepressants	group
false

The concomitant use of other DRUGN including DRUGN , DRUGN , DRUGN , general DRUGA , DRUGN , other DRUGN , DRUGN , DRUGB , and DRUGN may produce additive CNS depressant effects .
anesthetics	group	monoamine oxidase (MAO) inhibitors	group
false

The concomitant use of other DRUGN including DRUGN , DRUGN , DRUGN , general DRUGA , DRUGN , other DRUGN , DRUGN , DRUGN , and DRUGB may produce additive CNS depressant effects .
anesthetics	group	alcohol	drug
false

The concomitant use of other DRUGN including DRUGN , DRUGN , DRUGN , general DRUGN , DRUGA , other DRUGB , DRUGN , DRUGN , and DRUGN may produce additive CNS depressant effects .
phenothiazines	group	opioids	group
false

The concomitant use of other DRUGN including DRUGN , DRUGN , DRUGN , general DRUGN , DRUGA , other DRUGN , DRUGB , DRUGN , and DRUGN may produce additive CNS depressant effects .
phenothiazines	group	tricyclic antidepressants	group
false

The concomitant use of other DRUGN including DRUGN , DRUGN , DRUGN , general DRUGN , DRUGA , other DRUGN , DRUGN , DRUGB , and DRUGN may produce additive CNS depressant effects .
phenothiazines	group	monoamine oxidase (MAO) inhibitors	group
false

The concomitant use of other DRUGN including DRUGN , DRUGN , DRUGN , general DRUGN , DRUGA , other DRUGN , DRUGN , DRUGN , and DRUGB may produce additive CNS depressant effects .
phenothiazines	group	alcohol	drug
false

The concomitant use of other DRUGN including DRUGN , DRUGN , DRUGN , general DRUGN , DRUGN , other DRUGA , DRUGB , DRUGN , and DRUGN may produce additive CNS depressant effects .
opioids	group	tricyclic antidepressants	group
false

The concomitant use of other DRUGN including DRUGN , DRUGN , DRUGN , general DRUGN , DRUGN , other DRUGA , DRUGN , DRUGB , and DRUGN may produce additive CNS depressant effects .
opioids	group	monoamine oxidase (MAO) inhibitors	group
false

The concomitant use of other DRUGN including DRUGN , DRUGN , DRUGN , general DRUGN , DRUGN , other DRUGA , DRUGN , DRUGN , and DRUGB may produce additive CNS depressant effects .
opioids	group	alcohol	drug
false

The concomitant use of other DRUGN including DRUGN , DRUGN , DRUGN , general DRUGN , DRUGN , other DRUGN , DRUGA , DRUGB , and DRUGN may produce additive CNS depressant effects .
tricyclic antidepressants	group	monoamine oxidase (MAO) inhibitors	group
false

The concomitant use of other DRUGN including DRUGN , DRUGN , DRUGN , general DRUGN , DRUGN , other DRUGN , DRUGA , DRUGN , and DRUGB may produce additive CNS depressant effects .
tricyclic antidepressants	group	alcohol	drug
false

The concomitant use of other DRUGN including DRUGN , DRUGN , DRUGN , general DRUGN , DRUGN , other DRUGN , DRUGN , DRUGA , and DRUGB may produce additive CNS depressant effects .
monoamine oxidase (MAO) inhibitors	group	alcohol	drug
false

DRUGA or other medications with anticholinergic activity when used concurrently with DRUGB may result in increased risk of urinary retention and / or severe constipation , which may lead to paralytic ileus .
Anticholinergics	group	opioid analgesics	group
effect

It has been reported that the incidence of bradycardia was increased when DRUGA was combined with DRUGB for induction of anesthesia .
oxymorphone	drug	propofol	drug
effect

In addition , CNS toxicity has been reported ( confusion , disorientation , respiratory depression , apnea , seizures ) following coadministration of DRUGA with DRUGB ;
cimetidine	drug	opioid analgesics	group
effect

Potential for DRUGA to Affect Other Drugs DRUGB is not expected to cause clinically important pharmacokinetic interactions with drugs that are metabolized by cytochrome Pdgb isozymes .
INVEGA	brand	Paliperidone	drug
false

Given the primary CNS effects of DRUGA , DRUGB should be used with caution in combination with other DRUGN and DRUGN .
paliperidone	drug	INVEGA	brand
false

Given the primary CNS effects of DRUGA , DRUGN should be used with caution in combination with other DRUGB and DRUGN .
paliperidone	drug	centrally acting drugs	group
advise

Given the primary CNS effects of DRUGA , DRUGN should be used with caution in combination with other DRUGN and DRUGB .
paliperidone	drug	alcohol	drug
advise

Given the primary CNS effects of DRUGN , DRUGA should be used with caution in combination with other DRUGB and DRUGN .
INVEGA	brand	centrally acting drugs	group
advise

Given the primary CNS effects of DRUGN , DRUGA should be used with caution in combination with other DRUGN and DRUGB .
INVEGA	brand	alcohol	drug
advise

Given the primary CNS effects of DRUGN , DRUGN should be used with caution in combination with other DRUGA and DRUGB .
centrally acting drugs	group	alcohol	drug
false

DRUGA may antagonize the effect of DRUGB and other DRUGN .
Paliperidone	drug	levodopa	drug
effect

DRUGA may antagonize the effect of DRUGN and other DRUGB .
Paliperidone	drug	dopamine agonists	group
effect

DRUGN may antagonize the effect of DRUGA and other DRUGB .
levodopa	drug	dopamine agonists	group
false

Potential for Other Drugs to Affect DRUGA DRUGB is not a substrate of CYPdgbAdgb , CYPdgbAdgb , CYPdgbCdgb , and CYPdgbCdgb , so that an interaction with inhibitors or inducers of these isozymes is unlikely .
INVEGA	brand	Paliperidone	drug
false

There have been postmarketing reports of increased INR and prothrombin time in patients receiving DRUGA , including DRUGB , and DRUGN concomitantly .
proton pump inhibitors	group	pantoprazole	drug
false

There have been postmarketing reports of increased INR and prothrombin time in patients receiving DRUGA , including DRUGN , and DRUGB concomitantly .
proton pump inhibitors	group	warfarin	drug
effect

There have been postmarketing reports of increased INR and prothrombin time in patients receiving DRUGN , including DRUGA , and DRUGB concomitantly .
pantoprazole	drug	warfarin	drug
effect

Patients treated with DRUGA and DRUGB concomitantly should be monitored for increases in INR and prothrombin time .
proton pump inhibitors	group	warfarin	drug
advise

Laboratory Tests There have been reports of false positive urine screening tests for DRUGA ( DRUGB ) in patients receiving most DRUGN , including DRUGN .
tetrahydrocannabinol	drug	THC	drug
false

Laboratory Tests There have been reports of false positive urine screening tests for DRUGA ( DRUGN ) in patients receiving most DRUGB , including DRUGN .
tetrahydrocannabinol	drug	proton pump inhibitors	group
false

Laboratory Tests There have been reports of false positive urine screening tests for DRUGA ( DRUGN ) in patients receiving most DRUGN , including DRUGB .
tetrahydrocannabinol	drug	pantoprazole	drug
false

Laboratory Tests There have been reports of false positive urine screening tests for DRUGN ( DRUGA ) in patients receiving most DRUGB , including DRUGN .
THC	drug	proton pump inhibitors	group
false

Laboratory Tests There have been reports of false positive urine screening tests for DRUGN ( DRUGA ) in patients receiving most DRUGN , including DRUGB .
THC	drug	pantoprazole	drug
false

Laboratory Tests There have been reports of false positive urine screening tests for DRUGN ( DRUGN ) in patients receiving most DRUGA , including DRUGB .
proton pump inhibitors	group	pantoprazole	drug
false

Dose adjustment of DRUGA Capsules may be required , and iPTH and serum calcium concentrations should be closely monitored if a patient initiates or discontinues therapy with a strong CYPdgbAdgb inhibitor such as DRUGB .
Zemplar	brand	ketoconazole	drug
advise

Drugs that impair intestinal absorption of DRUGA , such as DRUGB , may interfere with the absorption of DRUGN Capsules .
fat-soluble vitamins	group	cholestyramine	drug
mechanism

Drugs that impair intestinal absorption of DRUGA , such as DRUGN , may interfere with the absorption of DRUGB Capsules .
fat-soluble vitamins	group	Zemplar	brand
false

Drugs that impair intestinal absorption of DRUGN , such as DRUGA , may interfere with the absorption of DRUGB Capsules .
cholestyramine	drug	Zemplar	brand
mechanism

patients receiving DRUGA and DRUGB should have more frequent monitoring of neutrophil counts .
lithium	drug	Neulasta	brand
advise

In a pharmacokinetic study of dgb chronic hepatitis C patients concomitantly receiving DRUGA , treatment with DRUGB once weekly for dgb weeks was associated with a mean increase of dgb % in DRUGN AUC ;
methadone	drug	PEG-Intron	brand
mechanism

In a pharmacokinetic study of dgb chronic hepatitis C patients concomitantly receiving DRUGN , treatment with DRUGA once weekly for dgb weeks was associated with a mean increase of dgb % in DRUGB AUC ;
PEG-Intron	brand	methadone	drug
false

Acromegalic patients with diabetes mellitus being treated with DRUGA and / or oral DRUGB agents may require dose reductions of these therapeutic agents after the initiation of therapy with DRUGN .
insulin	drug	hypoglycemic	group
false

Acromegalic patients with diabetes mellitus being treated with DRUGA and / or oral DRUGN agents may require dose reductions of these therapeutic agents after the initiation of therapy with DRUGB .
insulin	drug	SOMAVERT	brand
advise

Acromegalic patients with diabetes mellitus being treated with DRUGN and / or oral DRUGA agents may require dose reductions of these therapeutic agents after the initiation of therapy with DRUGB .
hypoglycemic	group	SOMAVERT	brand
advise

In clinical studies , patients on DRUGA often needed higher serum DRUGB concentrations to achieve appropriate IGF I suppression compared with patients not receiving DRUGN .
opioids	group	pegvisomant	drug
mechanism

In clinical studies , patients on DRUGN often needed higher serum DRUGA concentrations to achieve appropriate IGF I suppression compared with patients not receiving DRUGB .
pegvisomant	drug	opioids	group
false

Concomitant administration of substances that are also tubularly secreted ( e.g . , DRUGA ) could potentially result in delayed clearance of DRUGB .
probenecid	drug	ALIMTA	brand
mechanism

Patients with mild to moderate renal insufficiency should avoid taking DRUGA with short elimination half lives for a period of dgb days before , the day of , and dgb days following administration of DRUGB .
NSAIDs	group	ALIMTA	brand
advise

The interaction of DRUGA ( DRUGB ) with other drugs has not been studied in humans .
CYLERT	brand	pemoline	drug
false

Decreased seizure threshold has been reported in patients receiving DRUGA concomitantly with DRUGB .
CYLERT	brand	antiepileptic medications	group
effect

Concurrent administration of DRUGA ( e.g . , DRUGB , DRUGN ) may diminish the bactericidal effects of DRUGN by slowing the rate of bacterial growth .
bacteriostatic antibiotics	group	erythromycin	drug
false

Concurrent administration of DRUGA ( e.g . , DRUGN , DRUGB ) may diminish the bactericidal effects of DRUGN by slowing the rate of bacterial growth .
bacteriostatic antibiotics	group	tetracycline	drug
false

Concurrent administration of DRUGA ( e.g . , DRUGN , DRUGN ) may diminish the bactericidal effects of DRUGB by slowing the rate of bacterial growth .
bacteriostatic antibiotics	group	penicillins	group
effect

Concurrent administration of DRUGN ( e.g . , DRUGA , DRUGB ) may diminish the bactericidal effects of DRUGN by slowing the rate of bacterial growth .
erythromycin	drug	tetracycline	drug
false

Concurrent administration of DRUGN ( e.g . , DRUGA , DRUGN ) may diminish the bactericidal effects of DRUGB by slowing the rate of bacterial growth .
erythromycin	drug	penicillins	group
effect

Concurrent administration of DRUGN ( e.g . , DRUGN , DRUGA ) may diminish the bactericidal effects of DRUGB by slowing the rate of bacterial growth .
tetracycline	drug	penicillins	group
effect

DRUGA blood levels may be prolonged by concurrent administration of DRUGB which blocks the renal tubular secretion of DRUGN .
Penicillin	group	probenecid	drug
mechanism

DRUGA blood levels may be prolonged by concurrent administration of DRUGN which blocks the renal tubular secretion of DRUGB .
Penicillin	group	penicillins	group
false

DRUGN blood levels may be prolonged by concurrent administration of DRUGA which blocks the renal tubular secretion of DRUGB .
probenecid	drug	penicillins	group
false

Usage with DRUGA : Due to the potential for increased CNS depressants effects , DRUGB should be used with caution in patients who are currently receiving DRUGN .
Alcohol	drug	alcohol	drug
false

Usage with DRUGA : Due to the potential for increased CNS depressants effects , DRUGN should be used with caution in patients who are currently receiving DRUGB .
Alcohol	drug	pentazocine	drug
false

Usage with DRUGN : Due to the potential for increased CNS depressants effects , DRUGA should be used with caution in patients who are currently receiving DRUGB .
alcohol	drug	pentazocine	drug
advise

Although a causal relationship has not been established , there have been reports of bleeding and / or prolonged prothrombin time in patients treated with DRUGA with and without DRUGB or DRUGN .
TRENTAL	brand	anticoagulants	group
effect

Although a causal relationship has not been established , there have been reports of bleeding and / or prolonged prothrombin time in patients treated with DRUGA with and without DRUGN or DRUGB .
TRENTAL	brand	platelet aggregation inhibitors	group
effect

Although a causal relationship has not been established , there have been reports of bleeding and / or prolonged prothrombin time in patients treated with DRUGN with and without DRUGA or DRUGB .
anticoagulants	group	platelet aggregation inhibitors	group
false

Concomitant administration of DRUGA and DRUGB containing drugs leads to increased DRUGN levels and DRUGN toxicity in some individuals .
TRENTAL	brand	theophylline	drug
mechanism

Concomitant administration of DRUGA and DRUGN containing drugs leads to increased DRUGB levels and DRUGN toxicity in some individuals .
TRENTAL	brand	theophylline	drug
false

Concomitant administration of DRUGA and DRUGN containing drugs leads to increased DRUGN levels and DRUGB toxicity in some individuals .
TRENTAL	brand	theophylline	drug
false

DRUGA has been used concurrently with DRUGB , DRUGN , DRUGN , DRUGN , DRUGN , and DRUGN , without observed problems .
TRENTAL	brand	antihypertensive drugs	group
false

DRUGA has been used concurrently with DRUGN , DRUGB , DRUGN , DRUGN , DRUGN , and DRUGN , without observed problems .
TRENTAL	brand	beta blockers	group
false

DRUGA has been used concurrently with DRUGN , DRUGN , DRUGB , DRUGN , DRUGN , and DRUGN , without observed problems .
TRENTAL	brand	digitalis	group
false

DRUGA has been used concurrently with DRUGN , DRUGN , DRUGN , DRUGB , DRUGN , and DRUGN , without observed problems .
TRENTAL	brand	diuretics	group
false

DRUGA has been used concurrently with DRUGN , DRUGN , DRUGN , DRUGN , DRUGB , and DRUGN , without observed problems .
TRENTAL	brand	antidiabetic agents	group
false

DRUGA has been used concurrently with DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , and DRUGB , without observed problems .
TRENTAL	brand	antiarrhythmics	group
false

DRUGN has been used concurrently with DRUGA , DRUGB , DRUGN , DRUGN , DRUGN , and DRUGN , without observed problems .
antihypertensive drugs	group	beta blockers	group
false

DRUGN has been used concurrently with DRUGA , DRUGN , DRUGB , DRUGN , DRUGN , and DRUGN , without observed problems .
antihypertensive drugs	group	digitalis	group
false

DRUGN has been used concurrently with DRUGA , DRUGN , DRUGN , DRUGB , DRUGN , and DRUGN , without observed problems .
antihypertensive drugs	group	diuretics	group
false

DRUGN has been used concurrently with DRUGA , DRUGN , DRUGN , DRUGN , DRUGB , and DRUGN , without observed problems .
antihypertensive drugs	group	antidiabetic agents	group
false

DRUGN has been used concurrently with DRUGA , DRUGN , DRUGN , DRUGN , DRUGN , and DRUGB , without observed problems .
antihypertensive drugs	group	antiarrhythmics	group
false

DRUGN has been used concurrently with DRUGN , DRUGA , DRUGB , DRUGN , DRUGN , and DRUGN , without observed problems .
beta blockers	group	digitalis	group
false

DRUGN has been used concurrently with DRUGN , DRUGA , DRUGN , DRUGB , DRUGN , and DRUGN , without observed problems .
beta blockers	group	diuretics	group
false

DRUGN has been used concurrently with DRUGN , DRUGA , DRUGN , DRUGN , DRUGB , and DRUGN , without observed problems .
beta blockers	group	antidiabetic agents	group
false

DRUGN has been used concurrently with DRUGN , DRUGA , DRUGN , DRUGN , DRUGN , and DRUGB , without observed problems .
beta blockers	group	antiarrhythmics	group
false

DRUGN has been used concurrently with DRUGN , DRUGN , DRUGA , DRUGB , DRUGN , and DRUGN , without observed problems .
digitalis	group	diuretics	group
false

DRUGN has been used concurrently with DRUGN , DRUGN , DRUGA , DRUGN , DRUGB , and DRUGN , without observed problems .
digitalis	group	antidiabetic agents	group
false

DRUGN has been used concurrently with DRUGN , DRUGN , DRUGA , DRUGN , DRUGN , and DRUGB , without observed problems .
digitalis	group	antiarrhythmics	group
false

DRUGN has been used concurrently with DRUGN , DRUGN , DRUGN , DRUGA , DRUGB , and DRUGN , without observed problems .
diuretics	group	antidiabetic agents	group
false

DRUGN has been used concurrently with DRUGN , DRUGN , DRUGN , DRUGA , DRUGN , and DRUGB , without observed problems .
diuretics	group	antiarrhythmics	group
false

DRUGN has been used concurrently with DRUGN , DRUGN , DRUGN , DRUGN , DRUGA , and DRUGB , without observed problems .
antidiabetic agents	group	antiarrhythmics	group
false

DRUGA , such as the DRUGB ( DRUGN , DRUGN , DRUGN ) or DRUGN , ordinarily should not be administered concurrently with DRUGN ( a DRUGN ) ;
Dopamine antagonists	group	neuroleptics	group
false

DRUGA , such as the DRUGN ( DRUGB , DRUGN , DRUGN ) or DRUGN , ordinarily should not be administered concurrently with DRUGN ( a DRUGN ) ;
Dopamine antagonists	group	phenothiazines	group
false

DRUGA , such as the DRUGN ( DRUGN , DRUGB , DRUGN ) or DRUGN , ordinarily should not be administered concurrently with DRUGN ( a DRUGN ) ;
Dopamine antagonists	group	butyrophenones	group
false

DRUGA , such as the DRUGN ( DRUGN , DRUGN , DRUGB ) or DRUGN , ordinarily should not be administered concurrently with DRUGN ( a DRUGN ) ;
Dopamine antagonists	group	thioxanthines	group
false

DRUGA , such as the DRUGN ( DRUGN , DRUGN , DRUGN ) or DRUGB , ordinarily should not be administered concurrently with DRUGN ( a DRUGN ) ;
Dopamine antagonists	group	metoclopramide	drug
false

DRUGA , such as the DRUGN ( DRUGN , DRUGN , DRUGN ) or DRUGN , ordinarily should not be administered concurrently with DRUGB ( a DRUGN ) ;
Dopamine antagonists	group	Permax	brand
advise

DRUGA , such as the DRUGN ( DRUGN , DRUGN , DRUGN ) or DRUGN , ordinarily should not be administered concurrently with DRUGN ( a DRUGB ) ;
Dopamine antagonists	group	dopamine agonist	group
false

DRUGN , such as the DRUGA ( DRUGB , DRUGN , DRUGN ) or DRUGN , ordinarily should not be administered concurrently with DRUGN ( a DRUGN ) ;
neuroleptics	group	phenothiazines	group
false

DRUGN , such as the DRUGA ( DRUGN , DRUGB , DRUGN ) or DRUGN , ordinarily should not be administered concurrently with DRUGN ( a DRUGN ) ;
neuroleptics	group	butyrophenones	group
false

DRUGN , such as the DRUGA ( DRUGN , DRUGN , DRUGB ) or DRUGN , ordinarily should not be administered concurrently with DRUGN ( a DRUGN ) ;
neuroleptics	group	thioxanthines	group
false

DRUGN , such as the DRUGA ( DRUGN , DRUGN , DRUGN ) or DRUGB , ordinarily should not be administered concurrently with DRUGN ( a DRUGN ) ;
neuroleptics	group	metoclopramide	drug
false

DRUGN , such as the DRUGA ( DRUGN , DRUGN , DRUGN ) or DRUGN , ordinarily should not be administered concurrently with DRUGB ( a DRUGN ) ;
neuroleptics	group	Permax	brand
advise

DRUGN , such as the DRUGA ( DRUGN , DRUGN , DRUGN ) or DRUGN , ordinarily should not be administered concurrently with DRUGN ( a DRUGB ) ;
neuroleptics	group	dopamine agonist	group
false

DRUGN , such as the DRUGN ( DRUGA , DRUGB , DRUGN ) or DRUGN , ordinarily should not be administered concurrently with DRUGN ( a DRUGN ) ;
phenothiazines	group	butyrophenones	group
false

DRUGN , such as the DRUGN ( DRUGA , DRUGN , DRUGB ) or DRUGN , ordinarily should not be administered concurrently with DRUGN ( a DRUGN ) ;
phenothiazines	group	thioxanthines	group
false

DRUGN , such as the DRUGN ( DRUGA , DRUGN , DRUGN ) or DRUGB , ordinarily should not be administered concurrently with DRUGN ( a DRUGN ) ;
phenothiazines	group	metoclopramide	drug
false

DRUGN , such as the DRUGN ( DRUGA , DRUGN , DRUGN ) or DRUGN , ordinarily should not be administered concurrently with DRUGB ( a DRUGN ) ;
phenothiazines	group	Permax	brand
advise

DRUGN , such as the DRUGN ( DRUGA , DRUGN , DRUGN ) or DRUGN , ordinarily should not be administered concurrently with DRUGN ( a DRUGB ) ;
phenothiazines	group	dopamine agonist	group
false

DRUGN , such as the DRUGN ( DRUGN , DRUGA , DRUGB ) or DRUGN , ordinarily should not be administered concurrently with DRUGN ( a DRUGN ) ;
butyrophenones	group	thioxanthines	group
false

DRUGN , such as the DRUGN ( DRUGN , DRUGA , DRUGN ) or DRUGB , ordinarily should not be administered concurrently with DRUGN ( a DRUGN ) ;
butyrophenones	group	metoclopramide	drug
false

DRUGN , such as the DRUGN ( DRUGN , DRUGA , DRUGN ) or DRUGN , ordinarily should not be administered concurrently with DRUGB ( a DRUGN ) ;
butyrophenones	group	Permax	brand
advise

DRUGN , such as the DRUGN ( DRUGN , DRUGA , DRUGN ) or DRUGN , ordinarily should not be administered concurrently with DRUGN ( a DRUGB ) ;
butyrophenones	group	dopamine agonist	group
false

DRUGN , such as the DRUGN ( DRUGN , DRUGN , DRUGA ) or DRUGB , ordinarily should not be administered concurrently with DRUGN ( a DRUGN ) ;
thioxanthines	group	metoclopramide	drug
false

DRUGN , such as the DRUGN ( DRUGN , DRUGN , DRUGA ) or DRUGN , ordinarily should not be administered concurrently with DRUGB ( a DRUGN ) ;
thioxanthines	group	Permax	brand
advise

DRUGN , such as the DRUGN ( DRUGN , DRUGN , DRUGA ) or DRUGN , ordinarily should not be administered concurrently with DRUGN ( a DRUGB ) ;
thioxanthines	group	dopamine agonist	group
false

DRUGN , such as the DRUGN ( DRUGN , DRUGN , DRUGN ) or DRUGA , ordinarily should not be administered concurrently with DRUGB ( a DRUGN ) ;
metoclopramide	drug	Permax	brand
advise

DRUGN , such as the DRUGN ( DRUGN , DRUGN , DRUGN ) or DRUGA , ordinarily should not be administered concurrently with DRUGN ( a DRUGB ) ;
metoclopramide	drug	dopamine agonist	group
false

DRUGN , such as the DRUGN ( DRUGN , DRUGN , DRUGN ) or DRUGN , ordinarily should not be administered concurrently with DRUGA ( a DRUGB ) ;
Permax	brand	dopamine agonist	group
false

DRUGA : Patients on DRUGB , and especially those started recently , may occasionally experience an excessive reduction of blood pressure after initiation of DRUGN Tablets therapy .
Diuretics	group	diuretics	group
false

DRUGA : Patients on DRUGN , and especially those started recently , may occasionally experience an excessive reduction of blood pressure after initiation of DRUGB Tablets therapy .
Diuretics	group	ACEON	brand
false

DRUGN : Patients on DRUGA , and especially those started recently , may occasionally experience an excessive reduction of blood pressure after initiation of DRUGB Tablets therapy .
diuretics	group	ACEON	brand
effect

The possibility of hypotensive effects can be minimized by either discontinuing the DRUGA or increasing the salt intake prior to initiation of treatment with DRUGB .
diuretic	group	perindopril	drug
effect

If DRUGA can not be interrupted , close medical supervision should be provided with the first dose of DRUGB Tablets , for at least two hours and until blood pressure has stabilized for another hour .
diuretics	group	ACEON	brand
advise

The rate and extent of DRUGA absorption and elimination are not affected by concomitant DRUGB .
perindopril	drug	diuretics	group
false

The bioavailability of DRUGA was reduced by DRUGB , however , and this was associated with a decrease in plasma ACE inhibition .
perindoprilat	drug_n	diuretics	group
false

DRUGA Supplements and DRUGB : DRUGN Tablets may increase serum potassium because of its potential to decrease aldosterone production .
Potassium	drug	Potassium-Sparing Diuretics	group
false

DRUGA Supplements and DRUGN : DRUGB Tablets may increase serum potassium because of its potential to decrease aldosterone production .
Potassium	drug	ACEON	brand
false

DRUGN Supplements and DRUGA : DRUGB Tablets may increase serum potassium because of its potential to decrease aldosterone production .
Potassium-Sparing Diuretics	group	ACEON	brand
false

Use of DRUGA ( DRUGB , DRUGN , DRUGN and others ) , DRUGN supplements or other drugs capable of increasing serum potassium ( DRUGN , DRUGN , DRUGN and others ) can increase the risk of hyperkalemia .
potassium-sparing diuretics	group	spironolactone	drug
false

Use of DRUGA ( DRUGN , DRUGB , DRUGN and others ) , DRUGN supplements or other drugs capable of increasing serum potassium ( DRUGN , DRUGN , DRUGN and others ) can increase the risk of hyperkalemia .
potassium-sparing diuretics	group	amiloride	drug
false

Use of DRUGA ( DRUGN , DRUGN , DRUGB and others ) , DRUGN supplements or other drugs capable of increasing serum potassium ( DRUGN , DRUGN , DRUGN and others ) can increase the risk of hyperkalemia .
potassium-sparing diuretics	group	triamterene	drug
false

Use of DRUGA ( DRUGN , DRUGN , DRUGN and others ) , DRUGB supplements or other drugs capable of increasing serum potassium ( DRUGN , DRUGN , DRUGN and others ) can increase the risk of hyperkalemia .
potassium-sparing diuretics	group	potassium	drug
false

Use of DRUGA ( DRUGN , DRUGN , DRUGN and others ) , DRUGN supplements or other drugs capable of increasing serum potassium ( DRUGB , DRUGN , DRUGN and others ) can increase the risk of hyperkalemia .
potassium-sparing diuretics	group	indomethacin	drug
false

Use of DRUGA ( DRUGN , DRUGN , DRUGN and others ) , DRUGN supplements or other drugs capable of increasing serum potassium ( DRUGN , DRUGB , DRUGN and others ) can increase the risk of hyperkalemia .
potassium-sparing diuretics	group	heparin	drug
false

Use of DRUGA ( DRUGN , DRUGN , DRUGN and others ) , DRUGN supplements or other drugs capable of increasing serum potassium ( DRUGN , DRUGN , DRUGB and others ) can increase the risk of hyperkalemia .
potassium-sparing diuretics	group	cyclosporine	drug
false

Use of DRUGN ( DRUGA , DRUGB , DRUGN and others ) , DRUGN supplements or other drugs capable of increasing serum potassium ( DRUGN , DRUGN , DRUGN and others ) can increase the risk of hyperkalemia .
spironolactone	drug	amiloride	drug
false

Use of DRUGN ( DRUGA , DRUGN , DRUGB and others ) , DRUGN supplements or other drugs capable of increasing serum potassium ( DRUGN , DRUGN , DRUGN and others ) can increase the risk of hyperkalemia .
spironolactone	drug	triamterene	drug
false

Use of DRUGN ( DRUGA , DRUGN , DRUGN and others ) , DRUGB supplements or other drugs capable of increasing serum potassium ( DRUGN , DRUGN , DRUGN and others ) can increase the risk of hyperkalemia .
spironolactone	drug	potassium	drug
false

Use of DRUGN ( DRUGA , DRUGN , DRUGN and others ) , DRUGN supplements or other drugs capable of increasing serum potassium ( DRUGB , DRUGN , DRUGN and others ) can increase the risk of hyperkalemia .
spironolactone	drug	indomethacin	drug
false

Use of DRUGN ( DRUGA , DRUGN , DRUGN and others ) , DRUGN supplements or other drugs capable of increasing serum potassium ( DRUGN , DRUGB , DRUGN and others ) can increase the risk of hyperkalemia .
spironolactone	drug	heparin	drug
false

Use of DRUGN ( DRUGA , DRUGN , DRUGN and others ) , DRUGN supplements or other drugs capable of increasing serum potassium ( DRUGN , DRUGN , DRUGB and others ) can increase the risk of hyperkalemia .
spironolactone	drug	cyclosporine	drug
false

Use of DRUGN ( DRUGN , DRUGA , DRUGB and others ) , DRUGN supplements or other drugs capable of increasing serum potassium ( DRUGN , DRUGN , DRUGN and others ) can increase the risk of hyperkalemia .
amiloride	drug	triamterene	drug
false

Use of DRUGN ( DRUGN , DRUGA , DRUGN and others ) , DRUGB supplements or other drugs capable of increasing serum potassium ( DRUGN , DRUGN , DRUGN and others ) can increase the risk of hyperkalemia .
amiloride	drug	potassium	drug
false

Use of DRUGN ( DRUGN , DRUGA , DRUGN and others ) , DRUGN supplements or other drugs capable of increasing serum potassium ( DRUGB , DRUGN , DRUGN and others ) can increase the risk of hyperkalemia .
amiloride	drug	indomethacin	drug
false

Use of DRUGN ( DRUGN , DRUGA , DRUGN and others ) , DRUGN supplements or other drugs capable of increasing serum potassium ( DRUGN , DRUGB , DRUGN and others ) can increase the risk of hyperkalemia .
amiloride	drug	heparin	drug
false

Use of DRUGN ( DRUGN , DRUGA , DRUGN and others ) , DRUGN supplements or other drugs capable of increasing serum potassium ( DRUGN , DRUGN , DRUGB and others ) can increase the risk of hyperkalemia .
amiloride	drug	cyclosporine	drug
false

Use of DRUGN ( DRUGN , DRUGN , DRUGA and others ) , DRUGB supplements or other drugs capable of increasing serum potassium ( DRUGN , DRUGN , DRUGN and others ) can increase the risk of hyperkalemia .
triamterene	drug	potassium	drug
false

Use of DRUGN ( DRUGN , DRUGN , DRUGA and others ) , DRUGN supplements or other drugs capable of increasing serum potassium ( DRUGB , DRUGN , DRUGN and others ) can increase the risk of hyperkalemia .
triamterene	drug	indomethacin	drug
false

Use of DRUGN ( DRUGN , DRUGN , DRUGA and others ) , DRUGN supplements or other drugs capable of increasing serum potassium ( DRUGN , DRUGB , DRUGN and others ) can increase the risk of hyperkalemia .
triamterene	drug	heparin	drug
false

Use of DRUGN ( DRUGN , DRUGN , DRUGA and others ) , DRUGN supplements or other drugs capable of increasing serum potassium ( DRUGN , DRUGN , DRUGB and others ) can increase the risk of hyperkalemia .
triamterene	drug	cyclosporine	drug
false

Use of DRUGN ( DRUGN , DRUGN , DRUGN and others ) , DRUGA supplements or other drugs capable of increasing serum potassium ( DRUGB , DRUGN , DRUGN and others ) can increase the risk of hyperkalemia .
potassium	drug	indomethacin	drug
false

Use of DRUGN ( DRUGN , DRUGN , DRUGN and others ) , DRUGA supplements or other drugs capable of increasing serum potassium ( DRUGN , DRUGB , DRUGN and others ) can increase the risk of hyperkalemia .
potassium	drug	heparin	drug
false

Use of DRUGN ( DRUGN , DRUGN , DRUGN and others ) , DRUGA supplements or other drugs capable of increasing serum potassium ( DRUGN , DRUGN , DRUGB and others ) can increase the risk of hyperkalemia .
potassium	drug	cyclosporine	drug
false

Use of DRUGN ( DRUGN , DRUGN , DRUGN and others ) , DRUGN supplements or other drugs capable of increasing serum potassium ( DRUGA , DRUGB , DRUGN and others ) can increase the risk of hyperkalemia .
indomethacin	drug	heparin	drug
false

Use of DRUGN ( DRUGN , DRUGN , DRUGN and others ) , DRUGN supplements or other drugs capable of increasing serum potassium ( DRUGA , DRUGN , DRUGB and others ) can increase the risk of hyperkalemia .
indomethacin	drug	cyclosporine	drug
false

Use of DRUGN ( DRUGN , DRUGN , DRUGN and others ) , DRUGN supplements or other drugs capable of increasing serum potassium ( DRUGN , DRUGA , DRUGB and others ) can increase the risk of hyperkalemia .
heparin	drug	cyclosporine	drug
false

DRUGA : Increased serum DRUGB and symptoms of DRUGN toxicity have been reported in patients receiving concomitant DRUGN and ACE inhibitor therapy .
Lithium	drug	lithium	drug
false

DRUGA : Increased serum DRUGN and symptoms of DRUGB toxicity have been reported in patients receiving concomitant DRUGN and ACE inhibitor therapy .
Lithium	drug	lithium	drug
false

DRUGA : Increased serum DRUGN and symptoms of DRUGN toxicity have been reported in patients receiving concomitant DRUGB and ACE inhibitor therapy .
Lithium	drug	lithium	drug
false

Use of a DRUGA may further increase the risk of DRUGB toxicity .
diuretic	group	lithium	drug
false

DRUGA : A controlled pharmacokinetic study has shown no effect on plasma DRUGB concentrations when coadministered with DRUGN Tablets , but an effect of DRUGN on the plasma concentration of DRUGN / DRUGN has not been excluded .
Digoxin	drug	digoxin	drug
false

DRUGA : A controlled pharmacokinetic study has shown no effect on plasma DRUGN concentrations when coadministered with DRUGB Tablets , but an effect of DRUGN on the plasma concentration of DRUGN / DRUGN has not been excluded .
Digoxin	drug	ACEON	brand
false

DRUGA : A controlled pharmacokinetic study has shown no effect on plasma DRUGN concentrations when coadministered with DRUGN Tablets , but an effect of DRUGB on the plasma concentration of DRUGN / DRUGN has not been excluded .
Digoxin	drug	digoxin	drug
false

DRUGA : A controlled pharmacokinetic study has shown no effect on plasma DRUGN concentrations when coadministered with DRUGN Tablets , but an effect of DRUGN on the plasma concentration of DRUGB / DRUGN has not been excluded .
Digoxin	drug	perindopril	drug
false

DRUGA : A controlled pharmacokinetic study has shown no effect on plasma DRUGN concentrations when coadministered with DRUGN Tablets , but an effect of DRUGN on the plasma concentration of DRUGN / DRUGB has not been excluded .
Digoxin	drug	perindoprilat	drug_n
false

DRUGN : A controlled pharmacokinetic study has shown no effect on plasma DRUGA concentrations when coadministered with DRUGB Tablets , but an effect of DRUGN on the plasma concentration of DRUGN / DRUGN has not been excluded .
digoxin	drug	ACEON	brand
false

DRUGN : A controlled pharmacokinetic study has shown no effect on plasma DRUGA concentrations when coadministered with DRUGN Tablets , but an effect of DRUGN on the plasma concentration of DRUGB / DRUGN has not been excluded .
digoxin	drug	perindopril	drug
false

DRUGN : A controlled pharmacokinetic study has shown no effect on plasma DRUGA concentrations when coadministered with DRUGN Tablets , but an effect of DRUGN on the plasma concentration of DRUGN / DRUGB has not been excluded .
digoxin	drug	perindoprilat	drug_n
false

DRUGN : A controlled pharmacokinetic study has shown no effect on plasma DRUGN concentrations when coadministered with DRUGA Tablets , but an effect of DRUGB on the plasma concentration of DRUGN / DRUGN has not been excluded .
ACEON	brand	digoxin	drug
false

DRUGN : A controlled pharmacokinetic study has shown no effect on plasma DRUGN concentrations when coadministered with DRUGA Tablets , but an effect of DRUGN on the plasma concentration of DRUGB / DRUGN has not been excluded .
ACEON	brand	perindopril	drug
false

DRUGN : A controlled pharmacokinetic study has shown no effect on plasma DRUGN concentrations when coadministered with DRUGA Tablets , but an effect of DRUGN on the plasma concentration of DRUGN / DRUGB has not been excluded .
ACEON	brand	perindoprilat	drug_n
false

DRUGN : A controlled pharmacokinetic study has shown no effect on plasma DRUGN concentrations when coadministered with DRUGN Tablets , but an effect of DRUGA on the plasma concentration of DRUGB / DRUGN has not been excluded .
digoxin	drug	perindopril	drug
mechanism

DRUGN : A controlled pharmacokinetic study has shown no effect on plasma DRUGN concentrations when coadministered with DRUGN Tablets , but an effect of DRUGA on the plasma concentration of DRUGN / DRUGB has not been excluded .
digoxin	drug	perindoprilat	drug_n
mechanism

DRUGN : A controlled pharmacokinetic study has shown no effect on plasma DRUGN concentrations when coadministered with DRUGN Tablets , but an effect of DRUGN on the plasma concentration of DRUGA / DRUGB has not been excluded .
perindopril	drug	perindoprilat	drug_n
false

DRUGA : Animal data have suggested the possibility of interaction between DRUGB and DRUGN .
Gentamicin	drug	perindopril	drug
false

DRUGA : Animal data have suggested the possibility of interaction between DRUGN and DRUGB .
Gentamicin	drug	gentamicin	drug
false

DRUGN : Animal data have suggested the possibility of interaction between DRUGA and DRUGB .
perindopril	drug	gentamicin	drug
int

Food Interaction : Oral administration of DRUGA Tablets with food does not significantly lower the rate or extent of DRUGB absorption relative to the fasted state .
ACEON	brand	perindopril	drug
false

However , the extent of biotransformation of DRUGA to the active metabolite , DRUGB , is reduced approximately dgb % , resulting in a reduction in the plasma ACE inhibition curve of approximately dgb % , probably clinically insignificant .
perindopril	drug	perindoprilat	drug_n
false

Concomitant use of DRUGA with DRUGB may result in an adverse drug interaction .
alcohol	drug	phentermine hydrochloride	drug
int

DRUGA , particularly DRUGB , may cause serious cardiac arrhythmias during DRUGN anesthesia and therefore should be used only with great caution or not at all .
Vasopressors	group	metaraminol	drug
false

DRUGA , particularly DRUGN , may cause serious cardiac arrhythmias during DRUGB anesthesia and therefore should be used only with great caution or not at all .
Vasopressors	group	halothane	drug
effect

DRUGN , particularly DRUGA , may cause serious cardiac arrhythmias during DRUGB anesthesia and therefore should be used only with great caution or not at all .
metaraminol	drug	halothane	drug
effect

DRUGA : The pressor effect of DRUGB is markedly potentiated in patients receiving DRUGN ( DRUGN ) .
MAO Inhibitors	group	sympathomimetic pressor amines	group
false

DRUGA : The pressor effect of DRUGN is markedly potentiated in patients receiving DRUGB ( DRUGN ) .
MAO Inhibitors	group	monoamine oxidase inhibitors	group
false

DRUGA : The pressor effect of DRUGN is markedly potentiated in patients receiving DRUGN ( DRUGB ) .
MAO Inhibitors	group	MAOI	group
false

DRUGN : The pressor effect of DRUGA is markedly potentiated in patients receiving DRUGB ( DRUGN ) .
sympathomimetic pressor amines	group	monoamine oxidase inhibitors	group
effect

DRUGN : The pressor effect of DRUGA is markedly potentiated in patients receiving DRUGN ( DRUGB ) .
sympathomimetic pressor amines	group	MAOI	group
effect

DRUGN : The pressor effect of DRUGN is markedly potentiated in patients receiving DRUGA ( DRUGB ) .
monoamine oxidase inhibitors	group	MAOI	group
false

The pressor response of DRUGA may also be potentiated by DRUGB .
adrenergic agents	group	tricyclic antidepressants	group
effect

DRUGA , particularly DRUGB , may cause serious cardiac arrhythmias during DRUGN anesthesia and therefore should be used only with great caution or not at all .
Vasopressors	group	metaraminol	drug
false

DRUGA , particularly DRUGN , may cause serious cardiac arrhythmias during DRUGB anesthesia and therefore should be used only with great caution or not at all .
Vasopressors	group	halothane	drug
effect

DRUGN , particularly DRUGA , may cause serious cardiac arrhythmias during DRUGB anesthesia and therefore should be used only with great caution or not at all .
metaraminol	drug	halothane	drug
effect

DRUGA The pressor effect of DRUGB is markedly potentiated in patients receiving DRUGN ( DRUGN ) .
MAO Inhibitors	group	sympathomimetic pressor amines	group
false

DRUGA The pressor effect of DRUGN is markedly potentiated in patients receiving DRUGB ( DRUGN ) .
MAO Inhibitors	group	monoamine oxidase inhibitors	group
false

DRUGA The pressor effect of DRUGN is markedly potentiated in patients receiving DRUGN ( DRUGB ) .
MAO Inhibitors	group	MAOI	group
false

DRUGN The pressor effect of DRUGA is markedly potentiated in patients receiving DRUGB ( DRUGN ) .
sympathomimetic pressor amines	group	monoamine oxidase inhibitors	group
effect

DRUGN The pressor effect of DRUGA is markedly potentiated in patients receiving DRUGN ( DRUGB ) .
sympathomimetic pressor amines	group	MAOI	group
effect

DRUGN The pressor effect of DRUGN is markedly potentiated in patients receiving DRUGA ( DRUGB ) .
monoamine oxidase inhibitors	group	MAOI	group
false

The pressor response of DRUGA may also be potentiated by DRUGB .
adrenergic agents	group	tricyclic antidepressants	group
effect

DRUGA should be administered with caution to patients taking DRUGB because of the possibility of conduction disturbances .
Pilocarpine	drug	beta adrenergic antagonists	group
advise

These effects should be considered when anticholinergic properties may be contributing to the therapeutic effect of concomitant medication ( e.g . , DRUGA , inhaled DRUGB ) .
atropine	drug	ipratropium	drug
false

Catecholamine depleting drugs ( e.g . , DRUGA ) may have an additive effect when given with DRUGB .
reserpine	drug	beta-blocking agents	group
effect

DRUGA has been used with a variety of DRUGB , including DRUGN , DRUGN , and DRUGN without unexpected adverse interactions .
Pindolol	drug	antihypertensive agents	group
false

DRUGA has been used with a variety of DRUGN , including DRUGB , DRUGN , and DRUGN without unexpected adverse interactions .
Pindolol	drug	hydrochlorothiazide	drug
false

DRUGA has been used with a variety of DRUGN , including DRUGN , DRUGB , and DRUGN without unexpected adverse interactions .
Pindolol	drug	hydralazine	drug
false

DRUGA has been used with a variety of DRUGN , including DRUGN , DRUGN , and DRUGB without unexpected adverse interactions .
Pindolol	drug	guanethidine	drug
false

DRUGN has been used with a variety of DRUGA , including DRUGB , DRUGN , and DRUGN without unexpected adverse interactions .
antihypertensive agents	group	hydrochlorothiazide	drug
false

DRUGN has been used with a variety of DRUGA , including DRUGN , DRUGB , and DRUGN without unexpected adverse interactions .
antihypertensive agents	group	hydralazine	drug
false

DRUGN has been used with a variety of DRUGA , including DRUGN , DRUGN , and DRUGB without unexpected adverse interactions .
antihypertensive agents	group	guanethidine	drug
false

DRUGN has been used with a variety of DRUGN , including DRUGA , DRUGB , and DRUGN without unexpected adverse interactions .
hydrochlorothiazide	drug	hydralazine	drug
false

DRUGN has been used with a variety of DRUGN , including DRUGA , DRUGN , and DRUGB without unexpected adverse interactions .
hydrochlorothiazide	drug	guanethidine	drug
false

DRUGN has been used with a variety of DRUGN , including DRUGN , DRUGA , and DRUGB without unexpected adverse interactions .
hydralazine	drug	guanethidine	drug
false

DRUGA has been shown to increase serum DRUGB levels when both drugs are co administered .
Pindolol	drug	thioridazine	drug
mechanism

Other DRUGA should not be used concomitantly with DRUGB because they may have additive effects .
short-acting beta adrenergic aerosol bronchodilators	group	MAXAIR AUTOHALER	brand
advise

It is recommended that plasma DRUGA levels be monitored when initiating , adjusting and discontinuing DRUGB .
lithium	drug	FELDENE	brand
advise

When DRUGA and DRUGB are used together , the signs of atropinization ( flushing , mydriasis , tachycardia , dryness of the mouth and nose ) may occur earlier than might be expected when DRUGN is used alone .
atropine	drug	pralidoxime	drug
effect

When DRUGN and DRUGA are used together , the signs of atropinization ( flushing , mydriasis , tachycardia , dryness of the mouth and nose ) may occur earlier than might be expected when DRUGB is used alone .
pralidoxime	drug	atropine	drug
false

This is especially true if the total dose of DRUGA has been large and the administration of DRUGB has been delayed .
atropine	drug	pralidoxime	drug
false

DRUGA , DRUGB , DRUGN , DRUGN , DRUGN , and DRUGN should be avoided in patients with organophosphate poisoning .
morphine	drug	theophylline	drug
false

DRUGA , DRUGN , DRUGB , DRUGN , DRUGN , and DRUGN should be avoided in patients with organophosphate poisoning .
morphine	drug	aminophylline	drug
false

DRUGA , DRUGN , DRUGN , DRUGB , DRUGN , and DRUGN should be avoided in patients with organophosphate poisoning .
morphine	drug	succinylcholine	drug
false

DRUGA , DRUGN , DRUGN , DRUGN , DRUGB , and DRUGN should be avoided in patients with organophosphate poisoning .
morphine	drug	reserpine	drug
false

DRUGA , DRUGN , DRUGN , DRUGN , DRUGN , and DRUGB should be avoided in patients with organophosphate poisoning .
morphine	drug	phenothiazine-type tranquilizers	group
false

DRUGN , DRUGA , DRUGB , DRUGN , DRUGN , and DRUGN should be avoided in patients with organophosphate poisoning .
theophylline	drug	aminophylline	drug
false

DRUGN , DRUGA , DRUGN , DRUGB , DRUGN , and DRUGN should be avoided in patients with organophosphate poisoning .
theophylline	drug	succinylcholine	drug
false

DRUGN , DRUGA , DRUGN , DRUGN , DRUGB , and DRUGN should be avoided in patients with organophosphate poisoning .
theophylline	drug	reserpine	drug
false

DRUGN , DRUGA , DRUGN , DRUGN , DRUGN , and DRUGB should be avoided in patients with organophosphate poisoning .
theophylline	drug	phenothiazine-type tranquilizers	group
false

DRUGN , DRUGN , DRUGA , DRUGB , DRUGN , and DRUGN should be avoided in patients with organophosphate poisoning .
aminophylline	drug	succinylcholine	drug
false

DRUGN , DRUGN , DRUGA , DRUGN , DRUGB , and DRUGN should be avoided in patients with organophosphate poisoning .
aminophylline	drug	reserpine	drug
false

DRUGN , DRUGN , DRUGA , DRUGN , DRUGN , and DRUGB should be avoided in patients with organophosphate poisoning .
aminophylline	drug	phenothiazine-type tranquilizers	group
false

DRUGN , DRUGN , DRUGN , DRUGA , DRUGB , and DRUGN should be avoided in patients with organophosphate poisoning .
succinylcholine	drug	reserpine	drug
false

DRUGN , DRUGN , DRUGN , DRUGA , DRUGN , and DRUGB should be avoided in patients with organophosphate poisoning .
succinylcholine	drug	phenothiazine-type tranquilizers	group
false

DRUGN , DRUGN , DRUGN , DRUGN , DRUGA , and DRUGB should be avoided in patients with organophosphate poisoning .
reserpine	drug	phenothiazine-type tranquilizers	group
false

DRUGA / DRUGB : DRUGN / DRUGN does not influence the pharmacokinetics of DRUGN in healthy volunteers ( N= dgb ) .
Carbidopa	drug	Levodopa	drug
false

DRUGA / DRUGN : DRUGN / DRUGB does not influence the pharmacokinetics of DRUGN in healthy volunteers ( N= dgb ) .
Carbidopa	drug	Levodopa	drug
false

DRUGA / DRUGN : DRUGN / DRUGN does not influence the pharmacokinetics of DRUGB in healthy volunteers ( N= dgb ) .
Carbidopa	drug	pramipexole	drug
false

DRUGN / DRUGA : DRUGB / DRUGN does not influence the pharmacokinetics of DRUGN in healthy volunteers ( N= dgb ) .
Levodopa	drug	Carbidopa	drug
false

DRUGN / DRUGA : DRUGN / DRUGN does not influence the pharmacokinetics of DRUGB in healthy volunteers ( N= dgb ) .
Levodopa	drug	pramipexole	drug
false

DRUGN / DRUGN : DRUGA / DRUGB does not influence the pharmacokinetics of DRUGN in healthy volunteers ( N= dgb ) .
Carbidopa	drug	Levodopa	drug
false

DRUGN / DRUGN : DRUGA / DRUGN does not influence the pharmacokinetics of DRUGB in healthy volunteers ( N= dgb ) .
Carbidopa	drug	pramipexole	drug
false

DRUGN / DRUGN : DRUGN / DRUGA does not influence the pharmacokinetics of DRUGB in healthy volunteers ( N= dgb ) .
Levodopa	drug	pramipexole	drug
false

DRUGA : In healthy volunteers ( N= dgb ) , DRUGB did not influence the pharmacokinetics of DRUGN .
Selegiline	drug	selegiline	drug
false

DRUGA : In healthy volunteers ( N= dgb ) , DRUGN did not influence the pharmacokinetics of DRUGB .
Selegiline	drug	pramipexole	drug
false

DRUGN : In healthy volunteers ( N= dgb ) , DRUGA did not influence the pharmacokinetics of DRUGB .
selegiline	drug	pramipexole	drug
false

DRUGA : Population pharmacokinetic analysis suggests that DRUGB is unlikely to alter the oral clearance of DRUGN ( N= dgb ) .
Amantadine	drug	amantadine	drug
false

DRUGA : Population pharmacokinetic analysis suggests that DRUGN is unlikely to alter the oral clearance of DRUGB ( N= dgb ) .
Amantadine	drug	pramipexole	drug
false

DRUGN : Population pharmacokinetic analysis suggests that DRUGA is unlikely to alter the oral clearance of DRUGB ( N= dgb ) .
amantadine	drug	pramipexole	drug
false

DRUGA : DRUGN , a known inhibitor of renal tubular secretion of organic acids via the aruonic transporter , did not noticeably influence DRUGB pharmacokinetics ( N= dgb ) .
Probenecid	drug	pramipexole	drug
false

DRUGN : DRUGA , a known inhibitor of renal tubular secretion of organic acids via the aruonic transporter , did not noticeably influence DRUGB pharmacokinetics ( N= dgb ) .
Probenecid	drug	pramipexole	drug
false

DRUGA : Since DRUGB is a DRUGN , it is possible that DRUGN , such as the DRUGN ( DRUGN , DRUGN , DRUGN ) or DRUGN , may diminish the effectiveness of DRUGN .
Dopamine antagonists	group	pramipexole	drug
false

DRUGA : Since DRUGN is a DRUGB , it is possible that DRUGN , such as the DRUGN ( DRUGN , DRUGN , DRUGN ) or DRUGN , may diminish the effectiveness of DRUGN .
Dopamine antagonists	group	dopamine agonist	group
false

DRUGA : Since DRUGN is a DRUGN , it is possible that DRUGB , such as the DRUGN ( DRUGN , DRUGN , DRUGN ) or DRUGN , may diminish the effectiveness of DRUGN .
Dopamine antagonists	group	dopamine antagonists	group
false

DRUGA : Since DRUGN is a DRUGN , it is possible that DRUGN , such as the DRUGB ( DRUGN , DRUGN , DRUGN ) or DRUGN , may diminish the effectiveness of DRUGN .
Dopamine antagonists	group	neuroleptics	group
false

DRUGA : Since DRUGN is a DRUGN , it is possible that DRUGN , such as the DRUGN ( DRUGB , DRUGN , DRUGN ) or DRUGN , may diminish the effectiveness of DRUGN .
Dopamine antagonists	group	phenothiazines	group
false

DRUGA : Since DRUGN is a DRUGN , it is possible that DRUGN , such as the DRUGN ( DRUGN , DRUGB , DRUGN ) or DRUGN , may diminish the effectiveness of DRUGN .
Dopamine antagonists	group	butyrophenones	group
false

DRUGA : Since DRUGN is a DRUGN , it is possible that DRUGN , such as the DRUGN ( DRUGN , DRUGN , DRUGB ) or DRUGN , may diminish the effectiveness of DRUGN .
Dopamine antagonists	group	thioxanthenes	group
false

DRUGA : Since DRUGN is a DRUGN , it is possible that DRUGN , such as the DRUGN ( DRUGN , DRUGN , DRUGN ) or DRUGB , may diminish the effectiveness of DRUGN .
Dopamine antagonists	group	metoclopramide	group
false

DRUGA : Since DRUGN is a DRUGN , it is possible that DRUGN , such as the DRUGN ( DRUGN , DRUGN , DRUGN ) or DRUGN , may diminish the effectiveness of DRUGB .
Dopamine antagonists	group	MIRAPEX	brand
false

DRUGN : Since DRUGA is a DRUGB , it is possible that DRUGN , such as the DRUGN ( DRUGN , DRUGN , DRUGN ) or DRUGN , may diminish the effectiveness of DRUGN .
pramipexole	drug	dopamine agonist	group
false

DRUGN : Since DRUGA is a DRUGN , it is possible that DRUGB , such as the DRUGN ( DRUGN , DRUGN , DRUGN ) or DRUGN , may diminish the effectiveness of DRUGN .
pramipexole	drug	dopamine antagonists	group
false

DRUGN : Since DRUGA is a DRUGN , it is possible that DRUGN , such as the DRUGB ( DRUGN , DRUGN , DRUGN ) or DRUGN , may diminish the effectiveness of DRUGN .
pramipexole	drug	neuroleptics	group
false

DRUGN : Since DRUGA is a DRUGN , it is possible that DRUGN , such as the DRUGN ( DRUGB , DRUGN , DRUGN ) or DRUGN , may diminish the effectiveness of DRUGN .
pramipexole	drug	phenothiazines	group
false

DRUGN : Since DRUGA is a DRUGN , it is possible that DRUGN , such as the DRUGN ( DRUGN , DRUGB , DRUGN ) or DRUGN , may diminish the effectiveness of DRUGN .
pramipexole	drug	butyrophenones	group
false

DRUGN : Since DRUGA is a DRUGN , it is possible that DRUGN , such as the DRUGN ( DRUGN , DRUGN , DRUGB ) or DRUGN , may diminish the effectiveness of DRUGN .
pramipexole	drug	thioxanthenes	group
false

DRUGN : Since DRUGA is a DRUGN , it is possible that DRUGN , such as the DRUGN ( DRUGN , DRUGN , DRUGN ) or DRUGB , may diminish the effectiveness of DRUGN .
pramipexole	drug	metoclopramide	group
false

DRUGN : Since DRUGA is a DRUGN , it is possible that DRUGN , such as the DRUGN ( DRUGN , DRUGN , DRUGN ) or DRUGN , may diminish the effectiveness of DRUGB .
pramipexole	drug	MIRAPEX	brand
false

DRUGN : Since DRUGN is a DRUGA , it is possible that DRUGB , such as the DRUGN ( DRUGN , DRUGN , DRUGN ) or DRUGN , may diminish the effectiveness of DRUGN .
dopamine agonist	group	dopamine antagonists	group
false

DRUGN : Since DRUGN is a DRUGA , it is possible that DRUGN , such as the DRUGB ( DRUGN , DRUGN , DRUGN ) or DRUGN , may diminish the effectiveness of DRUGN .
dopamine agonist	group	neuroleptics	group
false

DRUGN : Since DRUGN is a DRUGA , it is possible that DRUGN , such as the DRUGN ( DRUGB , DRUGN , DRUGN ) or DRUGN , may diminish the effectiveness of DRUGN .
dopamine agonist	group	phenothiazines	group
false

DRUGN : Since DRUGN is a DRUGA , it is possible that DRUGN , such as the DRUGN ( DRUGN , DRUGB , DRUGN ) or DRUGN , may diminish the effectiveness of DRUGN .
dopamine agonist	group	butyrophenones	group
false

DRUGN : Since DRUGN is a DRUGA , it is possible that DRUGN , such as the DRUGN ( DRUGN , DRUGN , DRUGB ) or DRUGN , may diminish the effectiveness of DRUGN .
dopamine agonist	group	thioxanthenes	group
false

DRUGN : Since DRUGN is a DRUGA , it is possible that DRUGN , such as the DRUGN ( DRUGN , DRUGN , DRUGN ) or DRUGB , may diminish the effectiveness of DRUGN .
dopamine agonist	group	metoclopramide	group
false

DRUGN : Since DRUGN is a DRUGA , it is possible that DRUGN , such as the DRUGN ( DRUGN , DRUGN , DRUGN ) or DRUGN , may diminish the effectiveness of DRUGB .
dopamine agonist	group	MIRAPEX	brand
false

DRUGN : Since DRUGN is a DRUGN , it is possible that DRUGA , such as the DRUGB ( DRUGN , DRUGN , DRUGN ) or DRUGN , may diminish the effectiveness of DRUGN .
dopamine antagonists	group	neuroleptics	group
false

DRUGN : Since DRUGN is a DRUGN , it is possible that DRUGA , such as the DRUGN ( DRUGB , DRUGN , DRUGN ) or DRUGN , may diminish the effectiveness of DRUGN .
dopamine antagonists	group	phenothiazines	group
false

DRUGN : Since DRUGN is a DRUGN , it is possible that DRUGA , such as the DRUGN ( DRUGN , DRUGB , DRUGN ) or DRUGN , may diminish the effectiveness of DRUGN .
dopamine antagonists	group	butyrophenones	group
false

DRUGN : Since DRUGN is a DRUGN , it is possible that DRUGA , such as the DRUGN ( DRUGN , DRUGN , DRUGB ) or DRUGN , may diminish the effectiveness of DRUGN .
dopamine antagonists	group	thioxanthenes	group
false

DRUGN : Since DRUGN is a DRUGN , it is possible that DRUGA , such as the DRUGN ( DRUGN , DRUGN , DRUGN ) or DRUGB , may diminish the effectiveness of DRUGN .
dopamine antagonists	group	metoclopramide	group
false

DRUGN : Since DRUGN is a DRUGN , it is possible that DRUGA , such as the DRUGN ( DRUGN , DRUGN , DRUGN ) or DRUGN , may diminish the effectiveness of DRUGB .
dopamine antagonists	group	MIRAPEX	brand
effect

DRUGN : Since DRUGN is a DRUGN , it is possible that DRUGN , such as the DRUGA ( DRUGB , DRUGN , DRUGN ) or DRUGN , may diminish the effectiveness of DRUGN .
neuroleptics	group	phenothiazines	group
false

DRUGN : Since DRUGN is a DRUGN , it is possible that DRUGN , such as the DRUGA ( DRUGN , DRUGB , DRUGN ) or DRUGN , may diminish the effectiveness of DRUGN .
neuroleptics	group	butyrophenones	group
false

DRUGN : Since DRUGN is a DRUGN , it is possible that DRUGN , such as the DRUGA ( DRUGN , DRUGN , DRUGB ) or DRUGN , may diminish the effectiveness of DRUGN .
neuroleptics	group	thioxanthenes	group
false

DRUGN : Since DRUGN is a DRUGN , it is possible that DRUGN , such as the DRUGA ( DRUGN , DRUGN , DRUGN ) or DRUGB , may diminish the effectiveness of DRUGN .
neuroleptics	group	metoclopramide	group
false

DRUGN : Since DRUGN is a DRUGN , it is possible that DRUGN , such as the DRUGA ( DRUGN , DRUGN , DRUGN ) or DRUGN , may diminish the effectiveness of DRUGB .
neuroleptics	group	MIRAPEX	brand
effect

DRUGN : Since DRUGN is a DRUGN , it is possible that DRUGN , such as the DRUGN ( DRUGA , DRUGB , DRUGN ) or DRUGN , may diminish the effectiveness of DRUGN .
phenothiazines	group	butyrophenones	group
false

DRUGN : Since DRUGN is a DRUGN , it is possible that DRUGN , such as the DRUGN ( DRUGA , DRUGN , DRUGB ) or DRUGN , may diminish the effectiveness of DRUGN .
phenothiazines	group	thioxanthenes	group
false

DRUGN : Since DRUGN is a DRUGN , it is possible that DRUGN , such as the DRUGN ( DRUGA , DRUGN , DRUGN ) or DRUGB , may diminish the effectiveness of DRUGN .
phenothiazines	group	metoclopramide	group
false

DRUGN : Since DRUGN is a DRUGN , it is possible that DRUGN , such as the DRUGN ( DRUGA , DRUGN , DRUGN ) or DRUGN , may diminish the effectiveness of DRUGB .
phenothiazines	group	MIRAPEX	brand
effect

DRUGN : Since DRUGN is a DRUGN , it is possible that DRUGN , such as the DRUGN ( DRUGN , DRUGA , DRUGB ) or DRUGN , may diminish the effectiveness of DRUGN .
butyrophenones	group	thioxanthenes	group
false

DRUGN : Since DRUGN is a DRUGN , it is possible that DRUGN , such as the DRUGN ( DRUGN , DRUGA , DRUGN ) or DRUGB , may diminish the effectiveness of DRUGN .
butyrophenones	group	metoclopramide	group
false

DRUGN : Since DRUGN is a DRUGN , it is possible that DRUGN , such as the DRUGN ( DRUGN , DRUGA , DRUGN ) or DRUGN , may diminish the effectiveness of DRUGB .
butyrophenones	group	MIRAPEX	brand
effect

DRUGN : Since DRUGN is a DRUGN , it is possible that DRUGN , such as the DRUGN ( DRUGN , DRUGN , DRUGA ) or DRUGB , may diminish the effectiveness of DRUGN .
thioxanthenes	group	metoclopramide	group
false

DRUGN : Since DRUGN is a DRUGN , it is possible that DRUGN , such as the DRUGN ( DRUGN , DRUGN , DRUGA ) or DRUGN , may diminish the effectiveness of DRUGB .
thioxanthenes	group	MIRAPEX	brand
effect

DRUGN : Since DRUGN is a DRUGN , it is possible that DRUGN , such as the DRUGN ( DRUGN , DRUGN , DRUGN ) or DRUGA , may diminish the effectiveness of DRUGB .
metoclopramide	group	MIRAPEX	brand
effect

When the rapid onset of a concomitant orally administered agent is a critical determinant of effectiveness ( such as DRUGA ) , the agent should be administered at least dgb hour prior to or dgb hours after DRUGB injection .
analgesics	group	SYMLIN	brand
advise

In clinical trials , the concomitant use of DRUGA or DRUGB did not alter the adverse event profile of DRUGN .
sulfonylureas	group	biguanides	group
false

In clinical trials , the concomitant use of DRUGA or DRUGN did not alter the adverse event profile of DRUGB .
sulfonylureas	group	SYMLIN	brand
false

In clinical trials , the concomitant use of DRUGN or DRUGA did not alter the adverse event profile of DRUGB .
biguanides	group	SYMLIN	brand
false

No formal interaction studies have been performed to assess the effect of DRUGA on the kinetics of oral DRUGB .
SYMLIN	brand	antidiabetic agents	group
false

Mixing DRUGA and DRUGB The pharmacokinetic parameters of DRUGN were altered when mixed with regular , NPH , and dgb / dgb premixed formulations of recombinant DRUGN immediately prior to injection .
SYMLIN	brand	Insulin	drug
false

Mixing DRUGA and DRUGN The pharmacokinetic parameters of DRUGN were altered when mixed with regular , NPH , and dgb / dgb premixed formulations of recombinant DRUGB immediately prior to injection .
SYMLIN	brand	human insulin	drug
false

Mixing DRUGN and DRUGA The pharmacokinetic parameters of DRUGB were altered when mixed with regular , NPH , and dgb / dgb premixed formulations of recombinant DRUGN immediately prior to injection .
Insulin	drug	SYMLIN	brand
false

Mixing DRUGN and DRUGA The pharmacokinetic parameters of DRUGN were altered when mixed with regular , NPH , and dgb / dgb premixed formulations of recombinant DRUGB immediately prior to injection .
Insulin	drug	human insulin	drug
false

Mixing DRUGN and DRUGN The pharmacokinetic parameters of DRUGA were altered when mixed with regular , NPH , and dgb / dgb premixed formulations of recombinant DRUGB immediately prior to injection .
SYMLIN	brand	human insulin	drug
mechanism

Thus , DRUGA and DRUGB should not be mixed and must be administered separately .
SYMLIN	brand	insulin	drug
false

Drugs that induce hepatic enzymes such as DRUGA , DRUGB and DRUGN may increase the clearance of DRUGN and may require increases in DRUGN dose to achieve the desired response .
phenobarbital	drug	phenytoin	drug
false

Drugs that induce hepatic enzymes such as DRUGA , DRUGN and DRUGB may increase the clearance of DRUGN and may require increases in DRUGN dose to achieve the desired response .
phenobarbital	drug	rifampin	drug
false

Drugs that induce hepatic enzymes such as DRUGA , DRUGN and DRUGN may increase the clearance of DRUGB and may require increases in DRUGN dose to achieve the desired response .
phenobarbital	drug	corticosteroids	group
mechanism

Drugs that induce hepatic enzymes such as DRUGA , DRUGN and DRUGN may increase the clearance of DRUGN and may require increases in DRUGB dose to achieve the desired response .
phenobarbital	drug	corticosteroid	group
mechanism

Drugs that induce hepatic enzymes such as DRUGN , DRUGA and DRUGB may increase the clearance of DRUGN and may require increases in DRUGN dose to achieve the desired response .
phenytoin	drug	rifampin	drug
false

Drugs that induce hepatic enzymes such as DRUGN , DRUGA and DRUGN may increase the clearance of DRUGB and may require increases in DRUGN dose to achieve the desired response .
phenytoin	drug	corticosteroids	group
mechanism

Drugs that induce hepatic enzymes such as DRUGN , DRUGA and DRUGN may increase the clearance of DRUGN and may require increases in DRUGB dose to achieve the desired response .
phenytoin	drug	corticosteroid	group
mechanism

Drugs that induce hepatic enzymes such as DRUGN , DRUGN and DRUGA may increase the clearance of DRUGB and may require increases in DRUGN dose to achieve the desired response .
rifampin	drug	corticosteroids	group
mechanism

Drugs that induce hepatic enzymes such as DRUGN , DRUGN and DRUGA may increase the clearance of DRUGN and may require increases in DRUGB dose to achieve the desired response .
rifampin	drug	corticosteroid	group
mechanism

Drugs that induce hepatic enzymes such as DRUGN , DRUGN and DRUGN may increase the clearance of DRUGA and may require increases in DRUGB dose to achieve the desired response .
corticosteroids	group	corticosteroid	group
false

Drugs such as DRUGA and DRUGB may inhibit the metabolism of DRUGN and thus decrease their clearance .
troleandomycin	drug	ketoconazole	drug
false

Drugs such as DRUGA and DRUGN may inhibit the metabolism of DRUGB and thus decrease their clearance .
troleandomycin	drug	corticosteroids	group
mechanism

Drugs such as DRUGN and DRUGA may inhibit the metabolism of DRUGB and thus decrease their clearance .
ketoconazole	drug	corticosteroids	group
mechanism

DRUGA may increase the clearance of chronic high dose DRUGB .
Corticosteroids	group	aspirin	brand
mechanism

This could lead to decreased DRUGA serum levels or increase the risk of DRUGN toxicity when DRUGB is withdrawn .
salicylate	group	corticosteroid	group
false

This could lead to decreased DRUGN serum levels or increase the risk of DRUGA toxicity when DRUGB is withdrawn .
salicylate	group	corticosteroid	group
effect

DRUGA should be used cautiously in conjunction with DRUGB in patients suffering from hypoprothrombinemia .
Aspirin	brand	corticosteroids	group
advise

The effect of DRUGA on oral DRUGB is variable .
corticosteroids	group	anticoagulants	group
effect

There are reports of enhanced as well as diminished effects of DRUGA when given concurrently with DRUGB .
anticoagulants	group	corticosteroids	group
effect

DRUGA : Concurrent use of DRUGB and DRUGN may result in increased systemic toxicity since DRUGN inhibit the breakdown of DRUGN .
Anticholinesterases	group	procaine hydrochloride	drug
false

DRUGA : Concurrent use of DRUGN and DRUGB may result in increased systemic toxicity since DRUGN inhibit the breakdown of DRUGN .
Anticholinesterases	group	anticholinesterase agents	group
false

DRUGA : Concurrent use of DRUGN and DRUGN may result in increased systemic toxicity since DRUGB inhibit the breakdown of DRUGN .
Anticholinesterases	group	anticholinesterases	group
false

DRUGA : Concurrent use of DRUGN and DRUGN may result in increased systemic toxicity since DRUGN inhibit the breakdown of DRUGB .
Anticholinesterases	group	procaine hydrochloride	drug
false

DRUGN : Concurrent use of DRUGA and DRUGB may result in increased systemic toxicity since DRUGN inhibit the breakdown of DRUGN .
procaine hydrochloride	drug	anticholinesterase agents	group
effect

DRUGN : Concurrent use of DRUGA and DRUGN may result in increased systemic toxicity since DRUGB inhibit the breakdown of DRUGN .
procaine hydrochloride	drug	anticholinesterases	group
false

DRUGN : Concurrent use of DRUGN and DRUGA may result in increased systemic toxicity since DRUGB inhibit the breakdown of DRUGN .
anticholinesterase agents	group	anticholinesterases	group
false

DRUGN : Concurrent use of DRUGN and DRUGA may result in increased systemic toxicity since DRUGN inhibit the breakdown of DRUGB .
anticholinesterase agents	group	procaine hydrochloride	drug
false

DRUGN : Concurrent use of DRUGN and DRUGN may result in increased systemic toxicity since DRUGA inhibit the breakdown of DRUGB .
anticholinesterases	group	procaine hydrochloride	drug
mechanism

DRUGA medications : Concurrent use of DRUGB and DRUGN may result in additive depressant effects .
CNS depressant	group	procaine hydrochloride	drug
false

DRUGA medications : Concurrent use of DRUGN and DRUGB may result in additive depressant effects .
CNS depressant	group	CNS depressant medications	group
false

DRUGN medications : Concurrent use of DRUGA and DRUGB may result in additive depressant effects .
procaine hydrochloride	drug	CNS depressant medications	group
effect

DRUGA : DRUGN may increase the diffusion rate of DRUGB , resulting in a decreased time of onset , but an increase in systemic toxicity .
Hyaluronidase	drug	procaine hydrochloride	drug
false

DRUGN : DRUGA may increase the diffusion rate of DRUGB , resulting in a decreased time of onset , but an increase in systemic toxicity .
Hyaluronidase	drug	procaine hydrochloride	drug
mechanism

DRUGA ( such as DRUGB ) : Concurrent use of DRUGN and DRUGN may result in prolongation or enhancement of the neuromuscular blockade .
Neuromuscular blocking agents	group	suxamethonium chloride	drug
false

DRUGA ( such as DRUGN ) : Concurrent use of DRUGB and DRUGN may result in prolongation or enhancement of the neuromuscular blockade .
Neuromuscular blocking agents	group	procaine hydrochloride	drug
false

DRUGA ( such as DRUGN ) : Concurrent use of DRUGN and DRUGB may result in prolongation or enhancement of the neuromuscular blockade .
Neuromuscular blocking agents	group	neuromuscular blocking agents	group
false

DRUGN ( such as DRUGA ) : Concurrent use of DRUGB and DRUGN may result in prolongation or enhancement of the neuromuscular blockade .
suxamethonium chloride	drug	procaine hydrochloride	drug
false

DRUGN ( such as DRUGA ) : Concurrent use of DRUGN and DRUGB may result in prolongation or enhancement of the neuromuscular blockade .
suxamethonium chloride	drug	neuromuscular blocking agents	group
false

DRUGN ( such as DRUGN ) : Concurrent use of DRUGA and DRUGB may result in prolongation or enhancement of the neuromuscular blockade .
procaine hydrochloride	drug	neuromuscular blocking agents	group
effect

DRUGA : Concurrent use of DRUGB and DRUGN may result in a reduction of the antibacterial action of the DRUGN .
Sulfonamides	group	procaine hydrochloride	drug
false

DRUGA : Concurrent use of DRUGN and DRUGB may result in a reduction of the antibacterial action of the DRUGN .
Sulfonamides	group	sulfonamides	group
false

DRUGA : Concurrent use of DRUGN and DRUGN may result in a reduction of the antibacterial action of the DRUGB .
Sulfonamides	group	sulfonamide	group
false

DRUGN : Concurrent use of DRUGA and DRUGB may result in a reduction of the antibacterial action of the DRUGN .
procaine hydrochloride	drug	sulfonamides	group
effect

DRUGN : Concurrent use of DRUGA and DRUGN may result in a reduction of the antibacterial action of the DRUGB .
procaine hydrochloride	drug	sulfonamide	group
false

DRUGN : Concurrent use of DRUGN and DRUGA may result in a reduction of the antibacterial action of the DRUGB .
sulfonamides	group	sulfonamide	group
false

DRUGA : Concurrent use of DRUGB and DRUGN may extend the plasma half life of DRUGN .
Acetazolamide	drug	acetazolamide	drug
false

DRUGA : Concurrent use of DRUGN and DRUGB may extend the plasma half life of DRUGN .
Acetazolamide	drug	procaine hydrochloride	drug
false

DRUGA : Concurrent use of DRUGN and DRUGN may extend the plasma half life of DRUGB .
Acetazolamide	drug	procaine	drug
false

DRUGN : Concurrent use of DRUGA and DRUGB may extend the plasma half life of DRUGN .
acetazolamide	drug	procaine hydrochloride	drug
mechanism

DRUGN : Concurrent use of DRUGA and DRUGN may extend the plasma half life of DRUGB .
acetazolamide	drug	procaine	drug
false

DRUGN : Concurrent use of DRUGN and DRUGA may extend the plasma half life of DRUGB .
procaine hydrochloride	drug	procaine	drug
false

To minimize CNS depression and possible potentiation , DRUGA , DRUGB , DRUGN , DRUGN or DRUGN should be used with caution .
barbiturates	group	antihistamines	group
false

To minimize CNS depression and possible potentiation , DRUGA , DRUGN , DRUGB , DRUGN or DRUGN should be used with caution .
barbiturates	group	narcotics	group
false

To minimize CNS depression and possible potentiation , DRUGA , DRUGN , DRUGN , DRUGB or DRUGN should be used with caution .
barbiturates	group	hypotensive agents	group
false

To minimize CNS depression and possible potentiation , DRUGA , DRUGN , DRUGN , DRUGN or DRUGB should be used with caution .
barbiturates	group	phenothiazines	group
false

To minimize CNS depression and possible potentiation , DRUGN , DRUGA , DRUGB , DRUGN or DRUGN should be used with caution .
antihistamines	group	narcotics	group
false

To minimize CNS depression and possible potentiation , DRUGN , DRUGA , DRUGN , DRUGB or DRUGN should be used with caution .
antihistamines	group	hypotensive agents	group
false

To minimize CNS depression and possible potentiation , DRUGN , DRUGA , DRUGN , DRUGN or DRUGB should be used with caution .
antihistamines	group	phenothiazines	group
false

To minimize CNS depression and possible potentiation , DRUGN , DRUGN , DRUGA , DRUGB or DRUGN should be used with caution .
narcotics	group	hypotensive agents	group
false

To minimize CNS depression and possible potentiation , DRUGN , DRUGN , DRUGA , DRUGN or DRUGB should be used with caution .
narcotics	group	phenothiazines	group
false

To minimize CNS depression and possible potentiation , DRUGN , DRUGN , DRUGN , DRUGA or DRUGB should be used with caution .
hypotensive agents	group	phenothiazines	group
false

No cross resistance with other DRUGA , radiotherapy or DRUGB has been demonstrated .
chemotherapeutic agents	group	steroids	group
false

DRUGA may accentuate the orthostatic hypotension that may occur with DRUGB .
Thiazide diuretics	group	phenothiazines	group
effect

Antihypertensive effects of DRUGA and related compounds may be counteracted when DRUGB are used concomitantly .
guanethidine	drug	phenothiazines	group
effect

Concomitant administration of DRUGA with DRUGB results in increased plasma levels of both drugs .
propranolol	drug	phenothiazines	group
mechanism

The induction dose requirements of DRUGA Injectable Emulsion may be reduced in patients with intramuscular or intravenous premedication , particularly with DRUGB ( eg , DRUGN , DRUGN , and DRUGN , etc . )
DIPRIVAN	brand	narcotics	group
effect

The induction dose requirements of DRUGA Injectable Emulsion may be reduced in patients with intramuscular or intravenous premedication , particularly with DRUGN ( eg , DRUGB , DRUGN , and DRUGN , etc . )
DIPRIVAN	brand	morphine	drug
effect

The induction dose requirements of DRUGA Injectable Emulsion may be reduced in patients with intramuscular or intravenous premedication , particularly with DRUGN ( eg , DRUGN , DRUGB , and DRUGN , etc . )
DIPRIVAN	brand	meperidine	drug
effect

The induction dose requirements of DRUGA Injectable Emulsion may be reduced in patients with intramuscular or intravenous premedication , particularly with DRUGN ( eg , DRUGN , DRUGN , and DRUGB , etc . )
DIPRIVAN	brand	fentanyl	drug
effect

The induction dose requirements of DRUGN Injectable Emulsion may be reduced in patients with intramuscular or intravenous premedication , particularly with DRUGA ( eg , DRUGB , DRUGN , and DRUGN , etc . )
narcotics	group	morphine	drug
false

The induction dose requirements of DRUGN Injectable Emulsion may be reduced in patients with intramuscular or intravenous premedication , particularly with DRUGA ( eg , DRUGN , DRUGB , and DRUGN , etc . )
narcotics	group	meperidine	drug
false

The induction dose requirements of DRUGN Injectable Emulsion may be reduced in patients with intramuscular or intravenous premedication , particularly with DRUGA ( eg , DRUGN , DRUGN , and DRUGB , etc . )
narcotics	group	fentanyl	drug
false

The induction dose requirements of DRUGN Injectable Emulsion may be reduced in patients with intramuscular or intravenous premedication , particularly with DRUGN ( eg , DRUGA , DRUGB , and DRUGN , etc . )
morphine	drug	meperidine	drug
false

The induction dose requirements of DRUGN Injectable Emulsion may be reduced in patients with intramuscular or intravenous premedication , particularly with DRUGN ( eg , DRUGA , DRUGN , and DRUGB , etc . )
morphine	drug	fentanyl	drug
false

The induction dose requirements of DRUGN Injectable Emulsion may be reduced in patients with intramuscular or intravenous premedication , particularly with DRUGN ( eg , DRUGN , DRUGA , and DRUGB , etc . )
meperidine	drug	fentanyl	drug
false

and combinations of DRUGA and DRUGB ( eg , DRUGN , DRUGN , DRUGN , DRUGN , etc . ) .
opioids	group	sedatives	group
false

and combinations of DRUGA and DRUGN ( eg , DRUGB , DRUGN , DRUGN , DRUGN , etc . ) .
opioids	group	benzodiazepines	group
false

and combinations of DRUGA and DRUGN ( eg , DRUGN , DRUGB , DRUGN , DRUGN , etc . ) .
opioids	group	barbiturates	group
false

and combinations of DRUGA and DRUGN ( eg , DRUGN , DRUGN , DRUGB , DRUGN , etc . ) .
opioids	group	chloral hydrate	drug
false

and combinations of DRUGA and DRUGN ( eg , DRUGN , DRUGN , DRUGN , DRUGB , etc . ) .
opioids	group	droperidol	drug
false

and combinations of DRUGN and DRUGA ( eg , DRUGB , DRUGN , DRUGN , DRUGN , etc . ) .
sedatives	group	benzodiazepines	group
false

and combinations of DRUGN and DRUGA ( eg , DRUGN , DRUGB , DRUGN , DRUGN , etc . ) .
sedatives	group	barbiturates	group
false

and combinations of DRUGN and DRUGA ( eg , DRUGN , DRUGN , DRUGB , DRUGN , etc . ) .
sedatives	group	chloral hydrate	drug
false

and combinations of DRUGN and DRUGA ( eg , DRUGN , DRUGN , DRUGN , DRUGB , etc . ) .
sedatives	group	droperidol	drug
false

and combinations of DRUGN and DRUGN ( eg , DRUGA , DRUGB , DRUGN , DRUGN , etc . ) .
benzodiazepines	group	barbiturates	group
false

and combinations of DRUGN and DRUGN ( eg , DRUGA , DRUGN , DRUGB , DRUGN , etc . ) .
benzodiazepines	group	chloral hydrate	drug
false

and combinations of DRUGN and DRUGN ( eg , DRUGA , DRUGN , DRUGN , DRUGB , etc . ) .
benzodiazepines	group	droperidol	drug
false

and combinations of DRUGN and DRUGN ( eg , DRUGN , DRUGA , DRUGB , DRUGN , etc . ) .
barbiturates	group	chloral hydrate	drug
false

and combinations of DRUGN and DRUGN ( eg , DRUGN , DRUGA , DRUGN , DRUGB , etc . ) .
barbiturates	group	droperidol	drug
false

and combinations of DRUGN and DRUGN ( eg , DRUGN , DRUGN , DRUGA , DRUGB , etc . ) .
chloral hydrate	drug	droperidol	drug
false

The concurrent administration of potent inhalational agents ( eg , DRUGA , DRUGB , and DRUGN ) during maintenance with DRUGN Injectable Emulsion has not been extensively evaluated .
isoflurane	drug	enflurane	drug
false

The concurrent administration of potent inhalational agents ( eg , DRUGA , DRUGN , and DRUGB ) during maintenance with DRUGN Injectable Emulsion has not been extensively evaluated .
isoflurane	drug	halothane	drug
false

The concurrent administration of potent inhalational agents ( eg , DRUGA , DRUGN , and DRUGN ) during maintenance with DRUGB Injectable Emulsion has not been extensively evaluated .
isoflurane	drug	DIPRIVAN	brand
false

The concurrent administration of potent inhalational agents ( eg , DRUGN , DRUGA , and DRUGB ) during maintenance with DRUGN Injectable Emulsion has not been extensively evaluated .
enflurane	drug	halothane	drug
false

The concurrent administration of potent inhalational agents ( eg , DRUGN , DRUGA , and DRUGN ) during maintenance with DRUGB Injectable Emulsion has not been extensively evaluated .
enflurane	drug	DIPRIVAN	brand
false

The concurrent administration of potent inhalational agents ( eg , DRUGN , DRUGN , and DRUGA ) during maintenance with DRUGB Injectable Emulsion has not been extensively evaluated .
halothane	drug	DIPRIVAN	brand
false

DRUGA Injectable Emulsion does not cause a clinically significant change in onset , intensity , or duration of action of the commonly used DRUGB ( eg , DRUGN and DRUGN ) .
DIPRIVAN	brand	neuromuscular blocking agents	group
false

DRUGA Injectable Emulsion does not cause a clinically significant change in onset , intensity , or duration of action of the commonly used DRUGN ( eg , DRUGB and DRUGN ) .
DIPRIVAN	brand	succinylcholine	drug
false

DRUGA Injectable Emulsion does not cause a clinically significant change in onset , intensity , or duration of action of the commonly used DRUGN ( eg , DRUGN and DRUGB ) .
DIPRIVAN	brand	nondepolarizing muscle relaxants	group
false

DRUGN Injectable Emulsion does not cause a clinically significant change in onset , intensity , or duration of action of the commonly used DRUGA ( eg , DRUGB and DRUGN ) .
neuromuscular blocking agents	group	succinylcholine	drug
false

DRUGN Injectable Emulsion does not cause a clinically significant change in onset , intensity , or duration of action of the commonly used DRUGA ( eg , DRUGN and DRUGB ) .
neuromuscular blocking agents	group	nondepolarizing muscle relaxants	group
false

DRUGN Injectable Emulsion does not cause a clinically significant change in onset , intensity , or duration of action of the commonly used DRUGN ( eg , DRUGA and DRUGB ) .
succinylcholine	drug	nondepolarizing muscle relaxants	group
false

No significant adverse interactions with commonly used premedications or drugs used during anesthesia or sedation ( including a range of DRUGA , inhalational agents , DRUGB , and local DRUGN ) have been observed .
muscle relaxants	group	analgesic agents	group
false

No significant adverse interactions with commonly used premedications or drugs used during anesthesia or sedation ( including a range of DRUGA , inhalational agents , DRUGN , and local DRUGB ) have been observed .
muscle relaxants	group	anesthetic agents	group
false

No significant adverse interactions with commonly used premedications or drugs used during anesthesia or sedation ( including a range of DRUGN , inhalational agents , DRUGA , and local DRUGB ) have been observed .
analgesic agents	group	anesthetic agents	group
false

The CNS depressant effect of DRUGA is additive with that of other DRUGB , including DRUGN .
propoxyphene	drug	CNS depressants	group
effect

The CNS depressant effect of DRUGA is additive with that of other DRUGN , including DRUGB .
propoxyphene	drug	alcohol	drug
effect

The CNS depressant effect of DRUGN is additive with that of other DRUGA , including DRUGB .
CNS depressants	group	alcohol	drug
false

Such occurrences have been reported when DRUGA was administered to patients on DRUGB , DRUGN , or DRUGN like drugs .
propoxyphene	drug	antidepressants	group
false

Such occurrences have been reported when DRUGA was administered to patients on DRUGN , DRUGB , or DRUGN like drugs .
propoxyphene	drug	anticonvulsants	group
false

Such occurrences have been reported when DRUGA was administered to patients on DRUGN , DRUGN , or DRUGB like drugs .
propoxyphene	drug	warfarin	drug
false

Such occurrences have been reported when DRUGN was administered to patients on DRUGA , DRUGB , or DRUGN like drugs .
antidepressants	group	anticonvulsants	group
false

Such occurrences have been reported when DRUGN was administered to patients on DRUGA , DRUGN , or DRUGB like drugs .
antidepressants	group	warfarin	drug
false

Such occurrences have been reported when DRUGN was administered to patients on DRUGN , DRUGA , or DRUGB like drugs .
anticonvulsants	group	warfarin	drug
false

DRUGA and DRUGB increase the effects of DRUGN .
MAO inhibitors	group	beta adrenergic blockers	group
false

DRUGA and DRUGN increase the effects of DRUGB .
MAO inhibitors	group	pseudoephedrine	drug
effect

DRUGN and DRUGA increase the effects of DRUGB .
beta adrenergic blockers	group	pseudoephedrine	drug
effect

DRUGA may reduce the antihypertensive effects of DRUGB , DRUGN , DRUGN and DRUGN .
Sympathomimetics	group	methyldopa	drug
effect

DRUGA may reduce the antihypertensive effects of DRUGN , DRUGB , DRUGN and DRUGN .
Sympathomimetics	group	mecamylamine	drug
effect

DRUGA may reduce the antihypertensive effects of DRUGN , DRUGN , DRUGB and DRUGN .
Sympathomimetics	group	reserpine	drug
effect

DRUGA may reduce the antihypertensive effects of DRUGN , DRUGN , DRUGN and DRUGB .
Sympathomimetics	group	veratrum alkaloids	group
effect

DRUGN may reduce the antihypertensive effects of DRUGA , DRUGB , DRUGN and DRUGN .
methyldopa	drug	mecamylamine	drug
false

DRUGN may reduce the antihypertensive effects of DRUGA , DRUGN , DRUGB and DRUGN .
methyldopa	drug	reserpine	drug
false

DRUGN may reduce the antihypertensive effects of DRUGA , DRUGN , DRUGN and DRUGB .
methyldopa	drug	veratrum alkaloids	group
false

DRUGN may reduce the antihypertensive effects of DRUGN , DRUGA , DRUGB and DRUGN .
mecamylamine	drug	reserpine	drug
false

DRUGN may reduce the antihypertensive effects of DRUGN , DRUGA , DRUGN and DRUGB .
mecamylamine	drug	veratrum alkaloids	group
false

DRUGN may reduce the antihypertensive effects of DRUGN , DRUGN , DRUGA and DRUGB .
reserpine	drug	veratrum alkaloids	group
false

DRUGA may be used with DRUGB , DRUGN and other DRUGN , and with other DRUGN .
Pyrimethamine	drug	sulfonamides	group
false

DRUGA may be used with DRUGN , DRUGB and other DRUGN , and with other DRUGN .
Pyrimethamine	drug	quinine	drug
false

DRUGA may be used with DRUGN , DRUGN and other DRUGB , and with other DRUGN .
Pyrimethamine	drug	antimalarials	group
false

DRUGA may be used with DRUGN , DRUGN and other DRUGN , and with other DRUGB .
Pyrimethamine	drug	antibiotics	group
false

DRUGN may be used with DRUGA , DRUGB and other DRUGN , and with other DRUGN .
sulfonamides	group	quinine	drug
false

DRUGN may be used with DRUGA , DRUGN and other DRUGB , and with other DRUGN .
sulfonamides	group	antimalarials	group
false

DRUGN may be used with DRUGA , DRUGN and other DRUGN , and with other DRUGB .
sulfonamides	group	antibiotics	group
false

DRUGN may be used with DRUGN , DRUGA and other DRUGB , and with other DRUGN .
quinine	drug	antimalarials	group
false

DRUGN may be used with DRUGN , DRUGA and other DRUGN , and with other DRUGB .
quinine	drug	antibiotics	group
false

DRUGN may be used with DRUGN , DRUGN and other DRUGA , and with other DRUGB .
antimalarials	group	antibiotics	group
false

DRUGA ( DRUGB ) should be administered until normal hematopoiesis is restored .
Folinic acid	drug	leucovorin	drug
false

Mild hepatotoxicity has been reported in some patients when DRUGA and DRUGB were administered concomitantly .
lorazepam	drug	pyrimethamine	drug
effect

DRUGA : DRUGN causes a dgb % reduction in the absorption and enterohepatic cycling of DRUGB and should not be coadministered with DRUGN .
Cholestyramine	drug	raloxifene	drug
false

DRUGA : DRUGN causes a dgb % reduction in the absorption and enterohepatic cycling of DRUGN and should not be coadministered with DRUGB .
Cholestyramine	drug	EVISTA	brand
false

DRUGN : DRUGA causes a dgb % reduction in the absorption and enterohepatic cycling of DRUGB and should not be coadministered with DRUGN .
Cholestyramine	drug	raloxifene	drug
mechanism

DRUGN : DRUGA causes a dgb % reduction in the absorption and enterohepatic cycling of DRUGN and should not be coadministered with DRUGB .
Cholestyramine	drug	EVISTA	brand
advise

DRUGN : DRUGN causes a dgb % reduction in the absorption and enterohepatic cycling of DRUGA and should not be coadministered with DRUGB .
raloxifene	drug	EVISTA	brand
false

DRUGA : The coadministration of DRUGB and DRUGN has not been assessed under chronic conditions .
Warfarin	drug	EVISTA	brand
false

DRUGA : The coadministration of DRUGN and DRUGB has not been assessed under chronic conditions .
Warfarin	drug	warfarin	drug
false

DRUGN : The coadministration of DRUGA and DRUGB has not been assessed under chronic conditions .
EVISTA	brand	warfarin	drug
false

If DRUGA is given concurrently with DRUGB , prothrombin time should be monitored .
EVISTA	brand	warfarin	drug
advise

In vitro , DRUGA did not affect the binding of DRUGB , DRUGN , or DRUGN .
raloxifene	drug	warfarin	drug
false

In vitro , DRUGA did not affect the binding of DRUGN , DRUGB , or DRUGN .
raloxifene	drug	phenytoin	drug
false

In vitro , DRUGA did not affect the binding of DRUGN , DRUGN , or DRUGB .
raloxifene	drug	tamoxifen	drug
false

In vitro , DRUGN did not affect the binding of DRUGA , DRUGB , or DRUGN .
warfarin	drug	phenytoin	drug
false

In vitro , DRUGN did not affect the binding of DRUGA , DRUGN , or DRUGB .
warfarin	drug	tamoxifen	drug
false

In vitro , DRUGN did not affect the binding of DRUGN , DRUGA , or DRUGB .
phenytoin	drug	tamoxifen	drug
false

Caution should be used when DRUGA is coadministered with other highly protein bound drugs , such as DRUGB , DRUGN , DRUGN , DRUGN , DRUGN , and DRUGN .
EVISTA	brand	clofibrate	drug
advise

Caution should be used when DRUGA is coadministered with other highly protein bound drugs , such as DRUGN , DRUGB , DRUGN , DRUGN , DRUGN , and DRUGN .
EVISTA	brand	indomethacin	drug
advise

Caution should be used when DRUGA is coadministered with other highly protein bound drugs , such as DRUGN , DRUGN , DRUGB , DRUGN , DRUGN , and DRUGN .
EVISTA	brand	naproxen	drug
advise

Caution should be used when DRUGA is coadministered with other highly protein bound drugs , such as DRUGN , DRUGN , DRUGN , DRUGB , DRUGN , and DRUGN .
EVISTA	brand	ibuprofen	drug
advise

Caution should be used when DRUGA is coadministered with other highly protein bound drugs , such as DRUGN , DRUGN , DRUGN , DRUGN , DRUGB , and DRUGN .
EVISTA	brand	diazepam	drug
advise

Caution should be used when DRUGA is coadministered with other highly protein bound drugs , such as DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , and DRUGB .
EVISTA	brand	diazoxide	drug
advise

Caution should be used when DRUGN is coadministered with other highly protein bound drugs , such as DRUGA , DRUGB , DRUGN , DRUGN , DRUGN , and DRUGN .
clofibrate	drug	indomethacin	drug
false

Caution should be used when DRUGN is coadministered with other highly protein bound drugs , such as DRUGA , DRUGN , DRUGB , DRUGN , DRUGN , and DRUGN .
clofibrate	drug	naproxen	drug
false

Caution should be used when DRUGN is coadministered with other highly protein bound drugs , such as DRUGA , DRUGN , DRUGN , DRUGB , DRUGN , and DRUGN .
clofibrate	drug	ibuprofen	drug
false

Caution should be used when DRUGN is coadministered with other highly protein bound drugs , such as DRUGA , DRUGN , DRUGN , DRUGN , DRUGB , and DRUGN .
clofibrate	drug	diazepam	drug
false

Caution should be used when DRUGN is coadministered with other highly protein bound drugs , such as DRUGA , DRUGN , DRUGN , DRUGN , DRUGN , and DRUGB .
clofibrate	drug	diazoxide	drug
false

Caution should be used when DRUGN is coadministered with other highly protein bound drugs , such as DRUGN , DRUGA , DRUGB , DRUGN , DRUGN , and DRUGN .
indomethacin	drug	naproxen	drug
false

Caution should be used when DRUGN is coadministered with other highly protein bound drugs , such as DRUGN , DRUGA , DRUGN , DRUGB , DRUGN , and DRUGN .
indomethacin	drug	ibuprofen	drug
false

Caution should be used when DRUGN is coadministered with other highly protein bound drugs , such as DRUGN , DRUGA , DRUGN , DRUGN , DRUGB , and DRUGN .
indomethacin	drug	diazepam	drug
false

Caution should be used when DRUGN is coadministered with other highly protein bound drugs , such as DRUGN , DRUGA , DRUGN , DRUGN , DRUGN , and DRUGB .
indomethacin	drug	diazoxide	drug
false

Caution should be used when DRUGN is coadministered with other highly protein bound drugs , such as DRUGN , DRUGN , DRUGA , DRUGB , DRUGN , and DRUGN .
naproxen	drug	ibuprofen	drug
false

Caution should be used when DRUGN is coadministered with other highly protein bound drugs , such as DRUGN , DRUGN , DRUGA , DRUGN , DRUGB , and DRUGN .
naproxen	drug	diazepam	drug
false

Caution should be used when DRUGN is coadministered with other highly protein bound drugs , such as DRUGN , DRUGN , DRUGA , DRUGN , DRUGN , and DRUGB .
naproxen	drug	diazoxide	drug
false

Caution should be used when DRUGN is coadministered with other highly protein bound drugs , such as DRUGN , DRUGN , DRUGN , DRUGA , DRUGB , and DRUGN .
ibuprofen	drug	diazepam	drug
false

Caution should be used when DRUGN is coadministered with other highly protein bound drugs , such as DRUGN , DRUGN , DRUGN , DRUGA , DRUGN , and DRUGB .
ibuprofen	drug	diazoxide	drug
false

Caution should be used when DRUGN is coadministered with other highly protein bound drugs , such as DRUGN , DRUGN , DRUGN , DRUGN , DRUGA , and DRUGB .
diazepam	drug	diazoxide	drug
false

Coadministration of DRUGA with DRUGB resulted in increased plasma DRUGN concentrations ( dgb % ) , increased plasma bismuth trough concentrations ( dgb % ) , and increased DRUGN plasma concentrations ( dgb % ) .
TRITEC	brand	clarithromycin	drug
mechanism

Coadministration of DRUGA with DRUGN resulted in increased plasma DRUGB concentrations ( dgb % ) , increased plasma bismuth trough concentrations ( dgb % ) , and increased DRUGN plasma concentrations ( dgb % ) .
TRITEC	brand	ranitidine	drug
false

Coadministration of DRUGA with DRUGN resulted in increased plasma DRUGN concentrations ( dgb % ) , increased plasma bismuth trough concentrations ( dgb % ) , and increased DRUGB plasma concentrations ( dgb % ) .
TRITEC	brand	14- hydroxy- clarithromycin	drug_n
false

Coadministration of DRUGN with DRUGA resulted in increased plasma DRUGB concentrations ( dgb % ) , increased plasma bismuth trough concentrations ( dgb % ) , and increased DRUGN plasma concentrations ( dgb % ) .
clarithromycin	drug	ranitidine	drug
false

Coadministration of DRUGN with DRUGA resulted in increased plasma DRUGN concentrations ( dgb % ) , increased plasma bismuth trough concentrations ( dgb % ) , and increased DRUGB plasma concentrations ( dgb % ) .
clarithromycin	drug	14- hydroxy- clarithromycin	drug_n
false

Coadministration of DRUGN with DRUGN resulted in increased plasma DRUGA concentrations ( dgb % ) , increased plasma bismuth trough concentrations ( dgb % ) , and increased DRUGB plasma concentrations ( dgb % ) .
ranitidine	drug	14- hydroxy- clarithromycin	drug_n
false

Coadministration with DRUGA results in a slight decrease in the rate of DRUGB absorption that is clinically unimportant .
aspirin	brand	salicylate	group
false

Coadministration with a high dose of DRUGA ( dgb mEq ) results in a dgb % decrease in plasma concentrations of DRUGB and may decrease plasma concentrations of bismuth from DRUGN .
antacid	group	ranitidine	drug
mechanism

Coadministration with a high dose of DRUGA ( dgb mEq ) results in a dgb % decrease in plasma concentrations of DRUGN and may decrease plasma concentrations of bismuth from DRUGB .
antacid	group	TRITEC	brand
mechanism

Coadministration with a high dose of DRUGN ( dgb mEq ) results in a dgb % decrease in plasma concentrations of DRUGA and may decrease plasma concentrations of bismuth from DRUGB .
ranitidine	drug	TRITEC	brand
false

For information on drug interactions associated with DRUGA , refer to the DRUGB package insert .
ranitidine	drug	ZANTAC	brand
false

Due to low systemic exposure to DRUGA following topical application in patients , dosage adjustments for DRUGN are unnecessary when co administered with CYPdgbAdgb inhibitors , such as DRUGB .
retapamulin	drug	ketoconazole	drug
false

Due to low systemic exposure to DRUGN following topical application in patients , dosage adjustments for DRUGA are unnecessary when co administered with CYPdgbAdgb inhibitors , such as DRUGB .
retapamulin	drug	ketoconazole	drug
false

Based on in vitro Pdgb inhibition studies and the low systemic exposure observed following topical application of DRUGA , DRUGB is unlikely to affect the metabolism of other Pdgb substrates .
ALTABAX	brand	retapamulin	drug
false

In addition to bleeding associated with DRUGA and DRUGB , drugs that alter platelet function ( such as DRUGN , DRUGN , and DRUGN ) may increase the risk of bleeding if administered prior to or after DRUGN therapy .
heparin	drug	vitamin K antagonists	group
false

In addition to bleeding associated with DRUGA and DRUGN , drugs that alter platelet function ( such as DRUGB , DRUGN , and DRUGN ) may increase the risk of bleeding if administered prior to or after DRUGN therapy .
heparin	drug	aspirin	brand
false

In addition to bleeding associated with DRUGA and DRUGN , drugs that alter platelet function ( such as DRUGN , DRUGB , and DRUGN ) may increase the risk of bleeding if administered prior to or after DRUGN therapy .
heparin	drug	dipyridamole	drug
false

In addition to bleeding associated with DRUGA and DRUGN , drugs that alter platelet function ( such as DRUGN , DRUGN , and DRUGB ) may increase the risk of bleeding if administered prior to or after DRUGN therapy .
heparin	drug	abciximab	drug
false

In addition to bleeding associated with DRUGA and DRUGN , drugs that alter platelet function ( such as DRUGN , DRUGN , and DRUGN ) may increase the risk of bleeding if administered prior to or after DRUGB therapy .
heparin	drug	Retavase	brand
effect

In addition to bleeding associated with DRUGN and DRUGA , drugs that alter platelet function ( such as DRUGB , DRUGN , and DRUGN ) may increase the risk of bleeding if administered prior to or after DRUGN therapy .
vitamin K antagonists	group	aspirin	brand
false

In addition to bleeding associated with DRUGN and DRUGA , drugs that alter platelet function ( such as DRUGN , DRUGB , and DRUGN ) may increase the risk of bleeding if administered prior to or after DRUGN therapy .
vitamin K antagonists	group	dipyridamole	drug
false

In addition to bleeding associated with DRUGN and DRUGA , drugs that alter platelet function ( such as DRUGN , DRUGN , and DRUGB ) may increase the risk of bleeding if administered prior to or after DRUGN therapy .
vitamin K antagonists	group	abciximab	drug
false

In addition to bleeding associated with DRUGN and DRUGA , drugs that alter platelet function ( such as DRUGN , DRUGN , and DRUGN ) may increase the risk of bleeding if administered prior to or after DRUGB therapy .
vitamin K antagonists	group	Retavase	brand
effect

In addition to bleeding associated with DRUGN and DRUGN , drugs that alter platelet function ( such as DRUGA , DRUGB , and DRUGN ) may increase the risk of bleeding if administered prior to or after DRUGN therapy .
aspirin	brand	dipyridamole	drug
false

In addition to bleeding associated with DRUGN and DRUGN , drugs that alter platelet function ( such as DRUGA , DRUGN , and DRUGB ) may increase the risk of bleeding if administered prior to or after DRUGN therapy .
aspirin	brand	abciximab	drug
false

In addition to bleeding associated with DRUGN and DRUGN , drugs that alter platelet function ( such as DRUGA , DRUGN , and DRUGN ) may increase the risk of bleeding if administered prior to or after DRUGB therapy .
aspirin	brand	Retavase	brand
effect

In addition to bleeding associated with DRUGN and DRUGN , drugs that alter platelet function ( such as DRUGN , DRUGA , and DRUGB ) may increase the risk of bleeding if administered prior to or after DRUGN therapy .
dipyridamole	drug	abciximab	drug
false

In addition to bleeding associated with DRUGN and DRUGN , drugs that alter platelet function ( such as DRUGN , DRUGA , and DRUGN ) may increase the risk of bleeding if administered prior to or after DRUGB therapy .
dipyridamole	drug	Retavase	brand
effect

In addition to bleeding associated with DRUGN and DRUGN , drugs that alter platelet function ( such as DRUGN , DRUGN , and DRUGA ) may increase the risk of bleeding if administered prior to or after DRUGB therapy .
abciximab	drug	Retavase	brand
effect

Interactions for DRUGA ( DRUGB ) : DRUGN impairs the intestinal absorption of DRUGN
Vitamin B2	drug	Riboflavin	drug
false

Interactions for DRUGA ( DRUGN ) : DRUGB impairs the intestinal absorption of DRUGN
Vitamin B2	drug	Alcohol	drug
false

Interactions for DRUGA ( DRUGN ) : DRUGN impairs the intestinal absorption of DRUGB
Vitamin B2	drug	riboflavin	drug
false

Interactions for DRUGN ( DRUGA ) : DRUGB impairs the intestinal absorption of DRUGN
Riboflavin	drug	Alcohol	drug
false

Interactions for DRUGN ( DRUGA ) : DRUGN impairs the intestinal absorption of DRUGB
Riboflavin	drug	riboflavin	drug
false

Interactions for DRUGN ( DRUGN ) : DRUGA impairs the intestinal absorption of DRUGB
Alcohol	drug	riboflavin	drug
mechanism

DRUGA concurrent use decreases gastrointestinal absorption of DRUGB ;
Probenecid	drug	riboflavin	drug
mechanism

requirements for DRUGA may be increased in patients receiving DRUGB .
riboflavin	drug	probenecid	drug
effect

DRUGA : The effects of chronic DRUGB use on the metabolism of DRUGN are not known .
Cimetidine	drug	cimetidine	drug
false

DRUGA : The effects of chronic DRUGN use on the metabolism of DRUGB are not known .
Cimetidine	drug	rimantadine	drug
false

DRUGN : The effects of chronic DRUGA use on the metabolism of DRUGB are not known .
cimetidine	drug	rimantadine	drug
false

DRUGA : DRUGB , dgb mg , was given twice daily for dgb days to dgb healthy volunteers .
Acetaminophen	drug	Rimantadine HCl	drug
false

Coadministration with DRUGA reduced the peak concentration and AUC values for DRUGB by approximately dgb % .
acetaminophen	drug	rimantadine	drug
mechanism

DRUGA : DRUGB , dgb mg , was given twice daily fro dgb days to dgb healthy volunteers .
Aspirin	brand	Rimantadine HCl	drug
false

Peak plasma concentrations and AUC of DRUGA were reduced approximately dgb % in the presence of DRUGB .
rimantadine	drug	aspirin	brand
mechanism

Drug Drug Interactions Effect of DRUGA ( DRUGB ) on the Metabolism of Other Drugs : DRUGN is primarily metabolized through hydrolysis by esterases .
Exelon	brand	rivastigmine tartrate	drug
false

Drug Drug Interactions Effect of DRUGA ( DRUGN ) on the Metabolism of Other Drugs : DRUGB is primarily metabolized through hydrolysis by esterases .
Exelon	brand	Rivastigmine	drug
false

Drug Drug Interactions Effect of DRUGN ( DRUGA ) on the Metabolism of Other Drugs : DRUGB is primarily metabolized through hydrolysis by esterases .
rivastigmine tartrate	drug	Rivastigmine	drug
false

No pharmacokinetic interaction was observed between DRUGA and DRUGB , DRUGN , DRUGN , or DRUGN in studies in healthy volunteers .
rivastigmine	drug	digoxin	drug
false

No pharmacokinetic interaction was observed between DRUGA and DRUGN , DRUGB , DRUGN , or DRUGN in studies in healthy volunteers .
rivastigmine	drug	warfarin	drug
false

No pharmacokinetic interaction was observed between DRUGA and DRUGN , DRUGN , DRUGB , or DRUGN in studies in healthy volunteers .
rivastigmine	drug	diazepam	drug
false

No pharmacokinetic interaction was observed between DRUGA and DRUGN , DRUGN , DRUGN , or DRUGB in studies in healthy volunteers .
rivastigmine	drug	fluoxetine	drug
false

No pharmacokinetic interaction was observed between DRUGN and DRUGA , DRUGB , DRUGN , or DRUGN in studies in healthy volunteers .
digoxin	drug	warfarin	drug
false

No pharmacokinetic interaction was observed between DRUGN and DRUGA , DRUGN , DRUGB , or DRUGN in studies in healthy volunteers .
digoxin	drug	diazepam	drug
false

No pharmacokinetic interaction was observed between DRUGN and DRUGA , DRUGN , DRUGN , or DRUGB in studies in healthy volunteers .
digoxin	drug	fluoxetine	drug
false

No pharmacokinetic interaction was observed between DRUGN and DRUGN , DRUGA , DRUGB , or DRUGN in studies in healthy volunteers .
warfarin	drug	diazepam	drug
false

No pharmacokinetic interaction was observed between DRUGN and DRUGN , DRUGA , DRUGN , or DRUGB in studies in healthy volunteers .
warfarin	drug	fluoxetine	drug
false

No pharmacokinetic interaction was observed between DRUGN and DRUGN , DRUGN , DRUGA , or DRUGB in studies in healthy volunteers .
diazepam	drug	fluoxetine	drug
false

The elevation of prothrombin time induced by DRUGA is not affected by administration of DRUGB .
warfarin	drug	Exelon	brand
false

Effect of Other Drugs on the Metabolism of DRUGA : Drugs that induce or inhibit CYPdgb metabolism are not expected to alter the metabolism of DRUGB .
Exelon	brand	rivastigmine	drug
false

Single dose pharmacokinetic studies demonstrated that the metabolism of DRUGA is not significantly affected by concurrent administration of DRUGB , DRUGN , DRUGN , or DRUGN .
rivastigmine	drug	digoxin	drug
false

Single dose pharmacokinetic studies demonstrated that the metabolism of DRUGA is not significantly affected by concurrent administration of DRUGN , DRUGB , DRUGN , or DRUGN .
rivastigmine	drug	warfarin	drug
false

Single dose pharmacokinetic studies demonstrated that the metabolism of DRUGA is not significantly affected by concurrent administration of DRUGN , DRUGN , DRUGB , or DRUGN .
rivastigmine	drug	diazepam	drug
false

Single dose pharmacokinetic studies demonstrated that the metabolism of DRUGA is not significantly affected by concurrent administration of DRUGN , DRUGN , DRUGN , or DRUGB .
rivastigmine	drug	fluoxetine	drug
false

Single dose pharmacokinetic studies demonstrated that the metabolism of DRUGN is not significantly affected by concurrent administration of DRUGA , DRUGB , DRUGN , or DRUGN .
digoxin	drug	warfarin	drug
false

Single dose pharmacokinetic studies demonstrated that the metabolism of DRUGN is not significantly affected by concurrent administration of DRUGA , DRUGN , DRUGB , or DRUGN .
digoxin	drug	diazepam	drug
false

Single dose pharmacokinetic studies demonstrated that the metabolism of DRUGN is not significantly affected by concurrent administration of DRUGA , DRUGN , DRUGN , or DRUGB .
digoxin	drug	fluoxetine	drug
false

Single dose pharmacokinetic studies demonstrated that the metabolism of DRUGN is not significantly affected by concurrent administration of DRUGN , DRUGA , DRUGB , or DRUGN .
warfarin	drug	diazepam	drug
false

Single dose pharmacokinetic studies demonstrated that the metabolism of DRUGN is not significantly affected by concurrent administration of DRUGN , DRUGA , DRUGN , or DRUGB .
warfarin	drug	fluoxetine	drug
false

Single dose pharmacokinetic studies demonstrated that the metabolism of DRUGN is not significantly affected by concurrent administration of DRUGN , DRUGN , DRUGA , or DRUGB .
diazepam	drug	fluoxetine	drug
false

Use with DRUGA : Because of their mechanism of action , DRUGB have the potential to interfere with the activity of DRUGN .
Anticholinergics	group	cholinesterase inhibitors	group
false

Use with DRUGA : Because of their mechanism of action , DRUGN have the potential to interfere with the activity of DRUGB .
Anticholinergics	group	anticholinergic medications	group
false

Use with DRUGN : Because of their mechanism of action , DRUGA have the potential to interfere with the activity of DRUGB .
cholinesterase inhibitors	group	anticholinergic medications	group
int

Use with DRUGA and Other DRUGB : A synergistic effect may be expected when DRUGN are given concurrently with DRUGN , similar DRUGN or DRUGN such as DRUGN .
Cholinomimetics	group	Cholinesterase Inhibitors	group
false

Use with DRUGA and Other DRUGN : A synergistic effect may be expected when DRUGB are given concurrently with DRUGN , similar DRUGN or DRUGN such as DRUGN .
Cholinomimetics	group	cholinesterase inhibitors	group
false

Use with DRUGA and Other DRUGN : A synergistic effect may be expected when DRUGN are given concurrently with DRUGB , similar DRUGN or DRUGN such as DRUGN .
Cholinomimetics	group	succinylcholine	drug
false

Use with DRUGA and Other DRUGN : A synergistic effect may be expected when DRUGN are given concurrently with DRUGN , similar DRUGB or DRUGN such as DRUGN .
Cholinomimetics	group	neuromuscular blocking agents	group
false

Use with DRUGA and Other DRUGN : A synergistic effect may be expected when DRUGN are given concurrently with DRUGN , similar DRUGN or DRUGB such as DRUGN .
Cholinomimetics	group	cholinergic agonists	group
false

Use with DRUGA and Other DRUGN : A synergistic effect may be expected when DRUGN are given concurrently with DRUGN , similar DRUGN or DRUGN such as DRUGB .
Cholinomimetics	group	bethanechol	drug
false

Use with DRUGN and Other DRUGA : A synergistic effect may be expected when DRUGB are given concurrently with DRUGN , similar DRUGN or DRUGN such as DRUGN .
Cholinesterase Inhibitors	group	cholinesterase inhibitors	group
false

Use with DRUGN and Other DRUGA : A synergistic effect may be expected when DRUGN are given concurrently with DRUGB , similar DRUGN or DRUGN such as DRUGN .
Cholinesterase Inhibitors	group	succinylcholine	drug
false

Use with DRUGN and Other DRUGA : A synergistic effect may be expected when DRUGN are given concurrently with DRUGN , similar DRUGB or DRUGN such as DRUGN .
Cholinesterase Inhibitors	group	neuromuscular blocking agents	group
false

Use with DRUGN and Other DRUGA : A synergistic effect may be expected when DRUGN are given concurrently with DRUGN , similar DRUGN or DRUGB such as DRUGN .
Cholinesterase Inhibitors	group	cholinergic agonists	group
false

Use with DRUGN and Other DRUGA : A synergistic effect may be expected when DRUGN are given concurrently with DRUGN , similar DRUGN or DRUGN such as DRUGB .
Cholinesterase Inhibitors	group	bethanechol	drug
false

Use with DRUGN and Other DRUGN : A synergistic effect may be expected when DRUGA are given concurrently with DRUGB , similar DRUGN or DRUGN such as DRUGN .
cholinesterase inhibitors	group	succinylcholine	drug
effect

Use with DRUGN and Other DRUGN : A synergistic effect may be expected when DRUGA are given concurrently with DRUGN , similar DRUGB or DRUGN such as DRUGN .
cholinesterase inhibitors	group	neuromuscular blocking agents	group
effect

Use with DRUGN and Other DRUGN : A synergistic effect may be expected when DRUGA are given concurrently with DRUGN , similar DRUGN or DRUGB such as DRUGN .
cholinesterase inhibitors	group	cholinergic agonists	group
effect

Use with DRUGN and Other DRUGN : A synergistic effect may be expected when DRUGA are given concurrently with DRUGN , similar DRUGN or DRUGN such as DRUGB .
cholinesterase inhibitors	group	bethanechol	drug
effect

Use with DRUGN and Other DRUGN : A synergistic effect may be expected when DRUGN are given concurrently with DRUGA , similar DRUGB or DRUGN such as DRUGN .
succinylcholine	drug	neuromuscular blocking agents	group
false

Use with DRUGN and Other DRUGN : A synergistic effect may be expected when DRUGN are given concurrently with DRUGA , similar DRUGN or DRUGB such as DRUGN .
succinylcholine	drug	cholinergic agonists	group
false

Use with DRUGN and Other DRUGN : A synergistic effect may be expected when DRUGN are given concurrently with DRUGA , similar DRUGN or DRUGN such as DRUGB .
succinylcholine	drug	bethanechol	drug
false

Use with DRUGN and Other DRUGN : A synergistic effect may be expected when DRUGN are given concurrently with DRUGN , similar DRUGA or DRUGB such as DRUGN .
neuromuscular blocking agents	group	cholinergic agonists	group
false

Use with DRUGN and Other DRUGN : A synergistic effect may be expected when DRUGN are given concurrently with DRUGN , similar DRUGA or DRUGN such as DRUGB .
neuromuscular blocking agents	group	bethanechol	drug
false

Use with DRUGN and Other DRUGN : A synergistic effect may be expected when DRUGN are given concurrently with DRUGN , similar DRUGN or DRUGA such as DRUGB .
cholinergic agonists	group	bethanechol	drug
false

Drug Interactions : The use of DRUGA ( DRUGB ) Injection before DRUGN , for the purpose of attenuating some of the side effects of DRUGN , has not been studied .
ZEMURON	brand	rocuronium bromide	drug
false

Drug Interactions : The use of DRUGA ( DRUGN ) Injection before DRUGB , for the purpose of attenuating some of the side effects of DRUGN , has not been studied .
ZEMURON	brand	succinylcholine	drug
false

Drug Interactions : The use of DRUGA ( DRUGN ) Injection before DRUGN , for the purpose of attenuating some of the side effects of DRUGB , has not been studied .
ZEMURON	brand	succinylcholine	drug
false

Drug Interactions : The use of DRUGN ( DRUGA ) Injection before DRUGB , for the purpose of attenuating some of the side effects of DRUGN , has not been studied .
rocuronium bromide	drug	succinylcholine	drug
false

Drug Interactions : The use of DRUGN ( DRUGA ) Injection before DRUGN , for the purpose of attenuating some of the side effects of DRUGB , has not been studied .
rocuronium bromide	drug	succinylcholine	drug
false

If DRUGA is administered following administration of DRUGB , it should not be given until recovery from DRUGN has been observed .
ZEMURON	brand	succinylcholine	drug
advise

If DRUGA is administered following administration of DRUGN , it should not be given until recovery from DRUGB has been observed .
ZEMURON	brand	succinylcholine	drug
false

There are no controlled studies documenting the use of DRUGA before or after other DRUGB .
ZEMURON	brand	nondepolarizing muscle relaxants	group
false

DRUGA should be used with caution in patients receiving other local DRUGB or agents structurally related to DRUGN , since the toxic effects of these drugs are additive .
Ropivacaine	drug	anesthetics	group
advise

DRUGA should be used with caution in patients receiving other local DRUGN or agents structurally related to DRUGB , since the toxic effects of these drugs are additive .
Ropivacaine	drug	amide-type local anesthetics	group
false

DRUGN should be used with caution in patients receiving other local DRUGA or agents structurally related to DRUGB , since the toxic effects of these drugs are additive .
anesthetics	group	amide-type local anesthetics	group
false

In vivo , the plasma clearance of DRUGA was reduced by dgb % during coadministration of DRUGB ( dgb mg bid for dgb days ) , a selective and potent CYPdgbAdgb inhibitor .
ropivacaine	drug	fluvoxamine	drug
mechanism

Thus strong inhibitors of cytochrome PdgbAdgb , such as DRUGA , given concomitantly during administration of DRUGB , can interact with DRUGN leading to increased DRUGN plasma levels .
fluvoxamine	drug	Ropivacaine	drug
int

Thus strong inhibitors of cytochrome PdgbAdgb , such as DRUGA , given concomitantly during administration of DRUGN , can interact with DRUGB leading to increased DRUGN plasma levels .
fluvoxamine	drug	Ropivacaine	drug
false

Thus strong inhibitors of cytochrome PdgbAdgb , such as DRUGA , given concomitantly during administration of DRUGN , can interact with DRUGN leading to increased DRUGB plasma levels .
fluvoxamine	drug	ropivacaine	drug
false

Thus strong inhibitors of cytochrome PdgbAdgb , such as DRUGN , given concomitantly during administration of DRUGA , can interact with DRUGN leading to increased DRUGB plasma levels .
Ropivacaine	drug	ropivacaine	drug
false

Thus strong inhibitors of cytochrome PdgbAdgb , such as DRUGN , given concomitantly during administration of DRUGN , can interact with DRUGA leading to increased DRUGB plasma levels .
Ropivacaine	drug	ropivacaine	drug
false

Possible interactions with drugs known to be metabolized by CYPdgbAdgb via competitive inhibition such as DRUGA and DRUGB may also occur .
theophylline	drug	imipramine	drug
false

Coadministration of a selective and potent inhibitor of CYPdgbAdgb , DRUGA ( dgb mg bid for dgb days with DRUGB infusion administered dgb hour after DRUGN ) caused a dgb % reduction in in vivo plasma clearance of DRUGN .
ketoconazole	drug	ropivacaine	drug
false

Coadministration of a selective and potent inhibitor of CYPdgbAdgb , DRUGA ( dgb mg bid for dgb days with DRUGN infusion administered dgb hour after DRUGN ) caused a dgb % reduction in in vivo plasma clearance of DRUGB .
ketoconazole	drug	ropivacaine	drug
mechanism

Coadministration of a selective and potent inhibitor of CYPdgbAdgb , DRUGN ( dgb mg bid for dgb days with DRUGA infusion administered dgb hour after DRUGB ) caused a dgb % reduction in in vivo plasma clearance of DRUGN .
ropivacaine	drug	ketoconazole	drug
false

Coadministration of a selective and potent inhibitor of CYPdgbAdgb , DRUGN ( dgb mg bid for dgb days with DRUGN infusion administered dgb hour after DRUGA ) caused a dgb % reduction in in vivo plasma clearance of DRUGB .
ketoconazole	drug	ropivacaine	drug
false

An inhibitor of CYPdgbCdgb ( such as DRUGA ) may increase the AUC of DRUGB and an inducer of CYPdgbCdgb ( such as DRUGN ) may decrease the AUC of DRUGN .
gemfibrozil	drug	rosiglitazone	drug
mechanism

An inhibitor of CYPdgbCdgb ( such as DRUGA ) may increase the AUC of DRUGN and an inducer of CYPdgbCdgb ( such as DRUGB ) may decrease the AUC of DRUGN .
gemfibrozil	drug	rifampin	drug
false

An inhibitor of CYPdgbCdgb ( such as DRUGA ) may increase the AUC of DRUGN and an inducer of CYPdgbCdgb ( such as DRUGN ) may decrease the AUC of DRUGB .
gemfibrozil	drug	rosiglitazone	drug
false

An inhibitor of CYPdgbCdgb ( such as DRUGN ) may increase the AUC of DRUGA and an inducer of CYPdgbCdgb ( such as DRUGB ) may decrease the AUC of DRUGN .
rosiglitazone	drug	rifampin	drug
false

An inhibitor of CYPdgbCdgb ( such as DRUGN ) may increase the AUC of DRUGN and an inducer of CYPdgbCdgb ( such as DRUGA ) may decrease the AUC of DRUGB .
rifampin	drug	rosiglitazone	drug
mechanism

Concomitant administrations not recommended : DRUGA and DRUGB : Certain DRUGN interact with DRUGN and DRUGN leading to increased serum concentrations of the latter .
Terfenadine	drug	astemizole	drug
false

Concomitant administrations not recommended : DRUGA and DRUGN : Certain DRUGB interact with DRUGN and DRUGN leading to increased serum concentrations of the latter .
Terfenadine	drug	macrolides	group
false

Concomitant administrations not recommended : DRUGA and DRUGN : Certain DRUGN interact with DRUGB and DRUGN leading to increased serum concentrations of the latter .
Terfenadine	drug	terfenadine	drug
false

Concomitant administrations not recommended : DRUGA and DRUGN : Certain DRUGN interact with DRUGN and DRUGB leading to increased serum concentrations of the latter .
Terfenadine	drug	astemizole	drug
false

Concomitant administrations not recommended : DRUGN and DRUGA : Certain DRUGB interact with DRUGN and DRUGN leading to increased serum concentrations of the latter .
astemizole	drug	macrolides	group
false

Concomitant administrations not recommended : DRUGN and DRUGA : Certain DRUGN interact with DRUGB and DRUGN leading to increased serum concentrations of the latter .
astemizole	drug	terfenadine	drug
false

Concomitant administrations not recommended : DRUGN and DRUGN : Certain DRUGA interact with DRUGB and DRUGN leading to increased serum concentrations of the latter .
macrolides	group	terfenadine	drug
int

Concomitant administrations not recommended : DRUGN and DRUGN : Certain DRUGA interact with DRUGN and DRUGB leading to increased serum concentrations of the latter .
macrolides	group	astemizole	drug
int

Concomitant administrations not recommended : DRUGN and DRUGN : Certain DRUGN interact with DRUGA and DRUGB leading to increased serum concentrations of the latter .
terfenadine	drug	astemizole	drug
false

Although such a reaction has not been demonstrated with DRUGA , concomitant administration of DRUGN with DRUGB or DRUGN is not recommended .
roxithromycin	drug	terfenadine	drug
false

Although such a reaction has not been demonstrated with DRUGA , concomitant administration of DRUGN with DRUGN or DRUGB is not recommended .
roxithromycin	drug	astemizole	drug
false

Although such a reaction has not been demonstrated with DRUGN , concomitant administration of DRUGA with DRUGB or DRUGN is not recommended .
roxithromycin	drug	terfenadine	drug
advise

Although such a reaction has not been demonstrated with DRUGN , concomitant administration of DRUGA with DRUGN or DRUGB is not recommended .
roxithromycin	drug	astemizole	drug
advise

Although such a reaction has not been demonstrated with DRUGN , concomitant administration of DRUGN with DRUGA or DRUGB is not recommended .
terfenadine	drug	astemizole	drug
false

however , in patients with Paget 's Disease prior DRUGA use appears to reduce the anti resorptive response to DRUGB nasal spray .
diphosphonate	group	Calcitonin (salmon)	drug
effect

DRUGA AND OTHER DRUGB WILL BE ADDITIVE TO DRUGN AND MAY INCREASE PLASMA CONCENTRATIONS OF DRUGN TO TOXIC LEVELS .
ASPIRIN	brand	SALICYLATE DRUGS	group
false

DRUGA AND OTHER DRUGN WILL BE ADDITIVE TO DRUGB AND MAY INCREASE PLASMA CONCENTRATIONS OF DRUGN TO TOXIC LEVELS .
ASPIRIN	brand	DISALCID	brand
effect

DRUGA AND OTHER DRUGN WILL BE ADDITIVE TO DRUGN AND MAY INCREASE PLASMA CONCENTRATIONS OF DRUGB TO TOXIC LEVELS .
ASPIRIN	brand	SALICYLIC ACID	drug
false

DRUGN AND OTHER DRUGA WILL BE ADDITIVE TO DRUGB AND MAY INCREASE PLASMA CONCENTRATIONS OF DRUGN TO TOXIC LEVELS .
SALICYLATE DRUGS	group	DISALCID	brand
effect

DRUGN AND OTHER DRUGA WILL BE ADDITIVE TO DRUGN AND MAY INCREASE PLASMA CONCENTRATIONS OF DRUGB TO TOXIC LEVELS .
SALICYLATE DRUGS	group	SALICYLIC ACID	drug
false

DRUGN AND OTHER DRUGN WILL BE ADDITIVE TO DRUGA AND MAY INCREASE PLASMA CONCENTRATIONS OF DRUGB TO TOXIC LEVELS .
DISALCID	brand	SALICYLIC ACID	drug
false

DRUGA given concomitantly with DRUGB may predispose to systemic bleeding .
Salicylates	group	anticoagulant drugs	group
effect

DRUGA may enhance the hypoglycemic effect of oral DRUGB of the sulfonylurea class .
Salicylates	group	antidiabetic drugs	group
effect

DRUGA competes with a number of drugs for protein binding sites , notably DRUGB , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , and possibly DRUGN .
Salicylate	group	penicillin	drug
mechanism

DRUGA competes with a number of drugs for protein binding sites , notably DRUGN , DRUGB , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , and possibly DRUGN .
Salicylate	group	thiopental	drug
mechanism

DRUGA competes with a number of drugs for protein binding sites , notably DRUGN , DRUGN , DRUGB , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , and possibly DRUGN .
Salicylate	group	thyroxine	drug
mechanism

DRUGA competes with a number of drugs for protein binding sites , notably DRUGN , DRUGN , DRUGN , DRUGB , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , and possibly DRUGN .
Salicylate	group	triiodothyronine	drug
mechanism

DRUGA competes with a number of drugs for protein binding sites , notably DRUGN , DRUGN , DRUGN , DRUGN , DRUGB , DRUGN , DRUGN , DRUGN , DRUGN , and possibly DRUGN .
Salicylate	group	phenytoin	drug
mechanism

DRUGA competes with a number of drugs for protein binding sites , notably DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGB , DRUGN , DRUGN , DRUGN , and possibly DRUGN .
Salicylate	group	sulfinpyrazone	drug
mechanism

DRUGA competes with a number of drugs for protein binding sites , notably DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGB , DRUGN , DRUGN , and possibly DRUGN .
Salicylate	group	naproxen	drug
mechanism

DRUGA competes with a number of drugs for protein binding sites , notably DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGB , DRUGN , and possibly DRUGN .
Salicylate	group	warfarin	drug
mechanism

DRUGA competes with a number of drugs for protein binding sites , notably DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGB , and possibly DRUGN .
Salicylate	group	methotrexate	drug
mechanism

DRUGA competes with a number of drugs for protein binding sites , notably DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , and possibly DRUGB .
Salicylate	group	corticosteroids	group
mechanism

DRUGN competes with a number of drugs for protein binding sites , notably DRUGA , DRUGB , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , and possibly DRUGN .
penicillin	drug	thiopental	drug
false

DRUGN competes with a number of drugs for protein binding sites , notably DRUGA , DRUGN , DRUGB , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , and possibly DRUGN .
penicillin	drug	thyroxine	drug
false

DRUGN competes with a number of drugs for protein binding sites , notably DRUGA , DRUGN , DRUGN , DRUGB , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , and possibly DRUGN .
penicillin	drug	triiodothyronine	drug
false

DRUGN competes with a number of drugs for protein binding sites , notably DRUGA , DRUGN , DRUGN , DRUGN , DRUGB , DRUGN , DRUGN , DRUGN , DRUGN , and possibly DRUGN .
penicillin	drug	phenytoin	drug
false

DRUGN competes with a number of drugs for protein binding sites , notably DRUGA , DRUGN , DRUGN , DRUGN , DRUGN , DRUGB , DRUGN , DRUGN , DRUGN , and possibly DRUGN .
penicillin	drug	sulfinpyrazone	drug
false

DRUGN competes with a number of drugs for protein binding sites , notably DRUGA , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGB , DRUGN , DRUGN , and possibly DRUGN .
penicillin	drug	naproxen	drug
false

DRUGN competes with a number of drugs for protein binding sites , notably DRUGA , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGB , DRUGN , and possibly DRUGN .
penicillin	drug	warfarin	drug
false

DRUGN competes with a number of drugs for protein binding sites , notably DRUGA , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGB , and possibly DRUGN .
penicillin	drug	methotrexate	drug
false

DRUGN competes with a number of drugs for protein binding sites , notably DRUGA , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , and possibly DRUGB .
penicillin	drug	corticosteroids	group
false

DRUGN competes with a number of drugs for protein binding sites , notably DRUGN , DRUGA , DRUGB , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , and possibly DRUGN .
thiopental	drug	thyroxine	drug
false

DRUGN competes with a number of drugs for protein binding sites , notably DRUGN , DRUGA , DRUGN , DRUGB , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , and possibly DRUGN .
thiopental	drug	triiodothyronine	drug
false

DRUGN competes with a number of drugs for protein binding sites , notably DRUGN , DRUGA , DRUGN , DRUGN , DRUGB , DRUGN , DRUGN , DRUGN , DRUGN , and possibly DRUGN .
thiopental	drug	phenytoin	drug
false

DRUGN competes with a number of drugs for protein binding sites , notably DRUGN , DRUGA , DRUGN , DRUGN , DRUGN , DRUGB , DRUGN , DRUGN , DRUGN , and possibly DRUGN .
thiopental	drug	sulfinpyrazone	drug
false

DRUGN competes with a number of drugs for protein binding sites , notably DRUGN , DRUGA , DRUGN , DRUGN , DRUGN , DRUGN , DRUGB , DRUGN , DRUGN , and possibly DRUGN .
thiopental	drug	naproxen	drug
false

DRUGN competes with a number of drugs for protein binding sites , notably DRUGN , DRUGA , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGB , DRUGN , and possibly DRUGN .
thiopental	drug	warfarin	drug
false

DRUGN competes with a number of drugs for protein binding sites , notably DRUGN , DRUGA , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGB , and possibly DRUGN .
thiopental	drug	methotrexate	drug
false

DRUGN competes with a number of drugs for protein binding sites , notably DRUGN , DRUGA , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , and possibly DRUGB .
thiopental	drug	corticosteroids	group
false

DRUGN competes with a number of drugs for protein binding sites , notably DRUGN , DRUGN , DRUGA , DRUGB , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , and possibly DRUGN .
thyroxine	drug	triiodothyronine	drug
false

DRUGN competes with a number of drugs for protein binding sites , notably DRUGN , DRUGN , DRUGA , DRUGN , DRUGB , DRUGN , DRUGN , DRUGN , DRUGN , and possibly DRUGN .
thyroxine	drug	phenytoin	drug
false

DRUGN competes with a number of drugs for protein binding sites , notably DRUGN , DRUGN , DRUGA , DRUGN , DRUGN , DRUGB , DRUGN , DRUGN , DRUGN , and possibly DRUGN .
thyroxine	drug	sulfinpyrazone	drug
false

DRUGN competes with a number of drugs for protein binding sites , notably DRUGN , DRUGN , DRUGA , DRUGN , DRUGN , DRUGN , DRUGB , DRUGN , DRUGN , and possibly DRUGN .
thyroxine	drug	naproxen	drug
false

DRUGN competes with a number of drugs for protein binding sites , notably DRUGN , DRUGN , DRUGA , DRUGN , DRUGN , DRUGN , DRUGN , DRUGB , DRUGN , and possibly DRUGN .
thyroxine	drug	warfarin	drug
false

DRUGN competes with a number of drugs for protein binding sites , notably DRUGN , DRUGN , DRUGA , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGB , and possibly DRUGN .
thyroxine	drug	methotrexate	drug
false

DRUGN competes with a number of drugs for protein binding sites , notably DRUGN , DRUGN , DRUGA , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , and possibly DRUGB .
thyroxine	drug	corticosteroids	group
false

DRUGN competes with a number of drugs for protein binding sites , notably DRUGN , DRUGN , DRUGN , DRUGA , DRUGB , DRUGN , DRUGN , DRUGN , DRUGN , and possibly DRUGN .
triiodothyronine	drug	phenytoin	drug
false

DRUGN competes with a number of drugs for protein binding sites , notably DRUGN , DRUGN , DRUGN , DRUGA , DRUGN , DRUGB , DRUGN , DRUGN , DRUGN , and possibly DRUGN .
triiodothyronine	drug	sulfinpyrazone	drug
false

DRUGN competes with a number of drugs for protein binding sites , notably DRUGN , DRUGN , DRUGN , DRUGA , DRUGN , DRUGN , DRUGB , DRUGN , DRUGN , and possibly DRUGN .
triiodothyronine	drug	naproxen	drug
false

DRUGN competes with a number of drugs for protein binding sites , notably DRUGN , DRUGN , DRUGN , DRUGA , DRUGN , DRUGN , DRUGN , DRUGB , DRUGN , and possibly DRUGN .
triiodothyronine	drug	warfarin	drug
false

DRUGN competes with a number of drugs for protein binding sites , notably DRUGN , DRUGN , DRUGN , DRUGA , DRUGN , DRUGN , DRUGN , DRUGN , DRUGB , and possibly DRUGN .
triiodothyronine	drug	methotrexate	drug
false

DRUGN competes with a number of drugs for protein binding sites , notably DRUGN , DRUGN , DRUGN , DRUGA , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , and possibly DRUGB .
triiodothyronine	drug	corticosteroids	group
false

DRUGN competes with a number of drugs for protein binding sites , notably DRUGN , DRUGN , DRUGN , DRUGN , DRUGA , DRUGB , DRUGN , DRUGN , DRUGN , and possibly DRUGN .
phenytoin	drug	sulfinpyrazone	drug
false

DRUGN competes with a number of drugs for protein binding sites , notably DRUGN , DRUGN , DRUGN , DRUGN , DRUGA , DRUGN , DRUGB , DRUGN , DRUGN , and possibly DRUGN .
phenytoin	drug	naproxen	drug
false

DRUGN competes with a number of drugs for protein binding sites , notably DRUGN , DRUGN , DRUGN , DRUGN , DRUGA , DRUGN , DRUGN , DRUGB , DRUGN , and possibly DRUGN .
phenytoin	drug	warfarin	drug
false

DRUGN competes with a number of drugs for protein binding sites , notably DRUGN , DRUGN , DRUGN , DRUGN , DRUGA , DRUGN , DRUGN , DRUGN , DRUGB , and possibly DRUGN .
phenytoin	drug	methotrexate	drug
false

DRUGN competes with a number of drugs for protein binding sites , notably DRUGN , DRUGN , DRUGN , DRUGN , DRUGA , DRUGN , DRUGN , DRUGN , DRUGN , and possibly DRUGB .
phenytoin	drug	corticosteroids	group
false

DRUGN competes with a number of drugs for protein binding sites , notably DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGA , DRUGB , DRUGN , DRUGN , and possibly DRUGN .
sulfinpyrazone	drug	naproxen	drug
false

DRUGN competes with a number of drugs for protein binding sites , notably DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGA , DRUGN , DRUGB , DRUGN , and possibly DRUGN .
sulfinpyrazone	drug	warfarin	drug
false

DRUGN competes with a number of drugs for protein binding sites , notably DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGA , DRUGN , DRUGN , DRUGB , and possibly DRUGN .
sulfinpyrazone	drug	methotrexate	drug
false

DRUGN competes with a number of drugs for protein binding sites , notably DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGA , DRUGN , DRUGN , DRUGN , and possibly DRUGB .
sulfinpyrazone	drug	corticosteroids	group
false

DRUGN competes with a number of drugs for protein binding sites , notably DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGA , DRUGB , DRUGN , and possibly DRUGN .
naproxen	drug	warfarin	drug
false

DRUGN competes with a number of drugs for protein binding sites , notably DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGA , DRUGN , DRUGB , and possibly DRUGN .
naproxen	drug	methotrexate	drug
false

DRUGN competes with a number of drugs for protein binding sites , notably DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGA , DRUGN , DRUGN , and possibly DRUGB .
naproxen	drug	corticosteroids	group
false

DRUGN competes with a number of drugs for protein binding sites , notably DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGA , DRUGB , and possibly DRUGN .
warfarin	drug	methotrexate	drug
false

DRUGN competes with a number of drugs for protein binding sites , notably DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGA , DRUGN , and possibly DRUGB .
warfarin	drug	corticosteroids	group
false

DRUGN competes with a number of drugs for protein binding sites , notably DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGA , and possibly DRUGB .
methotrexate	drug	corticosteroids	group
false

Drugs which may potentiate the myeloproliferative effects of DRUGA , such as DRUGB and DRUGN , should be used with caution .
Leukine	brand	lithium	drug
effect

Drugs which may potentiate the myeloproliferative effects of DRUGA , such as DRUGN and DRUGB , should be used with caution .
Leukine	brand	corticosteroids	group
effect

Drugs which may potentiate the myeloproliferative effects of DRUGN , such as DRUGA and DRUGB , should be used with caution .
lithium	drug	corticosteroids	group
false

DRUGA should be used with care in patients taking other drugs that are capable of causing CNS effects such as DRUGB , DRUGN , or DRUGN .
Scopolamine	drug	sedatives	group
advise

DRUGA should be used with care in patients taking other drugs that are capable of causing CNS effects such as DRUGN , DRUGB , or DRUGN .
Scopolamine	drug	tranquilizers	group
advise

DRUGA should be used with care in patients taking other drugs that are capable of causing CNS effects such as DRUGN , DRUGN , or DRUGB .
Scopolamine	drug	alcohol	drug
advise

DRUGN should be used with care in patients taking other drugs that are capable of causing CNS effects such as DRUGA , DRUGB , or DRUGN .
sedatives	group	tranquilizers	group
false

DRUGN should be used with care in patients taking other drugs that are capable of causing CNS effects such as DRUGA , DRUGN , or DRUGB .
sedatives	group	alcohol	drug
false

DRUGN should be used with care in patients taking other drugs that are capable of causing CNS effects such as DRUGN , DRUGA , or DRUGB .
tranquilizers	group	alcohol	drug
false

e.g . , other DRUGA , DRUGB ( including DRUGN ) , DRUGN , and DRUGN .
belladonna alkaloids	group	antihistamines	group
false

e.g . , other DRUGA , DRUGN ( including DRUGB ) , DRUGN , and DRUGN .
belladonna alkaloids	group	meclizine	drug
false

e.g . , other DRUGA , DRUGN ( including DRUGN ) , DRUGB , and DRUGN .
belladonna alkaloids	group	tricyclic antidepressants	group
false

e.g . , other DRUGA , DRUGN ( including DRUGN ) , DRUGN , and DRUGB .
belladonna alkaloids	group	muscle relaxants	group
false

e.g . , other DRUGN , DRUGA ( including DRUGB ) , DRUGN , and DRUGN .
antihistamines	group	meclizine	drug
false

e.g . , other DRUGN , DRUGA ( including DRUGN ) , DRUGB , and DRUGN .
antihistamines	group	tricyclic antidepressants	group
false

e.g . , other DRUGN , DRUGA ( including DRUGN ) , DRUGN , and DRUGB .
antihistamines	group	muscle relaxants	group
false

e.g . , other DRUGN , DRUGN ( including DRUGA ) , DRUGB , and DRUGN .
meclizine	drug	tricyclic antidepressants	group
false

e.g . , other DRUGN , DRUGN ( including DRUGA ) , DRUGN , and DRUGB .
meclizine	drug	muscle relaxants	group
false

e.g . , other DRUGN , DRUGN ( including DRUGN ) , DRUGA , and DRUGB .
tricyclic antidepressants	group	muscle relaxants	group
false

DRUGA may decrease the effectiveness of oral DRUGB , certain DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , and DRUGN .
Barbiturates	group	contraceptives	group
int

DRUGA may decrease the effectiveness of oral DRUGN , certain DRUGB , DRUGN , DRUGN , DRUGN , DRUGN , and DRUGN .
Barbiturates	group	antibiotics	group
int

DRUGA may decrease the effectiveness of oral DRUGN , certain DRUGN , DRUGB , DRUGN , DRUGN , DRUGN , and DRUGN .
Barbiturates	group	quinidine	group
int

DRUGA may decrease the effectiveness of oral DRUGN , certain DRUGN , DRUGN , DRUGB , DRUGN , DRUGN , and DRUGN .
Barbiturates	group	theophylline	drug
int

DRUGA may decrease the effectiveness of oral DRUGN , certain DRUGN , DRUGN , DRUGN , DRUGB , DRUGN , and DRUGN .
Barbiturates	group	corticosteroids	group
int

DRUGA may decrease the effectiveness of oral DRUGN , certain DRUGN , DRUGN , DRUGN , DRUGN , DRUGB , and DRUGN .
Barbiturates	group	anticoagulants	group
int

DRUGA may decrease the effectiveness of oral DRUGN , certain DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , and DRUGB .
Barbiturates	group	beta blockers	group
int

DRUGN may decrease the effectiveness of oral DRUGA , certain DRUGB , DRUGN , DRUGN , DRUGN , DRUGN , and DRUGN .
contraceptives	group	antibiotics	group
false

DRUGN may decrease the effectiveness of oral DRUGA , certain DRUGN , DRUGB , DRUGN , DRUGN , DRUGN , and DRUGN .
contraceptives	group	quinidine	group
false

DRUGN may decrease the effectiveness of oral DRUGA , certain DRUGN , DRUGN , DRUGB , DRUGN , DRUGN , and DRUGN .
contraceptives	group	theophylline	drug
false

DRUGN may decrease the effectiveness of oral DRUGA , certain DRUGN , DRUGN , DRUGN , DRUGB , DRUGN , and DRUGN .
contraceptives	group	corticosteroids	group
false

DRUGN may decrease the effectiveness of oral DRUGA , certain DRUGN , DRUGN , DRUGN , DRUGN , DRUGB , and DRUGN .
contraceptives	group	anticoagulants	group
false

DRUGN may decrease the effectiveness of oral DRUGA , certain DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , and DRUGB .
contraceptives	group	beta blockers	group
false

DRUGN may decrease the effectiveness of oral DRUGN , certain DRUGA , DRUGB , DRUGN , DRUGN , DRUGN , and DRUGN .
antibiotics	group	quinidine	group
false

DRUGN may decrease the effectiveness of oral DRUGN , certain DRUGA , DRUGN , DRUGB , DRUGN , DRUGN , and DRUGN .
antibiotics	group	theophylline	drug
false

DRUGN may decrease the effectiveness of oral DRUGN , certain DRUGA , DRUGN , DRUGN , DRUGB , DRUGN , and DRUGN .
antibiotics	group	corticosteroids	group
false

DRUGN may decrease the effectiveness of oral DRUGN , certain DRUGA , DRUGN , DRUGN , DRUGN , DRUGB , and DRUGN .
antibiotics	group	anticoagulants	group
false

DRUGN may decrease the effectiveness of oral DRUGN , certain DRUGA , DRUGN , DRUGN , DRUGN , DRUGN , and DRUGB .
antibiotics	group	beta blockers	group
false

DRUGN may decrease the effectiveness of oral DRUGN , certain DRUGN , DRUGA , DRUGB , DRUGN , DRUGN , and DRUGN .
quinidine	group	theophylline	drug
false

DRUGN may decrease the effectiveness of oral DRUGN , certain DRUGN , DRUGA , DRUGN , DRUGB , DRUGN , and DRUGN .
quinidine	group	corticosteroids	group
false

DRUGN may decrease the effectiveness of oral DRUGN , certain DRUGN , DRUGA , DRUGN , DRUGN , DRUGB , and DRUGN .
quinidine	group	anticoagulants	group
false

DRUGN may decrease the effectiveness of oral DRUGN , certain DRUGN , DRUGA , DRUGN , DRUGN , DRUGN , and DRUGB .
quinidine	group	beta blockers	group
false

DRUGN may decrease the effectiveness of oral DRUGN , certain DRUGN , DRUGN , DRUGA , DRUGB , DRUGN , and DRUGN .
theophylline	drug	corticosteroids	group
false

DRUGN may decrease the effectiveness of oral DRUGN , certain DRUGN , DRUGN , DRUGA , DRUGN , DRUGB , and DRUGN .
theophylline	drug	anticoagulants	group
false

DRUGN may decrease the effectiveness of oral DRUGN , certain DRUGN , DRUGN , DRUGA , DRUGN , DRUGN , and DRUGB .
theophylline	drug	beta blockers	group
false

DRUGN may decrease the effectiveness of oral DRUGN , certain DRUGN , DRUGN , DRUGN , DRUGA , DRUGB , and DRUGN .
corticosteroids	group	anticoagulants	group
false

DRUGN may decrease the effectiveness of oral DRUGN , certain DRUGN , DRUGN , DRUGN , DRUGA , DRUGN , and DRUGB .
corticosteroids	group	beta blockers	group
false

DRUGN may decrease the effectiveness of oral DRUGN , certain DRUGN , DRUGN , DRUGN , DRUGN , DRUGA , and DRUGB .
anticoagulants	group	beta blockers	group
false

The occurrence of stupor , muscular rigidity , severe agitation , and elevated temperature has been reported in some patients receiving the combination of DRUGA and DRUGB .
selegiline	drug	meperidine	drug
effect

This is typical of the interaction of DRUGA and DRUGB .
meperidine	drug	MAOIs	group
int

Severe toxicity has also been reported in patients receiving the combination of DRUGA and DRUGB and DRUGN and DRUGN .
tricyclic antidepressants	group	ELDEPRYL	brand
effect

Severe toxicity has also been reported in patients receiving the combination of DRUGA and DRUGN and DRUGB and DRUGN .
tricyclic antidepressants	group	selective serotonin reuptake inhibitors	group
false

Severe toxicity has also been reported in patients receiving the combination of DRUGA and DRUGN and DRUGN and DRUGB .
tricyclic antidepressants	group	ELDEPRYL	brand
false

Severe toxicity has also been reported in patients receiving the combination of DRUGN and DRUGA and DRUGB and DRUGN .
ELDEPRYL	brand	selective serotonin reuptake inhibitors	group
false

Severe toxicity has also been reported in patients receiving the combination of DRUGN and DRUGN and DRUGA and DRUGB .
selective serotonin reuptake inhibitors	group	ELDEPRYL	brand
effect

One case of hypertensive crisis has been reported in a patient taking the recommended doses of DRUGA and a DRUGB ( DRUGN ) .
selegiline	drug	sympathomimetic medication	group
effect

One case of hypertensive crisis has been reported in a patient taking the recommended doses of DRUGA and a DRUGN ( DRUGB ) .
selegiline	drug	ephedrine	drug
effect

One case of hypertensive crisis has been reported in a patient taking the recommended doses of DRUGN and a DRUGA ( DRUGB ) .
sympathomimetic medication	group	ephedrine	drug
false

No dosage adjustment of DRUGA or DRUGB is recommended .
digoxin	drug	JANUVIA	brand
false

DRUGA and DRUGB are incompatible with DRUGN solution .
norepinephrine	drug	dobutamine	drug
false

DRUGA and DRUGN are incompatible with DRUGB solution .
norepinephrine	drug	sodium bicarbonate	drug
int

DRUGN and DRUGA are incompatible with DRUGB solution .
dobutamine	drug	sodium bicarbonate	drug
int

The addition of DRUGA to parenteral solutions containing DRUGB should be avoided , except where compatibility has been previously established .
sodium bicarbonate	drug	calcium	drug
false

Do not exceed a dgb mg daily dose of DRUGA when administered with therapeutic doses of DRUGB or other potent CYPdgbAdgb inhibitors .
VESIcare	brand	ketoconazole	drug
advise

Limited published data indicate that DRUGA treatment increases cytochrome Pdgb ( CPdgb ) mediated DRUGB clearance in man .
GH	drug	antipyrine	drug
mechanism

These data suggest that DRUGA administration may alter the clearance of compounds known to be metabolized by CPdgb liver enzymes ( e.g . , DRUGB , DRUGN , DRUGN , DRUGN ) .
GH	drug	corticosteroids	group
mechanism

These data suggest that DRUGA administration may alter the clearance of compounds known to be metabolized by CPdgb liver enzymes ( e.g . , DRUGN , DRUGB , DRUGN , DRUGN ) .
GH	drug	sex steroids	group
mechanism

These data suggest that DRUGA administration may alter the clearance of compounds known to be metabolized by CPdgb liver enzymes ( e.g . , DRUGN , DRUGN , DRUGB , DRUGN ) .
GH	drug	anticonvulsants	group
mechanism

These data suggest that DRUGA administration may alter the clearance of compounds known to be metabolized by CPdgb liver enzymes ( e.g . , DRUGN , DRUGN , DRUGN , DRUGB ) .
GH	drug	cyclosporin	drug
mechanism

These data suggest that DRUGN administration may alter the clearance of compounds known to be metabolized by CPdgb liver enzymes ( e.g . , DRUGA , DRUGB , DRUGN , DRUGN ) .
corticosteroids	group	sex steroids	group
false

These data suggest that DRUGN administration may alter the clearance of compounds known to be metabolized by CPdgb liver enzymes ( e.g . , DRUGA , DRUGN , DRUGB , DRUGN ) .
corticosteroids	group	anticonvulsants	group
false

These data suggest that DRUGN administration may alter the clearance of compounds known to be metabolized by CPdgb liver enzymes ( e.g . , DRUGA , DRUGN , DRUGN , DRUGB ) .
corticosteroids	group	cyclosporin	drug
false

These data suggest that DRUGN administration may alter the clearance of compounds known to be metabolized by CPdgb liver enzymes ( e.g . , DRUGN , DRUGA , DRUGB , DRUGN ) .
sex steroids	group	anticonvulsants	group
false

These data suggest that DRUGN administration may alter the clearance of compounds known to be metabolized by CPdgb liver enzymes ( e.g . , DRUGN , DRUGA , DRUGN , DRUGB ) .
sex steroids	group	cyclosporin	drug
false

These data suggest that DRUGN administration may alter the clearance of compounds known to be metabolized by CPdgb liver enzymes ( e.g . , DRUGN , DRUGN , DRUGA , DRUGB ) .
anticonvulsants	group	cyclosporin	drug
false

Caution is recommended when administering DRUGA with compounds that are metabolized / eliminated predominantly by the UGTdgbAdgb pathway ( e.g . DRUGB ) .
NEXAVAR	brand	irinotecan	drug
advise

Concomitant treatment with DRUGA resulted in a dgb % increase in the AUC of DRUGB .
NEXAVAR	brand	doxorubicin	drug
mechanism

Caution is recommended when administering DRUGA with DRUGB .
doxorubicin	drug	NEXAVAR	brand
advise

DRUGA competitively inhibits the intracellular phosphorylation of DRUGB .
Zidovudine	drug	stavudine	drug
effect

Therefore , use of DRUGA in combination with DRUGB should be avoided .
zidovudine	drug	ZERIT	brand
advise

In vitro data indicate that the phosphorylation of DRUGA is also inhibited at relevant concentrations by DRUGB and DRUGN .
stavudine	drug	doxorubicin	drug
effect

In vitro data indicate that the phosphorylation of DRUGA is also inhibited at relevant concentrations by DRUGN and DRUGB .
stavudine	drug	ribavirin	drug
effect

In vitro data indicate that the phosphorylation of DRUGN is also inhibited at relevant concentrations by DRUGA and DRUGB .
doxorubicin	drug	ribavirin	drug
false

The interaction of DRUGA , DRUGB , with other drugs has not been well studied .
Streptase	brand	Streptokinase	drug
false

Use of DRUGA and DRUGB DRUGN , DRUGN , alone or in combination with DRUGN and DRUGN , may cause bleeding complications .
Anticoagulants	group	Antiplatelet Agents	group
false

Use of DRUGA and DRUGN DRUGB , DRUGN , alone or in combination with DRUGN and DRUGN , may cause bleeding complications .
Anticoagulants	group	Streptase	brand
false

Use of DRUGA and DRUGN DRUGN , DRUGB , alone or in combination with DRUGN and DRUGN , may cause bleeding complications .
Anticoagulants	group	Streptokinase	drug
false

Use of DRUGA and DRUGN DRUGN , DRUGN , alone or in combination with DRUGB and DRUGN , may cause bleeding complications .
Anticoagulants	group	antiplatelet agents	group
false

Use of DRUGA and DRUGN DRUGN , DRUGN , alone or in combination with DRUGN and DRUGB , may cause bleeding complications .
Anticoagulants	group	anticoagulants	group
false

Use of DRUGN and DRUGA DRUGB , DRUGN , alone or in combination with DRUGN and DRUGN , may cause bleeding complications .
Antiplatelet Agents	group	Streptase	brand
false

Use of DRUGN and DRUGA DRUGN , DRUGB , alone or in combination with DRUGN and DRUGN , may cause bleeding complications .
Antiplatelet Agents	group	Streptokinase	drug
false

Use of DRUGN and DRUGA DRUGN , DRUGN , alone or in combination with DRUGB and DRUGN , may cause bleeding complications .
Antiplatelet Agents	group	antiplatelet agents	group
false

Use of DRUGN and DRUGA DRUGN , DRUGN , alone or in combination with DRUGN and DRUGB , may cause bleeding complications .
Antiplatelet Agents	group	anticoagulants	group
false

Use of DRUGN and DRUGN DRUGA , DRUGB , alone or in combination with DRUGN and DRUGN , may cause bleeding complications .
Streptase	brand	Streptokinase	drug
false

Use of DRUGN and DRUGN DRUGA , DRUGN , alone or in combination with DRUGB and DRUGN , may cause bleeding complications .
Streptase	brand	antiplatelet agents	group
effect

Use of DRUGN and DRUGN DRUGA , DRUGN , alone or in combination with DRUGN and DRUGB , may cause bleeding complications .
Streptase	brand	anticoagulants	group
effect

Use of DRUGN and DRUGN DRUGN , DRUGA , alone or in combination with DRUGB and DRUGN , may cause bleeding complications .
Streptokinase	drug	antiplatelet agents	group
effect

Use of DRUGN and DRUGN DRUGN , DRUGA , alone or in combination with DRUGN and DRUGB , may cause bleeding complications .
Streptokinase	drug	anticoagulants	group
effect

Use of DRUGN and DRUGN DRUGN , DRUGN , alone or in combination with DRUGA and DRUGB , may cause bleeding complications .
antiplatelet agents	group	anticoagulants	group
false

In the treatment of acute MI , DRUGA , when not otherwise contraindicated , should be administered with DRUGB ( see below ) .
aspirin	brand	Streptokinase	drug
false

Anticoagulation and DRUGA After Treatment for Myocardial Infarction In the treatment of acute myocardial infarction , the use of DRUGB has been shown to reduce the incidence of reinfarction and stroke .
Antiplatelets	group	aspirin	brand
false

The addition of DRUGA to DRUGB causes a minimal increase in the risk of minor bleeding ( dga % vs. dga % ) , but does not appear to increase the incidence of major bleeding ( see
aspirin	brand	Streptokinase	drug
effect

DRUGA has been reported to prolong the elimination half life of DRUGB and may lead to severe bone marrow suppression ;
Streptozocin	drug	doxorubicin	drug
mechanism

a reduction of the DRUGA dosage should be considered in patients receiving DRUGB concurrently .
doxorubicin	drug	ZANOSAR	brand
advise

The concurrent use of DRUGA and DRUGB has been reported in one case to result in reduced DRUGN cytotoxicity .
streptozocin	drug	phenytoin	drug
effect

The concurrent use of DRUGN and DRUGA has been reported in one case to result in reduced DRUGB cytotoxicity .
phenytoin	drug	streptozocin	drug
false

DRUGA is not known to interact with other drugs including DRUGB supplements ;
CHEMET	brand	iron	drug
false

Concomitant administration of DRUGA with other chelation therapy , such as DRUGB is not recommended .
CHEMET	brand	CaNa 2 EDTA	drug
advise

DRUGA may increase the effects of DRUGB , DRUGN , and DRUGN .
Sulfamethizole	drug	barbiturates	group
effect

DRUGA may increase the effects of DRUGN , DRUGB , and DRUGN .
Sulfamethizole	drug	tolbutamide	drug
effect

DRUGA may increase the effects of DRUGN , DRUGN , and DRUGB .
Sulfamethizole	drug	uricosurics	group
effect

DRUGN may increase the effects of DRUGA , DRUGB , and DRUGN .
barbiturates	group	tolbutamide	drug
false

DRUGN may increase the effects of DRUGA , DRUGN , and DRUGB .
barbiturates	group	uricosurics	group
false

DRUGN may increase the effects of DRUGN , DRUGA , and DRUGB .
tolbutamide	drug	uricosurics	group
false

In elderly patients concurrently receiving certain DRUGA , primarily DRUGB , an increased incidence of thrombopenia with purpura has been reported .
diuretics	group	thiazides	group
false

It has been reported that DRUGA may prolong the prothrombin time in patients who are receiving the DRUGB DRUGN .
sulfamethoxazole	drug	anticoagulant	group
false

It has been reported that DRUGA may prolong the prothrombin time in patients who are receiving the DRUGN DRUGB .
sulfamethoxazole	drug	warfarin	drug
effect

It has been reported that DRUGN may prolong the prothrombin time in patients who are receiving the DRUGA DRUGB .
anticoagulant	group	warfarin	drug
false

DRUGA may inhibit the hepatic metabolism of DRUGB .
Sulfamethoxazole	drug	phenytoin	drug
mechanism

At a dga g dose , DRUGA produced a slight but significant increase in the half life of DRUGB but did not produce a corresponding decrease in the metabolic clearance rate .
sulfamethoxazole	drug	phenytoin	drug
mechanism

DRUGA can also displace DRUGB from plasma protein binding sites , thus increasing free DRUGN concentrations .
Sulfonamides	group	methotrexate	drug
mechanism

DRUGA can also displace DRUGN from plasma protein binding sites , thus increasing free DRUGB concentrations .
Sulfonamides	group	methotrexate	drug
false

Reduced absorption of DRUGA and DRUGB have been reported when those agents were administered concomitantly with DRUGN .
folic acid	drug	digoxin	drug
false

Reduced absorption of DRUGA and DRUGN have been reported when those agents were administered concomitantly with DRUGB .
folic acid	drug	sulfasalazine	drug
mechanism

Reduced absorption of DRUGN and DRUGA have been reported when those agents were administered concomitantly with DRUGB .
digoxin	drug	sulfasalazine	drug
mechanism

When daily doses of DRUGA dgb g and weekly doses of DRUGB dga mg were coadministered to dgb rheumatoid arthritis patients in a drug drug interaction study , the pharmacokinetic disposition of the drugs was not altered .
sulfasalazine	drug	methotrexate	drug
false

DRUGA may increase the effects of DRUGB , DRUGN , and DRUGN .
Sulfoxone	drug	barbiturates	group
effect

DRUGA may increase the effects of DRUGN , DRUGB , and DRUGN .
Sulfoxone	drug	tolbutamide	drug
effect

DRUGA may increase the effects of DRUGN , DRUGN , and DRUGB .
Sulfoxone	drug	uricosurics	group
effect

DRUGN may increase the effects of DRUGA , DRUGB , and DRUGN .
barbiturates	group	tolbutamide	drug
false

DRUGN may increase the effects of DRUGA , DRUGN , and DRUGB .
barbiturates	group	uricosurics	group
false

DRUGN may increase the effects of DRUGN , DRUGA , and DRUGB .
tolbutamide	drug	uricosurics	group
false

Because there is a theoretical basis that these effects may be additive , use of DRUGA containing or DRUGB ( like DRUGN or DRUGN ) and DRUGN within dgb hours of each other should be avoided .
ergotamine	drug	ergot-type medications	group
false

Because there is a theoretical basis that these effects may be additive , use of DRUGA containing or DRUGN ( like DRUGB or DRUGN ) and DRUGN within dgb hours of each other should be avoided .
ergotamine	drug	dihydroergotamine	drug
false

Because there is a theoretical basis that these effects may be additive , use of DRUGA containing or DRUGN ( like DRUGN or DRUGB ) and DRUGN within dgb hours of each other should be avoided .
ergotamine	drug	methysergide	drug
false

Because there is a theoretical basis that these effects may be additive , use of DRUGA containing or DRUGN ( like DRUGN or DRUGN ) and DRUGB within dgb hours of each other should be avoided .
ergotamine	drug	sumatriptan	drug
advise

Because there is a theoretical basis that these effects may be additive , use of DRUGN containing or DRUGA ( like DRUGB or DRUGN ) and DRUGN within dgb hours of each other should be avoided .
ergot-type medications	group	dihydroergotamine	drug
false

Because there is a theoretical basis that these effects may be additive , use of DRUGN containing or DRUGA ( like DRUGN or DRUGB ) and DRUGN within dgb hours of each other should be avoided .
ergot-type medications	group	methysergide	drug
false

Because there is a theoretical basis that these effects may be additive , use of DRUGN containing or DRUGA ( like DRUGN or DRUGN ) and DRUGB within dgb hours of each other should be avoided .
ergot-type medications	group	sumatriptan	drug
advise

Because there is a theoretical basis that these effects may be additive , use of DRUGN containing or DRUGN ( like DRUGA or DRUGB ) and DRUGN within dgb hours of each other should be avoided .
dihydroergotamine	drug	methysergide	drug
false

Because there is a theoretical basis that these effects may be additive , use of DRUGN containing or DRUGN ( like DRUGA or DRUGN ) and DRUGB within dgb hours of each other should be avoided .
dihydroergotamine	drug	sumatriptan	drug
advise

Because there is a theoretical basis that these effects may be additive , use of DRUGN containing or DRUGN ( like DRUGN or DRUGA ) and DRUGB within dgb hours of each other should be avoided .
methysergide	drug	sumatriptan	drug
advise

DRUGA reduce DRUGB clearance , significantly increasing systemic exposure .
MAO-A inhibitors	group	sumatriptan	drug
mechanism

If concomitant treatment with DRUGA and an DRUGB is clinically warranted , appropriate observation of the patient is advised .
sumatriptan	drug	SSRI	group
advise

Co administration of DRUGA with inducers of the CYPdgbAdgb family ( e.g . , DRUGB , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , St. Johns Wort ) may decrease DRUGN concentrations .
SUTENT	brand	dexamethasone	drug
mechanism

Co administration of DRUGA with inducers of the CYPdgbAdgb family ( e.g . , DRUGN , DRUGB , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , St. Johns Wort ) may decrease DRUGN concentrations .
SUTENT	brand	phenytoin	drug
mechanism

Co administration of DRUGA with inducers of the CYPdgbAdgb family ( e.g . , DRUGN , DRUGN , DRUGB , DRUGN , DRUGN , DRUGN , DRUGN , St. Johns Wort ) may decrease DRUGN concentrations .
SUTENT	brand	carbamazepine	drug
mechanism

Co administration of DRUGA with inducers of the CYPdgbAdgb family ( e.g . , DRUGN , DRUGN , DRUGN , DRUGB , DRUGN , DRUGN , DRUGN , St. Johns Wort ) may decrease DRUGN concentrations .
SUTENT	brand	rifampin	drug
mechanism

Co administration of DRUGA with inducers of the CYPdgbAdgb family ( e.g . , DRUGN , DRUGN , DRUGN , DRUGN , DRUGB , DRUGN , DRUGN , St. Johns Wort ) may decrease DRUGN concentrations .
SUTENT	brand	rifabutin	drug
mechanism

Co administration of DRUGA with inducers of the CYPdgbAdgb family ( e.g . , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGB , DRUGN , St. Johns Wort ) may decrease DRUGN concentrations .
SUTENT	brand	rifapentin	drug
mechanism

Co administration of DRUGA with inducers of the CYPdgbAdgb family ( e.g . , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGB , St. Johns Wort ) may decrease DRUGN concentrations .
SUTENT	brand	phenobarbital	drug
mechanism

Co administration of DRUGA with inducers of the CYPdgbAdgb family ( e.g . , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , St. Johns Wort ) may decrease DRUGB concentrations .
SUTENT	brand	sunitinib	drug
false

Co administration of DRUGN with inducers of the CYPdgbAdgb family ( e.g . , DRUGA , DRUGB , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , St. Johns Wort ) may decrease DRUGN concentrations .
dexamethasone	drug	phenytoin	drug
false

Co administration of DRUGN with inducers of the CYPdgbAdgb family ( e.g . , DRUGA , DRUGN , DRUGB , DRUGN , DRUGN , DRUGN , DRUGN , St. Johns Wort ) may decrease DRUGN concentrations .
dexamethasone	drug	carbamazepine	drug
false

Co administration of DRUGN with inducers of the CYPdgbAdgb family ( e.g . , DRUGA , DRUGN , DRUGN , DRUGB , DRUGN , DRUGN , DRUGN , St. Johns Wort ) may decrease DRUGN concentrations .
dexamethasone	drug	rifampin	drug
false

Co administration of DRUGN with inducers of the CYPdgbAdgb family ( e.g . , DRUGA , DRUGN , DRUGN , DRUGN , DRUGB , DRUGN , DRUGN , St. Johns Wort ) may decrease DRUGN concentrations .
dexamethasone	drug	rifabutin	drug
false

Co administration of DRUGN with inducers of the CYPdgbAdgb family ( e.g . , DRUGA , DRUGN , DRUGN , DRUGN , DRUGN , DRUGB , DRUGN , St. Johns Wort ) may decrease DRUGN concentrations .
dexamethasone	drug	rifapentin	drug
false

Co administration of DRUGN with inducers of the CYPdgbAdgb family ( e.g . , DRUGA , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGB , St. Johns Wort ) may decrease DRUGN concentrations .
dexamethasone	drug	phenobarbital	drug
false

Co administration of DRUGN with inducers of the CYPdgbAdgb family ( e.g . , DRUGA , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , St. Johns Wort ) may decrease DRUGB concentrations .
dexamethasone	drug	sunitinib	drug
false

Co administration of DRUGN with inducers of the CYPdgbAdgb family ( e.g . , DRUGN , DRUGA , DRUGB , DRUGN , DRUGN , DRUGN , DRUGN , St. Johns Wort ) may decrease DRUGN concentrations .
phenytoin	drug	carbamazepine	drug
false

Co administration of DRUGN with inducers of the CYPdgbAdgb family ( e.g . , DRUGN , DRUGA , DRUGN , DRUGB , DRUGN , DRUGN , DRUGN , St. Johns Wort ) may decrease DRUGN concentrations .
phenytoin	drug	rifampin	drug
false

Co administration of DRUGN with inducers of the CYPdgbAdgb family ( e.g . , DRUGN , DRUGA , DRUGN , DRUGN , DRUGB , DRUGN , DRUGN , St. Johns Wort ) may decrease DRUGN concentrations .
phenytoin	drug	rifabutin	drug
false

Co administration of DRUGN with inducers of the CYPdgbAdgb family ( e.g . , DRUGN , DRUGA , DRUGN , DRUGN , DRUGN , DRUGB , DRUGN , St. Johns Wort ) may decrease DRUGN concentrations .
phenytoin	drug	rifapentin	drug
false

Co administration of DRUGN with inducers of the CYPdgbAdgb family ( e.g . , DRUGN , DRUGA , DRUGN , DRUGN , DRUGN , DRUGN , DRUGB , St. Johns Wort ) may decrease DRUGN concentrations .
phenytoin	drug	phenobarbital	drug
false

Co administration of DRUGN with inducers of the CYPdgbAdgb family ( e.g . , DRUGN , DRUGA , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , St. Johns Wort ) may decrease DRUGB concentrations .
phenytoin	drug	sunitinib	drug
false

Co administration of DRUGN with inducers of the CYPdgbAdgb family ( e.g . , DRUGN , DRUGN , DRUGA , DRUGB , DRUGN , DRUGN , DRUGN , St. Johns Wort ) may decrease DRUGN concentrations .
carbamazepine	drug	rifampin	drug
false

Co administration of DRUGN with inducers of the CYPdgbAdgb family ( e.g . , DRUGN , DRUGN , DRUGA , DRUGN , DRUGB , DRUGN , DRUGN , St. Johns Wort ) may decrease DRUGN concentrations .
carbamazepine	drug	rifabutin	drug
false

Co administration of DRUGN with inducers of the CYPdgbAdgb family ( e.g . , DRUGN , DRUGN , DRUGA , DRUGN , DRUGN , DRUGB , DRUGN , St. Johns Wort ) may decrease DRUGN concentrations .
carbamazepine	drug	rifapentin	drug
false

Co administration of DRUGN with inducers of the CYPdgbAdgb family ( e.g . , DRUGN , DRUGN , DRUGA , DRUGN , DRUGN , DRUGN , DRUGB , St. Johns Wort ) may decrease DRUGN concentrations .
carbamazepine	drug	phenobarbital	drug
false

Co administration of DRUGN with inducers of the CYPdgbAdgb family ( e.g . , DRUGN , DRUGN , DRUGA , DRUGN , DRUGN , DRUGN , DRUGN , St. Johns Wort ) may decrease DRUGB concentrations .
carbamazepine	drug	sunitinib	drug
false

Co administration of DRUGN with inducers of the CYPdgbAdgb family ( e.g . , DRUGN , DRUGN , DRUGN , DRUGA , DRUGB , DRUGN , DRUGN , St. Johns Wort ) may decrease DRUGN concentrations .
rifampin	drug	rifabutin	drug
false

Co administration of DRUGN with inducers of the CYPdgbAdgb family ( e.g . , DRUGN , DRUGN , DRUGN , DRUGA , DRUGN , DRUGB , DRUGN , St. Johns Wort ) may decrease DRUGN concentrations .
rifampin	drug	rifapentin	drug
false

Co administration of DRUGN with inducers of the CYPdgbAdgb family ( e.g . , DRUGN , DRUGN , DRUGN , DRUGA , DRUGN , DRUGN , DRUGB , St. Johns Wort ) may decrease DRUGN concentrations .
rifampin	drug	phenobarbital	drug
false

Co administration of DRUGN with inducers of the CYPdgbAdgb family ( e.g . , DRUGN , DRUGN , DRUGN , DRUGA , DRUGN , DRUGN , DRUGN , St. Johns Wort ) may decrease DRUGB concentrations .
rifampin	drug	sunitinib	drug
false

Co administration of DRUGN with inducers of the CYPdgbAdgb family ( e.g . , DRUGN , DRUGN , DRUGN , DRUGN , DRUGA , DRUGB , DRUGN , St. Johns Wort ) may decrease DRUGN concentrations .
rifabutin	drug	rifapentin	drug
false

Co administration of DRUGN with inducers of the CYPdgbAdgb family ( e.g . , DRUGN , DRUGN , DRUGN , DRUGN , DRUGA , DRUGN , DRUGB , St. Johns Wort ) may decrease DRUGN concentrations .
rifabutin	drug	phenobarbital	drug
false

Co administration of DRUGN with inducers of the CYPdgbAdgb family ( e.g . , DRUGN , DRUGN , DRUGN , DRUGN , DRUGA , DRUGN , DRUGN , St. Johns Wort ) may decrease DRUGB concentrations .
rifabutin	drug	sunitinib	drug
false

Co administration of DRUGN with inducers of the CYPdgbAdgb family ( e.g . , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGA , DRUGB , St. Johns Wort ) may decrease DRUGN concentrations .
rifapentin	drug	phenobarbital	drug
false

Co administration of DRUGN with inducers of the CYPdgbAdgb family ( e.g . , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGA , DRUGN , St. Johns Wort ) may decrease DRUGB concentrations .
rifapentin	drug	sunitinib	drug
false

Co administration of DRUGN with inducers of the CYPdgbAdgb family ( e.g . , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGA , St. Johns Wort ) may decrease DRUGB concentrations .
phenobarbital	drug	sunitinib	drug
false

Other eye drops or medications such as DRUGA ( DRUGB ) and DRUGN ( DRUGN , DRUGN ) may decrease the effects of DRUGN ophthalmic .
acetylcholine chloride	drug	Miochol	brand
false

Other eye drops or medications such as DRUGA ( DRUGN ) and DRUGB ( DRUGN , DRUGN ) may decrease the effects of DRUGN ophthalmic .
acetylcholine chloride	drug	carbachol	drug
false

Other eye drops or medications such as DRUGA ( DRUGN ) and DRUGN ( DRUGB , DRUGN ) may decrease the effects of DRUGN ophthalmic .
acetylcholine chloride	drug	Carboptic	brand
false

Other eye drops or medications such as DRUGA ( DRUGN ) and DRUGN ( DRUGN , DRUGB ) may decrease the effects of DRUGN ophthalmic .
acetylcholine chloride	drug	Isopto Carbachol	brand
false

Other eye drops or medications such as DRUGA ( DRUGN ) and DRUGN ( DRUGN , DRUGN ) may decrease the effects of DRUGB ophthalmic .
acetylcholine chloride	drug	suprofen	drug
effect

Other eye drops or medications such as DRUGN ( DRUGA ) and DRUGB ( DRUGN , DRUGN ) may decrease the effects of DRUGN ophthalmic .
Miochol	brand	carbachol	drug
false

Other eye drops or medications such as DRUGN ( DRUGA ) and DRUGN ( DRUGB , DRUGN ) may decrease the effects of DRUGN ophthalmic .
Miochol	brand	Carboptic	brand
false

Other eye drops or medications such as DRUGN ( DRUGA ) and DRUGN ( DRUGN , DRUGB ) may decrease the effects of DRUGN ophthalmic .
Miochol	brand	Isopto Carbachol	brand
false

Other eye drops or medications such as DRUGN ( DRUGA ) and DRUGN ( DRUGN , DRUGN ) may decrease the effects of DRUGB ophthalmic .
Miochol	brand	suprofen	drug
effect

Other eye drops or medications such as DRUGN ( DRUGN ) and DRUGA ( DRUGB , DRUGN ) may decrease the effects of DRUGN ophthalmic .
carbachol	drug	Carboptic	brand
false

Other eye drops or medications such as DRUGN ( DRUGN ) and DRUGA ( DRUGN , DRUGB ) may decrease the effects of DRUGN ophthalmic .
carbachol	drug	Isopto Carbachol	brand
false

Other eye drops or medications such as DRUGN ( DRUGN ) and DRUGA ( DRUGN , DRUGN ) may decrease the effects of DRUGB ophthalmic .
carbachol	drug	suprofen	drug
effect

Other eye drops or medications such as DRUGN ( DRUGN ) and DRUGN ( DRUGA , DRUGB ) may decrease the effects of DRUGN ophthalmic .
Carboptic	brand	Isopto Carbachol	brand
false

Other eye drops or medications such as DRUGN ( DRUGN ) and DRUGN ( DRUGA , DRUGN ) may decrease the effects of DRUGB ophthalmic .
Carboptic	brand	suprofen	drug
effect

Other eye drops or medications such as DRUGN ( DRUGN ) and DRUGN ( DRUGN , DRUGA ) may decrease the effects of DRUGB ophthalmic .
Isopto Carbachol	brand	suprofen	drug
effect

Drug Drug Interactions : The pharmacokinetic and pharmacodynamic interactions between DRUGA capsules and other DRUGB have not been determined .
FLOMAX	brand	alpha-adrenergic blocking agents	group
false

However , interactions may be expected and DRUGA capsules should NOT be used in combination with other DRUGB .
FLOMAX	brand	alpha-adrenergic blocking agents	group
advise

The pharmacokinetic interaction between DRUGA and DRUGB capsules was investigated .
cimetidine	drug	FLOMAX	brand
false

Therefore , DRUGA capsules should be used with caution in combination with DRUGB , particularly at doses higher than dga mg .
FLOMAX	brand	cimetidine	drug
advise

Results from limited in vitro and in vivo drug drug interaction studies between DRUGA and DRUGB are inconclusive .
tamsulosin HCI	drug	warfarin	drug
false

Therefore , caution should be exercised with concomitant administration of DRUGA and DRUGB capsules .
warfarin	drug	FLOMAX	brand
advise

Administration of DRUGA decreases oral clearance of DRUGB by about dgb % .
valproic acid	drug	temozolomide	drug
mechanism

Patients studied in clinical trials of DRUGA were routinely treated with DRUGB and DRUGN .
TNKase	brand	heparin	drug
false

Patients studied in clinical trials of DRUGA were routinely treated with DRUGN and DRUGB .
TNKase	brand	aspirin	brand
false

Patients studied in clinical trials of DRUGN were routinely treated with DRUGA and DRUGB .
heparin	drug	aspirin	brand
false

In a study in which dgb different drugs were tested , therapeutically relevant concentrations of DRUGA , DRUGB and DRUGN displaced protein bound DRUGN in fresh human serum to a small but significant extent .
tolbutamide	drug	sodium salicylate	drug
false

In a study in which dgb different drugs were tested , therapeutically relevant concentrations of DRUGA , DRUGN and DRUGB displaced protein bound DRUGN in fresh human serum to a small but significant extent .
tolbutamide	drug	sulfamethizole	drug
false

In a study in which dgb different drugs were tested , therapeutically relevant concentrations of DRUGA , DRUGN and DRUGN displaced protein bound DRUGB in fresh human serum to a small but significant extent .
tolbutamide	drug	teniposide	drug
mechanism

In a study in which dgb different drugs were tested , therapeutically relevant concentrations of DRUGN , DRUGA and DRUGB displaced protein bound DRUGN in fresh human serum to a small but significant extent .
sodium salicylate	drug	sulfamethizole	drug
false

In a study in which dgb different drugs were tested , therapeutically relevant concentrations of DRUGN , DRUGA and DRUGN displaced protein bound DRUGB in fresh human serum to a small but significant extent .
sodium salicylate	drug	teniposide	drug
mechanism

In a study in which dgb different drugs were tested , therapeutically relevant concentrations of DRUGN , DRUGN and DRUGA displaced protein bound DRUGB in fresh human serum to a small but significant extent .
sulfamethizole	drug	teniposide	drug
mechanism

Therefore , caution should be used in administering DRUGA ( DRUGB injection ) to patients receiving these other agents .
VUMON	brand	teniposide	drug
false

There was no change in the plasma kinetics of DRUGA when coadministered with DRUGB .
teniposide	drug	methotrexate	drug
false

An increase in intracellular levels of DRUGA was observed in vitro in the presence of DRUGB .
methotrexate	drug	teniposide	drug
mechanism

In vitro studies with human liver microsomes showed that DRUGA does not inhibit the metabolism of DRUGB , DRUGN , DRUGN , and DRUGN .
terbinafine	drug	tolbutamide	drug
false

In vitro studies with human liver microsomes showed that DRUGA does not inhibit the metabolism of DRUGN , DRUGB , DRUGN , and DRUGN .
terbinafine	drug	ethinylestradiol	drug
false

In vitro studies with human liver microsomes showed that DRUGA does not inhibit the metabolism of DRUGN , DRUGN , DRUGB , and DRUGN .
terbinafine	drug	ethoxycoumarin	drug_n
false

In vitro studies with human liver microsomes showed that DRUGA does not inhibit the metabolism of DRUGN , DRUGN , DRUGN , and DRUGB .
terbinafine	drug	cyclosporine	drug
false

In vitro studies with human liver microsomes showed that DRUGN does not inhibit the metabolism of DRUGA , DRUGB , DRUGN , and DRUGN .
tolbutamide	drug	ethinylestradiol	drug
false

In vitro studies with human liver microsomes showed that DRUGN does not inhibit the metabolism of DRUGA , DRUGN , DRUGB , and DRUGN .
tolbutamide	drug	ethoxycoumarin	drug_n
false

In vitro studies with human liver microsomes showed that DRUGN does not inhibit the metabolism of DRUGA , DRUGN , DRUGN , and DRUGB .
tolbutamide	drug	cyclosporine	drug
false

In vitro studies with human liver microsomes showed that DRUGN does not inhibit the metabolism of DRUGN , DRUGA , DRUGB , and DRUGN .
ethinylestradiol	drug	ethoxycoumarin	drug_n
false

In vitro studies with human liver microsomes showed that DRUGN does not inhibit the metabolism of DRUGN , DRUGA , DRUGN , and DRUGB .
ethinylestradiol	drug	cyclosporine	drug
false

In vitro studies with human liver microsomes showed that DRUGN does not inhibit the metabolism of DRUGN , DRUGN , DRUGA , and DRUGB .
ethoxycoumarin	drug_n	cyclosporine	drug
false

This may be of clinical relevance for compounds predominantly metabolized by this enzyme , such as DRUGA , blockers , DRUGB ( DRUGN ) , and DRUGN , if they have a narrow therapeutic window .
tricyclic antidepressants	group	selective serotonin reuptake inhibitors	group
false

This may be of clinical relevance for compounds predominantly metabolized by this enzyme , such as DRUGA , blockers , DRUGN ( DRUGB ) , and DRUGN , if they have a narrow therapeutic window .
tricyclic antidepressants	group	SSRIs	group
false

This may be of clinical relevance for compounds predominantly metabolized by this enzyme , such as DRUGA , blockers , DRUGN ( DRUGN ) , and DRUGB , if they have a narrow therapeutic window .
tricyclic antidepressants	group	monoamine oxidase inhibitors (MAO-Is) Type B	group
false

This may be of clinical relevance for compounds predominantly metabolized by this enzyme , such as DRUGN , blockers , DRUGA ( DRUGB ) , and DRUGN , if they have a narrow therapeutic window .
selective serotonin reuptake inhibitors	group	SSRIs	group
false

This may be of clinical relevance for compounds predominantly metabolized by this enzyme , such as DRUGN , blockers , DRUGA ( DRUGN ) , and DRUGB , if they have a narrow therapeutic window .
selective serotonin reuptake inhibitors	group	monoamine oxidase inhibitors (MAO-Is) Type B	group
false

This may be of clinical relevance for compounds predominantly metabolized by this enzyme , such as DRUGN , blockers , DRUGN ( DRUGA ) , and DRUGB , if they have a narrow therapeutic window .
SSRIs	group	monoamine oxidase inhibitors (MAO-Is) Type B	group
false

In vivo drug drug interaction studies conducted in normal volunteer subjects showed that DRUGA does not affect the clearance of DRUGB or DRUGN .
terbinafine	drug	antipyrine	drug
false

In vivo drug drug interaction studies conducted in normal volunteer subjects showed that DRUGA does not affect the clearance of DRUGN or DRUGB .
terbinafine	drug	digoxin	drug
false

In vivo drug drug interaction studies conducted in normal volunteer subjects showed that DRUGN does not affect the clearance of DRUGA or DRUGB .
antipyrine	drug	digoxin	drug
false

DRUGA decreases the clearance of DRUGB by dgb % .
Terbinafine	drug	caffeine	drug
mechanism

DRUGA increases the clearance of DRUGB by dgb % .
Terbinafine	drug	cyclosporine	drug
mechanism

There have been spontaneous reports of increase or decrease in prothrombin times in patients concomitantly taking oral DRUGA and DRUGB , however , a causal relationship between DRUGN Tablets and these changes has not been established .
terbinafine	drug	warfarin	drug
effect

There have been spontaneous reports of increase or decrease in prothrombin times in patients concomitantly taking oral DRUGA and DRUGN , however , a causal relationship between DRUGB Tablets and these changes has not been established .
terbinafine	drug	LAMISIL	brand
false

There have been spontaneous reports of increase or decrease in prothrombin times in patients concomitantly taking oral DRUGN and DRUGA , however , a causal relationship between DRUGB Tablets and these changes has not been established .
warfarin	drug	LAMISIL	brand
false

DRUGA clearance is increased dgb % by DRUGB , a CyPdgb enzyme inducer , and decreased dgb % by DRUGN , a CyPdgb enzyme inhibitor .
Terbinafine	drug	rifampin	drug
mechanism

DRUGA clearance is increased dgb % by DRUGN , a CyPdgb enzyme inducer , and decreased dgb % by DRUGB , a CyPdgb enzyme inhibitor .
Terbinafine	drug	cimetidine	drug
mechanism

DRUGN clearance is increased dgb % by DRUGA , a CyPdgb enzyme inducer , and decreased dgb % by DRUGB , a CyPdgb enzyme inhibitor .
rifampin	drug	cimetidine	drug
false

DRUGA clearance is unaffected by DRUGB .
Terbinafine	drug	cyclosporine	drug
false

There is no information available from adequate drug drug interaction studies with the following classes of drugs : oral DRUGA , hormone replacement therapies , DRUGB , DRUGN , DRUGN , DRUGN , DRUGN , and DRUGN .
contraceptives	group	hypoglycemics	group
false

There is no information available from adequate drug drug interaction studies with the following classes of drugs : oral DRUGA , hormone replacement therapies , DRUGN , DRUGB , DRUGN , DRUGN , DRUGN , and DRUGN .
contraceptives	group	theophyllines	drug
false

There is no information available from adequate drug drug interaction studies with the following classes of drugs : oral DRUGA , hormone replacement therapies , DRUGN , DRUGN , DRUGB , DRUGN , DRUGN , and DRUGN .
contraceptives	group	phenytoins	drug
false

There is no information available from adequate drug drug interaction studies with the following classes of drugs : oral DRUGA , hormone replacement therapies , DRUGN , DRUGN , DRUGN , DRUGB , DRUGN , and DRUGN .
contraceptives	group	thiazide diuretics	group
false

There is no information available from adequate drug drug interaction studies with the following classes of drugs : oral DRUGA , hormone replacement therapies , DRUGN , DRUGN , DRUGN , DRUGN , DRUGB , and DRUGN .
contraceptives	group	beta blockers	group
false

There is no information available from adequate drug drug interaction studies with the following classes of drugs : oral DRUGA , hormone replacement therapies , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , and DRUGB .
contraceptives	group	calcium channel blockers	group
false

There is no information available from adequate drug drug interaction studies with the following classes of drugs : oral DRUGN , hormone replacement therapies , DRUGA , DRUGB , DRUGN , DRUGN , DRUGN , and DRUGN .
hypoglycemics	group	theophyllines	drug
false

There is no information available from adequate drug drug interaction studies with the following classes of drugs : oral DRUGN , hormone replacement therapies , DRUGA , DRUGN , DRUGB , DRUGN , DRUGN , and DRUGN .
hypoglycemics	group	phenytoins	drug
false

There is no information available from adequate drug drug interaction studies with the following classes of drugs : oral DRUGN , hormone replacement therapies , DRUGA , DRUGN , DRUGN , DRUGB , DRUGN , and DRUGN .
hypoglycemics	group	thiazide diuretics	group
false

There is no information available from adequate drug drug interaction studies with the following classes of drugs : oral DRUGN , hormone replacement therapies , DRUGA , DRUGN , DRUGN , DRUGN , DRUGB , and DRUGN .
hypoglycemics	group	beta blockers	group
false

There is no information available from adequate drug drug interaction studies with the following classes of drugs : oral DRUGN , hormone replacement therapies , DRUGA , DRUGN , DRUGN , DRUGN , DRUGN , and DRUGB .
hypoglycemics	group	calcium channel blockers	group
false

There is no information available from adequate drug drug interaction studies with the following classes of drugs : oral DRUGN , hormone replacement therapies , DRUGN , DRUGA , DRUGB , DRUGN , DRUGN , and DRUGN .
theophyllines	drug	phenytoins	drug
false

There is no information available from adequate drug drug interaction studies with the following classes of drugs : oral DRUGN , hormone replacement therapies , DRUGN , DRUGA , DRUGN , DRUGB , DRUGN , and DRUGN .
theophyllines	drug	thiazide diuretics	group
false

There is no information available from adequate drug drug interaction studies with the following classes of drugs : oral DRUGN , hormone replacement therapies , DRUGN , DRUGA , DRUGN , DRUGN , DRUGB , and DRUGN .
theophyllines	drug	beta blockers	group
false

There is no information available from adequate drug drug interaction studies with the following classes of drugs : oral DRUGN , hormone replacement therapies , DRUGN , DRUGA , DRUGN , DRUGN , DRUGN , and DRUGB .
theophyllines	drug	calcium channel blockers	group
false

There is no information available from adequate drug drug interaction studies with the following classes of drugs : oral DRUGN , hormone replacement therapies , DRUGN , DRUGN , DRUGA , DRUGB , DRUGN , and DRUGN .
phenytoins	drug	thiazide diuretics	group
false

There is no information available from adequate drug drug interaction studies with the following classes of drugs : oral DRUGN , hormone replacement therapies , DRUGN , DRUGN , DRUGA , DRUGN , DRUGB , and DRUGN .
phenytoins	drug	beta blockers	group
false

There is no information available from adequate drug drug interaction studies with the following classes of drugs : oral DRUGN , hormone replacement therapies , DRUGN , DRUGN , DRUGA , DRUGN , DRUGN , and DRUGB .
phenytoins	drug	calcium channel blockers	group
false

There is no information available from adequate drug drug interaction studies with the following classes of drugs : oral DRUGN , hormone replacement therapies , DRUGN , DRUGN , DRUGN , DRUGA , DRUGB , and DRUGN .
thiazide diuretics	group	beta blockers	group
false

There is no information available from adequate drug drug interaction studies with the following classes of drugs : oral DRUGN , hormone replacement therapies , DRUGN , DRUGN , DRUGN , DRUGA , DRUGN , and DRUGB .
thiazide diuretics	group	calcium channel blockers	group
false

There is no information available from adequate drug drug interaction studies with the following classes of drugs : oral DRUGN , hormone replacement therapies , DRUGN , DRUGN , DRUGN , DRUGN , DRUGA , and DRUGB .
beta blockers	group	calcium channel blockers	group
false

DRUGA : Spontaneous adverse reaction reports of patients taking concomitant DRUGB with recommended doses of DRUGN demonstrate QT interval prolongation and rare serious cardiac events , e.g .
Ketoconazole	drug	ketoconazole	drug
false

DRUGA : Spontaneous adverse reaction reports of patients taking concomitant DRUGN with recommended doses of DRUGB demonstrate QT interval prolongation and rare serious cardiac events , e.g .
Ketoconazole	drug	terfenadine	drug
false

DRUGN : Spontaneous adverse reaction reports of patients taking concomitant DRUGA with recommended doses of DRUGB demonstrate QT interval prolongation and rare serious cardiac events , e.g .
ketoconazole	drug	terfenadine	drug
effect

Pharmacokinetic data indicate that DRUGA markedly inhibits the metabolism of DRUGB , resulting in elevated plasma DRUGN levels .
ketoconazole	drug	terfenadine	drug
mechanism

Pharmacokinetic data indicate that DRUGA markedly inhibits the metabolism of DRUGN , resulting in elevated plasma DRUGB levels .
ketoconazole	drug	terfenadine	drug
false

Concomitant administration of DRUGA and DRUGB is contraindicated .
ketoconazole	drug	terfenadine	drug
advise

DRUGA : Torsades de pointes and elevated parent DRUGB levels have been reported during concomitant use of DRUGN and DRUGN in clinical trials of DRUGN and from foreign post marketing sources .
Itraconazole	drug	terfenadine	drug
false

DRUGA : Torsades de pointes and elevated parent DRUGN levels have been reported during concomitant use of DRUGB and DRUGN in clinical trials of DRUGN and from foreign post marketing sources .
Itraconazole	drug	terfenadine	drug
false

DRUGA : Torsades de pointes and elevated parent DRUGN levels have been reported during concomitant use of DRUGN and DRUGB in clinical trials of DRUGN and from foreign post marketing sources .
Itraconazole	drug	itraconazole	drug
false

DRUGA : Torsades de pointes and elevated parent DRUGN levels have been reported during concomitant use of DRUGN and DRUGN in clinical trials of DRUGB and from foreign post marketing sources .
Itraconazole	drug	itraconazole	drug
false

DRUGN : Torsades de pointes and elevated parent DRUGA levels have been reported during concomitant use of DRUGN and DRUGB in clinical trials of DRUGN and from foreign post marketing sources .
terfenadine	drug	itraconazole	drug
false

DRUGN : Torsades de pointes and elevated parent DRUGA levels have been reported during concomitant use of DRUGN and DRUGN in clinical trials of DRUGB and from foreign post marketing sources .
terfenadine	drug	itraconazole	drug
false

DRUGN : Torsades de pointes and elevated parent DRUGN levels have been reported during concomitant use of DRUGA and DRUGB in clinical trials of DRUGN and from foreign post marketing sources .
terfenadine	drug	itraconazole	drug
mechanism

DRUGN : Torsades de pointes and elevated parent DRUGN levels have been reported during concomitant use of DRUGA and DRUGN in clinical trials of DRUGB and from foreign post marketing sources .
terfenadine	drug	itraconazole	drug
false

Concomitant administration of DRUGA and DRUGB is contraindicated .
itraconazole	drug	terfenadine	drug
advise

Due to the chemical similarity of other DRUGA ( including DRUGB , DRUGN , and DRUGN ) to DRUGN , and DRUGN , concomitant use of these products with DRUGN is not recommended pending full examination of potential interactions .
azole-type antifungal agents	group	fluconazole	drug
false

Due to the chemical similarity of other DRUGA ( including DRUGN , DRUGB , and DRUGN ) to DRUGN , and DRUGN , concomitant use of these products with DRUGN is not recommended pending full examination of potential interactions .
azole-type antifungal agents	group	metronidazole	drug
false

Due to the chemical similarity of other DRUGA ( including DRUGN , DRUGN , and DRUGB ) to DRUGN , and DRUGN , concomitant use of these products with DRUGN is not recommended pending full examination of potential interactions .
azole-type antifungal agents	group	miconazole	drug
false

Due to the chemical similarity of other DRUGA ( including DRUGN , DRUGN , and DRUGN ) to DRUGB , and DRUGN , concomitant use of these products with DRUGN is not recommended pending full examination of potential interactions .
azole-type antifungal agents	group	ketoconazole	drug
false

Due to the chemical similarity of other DRUGA ( including DRUGN , DRUGN , and DRUGN ) to DRUGN , and DRUGB , concomitant use of these products with DRUGN is not recommended pending full examination of potential interactions .
azole-type antifungal agents	group	itraconazole	drug
false

Due to the chemical similarity of other DRUGA ( including DRUGN , DRUGN , and DRUGN ) to DRUGN , and DRUGN , concomitant use of these products with DRUGB is not recommended pending full examination of potential interactions .
azole-type antifungal agents	group	terfenadine	drug
advise

Due to the chemical similarity of other DRUGN ( including DRUGA , DRUGB , and DRUGN ) to DRUGN , and DRUGN , concomitant use of these products with DRUGN is not recommended pending full examination of potential interactions .
fluconazole	drug	metronidazole	drug
false

Due to the chemical similarity of other DRUGN ( including DRUGA , DRUGN , and DRUGB ) to DRUGN , and DRUGN , concomitant use of these products with DRUGN is not recommended pending full examination of potential interactions .
fluconazole	drug	miconazole	drug
false

Due to the chemical similarity of other DRUGN ( including DRUGA , DRUGN , and DRUGN ) to DRUGB , and DRUGN , concomitant use of these products with DRUGN is not recommended pending full examination of potential interactions .
fluconazole	drug	ketoconazole	drug
false

Due to the chemical similarity of other DRUGN ( including DRUGA , DRUGN , and DRUGN ) to DRUGN , and DRUGB , concomitant use of these products with DRUGN is not recommended pending full examination of potential interactions .
fluconazole	drug	itraconazole	drug
false

Due to the chemical similarity of other DRUGN ( including DRUGA , DRUGN , and DRUGN ) to DRUGN , and DRUGN , concomitant use of these products with DRUGB is not recommended pending full examination of potential interactions .
fluconazole	drug	terfenadine	drug
advise

Due to the chemical similarity of other DRUGN ( including DRUGN , DRUGA , and DRUGB ) to DRUGN , and DRUGN , concomitant use of these products with DRUGN is not recommended pending full examination of potential interactions .
metronidazole	drug	miconazole	drug
false

Due to the chemical similarity of other DRUGN ( including DRUGN , DRUGA , and DRUGN ) to DRUGB , and DRUGN , concomitant use of these products with DRUGN is not recommended pending full examination of potential interactions .
metronidazole	drug	ketoconazole	drug
false

Due to the chemical similarity of other DRUGN ( including DRUGN , DRUGA , and DRUGN ) to DRUGN , and DRUGB , concomitant use of these products with DRUGN is not recommended pending full examination of potential interactions .
metronidazole	drug	itraconazole	drug
false

Due to the chemical similarity of other DRUGN ( including DRUGN , DRUGA , and DRUGN ) to DRUGN , and DRUGN , concomitant use of these products with DRUGB is not recommended pending full examination of potential interactions .
metronidazole	drug	terfenadine	drug
advise

Due to the chemical similarity of other DRUGN ( including DRUGN , DRUGN , and DRUGA ) to DRUGB , and DRUGN , concomitant use of these products with DRUGN is not recommended pending full examination of potential interactions .
miconazole	drug	ketoconazole	drug
false

Due to the chemical similarity of other DRUGN ( including DRUGN , DRUGN , and DRUGA ) to DRUGN , and DRUGB , concomitant use of these products with DRUGN is not recommended pending full examination of potential interactions .
miconazole	drug	itraconazole	drug
false

Due to the chemical similarity of other DRUGN ( including DRUGN , DRUGN , and DRUGA ) to DRUGN , and DRUGN , concomitant use of these products with DRUGB is not recommended pending full examination of potential interactions .
miconazole	drug	terfenadine	drug
advise

Due to the chemical similarity of other DRUGN ( including DRUGN , DRUGN , and DRUGN ) to DRUGA , and DRUGB , concomitant use of these products with DRUGN is not recommended pending full examination of potential interactions .
ketoconazole	drug	itraconazole	drug
false

Due to the chemical similarity of other DRUGN ( including DRUGN , DRUGN , and DRUGN ) to DRUGA , and DRUGN , concomitant use of these products with DRUGB is not recommended pending full examination of potential interactions .
ketoconazole	drug	terfenadine	drug
false

Due to the chemical similarity of other DRUGN ( including DRUGN , DRUGN , and DRUGN ) to DRUGN , and DRUGA , concomitant use of these products with DRUGB is not recommended pending full examination of potential interactions .
itraconazole	drug	terfenadine	drug
false

DRUGA : Clinical drug interaction studies indicate that DRUGB and DRUGN can exert an effect on DRUGN metabolism by a mechanism which may be similar to that of DRUGN , but to a lesser extent .
Macrolides	group	erythromycin	drug
false

DRUGA : Clinical drug interaction studies indicate that DRUGN and DRUGB can exert an effect on DRUGN metabolism by a mechanism which may be similar to that of DRUGN , but to a lesser extent .
Macrolides	group	clarithromycin	drug
false

DRUGA : Clinical drug interaction studies indicate that DRUGN and DRUGN can exert an effect on DRUGB metabolism by a mechanism which may be similar to that of DRUGN , but to a lesser extent .
Macrolides	group	terfenadine	drug
false

DRUGA : Clinical drug interaction studies indicate that DRUGN and DRUGN can exert an effect on DRUGN metabolism by a mechanism which may be similar to that of DRUGB , but to a lesser extent .
Macrolides	group	ketoconazole	drug
false

DRUGN : Clinical drug interaction studies indicate that DRUGA and DRUGB can exert an effect on DRUGN metabolism by a mechanism which may be similar to that of DRUGN , but to a lesser extent .
erythromycin	drug	clarithromycin	drug
false

DRUGN : Clinical drug interaction studies indicate that DRUGA and DRUGN can exert an effect on DRUGB metabolism by a mechanism which may be similar to that of DRUGN , but to a lesser extent .
erythromycin	drug	terfenadine	drug
mechanism

DRUGN : Clinical drug interaction studies indicate that DRUGA and DRUGN can exert an effect on DRUGN metabolism by a mechanism which may be similar to that of DRUGB , but to a lesser extent .
erythromycin	drug	ketoconazole	drug
false

DRUGN : Clinical drug interaction studies indicate that DRUGN and DRUGA can exert an effect on DRUGB metabolism by a mechanism which may be similar to that of DRUGN , but to a lesser extent .
clarithromycin	drug	terfenadine	drug
mechanism

DRUGN : Clinical drug interaction studies indicate that DRUGN and DRUGA can exert an effect on DRUGN metabolism by a mechanism which may be similar to that of DRUGB , but to a lesser extent .
clarithromycin	drug	ketoconazole	drug
false

DRUGN : Clinical drug interaction studies indicate that DRUGN and DRUGN can exert an effect on DRUGA metabolism by a mechanism which may be similar to that of DRUGB , but to a lesser extent .
terfenadine	drug	ketoconazole	drug
false

A few spontaneous accounts of QT interval prolongation with ventricular arrhythmia including torsades de pointes , have been reported in patients receiving DRUGA or DRUGB .
erythromycin	drug	troleandomycin	drug
false

Concomitant administration of DRUGA with DRUGB , DRUGN , or DRUGN is contraindicated : Pending full characterization of potential interactions , concomitant administration of DRUGN with other DRUGN , including DRUGN , is not recommended .
terfenadine	drug	clarithromycin	drug
advise

Concomitant administration of DRUGA with DRUGN , DRUGB , or DRUGN is contraindicated : Pending full characterization of potential interactions , concomitant administration of DRUGN with other DRUGN , including DRUGN , is not recommended .
terfenadine	drug	erythromycin	drug
advise

Concomitant administration of DRUGA with DRUGN , DRUGN , or DRUGB is contraindicated : Pending full characterization of potential interactions , concomitant administration of DRUGN with other DRUGN , including DRUGN , is not recommended .
terfenadine	drug	troleandomycin	drug
advise

Concomitant administration of DRUGA with DRUGN , DRUGN , or DRUGN is contraindicated : Pending full characterization of potential interactions , concomitant administration of DRUGN with other DRUGB , including DRUGN , is not recommended .
terfenadine	drug	macrolide antibiotics	group
false

Concomitant administration of DRUGA with DRUGN , DRUGN , or DRUGN is contraindicated : Pending full characterization of potential interactions , concomitant administration of DRUGN with other DRUGN , including DRUGB , is not recommended .
terfenadine	drug	azithromycin	drug
false

Concomitant administration of DRUGN with DRUGA , DRUGB , or DRUGN is contraindicated : Pending full characterization of potential interactions , concomitant administration of DRUGN with other DRUGN , including DRUGN , is not recommended .
clarithromycin	drug	erythromycin	drug
false

Concomitant administration of DRUGN with DRUGA , DRUGN , or DRUGB is contraindicated : Pending full characterization of potential interactions , concomitant administration of DRUGN with other DRUGN , including DRUGN , is not recommended .
clarithromycin	drug	troleandomycin	drug
false

Concomitant administration of DRUGN with DRUGA , DRUGN , or DRUGN is contraindicated : Pending full characterization of potential interactions , concomitant administration of DRUGB with other DRUGN , including DRUGN , is not recommended .
clarithromycin	drug	terfenadine	drug
false

Concomitant administration of DRUGN with DRUGA , DRUGN , or DRUGN is contraindicated : Pending full characterization of potential interactions , concomitant administration of DRUGN with other DRUGB , including DRUGN , is not recommended .
clarithromycin	drug	macrolide antibiotics	group
false

Concomitant administration of DRUGN with DRUGA , DRUGN , or DRUGN is contraindicated : Pending full characterization of potential interactions , concomitant administration of DRUGN with other DRUGN , including DRUGB , is not recommended .
clarithromycin	drug	azithromycin	drug
false

Concomitant administration of DRUGN with DRUGN , DRUGA , or DRUGB is contraindicated : Pending full characterization of potential interactions , concomitant administration of DRUGN with other DRUGN , including DRUGN , is not recommended .
erythromycin	drug	troleandomycin	drug
false

Concomitant administration of DRUGN with DRUGN , DRUGA , or DRUGN is contraindicated : Pending full characterization of potential interactions , concomitant administration of DRUGB with other DRUGN , including DRUGN , is not recommended .
erythromycin	drug	terfenadine	drug
false

Concomitant administration of DRUGN with DRUGN , DRUGA , or DRUGN is contraindicated : Pending full characterization of potential interactions , concomitant administration of DRUGN with other DRUGB , including DRUGN , is not recommended .
erythromycin	drug	macrolide antibiotics	group
false

Concomitant administration of DRUGN with DRUGN , DRUGA , or DRUGN is contraindicated : Pending full characterization of potential interactions , concomitant administration of DRUGN with other DRUGN , including DRUGB , is not recommended .
erythromycin	drug	azithromycin	drug
false

Concomitant administration of DRUGN with DRUGN , DRUGN , or DRUGA is contraindicated : Pending full characterization of potential interactions , concomitant administration of DRUGB with other DRUGN , including DRUGN , is not recommended .
troleandomycin	drug	terfenadine	drug
false

Concomitant administration of DRUGN with DRUGN , DRUGN , or DRUGA is contraindicated : Pending full characterization of potential interactions , concomitant administration of DRUGN with other DRUGB , including DRUGN , is not recommended .
troleandomycin	drug	macrolide antibiotics	group
false

Concomitant administration of DRUGN with DRUGN , DRUGN , or DRUGA is contraindicated : Pending full characterization of potential interactions , concomitant administration of DRUGN with other DRUGN , including DRUGB , is not recommended .
troleandomycin	drug	azithromycin	drug
false

Concomitant administration of DRUGN with DRUGN , DRUGN , or DRUGN is contraindicated : Pending full characterization of potential interactions , concomitant administration of DRUGA with other DRUGB , including DRUGN , is not recommended .
terfenadine	drug	macrolide antibiotics	group
advise

Concomitant administration of DRUGN with DRUGN , DRUGN , or DRUGN is contraindicated : Pending full characterization of potential interactions , concomitant administration of DRUGA with other DRUGN , including DRUGB , is not recommended .
terfenadine	drug	azithromycin	drug
advise

Concomitant administration of DRUGN with DRUGN , DRUGN , or DRUGN is contraindicated : Pending full characterization of potential interactions , concomitant administration of DRUGN with other DRUGA , including DRUGB , is not recommended .
macrolide antibiotics	group	azithromycin	drug
false

Studies to evaluate potential interactions of DRUGA with DRUGB are in progress .
terfenadine	drug	azithromycin	drug
false

When administered concurrently , DRUGA may increase the effects of oral DRUGB ;
testolactone	drug	anticoagulants	group
effect

DRUGA has been reported to enhance the sedative activity of DRUGB , DRUGN , DRUGN , and DRUGN .
Thalidomide	drug	barbiturates	group
effect

DRUGA has been reported to enhance the sedative activity of DRUGN , DRUGB , DRUGN , and DRUGN .
Thalidomide	drug	alcohol	drug
false

DRUGA has been reported to enhance the sedative activity of DRUGN , DRUGN , DRUGB , and DRUGN .
Thalidomide	drug	chlorpromazine	drug
false

DRUGA has been reported to enhance the sedative activity of DRUGN , DRUGN , DRUGN , and DRUGB .
Thalidomide	drug	reserpine	drug
false

DRUGN has been reported to enhance the sedative activity of DRUGA , DRUGB , DRUGN , and DRUGN .
barbiturates	group	alcohol	drug
false

DRUGN has been reported to enhance the sedative activity of DRUGA , DRUGN , DRUGB , and DRUGN .
barbiturates	group	chlorpromazine	drug
false

DRUGN has been reported to enhance the sedative activity of DRUGA , DRUGN , DRUGN , and DRUGB .
barbiturates	group	reserpine	drug
false

DRUGN has been reported to enhance the sedative activity of DRUGN , DRUGA , DRUGB , and DRUGN .
alcohol	drug	chlorpromazine	drug
false

DRUGN has been reported to enhance the sedative activity of DRUGN , DRUGA , DRUGN , and DRUGB .
alcohol	drug	reserpine	drug
false

DRUGN has been reported to enhance the sedative activity of DRUGN , DRUGN , DRUGA , and DRUGB .
chlorpromazine	drug	reserpine	drug
false

Oral DRUGA : In dgb healthy women , the pharmacokinetic profiles of DRUGB and DRUGN following administration of a single dose containing dga mg of DRUGN and dgb g of DRUGN were studied .
Contraceptives	group	norethindrone	drug
false

Oral DRUGA : In dgb healthy women , the pharmacokinetic profiles of DRUGN and DRUGB following administration of a single dose containing dga mg of DRUGN and dgb g of DRUGN were studied .
Contraceptives	group	ethinyl estradiol	drug
false

Oral DRUGA : In dgb healthy women , the pharmacokinetic profiles of DRUGN and DRUGN following administration of a single dose containing dga mg of DRUGB and dgb g of DRUGN were studied .
Contraceptives	group	norethindrone acetate	drug
false

Oral DRUGA : In dgb healthy women , the pharmacokinetic profiles of DRUGN and DRUGN following administration of a single dose containing dga mg of DRUGN and dgb g of DRUGB were studied .
Contraceptives	group	ethinyl estradiol	drug
false

Oral DRUGN : In dgb healthy women , the pharmacokinetic profiles of DRUGA and DRUGB following administration of a single dose containing dga mg of DRUGN and dgb g of DRUGN were studied .
norethindrone	drug	ethinyl estradiol	drug
false

Oral DRUGN : In dgb healthy women , the pharmacokinetic profiles of DRUGA and DRUGN following administration of a single dose containing dga mg of DRUGB and dgb g of DRUGN were studied .
norethindrone	drug	norethindrone acetate	drug
false

Oral DRUGN : In dgb healthy women , the pharmacokinetic profiles of DRUGA and DRUGN following administration of a single dose containing dga mg of DRUGN and dgb g of DRUGB were studied .
norethindrone	drug	ethinyl estradiol	drug
false

Oral DRUGN : In dgb healthy women , the pharmacokinetic profiles of DRUGN and DRUGA following administration of a single dose containing dga mg of DRUGB and dgb g of DRUGN were studied .
ethinyl estradiol	drug	norethindrone acetate	drug
false

Oral DRUGN : In dgb healthy women , the pharmacokinetic profiles of DRUGN and DRUGN following administration of a single dose containing dga mg of DRUGA and dgb g of DRUGB were studied .
norethindrone acetate	drug	ethinyl estradiol	drug
false

Important Non DRUGA Drug Interactions Drugs That Interfere with DRUGB : Concomitant use of DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , or certain herbal supplements such as St .
Thalidomide	drug	Hormonal Contraceptives	group
false

Important Non DRUGA Drug Interactions Drugs That Interfere with DRUGN : Concomitant use of DRUGB , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , or certain herbal supplements such as St .
Thalidomide	drug	HIV-protease inhibitors	group
false

Important Non DRUGA Drug Interactions Drugs That Interfere with DRUGN : Concomitant use of DRUGN , DRUGB , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , or certain herbal supplements such as St .
Thalidomide	drug	griseofulvin	drug
false

Important Non DRUGA Drug Interactions Drugs That Interfere with DRUGN : Concomitant use of DRUGN , DRUGN , DRUGB , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , or certain herbal supplements such as St .
Thalidomide	drug	modafinil	drug
false

Important Non DRUGA Drug Interactions Drugs That Interfere with DRUGN : Concomitant use of DRUGN , DRUGN , DRUGN , DRUGB , DRUGN , DRUGN , DRUGN , DRUGN , or certain herbal supplements such as St .
Thalidomide	drug	penicillins	group
false

Important Non DRUGA Drug Interactions Drugs That Interfere with DRUGN : Concomitant use of DRUGN , DRUGN , DRUGN , DRUGN , DRUGB , DRUGN , DRUGN , DRUGN , or certain herbal supplements such as St .
Thalidomide	drug	rifampin	drug
false

Important Non DRUGA Drug Interactions Drugs That Interfere with DRUGN : Concomitant use of DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGB , DRUGN , DRUGN , or certain herbal supplements such as St .
Thalidomide	drug	rifabutin	drug
false

Important Non DRUGA Drug Interactions Drugs That Interfere with DRUGN : Concomitant use of DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGB , DRUGN , or certain herbal supplements such as St .
Thalidomide	drug	phenytoin	drug
false

Important Non DRUGA Drug Interactions Drugs That Interfere with DRUGN : Concomitant use of DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGB , or certain herbal supplements such as St .
Thalidomide	drug	carbamazepine	drug
false

Important Non DRUGN Drug Interactions Drugs That Interfere with DRUGA : Concomitant use of DRUGB , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , or certain herbal supplements such as St .
Hormonal Contraceptives	group	HIV-protease inhibitors	group
false

Important Non DRUGN Drug Interactions Drugs That Interfere with DRUGA : Concomitant use of DRUGN , DRUGB , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , or certain herbal supplements such as St .
Hormonal Contraceptives	group	griseofulvin	drug
false

Important Non DRUGN Drug Interactions Drugs That Interfere with DRUGA : Concomitant use of DRUGN , DRUGN , DRUGB , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , or certain herbal supplements such as St .
Hormonal Contraceptives	group	modafinil	drug
false

Important Non DRUGN Drug Interactions Drugs That Interfere with DRUGA : Concomitant use of DRUGN , DRUGN , DRUGN , DRUGB , DRUGN , DRUGN , DRUGN , DRUGN , or certain herbal supplements such as St .
Hormonal Contraceptives	group	penicillins	group
false

Important Non DRUGN Drug Interactions Drugs That Interfere with DRUGA : Concomitant use of DRUGN , DRUGN , DRUGN , DRUGN , DRUGB , DRUGN , DRUGN , DRUGN , or certain herbal supplements such as St .
Hormonal Contraceptives	group	rifampin	drug
false

Important Non DRUGN Drug Interactions Drugs That Interfere with DRUGA : Concomitant use of DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGB , DRUGN , DRUGN , or certain herbal supplements such as St .
Hormonal Contraceptives	group	rifabutin	drug
false

Important Non DRUGN Drug Interactions Drugs That Interfere with DRUGA : Concomitant use of DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGB , DRUGN , or certain herbal supplements such as St .
Hormonal Contraceptives	group	phenytoin	drug
false

Important Non DRUGN Drug Interactions Drugs That Interfere with DRUGA : Concomitant use of DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGB , or certain herbal supplements such as St .
Hormonal Contraceptives	group	carbamazepine	drug
false

Important Non DRUGN Drug Interactions Drugs That Interfere with DRUGN : Concomitant use of DRUGA , DRUGB , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , or certain herbal supplements such as St .
HIV-protease inhibitors	group	griseofulvin	drug
false

Important Non DRUGN Drug Interactions Drugs That Interfere with DRUGN : Concomitant use of DRUGA , DRUGN , DRUGB , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , or certain herbal supplements such as St .
HIV-protease inhibitors	group	modafinil	drug
false

Important Non DRUGN Drug Interactions Drugs That Interfere with DRUGN : Concomitant use of DRUGA , DRUGN , DRUGN , DRUGB , DRUGN , DRUGN , DRUGN , DRUGN , or certain herbal supplements such as St .
HIV-protease inhibitors	group	penicillins	group
false

Important Non DRUGN Drug Interactions Drugs That Interfere with DRUGN : Concomitant use of DRUGA , DRUGN , DRUGN , DRUGN , DRUGB , DRUGN , DRUGN , DRUGN , or certain herbal supplements such as St .
HIV-protease inhibitors	group	rifampin	drug
false

Important Non DRUGN Drug Interactions Drugs That Interfere with DRUGN : Concomitant use of DRUGA , DRUGN , DRUGN , DRUGN , DRUGN , DRUGB , DRUGN , DRUGN , or certain herbal supplements such as St .
HIV-protease inhibitors	group	rifabutin	drug
false

Important Non DRUGN Drug Interactions Drugs That Interfere with DRUGN : Concomitant use of DRUGA , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGB , DRUGN , or certain herbal supplements such as St .
HIV-protease inhibitors	group	phenytoin	drug
false

Important Non DRUGN Drug Interactions Drugs That Interfere with DRUGN : Concomitant use of DRUGA , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGB , or certain herbal supplements such as St .
HIV-protease inhibitors	group	carbamazepine	drug
false

Important Non DRUGN Drug Interactions Drugs That Interfere with DRUGN : Concomitant use of DRUGN , DRUGA , DRUGB , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , or certain herbal supplements such as St .
griseofulvin	drug	modafinil	drug
false

Important Non DRUGN Drug Interactions Drugs That Interfere with DRUGN : Concomitant use of DRUGN , DRUGA , DRUGN , DRUGB , DRUGN , DRUGN , DRUGN , DRUGN , or certain herbal supplements such as St .
griseofulvin	drug	penicillins	group
false

Important Non DRUGN Drug Interactions Drugs That Interfere with DRUGN : Concomitant use of DRUGN , DRUGA , DRUGN , DRUGN , DRUGB , DRUGN , DRUGN , DRUGN , or certain herbal supplements such as St .
griseofulvin	drug	rifampin	drug
false

Important Non DRUGN Drug Interactions Drugs That Interfere with DRUGN : Concomitant use of DRUGN , DRUGA , DRUGN , DRUGN , DRUGN , DRUGB , DRUGN , DRUGN , or certain herbal supplements such as St .
griseofulvin	drug	rifabutin	drug
false

Important Non DRUGN Drug Interactions Drugs That Interfere with DRUGN : Concomitant use of DRUGN , DRUGA , DRUGN , DRUGN , DRUGN , DRUGN , DRUGB , DRUGN , or certain herbal supplements such as St .
griseofulvin	drug	phenytoin	drug
false

Important Non DRUGN Drug Interactions Drugs That Interfere with DRUGN : Concomitant use of DRUGN , DRUGA , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGB , or certain herbal supplements such as St .
griseofulvin	drug	carbamazepine	drug
false

Important Non DRUGN Drug Interactions Drugs That Interfere with DRUGN : Concomitant use of DRUGN , DRUGN , DRUGA , DRUGB , DRUGN , DRUGN , DRUGN , DRUGN , or certain herbal supplements such as St .
modafinil	drug	penicillins	group
false

Important Non DRUGN Drug Interactions Drugs That Interfere with DRUGN : Concomitant use of DRUGN , DRUGN , DRUGA , DRUGN , DRUGB , DRUGN , DRUGN , DRUGN , or certain herbal supplements such as St .
modafinil	drug	rifampin	drug
false

Important Non DRUGN Drug Interactions Drugs That Interfere with DRUGN : Concomitant use of DRUGN , DRUGN , DRUGA , DRUGN , DRUGN , DRUGB , DRUGN , DRUGN , or certain herbal supplements such as St .
modafinil	drug	rifabutin	drug
false

Important Non DRUGN Drug Interactions Drugs That Interfere with DRUGN : Concomitant use of DRUGN , DRUGN , DRUGA , DRUGN , DRUGN , DRUGN , DRUGB , DRUGN , or certain herbal supplements such as St .
modafinil	drug	phenytoin	drug
false

Important Non DRUGN Drug Interactions Drugs That Interfere with DRUGN : Concomitant use of DRUGN , DRUGN , DRUGA , DRUGN , DRUGN , DRUGN , DRUGN , DRUGB , or certain herbal supplements such as St .
modafinil	drug	carbamazepine	drug
false

Important Non DRUGN Drug Interactions Drugs That Interfere with DRUGN : Concomitant use of DRUGN , DRUGN , DRUGN , DRUGA , DRUGB , DRUGN , DRUGN , DRUGN , or certain herbal supplements such as St .
penicillins	group	rifampin	drug
false

Important Non DRUGN Drug Interactions Drugs That Interfere with DRUGN : Concomitant use of DRUGN , DRUGN , DRUGN , DRUGA , DRUGN , DRUGB , DRUGN , DRUGN , or certain herbal supplements such as St .
penicillins	group	rifabutin	drug
false

Important Non DRUGN Drug Interactions Drugs That Interfere with DRUGN : Concomitant use of DRUGN , DRUGN , DRUGN , DRUGA , DRUGN , DRUGN , DRUGB , DRUGN , or certain herbal supplements such as St .
penicillins	group	phenytoin	drug
false

Important Non DRUGN Drug Interactions Drugs That Interfere with DRUGN : Concomitant use of DRUGN , DRUGN , DRUGN , DRUGA , DRUGN , DRUGN , DRUGN , DRUGB , or certain herbal supplements such as St .
penicillins	group	carbamazepine	drug
false

Important Non DRUGN Drug Interactions Drugs That Interfere with DRUGN : Concomitant use of DRUGN , DRUGN , DRUGN , DRUGN , DRUGA , DRUGB , DRUGN , DRUGN , or certain herbal supplements such as St .
rifampin	drug	rifabutin	drug
false

Important Non DRUGN Drug Interactions Drugs That Interfere with DRUGN : Concomitant use of DRUGN , DRUGN , DRUGN , DRUGN , DRUGA , DRUGN , DRUGB , DRUGN , or certain herbal supplements such as St .
rifampin	drug	phenytoin	drug
false

Important Non DRUGN Drug Interactions Drugs That Interfere with DRUGN : Concomitant use of DRUGN , DRUGN , DRUGN , DRUGN , DRUGA , DRUGN , DRUGN , DRUGB , or certain herbal supplements such as St .
rifampin	drug	carbamazepine	drug
false

Important Non DRUGN Drug Interactions Drugs That Interfere with DRUGN : Concomitant use of DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGA , DRUGB , DRUGN , or certain herbal supplements such as St .
rifabutin	drug	phenytoin	drug
false

Important Non DRUGN Drug Interactions Drugs That Interfere with DRUGN : Concomitant use of DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGA , DRUGN , DRUGB , or certain herbal supplements such as St .
rifabutin	drug	carbamazepine	drug
false

Important Non DRUGN Drug Interactions Drugs That Interfere with DRUGN : Concomitant use of DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , DRUGA , DRUGB , or certain herbal supplements such as St .
phenytoin	drug	carbamazepine	drug
false

DRUGA with DRUGB may reduce the effectiveness of the contraception and up to one month after discontinuation of these concomitant therapies .
John's Wort	drug_n	hormonal contraceptive agents	group
effect

DRUGA may compete with other drugs , such as DRUGB , for sites of metabolism in the liver , thus elevating the serum levels of such compounds to potentially toxic levels .
Thiabendazole	drug	theophylline	drug
mechanism

Therefore , when concomitant use of DRUGA and DRUGB is anticipated , it may be necessary to monitor blood levels and / or reduce the dosage of such compounds .
thiabendazole	drug	xanthine derivatives	group
advise

Interactions for DRUGA ( DRUGB ) : DRUGN , Oral DRUGN , DRUGN , DRUGN
Vitamin B1	drug	Thiamine	drug
false

Interactions for DRUGA ( DRUGN ) : DRUGB , Oral DRUGN , DRUGN , DRUGN
Vitamin B1	drug	Loop Diuretics	group
int

Interactions for DRUGA ( DRUGN ) : DRUGN , Oral DRUGB , DRUGN , DRUGN
Vitamin B1	drug	Contraceptives	group
int

Interactions for DRUGA ( DRUGN ) : DRUGN , Oral DRUGN , DRUGB , DRUGN
Vitamin B1	drug	Stavudine	drug
int

Interactions for DRUGA ( DRUGN ) : DRUGN , Oral DRUGN , DRUGN , DRUGB
Vitamin B1	drug	Tricyclic Antidepressants	group
int

Interactions for DRUGN ( DRUGA ) : DRUGB , Oral DRUGN , DRUGN , DRUGN
Thiamine	drug	Loop Diuretics	group
int

Interactions for DRUGN ( DRUGA ) : DRUGN , Oral DRUGB , DRUGN , DRUGN
Thiamine	drug	Contraceptives	group
int

Interactions for DRUGN ( DRUGA ) : DRUGN , Oral DRUGN , DRUGB , DRUGN
Thiamine	drug	Stavudine	drug
int

Interactions for DRUGN ( DRUGA ) : DRUGN , Oral DRUGN , DRUGN , DRUGB
Thiamine	drug	Tricyclic Antidepressants	group
int

Interactions for DRUGN ( DRUGN ) : DRUGA , Oral DRUGB , DRUGN , DRUGN
Loop Diuretics	group	Contraceptives	group
false

Interactions for DRUGN ( DRUGN ) : DRUGA , Oral DRUGN , DRUGB , DRUGN
Loop Diuretics	group	Stavudine	drug
false

Interactions for DRUGN ( DRUGN ) : DRUGA , Oral DRUGN , DRUGN , DRUGB
Loop Diuretics	group	Tricyclic Antidepressants	group
false

Interactions for DRUGN ( DRUGN ) : DRUGN , Oral DRUGA , DRUGB , DRUGN
Contraceptives	group	Stavudine	drug
false

Interactions for DRUGN ( DRUGN ) : DRUGN , Oral DRUGA , DRUGN , DRUGB
Contraceptives	group	Tricyclic Antidepressants	group
false

Interactions for DRUGN ( DRUGN ) : DRUGN , Oral DRUGN , DRUGA , DRUGB
Stavudine	drug	Tricyclic Antidepressants	group
false

DRUGA are capable of potentiating DRUGB ( e.g . , DRUGN , DRUGN , DRUGN , DRUGN , etc . )
Phenothiazines	group	CNS depressants	group
effect

DRUGA are capable of potentiating DRUGN ( e.g . , DRUGB , DRUGN , DRUGN , DRUGN , etc . )
Phenothiazines	group	barbiturates	group
effect

DRUGA are capable of potentiating DRUGN ( e.g . , DRUGN , DRUGB , DRUGN , DRUGN , etc . )
Phenothiazines	group	anesthetics	group
effect

DRUGA are capable of potentiating DRUGN ( e.g . , DRUGN , DRUGN , DRUGB , DRUGN , etc . )
Phenothiazines	group	opiates	group
effect

DRUGA are capable of potentiating DRUGN ( e.g . , DRUGN , DRUGN , DRUGN , DRUGB , etc . )
Phenothiazines	group	alcohol	drug
effect

DRUGN are capable of potentiating DRUGA ( e.g . , DRUGB , DRUGN , DRUGN , DRUGN , etc . )
CNS depressants	group	barbiturates	group
false

DRUGN are capable of potentiating DRUGA ( e.g . , DRUGN , DRUGB , DRUGN , DRUGN , etc . )
CNS depressants	group	anesthetics	group
false

DRUGN are capable of potentiating DRUGA ( e.g . , DRUGN , DRUGN , DRUGB , DRUGN , etc . )
CNS depressants	group	opiates	group
false

DRUGN are capable of potentiating DRUGA ( e.g . , DRUGN , DRUGN , DRUGN , DRUGB , etc . )
CNS depressants	group	alcohol	drug
false

DRUGN are capable of potentiating DRUGN ( e.g . , DRUGA , DRUGB , DRUGN , DRUGN , etc . )
barbiturates	group	anesthetics	group
false

DRUGN are capable of potentiating DRUGN ( e.g . , DRUGA , DRUGN , DRUGB , DRUGN , etc . )
barbiturates	group	opiates	group
false

DRUGN are capable of potentiating DRUGN ( e.g . , DRUGA , DRUGN , DRUGN , DRUGB , etc . )
barbiturates	group	alcohol	drug
false

DRUGN are capable of potentiating DRUGN ( e.g . , DRUGN , DRUGA , DRUGB , DRUGN , etc . )
anesthetics	group	opiates	group
false

DRUGN are capable of potentiating DRUGN ( e.g . , DRUGN , DRUGA , DRUGN , DRUGB , etc . )
anesthetics	group	alcohol	drug
false

DRUGN are capable of potentiating DRUGN ( e.g . , DRUGN , DRUGN , DRUGA , DRUGB , etc . )
opiates	group	alcohol	drug
false

as well as DRUGA and DRUGB .
atropine	drug	phosphorous insecticides	drug_n
false

There is usually complete cross resistance between DRUGA ( DRUGB ) and DRUGN brand DRUGN .
PURINETHOL	brand	mercaptopurine	drug
false

There is usually complete cross resistance between DRUGA ( DRUGN ) and DRUGB brand DRUGN .
PURINETHOL	brand	TABLOID	brand
effect

There is usually complete cross resistance between DRUGA ( DRUGN ) and DRUGN brand DRUGB .
PURINETHOL	brand	Thioguanine	drug
effect

There is usually complete cross resistance between DRUGN ( DRUGA ) and DRUGB brand DRUGN .
mercaptopurine	drug	TABLOID	brand
effect

There is usually complete cross resistance between DRUGN ( DRUGA ) and DRUGN brand DRUGB .
mercaptopurine	drug	Thioguanine	drug
effect

There is usually complete cross resistance between DRUGN ( DRUGN ) and DRUGA brand DRUGB .
TABLOID	brand	Thioguanine	drug
false

As there is in vitro evidence that DRUGA ( e.g . , DRUGB , DRUGN , or DRUGN ) inhibit the TPMT enzyme , they should be administered with caution to patients receiving concurrent DRUGN therapy .
aminosalicylate derivatives	group	olsalazine	drug
false

As there is in vitro evidence that DRUGA ( e.g . , DRUGN , DRUGB , or DRUGN ) inhibit the TPMT enzyme , they should be administered with caution to patients receiving concurrent DRUGN therapy .
aminosalicylate derivatives	group	mesalazine	drug
false

As there is in vitro evidence that DRUGA ( e.g . , DRUGN , DRUGN , or DRUGB ) inhibit the TPMT enzyme , they should be administered with caution to patients receiving concurrent DRUGN therapy .
aminosalicylate derivatives	group	sulphasalazine	drug
false

As there is in vitro evidence that DRUGA ( e.g . , DRUGN , DRUGN , or DRUGN ) inhibit the TPMT enzyme , they should be administered with caution to patients receiving concurrent DRUGB therapy .
aminosalicylate derivatives	group	thioguanine	drug
mechanism

As there is in vitro evidence that DRUGN ( e.g . , DRUGA , DRUGB , or DRUGN ) inhibit the TPMT enzyme , they should be administered with caution to patients receiving concurrent DRUGN therapy .
olsalazine	drug	mesalazine	drug
false

As there is in vitro evidence that DRUGN ( e.g . , DRUGA , DRUGN , or DRUGB ) inhibit the TPMT enzyme , they should be administered with caution to patients receiving concurrent DRUGN therapy .
olsalazine	drug	sulphasalazine	drug
false

As there is in vitro evidence that DRUGN ( e.g . , DRUGA , DRUGN , or DRUGN ) inhibit the TPMT enzyme , they should be administered with caution to patients receiving concurrent DRUGB therapy .
olsalazine	drug	thioguanine	drug
mechanism

As there is in vitro evidence that DRUGN ( e.g . , DRUGN , DRUGA , or DRUGB ) inhibit the TPMT enzyme , they should be administered with caution to patients receiving concurrent DRUGN therapy .
mesalazine	drug	sulphasalazine	drug
false

As there is in vitro evidence that DRUGN ( e.g . , DRUGN , DRUGA , or DRUGN ) inhibit the TPMT enzyme , they should be administered with caution to patients receiving concurrent DRUGB therapy .
mesalazine	drug	thioguanine	drug
mechanism

As there is in vitro evidence that DRUGN ( e.g . , DRUGN , DRUGN , or DRUGA ) inhibit the TPMT enzyme , they should be administered with caution to patients receiving concurrent DRUGB therapy .
sulphasalazine	drug	thioguanine	drug
mechanism

Caution should be exercised when administering DRUGA therapy in combination with other DRUGB .
ZADAXIN	brand	immunomodulating drugs	group
advise

Prothrombin time or other suitable anticoagulation test should be monitored if DRUGA is administered with DRUGB .
tigecycline	drug	warfarin	drug
advise

Concurrent use of DRUGA with oral DRUGB may render oral DRUGN less effective .
antibacterial drugs	group	contraceptives	group
effect

Concurrent use of DRUGA with oral DRUGN may render oral DRUGB less effective .
antibacterial drugs	group	contraceptives	group
false

The bioavailability of DRUGA is decreased dgb % by DRUGB , when DRUGN and DRUGN are administered at the same time , and dgb % by some DRUGN or DRUGN containing DRUGN , when administered dgb hour before DRUGN .
SKELID	brand	calcium	drug
mechanism

The bioavailability of DRUGA is decreased dgb % by DRUGN , when DRUGB and DRUGN are administered at the same time , and dgb % by some DRUGN or DRUGN containing DRUGN , when administered dgb hour before DRUGN .
SKELID	brand	calcium	drug
false

The bioavailability of DRUGA is decreased dgb % by DRUGN , when DRUGN and DRUGN are administered at the same time , and dgb % by some DRUGB or DRUGN containing DRUGN , when administered dgb hour before DRUGN .
SKELID	brand	aluminum	drug
false

The bioavailability of DRUGA is decreased dgb % by DRUGN , when DRUGN and DRUGN are administered at the same time , and dgb % by some DRUGN or DRUGB containing DRUGN , when administered dgb hour before DRUGN .
SKELID	brand	magnesium	drug
false

The bioavailability of DRUGA is decreased dgb % by DRUGN , when DRUGN and DRUGN are administered at the same time , and dgb % by some DRUGN or DRUGN containing DRUGB , when administered dgb hour before DRUGN .
SKELID	brand	antacids	drug
false

The bioavailability of DRUGN is decreased dgb % by DRUGA , when DRUGN and DRUGB are administered at the same time , and dgb % by some DRUGN or DRUGN containing DRUGN , when administered dgb hour before DRUGN .
calcium	drug	SKELID	brand
false

The bioavailability of DRUGN is decreased dgb % by DRUGA , when DRUGN and DRUGN are administered at the same time , and dgb % by some DRUGB or DRUGN containing DRUGN , when administered dgb hour before DRUGN .
calcium	drug	aluminum	drug
false

The bioavailability of DRUGN is decreased dgb % by DRUGA , when DRUGN and DRUGN are administered at the same time , and dgb % by some DRUGN or DRUGB containing DRUGN , when administered dgb hour before DRUGN .
calcium	drug	magnesium	drug
false

The bioavailability of DRUGN is decreased dgb % by DRUGA , when DRUGN and DRUGN are administered at the same time , and dgb % by some DRUGN or DRUGN containing DRUGB , when administered dgb hour before DRUGN .
calcium	drug	antacids	drug
false

The bioavailability of DRUGN is decreased dgb % by DRUGA , when DRUGN and DRUGN are administered at the same time , and dgb % by some DRUGN or DRUGN containing DRUGN , when administered dgb hour before DRUGB .
calcium	drug	SKELID	brand
false

The bioavailability of DRUGN is decreased dgb % by DRUGN , when DRUGA and DRUGB are administered at the same time , and dgb % by some DRUGN or DRUGN containing DRUGN , when administered dgb hour before DRUGN .
calcium	drug	SKELID	brand
false

The bioavailability of DRUGN is decreased dgb % by DRUGN , when DRUGA and DRUGN are administered at the same time , and dgb % by some DRUGB or DRUGN containing DRUGN , when administered dgb hour before DRUGN .
calcium	drug	aluminum	drug
false

The bioavailability of DRUGN is decreased dgb % by DRUGN , when DRUGA and DRUGN are administered at the same time , and dgb % by some DRUGN or DRUGB containing DRUGN , when administered dgb hour before DRUGN .
calcium	drug	magnesium	drug
false

The bioavailability of DRUGN is decreased dgb % by DRUGN , when DRUGA and DRUGN are administered at the same time , and dgb % by some DRUGN or DRUGN containing DRUGB , when administered dgb hour before DRUGN .
calcium	drug	antacids	drug
false

The bioavailability of DRUGN is decreased dgb % by DRUGN , when DRUGA and DRUGN are administered at the same time , and dgb % by some DRUGN or DRUGN containing DRUGN , when administered dgb hour before DRUGB .
calcium	drug	SKELID	brand
false

The bioavailability of DRUGN is decreased dgb % by DRUGN , when DRUGN and DRUGA are administered at the same time , and dgb % by some DRUGB or DRUGN containing DRUGN , when administered dgb hour before DRUGN .
SKELID	brand	aluminum	drug
false

The bioavailability of DRUGN is decreased dgb % by DRUGN , when DRUGN and DRUGA are administered at the same time , and dgb % by some DRUGN or DRUGB containing DRUGN , when administered dgb hour before DRUGN .
SKELID	brand	magnesium	drug
false

The bioavailability of DRUGN is decreased dgb % by DRUGN , when DRUGN and DRUGA are administered at the same time , and dgb % by some DRUGN or DRUGN containing DRUGB , when administered dgb hour before DRUGN .
SKELID	brand	antacids	drug
false

The bioavailability of DRUGN is decreased dgb % by DRUGN , when DRUGN and DRUGN are administered at the same time , and dgb % by some DRUGA or DRUGB containing DRUGN , when administered dgb hour before DRUGN .
aluminum	drug	magnesium	drug
false

The bioavailability of DRUGN is decreased dgb % by DRUGN , when DRUGN and DRUGN are administered at the same time , and dgb % by some DRUGA or DRUGN containing DRUGB , when administered dgb hour before DRUGN .
aluminum	drug	antacids	drug
false

The bioavailability of DRUGN is decreased dgb % by DRUGN , when DRUGN and DRUGN are administered at the same time , and dgb % by some DRUGA or DRUGN containing DRUGN , when administered dgb hour before DRUGB .
aluminum	drug	SKELID	brand
mechanism

The bioavailability of DRUGN is decreased dgb % by DRUGN , when DRUGN and DRUGN are administered at the same time , and dgb % by some DRUGN or DRUGA containing DRUGB , when administered dgb hour before DRUGN .
magnesium	drug	antacids	drug
false

The bioavailability of DRUGN is decreased dgb % by DRUGN , when DRUGN and DRUGN are administered at the same time , and dgb % by some DRUGN or DRUGA containing DRUGN , when administered dgb hour before DRUGB .
magnesium	drug	SKELID	brand
mechanism

The bioavailability of DRUGN is decreased dgb % by DRUGN , when DRUGN and DRUGN are administered at the same time , and dgb % by some DRUGN or DRUGN containing DRUGA , when administered dgb hour before DRUGB .
antacids	drug	SKELID	brand
false

DRUGA may decrease bioavailability of DRUGB by up to dgb % when taken dgb hours after DRUGN .
Aspirin	brand	SKELID	brand
mechanism

DRUGA may decrease bioavailability of DRUGN by up to dgb % when taken dgb hours after DRUGB .
Aspirin	brand	SKELID	brand
false

The bioavailability of DRUGA is increased dgb dgb fold by DRUGB but is not significantly altered by coadministration of DRUGN .
SKELID	brand	indomethacin	drug
mechanism

The bioavailability of DRUGA is increased dgb dgb fold by DRUGN but is not significantly altered by coadministration of DRUGB .
SKELID	brand	diclofenac	drug
false

The bioavailability of DRUGN is increased dgb dgb fold by DRUGA but is not significantly altered by coadministration of DRUGB .
indomethacin	drug	diclofenac	drug
false

The pharmacokinetic parameters of DRUGA are not significantly modified by DRUGB coadministration .
digoxin	drug	SKELID	brand
false

In vitro studies show that DRUGA does not displace DRUGB from its binding site on protein .
tiludronate	drug	warfarin	drug
false

These include DRUGA , DRUGB , and oral and inhaled DRUGN .
sympathomimetic bronchodilators	group	methylxanthines	group
false

These include DRUGA , DRUGN , and oral and inhaled DRUGB .
sympathomimetic bronchodilators	group	steroids	group
false

These include DRUGN , DRUGA , and oral and inhaled DRUGB .
methylxanthines	group	steroids	group
false

However , the co administration of DRUGA with other DRUGB containing drugs ( e.g . , DRUGN ) has not been studied and is therefore not recommended .
SPIRIVA	brand	anticholinergic	group
advise

However , the co administration of DRUGA with other DRUGN containing drugs ( e.g . , DRUGB ) has not been studied and is therefore not recommended .
SPIRIVA	brand	ipratropium	drug
advise

However , the co administration of DRUGN with other DRUGA containing drugs ( e.g . , DRUGB ) has not been studied and is therefore not recommended .
anticholinergic	group	ipratropium	drug
false

DRUGA has been studied on a background of DRUGB and DRUGN .
AGGRASTAT	brand	aspirin	brand
false

DRUGA has been studied on a background of DRUGN and DRUGB .
AGGRASTAT	brand	heparin	drug
false

DRUGN has been studied on a background of DRUGA and DRUGB .
aspirin	brand	heparin	drug
false

The use of DRUGA , in combination with DRUGB and DRUGN , has been associated with an increase in bleeding compared to DRUGN and DRUGN alone ( see
AGGRASTAT	brand	heparin	drug
effect

The use of DRUGA , in combination with DRUGN and DRUGB , has been associated with an increase in bleeding compared to DRUGN and DRUGN alone ( see
AGGRASTAT	brand	aspirin	brand
effect

The use of DRUGA , in combination with DRUGN and DRUGN , has been associated with an increase in bleeding compared to DRUGB and DRUGN alone ( see
AGGRASTAT	brand	heparin	drug
false

The use of DRUGA , in combination with DRUGN and DRUGN , has been associated with an increase in bleeding compared to DRUGN and DRUGB alone ( see
AGGRASTAT	brand	aspirin	drug
false

The use of DRUGN , in combination with DRUGA and DRUGB , has been associated with an increase in bleeding compared to DRUGN and DRUGN alone ( see
heparin	drug	aspirin	brand
false

The use of DRUGN , in combination with DRUGA and DRUGN , has been associated with an increase in bleeding compared to DRUGN and DRUGB alone ( see
heparin	drug	aspirin	drug
false

The use of DRUGN , in combination with DRUGN and DRUGA , has been associated with an increase in bleeding compared to DRUGB and DRUGN alone ( see
aspirin	brand	heparin	drug
false

The use of DRUGN , in combination with DRUGN and DRUGN , has been associated with an increase in bleeding compared to DRUGA and DRUGB alone ( see
heparin	drug	aspirin	drug
false

Some DRUGA can enhance DRUGB toxicity by altering DRUGN concentrations in serum and tissue .
diuretics	group	aminoglycoside	group
effect

Some DRUGA can enhance DRUGN toxicity by altering DRUGB concentrations in serum and tissue .
diuretics	group	antibiotic	group
false

Some DRUGN can enhance DRUGA toxicity by altering DRUGB concentrations in serum and tissue .
aminoglycoside	group	antibiotic	group
false

DRUGA should not be administered concomitantly with DRUGB , DRUGN , DRUGN , or DRUGN .
TOBI	brand	ethacrynic acid	drug
advise

DRUGA should not be administered concomitantly with DRUGN , DRUGB , DRUGN , or DRUGN .
TOBI	brand	furosemide	drug
advise

DRUGA should not be administered concomitantly with DRUGN , DRUGN , DRUGB , or DRUGN .
TOBI	brand	urea	drug
advise

DRUGA should not be administered concomitantly with DRUGN , DRUGN , DRUGN , or DRUGB .
TOBI	brand	mannitol	drug
advise

DRUGN should not be administered concomitantly with DRUGA , DRUGB , DRUGN , or DRUGN .
ethacrynic acid	drug	furosemide	drug
false

DRUGN should not be administered concomitantly with DRUGA , DRUGN , DRUGB , or DRUGN .
ethacrynic acid	drug	urea	drug
false

DRUGN should not be administered concomitantly with DRUGA , DRUGN , DRUGN , or DRUGB .
ethacrynic acid	drug	mannitol	drug
false

DRUGN should not be administered concomitantly with DRUGN , DRUGA , DRUGB , or DRUGN .
furosemide	drug	urea	drug
false

DRUGN should not be administered concomitantly with DRUGN , DRUGA , DRUGN , or DRUGB .
furosemide	drug	mannitol	drug
false

DRUGN should not be administered concomitantly with DRUGN , DRUGN , DRUGA , or DRUGB .
urea	drug	mannitol	drug
false

The in vitro binding of DRUGA to human plasma proteins is unaffected by DRUGB , and DRUGN does not alter the prothrombin time of normal volunteers .
warfarin	drug	tolmetin	drug
false

The in vitro binding of DRUGA to human plasma proteins is unaffected by DRUGN , and DRUGB does not alter the prothrombin time of normal volunteers .
warfarin	drug	tolmetin	drug
false

However , increased prothrombin time and bleeding have been reported in patients on concomitant DRUGA and DRUGB therapy .
TOLECTIN	brand	warfarin	drug
effect

Therefore , caution should be exercised when administering DRUGA to patients on DRUGB .
TOLECTIN	brand	anticoagulants	group
advise

In adult diabetic patients under treatment with either DRUGA or DRUGB there is no change in the clinical effects of either DRUGN or the DRUGN .
sulfonylureas	group	insulin	drug
false

In adult diabetic patients under treatment with either DRUGA or DRUGN there is no change in the clinical effects of either DRUGB or the DRUGN .
sulfonylureas	group	TOLECTIN	brand
false

In adult diabetic patients under treatment with either DRUGA or DRUGN there is no change in the clinical effects of either DRUGN or the DRUGB .
sulfonylureas	group	hypoglycemic agents	group
false

In adult diabetic patients under treatment with either DRUGN or DRUGA there is no change in the clinical effects of either DRUGB or the DRUGN .
insulin	drug	TOLECTIN	brand
false

In adult diabetic patients under treatment with either DRUGN or DRUGA there is no change in the clinical effects of either DRUGN or the DRUGB .
insulin	drug	hypoglycemic agents	group
false

In adult diabetic patients under treatment with either DRUGN or DRUGN there is no change in the clinical effects of either DRUGA or the DRUGB .
TOLECTIN	brand	hypoglycemic agents	group
false

Caution should be used if DRUGA is administered concomitantly with DRUGB .
TOLECTIN	brand	methotrexate	drug
advise

DRUGA and other DRUGB have been reported to reduce the tubular secretion of DRUGN in an animal model , possibly enhancing the toxicity of DRUGN .
TOLECTIN	brand	nonsteroidal anti-inflammatory drugs	group
false

DRUGA and other DRUGN have been reported to reduce the tubular secretion of DRUGB in an animal model , possibly enhancing the toxicity of DRUGN .
TOLECTIN	brand	methotrexate	drug
mechanism

DRUGA and other DRUGN have been reported to reduce the tubular secretion of DRUGN in an animal model , possibly enhancing the toxicity of DRUGB .
TOLECTIN	brand	methotrexate	drug
false

DRUGN and other DRUGA have been reported to reduce the tubular secretion of DRUGB in an animal model , possibly enhancing the toxicity of DRUGN .
nonsteroidal anti-inflammatory drugs	group	methotrexate	drug
mechanism

DRUGN and other DRUGA have been reported to reduce the tubular secretion of DRUGN in an animal model , possibly enhancing the toxicity of DRUGB .
nonsteroidal anti-inflammatory drugs	group	methotrexate	drug
false

Administration of DRUGA in combination with DRUGB resulted in a two fold decrease in DRUGN clearance in a non human primate study and in a dga fold increase in DRUGN serum levels in clinical studies .
paclitaxel	drug	HERCEPTIN	brand
mechanism

Administration of DRUGA in combination with DRUGN resulted in a two fold decrease in DRUGB clearance in a non human primate study and in a dga fold increase in DRUGN serum levels in clinical studies .
paclitaxel	drug	HERCEPTIN	brand
false

Administration of DRUGA in combination with DRUGN resulted in a two fold decrease in DRUGN clearance in a non human primate study and in a dga fold increase in DRUGB serum levels in clinical studies .
paclitaxel	drug	HERCEPTIN	brand
false

DRUGA may interact with DRUGB or DRUGN ( causing too great a decrease in adrenal function ) .
Trilostane	drug	aminoglutethimide	drug
int

DRUGA may interact with DRUGN or DRUGB ( causing too great a decrease in adrenal function ) .
Trilostane	drug	mitotane	drug
int

DRUGN may interact with DRUGA or DRUGB ( causing too great a decrease in adrenal function ) .
aminoglutethimide	drug	mitotane	drug
false

DRUGA may inhibit the hepatic metabolism of DRUGB .
Trimethoprim	drug	phenytoin	drug
mechanism

DRUGA , given at a common clinical dosage , increased the DRUGB half life by dgb % and decreased the DRUGN metabolic clearance rate by dgb % .
Trimethoprim	drug	phenytoin	drug
mechanism

DRUGA , given at a common clinical dosage , increased the DRUGN half life by dgb % and decreased the DRUGB metabolic clearance rate by dgb % .
Trimethoprim	drug	phenytoin	drug
mechanism

Agents that might be coadministered with DRUGA in AIDS patients for other indications that could elicit this activity include DRUGB , DRUGN , DRUGN , DRUGN , and DRUGN .
trimetrexate	drug	erythromycin	drug
effect

Agents that might be coadministered with DRUGA in AIDS patients for other indications that could elicit this activity include DRUGN , DRUGB , DRUGN , DRUGN , and DRUGN .
trimetrexate	drug	rifampin	drug
effect

Agents that might be coadministered with DRUGA in AIDS patients for other indications that could elicit this activity include DRUGN , DRUGN , DRUGB , DRUGN , and DRUGN .
trimetrexate	drug	rifabutin	drug
effect

Agents that might be coadministered with DRUGA in AIDS patients for other indications that could elicit this activity include DRUGN , DRUGN , DRUGN , DRUGB , and DRUGN .
trimetrexate	drug	ketoconazole	drug
effect

Agents that might be coadministered with DRUGA in AIDS patients for other indications that could elicit this activity include DRUGN , DRUGN , DRUGN , DRUGN , and DRUGB .
trimetrexate	drug	fluconazole	drug
effect

Agents that might be coadministered with DRUGN in AIDS patients for other indications that could elicit this activity include DRUGA , DRUGB , DRUGN , DRUGN , and DRUGN .
erythromycin	drug	rifampin	drug
false

Agents that might be coadministered with DRUGN in AIDS patients for other indications that could elicit this activity include DRUGA , DRUGN , DRUGB , DRUGN , and DRUGN .
erythromycin	drug	rifabutin	drug
false

Agents that might be coadministered with DRUGN in AIDS patients for other indications that could elicit this activity include DRUGA , DRUGN , DRUGN , DRUGB , and DRUGN .
erythromycin	drug	ketoconazole	drug
false

Agents that might be coadministered with DRUGN in AIDS patients for other indications that could elicit this activity include DRUGA , DRUGN , DRUGN , DRUGN , and DRUGB .
erythromycin	drug	fluconazole	drug
false

Agents that might be coadministered with DRUGN in AIDS patients for other indications that could elicit this activity include DRUGN , DRUGA , DRUGB , DRUGN , and DRUGN .
rifampin	drug	rifabutin	drug
false

Agents that might be coadministered with DRUGN in AIDS patients for other indications that could elicit this activity include DRUGN , DRUGA , DRUGN , DRUGB , and DRUGN .
rifampin	drug	ketoconazole	drug
false

Agents that might be coadministered with DRUGN in AIDS patients for other indications that could elicit this activity include DRUGN , DRUGA , DRUGN , DRUGN , and DRUGB .
rifampin	drug	fluconazole	drug
false

Agents that might be coadministered with DRUGN in AIDS patients for other indications that could elicit this activity include DRUGN , DRUGN , DRUGA , DRUGB , and DRUGN .
rifabutin	drug	ketoconazole	drug
false

Agents that might be coadministered with DRUGN in AIDS patients for other indications that could elicit this activity include DRUGN , DRUGN , DRUGA , DRUGN , and DRUGB .
rifabutin	drug	fluconazole	drug
false

Agents that might be coadministered with DRUGN in AIDS patients for other indications that could elicit this activity include DRUGN , DRUGN , DRUGN , DRUGA , and DRUGB .
ketoconazole	drug	fluconazole	drug
false

In vitro perfusion of isolated rat liver has shown that DRUGA caused a significant reduction in DRUGB metabolism and that DRUGN altered the relative concentration of trimetrexate metabolites possibly by competing for sulfate metabolites .
cimetidine	drug	trimetrexate	drug
mechanism

In vitro perfusion of isolated rat liver has shown that DRUGA caused a significant reduction in DRUGN metabolism and that DRUGB altered the relative concentration of trimetrexate metabolites possibly by competing for sulfate metabolites .
cimetidine	drug	acetaminophen	drug
false

In vitro perfusion of isolated rat liver has shown that DRUGN caused a significant reduction in DRUGA metabolism and that DRUGB altered the relative concentration of trimetrexate metabolites possibly by competing for sulfate metabolites .
trimetrexate	drug	acetaminophen	drug
false

Based on an in vitro rat liver model , nitrogen substituted DRUGA ( DRUGB , DRUGN , DRUGN ) were potent , non competitive inhibitors of DRUGN metabolism .
imidazole drugs	group	clotrimazole	drug
false

Based on an in vitro rat liver model , nitrogen substituted DRUGA ( DRUGN , DRUGB , DRUGN ) were potent , non competitive inhibitors of DRUGN metabolism .
imidazole drugs	group	ketoconazole	drug
false

Based on an in vitro rat liver model , nitrogen substituted DRUGA ( DRUGN , DRUGN , DRUGB ) were potent , non competitive inhibitors of DRUGN metabolism .
imidazole drugs	group	miconazole	drug
false

Based on an in vitro rat liver model , nitrogen substituted DRUGA ( DRUGN , DRUGN , DRUGN ) were potent , non competitive inhibitors of DRUGB metabolism .
imidazole drugs	group	trimetrexate	drug
mechanism

Based on an in vitro rat liver model , nitrogen substituted DRUGN ( DRUGA , DRUGB , DRUGN ) were potent , non competitive inhibitors of DRUGN metabolism .
clotrimazole	drug	ketoconazole	drug
false

Based on an in vitro rat liver model , nitrogen substituted DRUGN ( DRUGA , DRUGN , DRUGB ) were potent , non competitive inhibitors of DRUGN metabolism .
clotrimazole	drug	miconazole	drug
false

Based on an in vitro rat liver model , nitrogen substituted DRUGN ( DRUGA , DRUGN , DRUGN ) were potent , non competitive inhibitors of DRUGB metabolism .
clotrimazole	drug	trimetrexate	drug
mechanism

Based on an in vitro rat liver model , nitrogen substituted DRUGN ( DRUGN , DRUGA , DRUGB ) were potent , non competitive inhibitors of DRUGN metabolism .
ketoconazole	drug	miconazole	drug
false

Based on an in vitro rat liver model , nitrogen substituted DRUGN ( DRUGN , DRUGA , DRUGN ) were potent , non competitive inhibitors of DRUGB metabolism .
ketoconazole	drug	trimetrexate	drug
mechanism

Based on an in vitro rat liver model , nitrogen substituted DRUGN ( DRUGN , DRUGN , DRUGA ) were potent , non competitive inhibitors of DRUGB metabolism .
miconazole	drug	trimetrexate	drug
mechanism

DRUGA may enhance the sedative effects of DRUGB including DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , and DRUGN .
Triprolidine	drug	central nervous system depressants	group
effect

DRUGA may enhance the sedative effects of DRUGN including DRUGB , DRUGN , DRUGN , DRUGN , DRUGN , and DRUGN .
Triprolidine	drug	alcohol	drug
effect

DRUGA may enhance the sedative effects of DRUGN including DRUGN , DRUGB , DRUGN , DRUGN , DRUGN , and DRUGN .
Triprolidine	drug	barbiturates	group
effect

DRUGA may enhance the sedative effects of DRUGN including DRUGN , DRUGN , DRUGB , DRUGN , DRUGN , and DRUGN .
Triprolidine	drug	hypnotics	group
effect

DRUGA may enhance the sedative effects of DRUGN including DRUGN , DRUGN , DRUGN , DRUGB , DRUGN , and DRUGN .
Triprolidine	drug	narcotic analgesics	group
effect

DRUGA may enhance the sedative effects of DRUGN including DRUGN , DRUGN , DRUGN , DRUGN , DRUGB , and DRUGN .
Triprolidine	drug	sedatives	group
effect

DRUGA may enhance the sedative effects of DRUGN including DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , and DRUGB .
Triprolidine	drug	tranquillisers	group
effect

DRUGN may enhance the sedative effects of DRUGA including DRUGB , DRUGN , DRUGN , DRUGN , DRUGN , and DRUGN .
central nervous system depressants	group	alcohol	drug
false

DRUGN may enhance the sedative effects of DRUGA including DRUGN , DRUGB , DRUGN , DRUGN , DRUGN , and DRUGN .
central nervous system depressants	group	barbiturates	group
false

DRUGN may enhance the sedative effects of DRUGA including DRUGN , DRUGN , DRUGB , DRUGN , DRUGN , and DRUGN .
central nervous system depressants	group	hypnotics	group
false

DRUGN may enhance the sedative effects of DRUGA including DRUGN , DRUGN , DRUGN , DRUGB , DRUGN , and DRUGN .
central nervous system depressants	group	narcotic analgesics	group
false

DRUGN may enhance the sedative effects of DRUGA including DRUGN , DRUGN , DRUGN , DRUGN , DRUGB , and DRUGN .
central nervous system depressants	group	sedatives	group
false

DRUGN may enhance the sedative effects of DRUGA including DRUGN , DRUGN , DRUGN , DRUGN , DRUGN , and DRUGB .
central nervous system depressants	group	tranquillisers	group
false

DRUGN may enhance the sedative effects of DRUGN including DRUGA , DRUGB , DRUGN , DRUGN , DRUGN , and DRUGN .
alcohol	drug	barbiturates	group
false

DRUGN may enhance the sedative effects of DRUGN including DRUGA , DRUGN , DRUGB , DRUGN , DRUGN , and DRUGN .
alcohol	drug	hypnotics	group
false

DRUGN may enhance the sedative effects of DRUGN including DRUGA , DRUGN , DRUGN , DRUGB , DRUGN , and DRUGN .
alcohol	drug	narcotic analgesics	group
false

DRUGN may enhance the sedative effects of DRUGN including DRUGA , DRUGN , DRUGN , DRUGN , DRUGB , and DRUGN .
alcohol	drug	sedatives	group
false

DRUGN may enhance the sedative effects of DRUGN including DRUGA , DRUGN , DRUGN , DRUGN , DRUGN , and DRUGB .
alcohol	drug	tranquillisers	group
false

DRUGN may enhance the sedative effects of DRUGN including DRUGN , DRUGA , DRUGB , DRUGN , DRUGN , and DRUGN .
barbiturates	group	hypnotics	group
false

DRUGN may enhance the sedative effects of DRUGN including DRUGN , DRUGA , DRUGN , DRUGB , DRUGN , and DRUGN .
barbiturates	group	narcotic analgesics	group
false

DRUGN may enhance the sedative effects of DRUGN including DRUGN , DRUGA , DRUGN , DRUGN , DRUGB , and DRUGN .
barbiturates	group	sedatives	group
false

DRUGN may enhance the sedative effects of DRUGN including DRUGN , DRUGA , DRUGN , DRUGN , DRUGN , and DRUGB .
barbiturates	group	tranquillisers	group
false

DRUGN may enhance the sedative effects of DRUGN including DRUGN , DRUGN , DRUGA , DRUGB , DRUGN , and DRUGN .
hypnotics	group	narcotic analgesics	group
false

DRUGN may enhance the sedative effects of DRUGN including DRUGN , DRUGN , DRUGA , DRUGN , DRUGB , and DRUGN .
hypnotics	group	sedatives	group
false

DRUGN may enhance the sedative effects of DRUGN including DRUGN , DRUGN , DRUGA , DRUGN , DRUGN , and DRUGB .
hypnotics	group	tranquillisers	group
false

DRUGN may enhance the sedative effects of DRUGN including DRUGN , DRUGN , DRUGN , DRUGA , DRUGB , and DRUGN .
narcotic analgesics	group	sedatives	group
false

DRUGN may enhance the sedative effects of DRUGN including DRUGN , DRUGN , DRUGN , DRUGA , DRUGN , and DRUGB .
narcotic analgesics	group	tranquillisers	group
false

DRUGN may enhance the sedative effects of DRUGN including DRUGN , DRUGN , DRUGN , DRUGN , DRUGA , and DRUGB .
sedatives	group	tranquillisers	group
false

The effects of DRUGA , such as DRUGB and DRUGN may be enhanced by the concomitant administration of DRUGN .
anticholinergic drugs	group	atropine	drug
false

The effects of DRUGA , such as DRUGN and DRUGB may be enhanced by the concomitant administration of DRUGN .
anticholinergic drugs	group	tricyclic antidepressants	group
false

The effects of DRUGA , such as DRUGN and DRUGN may be enhanced by the concomitant administration of DRUGB .
anticholinergic drugs	group	triprolidine	drug
effect

The effects of DRUGN , such as DRUGA and DRUGB may be enhanced by the concomitant administration of DRUGN .
atropine	drug	tricyclic antidepressants	group
false

The effects of DRUGN , such as DRUGA and DRUGN may be enhanced by the concomitant administration of DRUGB .
atropine	drug	triprolidine	drug
effect

The effects of DRUGN , such as DRUGN and DRUGA may be enhanced by the concomitant administration of DRUGB .
tricyclic antidepressants	group	triprolidine	drug
effect

The concomitant use of DRUGA with other DRUGB that produce dry mouth , constipation , and other anticholinergic pharmacological effects may increase the frequency and / or severity of such effects .
Sanctura	brand	anticholinergic agents	group
effect

Concomitant administration of DRUGA and DRUGB has been associated with erythema and histamine like flushing and anaphylactoid reactions .
vancomycin	drug	anesthetic agents	group
effect

A study published in dgb found that DRUGA causes a statistically significant increase in plasma clearance of DRUGB .
vigabatrin	drug	carbamazepine	drug
mechanism

In dgb , Drs Rimmer and Richens at the University of Wales reported that administering DRUGA with DRUGB lowered the serum DRUGN concentration in patients with treatment resistant epilepsy .
vigabatrin	drug	phenytoin	drug
mechanism

In dgb , Drs Rimmer and Richens at the University of Wales reported that administering DRUGA with DRUGN lowered the serum DRUGB concentration in patients with treatment resistant epilepsy .
vigabatrin	drug	phenytoin	drug
false

Drug Interactions : Women on oral DRUGA have shown a significant increase in plasma DRUGB levels .
contraceptives	group	vitamin A	group
mechanism

Limited evidence suggests that DRUGA may influence the intensity and duration of action of DRUGB .
ascorbic acid	drug	bishydroxycoumarin	drug
mechanism

DRUGA : Prolongation of prothrombin time ( PT ) and International Normalized Ratio ( INR ) were observed in patients receiving DRUGB concomitantly with DRUGN .
Coumarin-Derivative Anticoagulants	group	ZOLINZA	brand
false

DRUGA : Prolongation of prothrombin time ( PT ) and International Normalized Ratio ( INR ) were observed in patients receiving DRUGN concomitantly with DRUGB .
Coumarin-Derivative Anticoagulants	group	coumarin-derivative anticoagulants	group
false

DRUGN : Prolongation of prothrombin time ( PT ) and International Normalized Ratio ( INR ) were observed in patients receiving DRUGA concomitantly with DRUGB .
ZOLINZA	brand	coumarin-derivative anticoagulants	group
effect

Physicians should carefully monitor PT and INR in patients concurrently administered DRUGA and DRUGB .
ZOLINZA	brand	coumarin derivatives	group
advise

Other DRUGA Severe thrombocytopenia and gastrointestinal bleeding have been reported with concomitant use of DRUGB and other DRUGN ( e.g . , DRUGN ) .
HDAC Inhibitors	group	ZOLINZA	brand
false

Other DRUGA Severe thrombocytopenia and gastrointestinal bleeding have been reported with concomitant use of DRUGN and other DRUGB ( e.g . , DRUGN ) .
HDAC Inhibitors	group	HDAC inhibitors	group
false

Other DRUGA Severe thrombocytopenia and gastrointestinal bleeding have been reported with concomitant use of DRUGN and other DRUGN ( e.g . , DRUGB ) .
HDAC Inhibitors	group	valproic acid	drug
false

Other DRUGN Severe thrombocytopenia and gastrointestinal bleeding have been reported with concomitant use of DRUGA and other DRUGB ( e.g . , DRUGN ) .
ZOLINZA	brand	HDAC inhibitors	group
effect

Other DRUGN Severe thrombocytopenia and gastrointestinal bleeding have been reported with concomitant use of DRUGA and other DRUGN ( e.g . , DRUGB ) .
ZOLINZA	brand	valproic acid	drug
effect

Other DRUGN Severe thrombocytopenia and gastrointestinal bleeding have been reported with concomitant use of DRUGN and other DRUGA ( e.g . , DRUGB ) .
HDAC inhibitors	group	valproic acid	drug
false

